Characterisation of paediatric odontogenic bacteraemia. by Jaffray, E.C.
Characterisation of Paediatric Odontogenic 
Bacteraemia
Thesis submitted by 
Emma Caroline Jaffray BSc. (Hons), 
For the degree of 
DOCTOR OF PHILOSOPHY
In the 
Faculty of Medicine 
University of London 
Division of Microbial Diseases 
Eastman Dental Institute 
University College London 
256 Grays Inn Road 
London 
WC1X 8LD 
UK
- 2006 -
1
UMI Number: U591972
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U591972
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
For Tav, my family and George
Table of Contents
Dedication............................................................................................................ 2
Abstract..............................................................................................................10
Declaration........................................................................................................ 12
Acknowledgements........................................................................................... 13
List of tables...................................................................................................... 14
List of figures.................................................................................................... 17
Commonly used abbreviations and acronyms................................................19
Units used in thesis........................................................................................... 20
1.0 Introduction................................................................................................ 22
1.1 Definitions of bacteraemia.........................................................................22
1.2 The aetiology of bacteraemia.....................................................................23
1.3 The intensity of bacteraemia...................................................................... 23
1.4 The duration of bacteraemia..................................................................... 24
1.5 Considerations for the detection of bacteraemia..................................... 26
1.5.1 Aseptic technique.....................................................................................26
1.5.2 Blood culture............................................................................................28
1.5.3 Volume and dilution of sample...............................................................28
1.5.4 Preservation of sample............................................................................ 29
1.5.4.1 Blood culture media additives..........................................  29
1.6 Detection techniques...................................................................................30
1.6.1 Conventional techniques......................................................................... 30
1.6.2 Experimental techniques......................................................................... 31
1.6.3 Plate-based methods for the isolation and enumeration of bacteria 
from blood......................................................................................................... 31
1.6.3.1 Lysis filtration technique....................................................................... 33
1.7 Molecular methods for detecting bacteraemia......................................... 34
1.7.1 PCR-based detection assays.................................................................... 35
1.7.2 Denaturing Gel Gradient Electrophoresis (DGGE).............................. 36
1.7.3 Single strand conformation polymorphism (SSCP).............................. 37
1.7.4 Fluorescent in situ hybridisation (FISH)................................................38
1.8 Bacteraemia following dental treatments..................................................39
3
1.8.1 Mechanism by which bacteria enter the bloodstream from the tissues 
of the oral cavity................................................................................................39
1.8.2 Dental procedures and their relationship to bacteraemia genesis 40
1.8.3 Oral health as a risk factor for bacteraemia......................................... 42
1.9 Focal infection theory................................  43
1.9.1 Infective endocarditis.............................................................................. 46
1.9.2 Antibiotic prophylaxis of Infective Endocarditis and other focal 
infections following dental procedures............................................................ 51
1.10 The oral microbiota...................................................................................56
1.11 Speciation of the oral microbiota.............................................................62
1.12 Antibiotics and the oral cavity................................................................. 64
1.12.1 Benzylpenicillin......................................................................................64
1.12.2 Ampicillin...............................................................................................64
1.12.3 Erythromycin.........................................................................................65
1.12.4 Tetracycline............................................................................................65
1.12.5 Vancomycin............................................................................................66
1.13 Antibiotic sensitivity testing (AST)..........................................................67
1.13.1 Genotypic investigation of antibiotic resistance................................ 69
1.14 Aims of this thesis......................................................................................70
2.0 Materials and methods............................................................................... 72
2.1 Sample collection........................................................................................ 72
2.2 Processing blood samples using lysis filtration........................................ 74
2.2.1 Media for lysis filtration.......................................................................... 74
2.2.1.1 Brain Heart Infusion agar supplemented with 5% v/v sterile 
defibrinated horse blood (BHI blood agar)...................................................... 74
2.2.1.2 Lysis solution (0.08% Ntt2C0 3  + 0. 05% Triton X100)......................... 74
2.2.1.3 Streptokinase-streptodornase solution.................................................. 74
2.2.2 Lysis filtration of blood samples...........................................................75
2.2.2.1 Lysis filtration apparatus....................................................................... 75
2.2.2.2 Filtration protocol..................................................................................76
2.3 Enumeration of isolates...............................................................................76
2.4 Characterisation of isolates........................................................................ 77
2.4.1 Microbiological methods......................................................................... 77
2.4.1.1 Gram stain..............................................................................................77
2.4.1.2 Catalase determination.......................................................................... 78
2.4.1.3 Oxidase determination........................................................................... 78
2.4.1.4 Selective media.......................................................................................78
2.4.2 Biochemical identification of oral streptococci using carbohydrate
fermentation and hydrolysis assays................................................................. 79
2.4.2.1. Preparation of carbohydrate substrates: amygdalin, arbutin, inulin, 
lactose, mannitol, melibiose, N-acetylglucosamine, raffinose and sorbitol 
substrate solutions.............................................................................................. 79
2.4.2.2 Preparation of aesculin carbohydrate substrate solution.....................79
2.4.2.3 Preparation of arginine carbohydrate substrate solution.....................79
2.4.2.4 Carbohydrate fermentation and hydrolysis assay................................. 79
2.4.3 Biochemical identification of oral streptococci using detection of pre­
formed enzymes................................................................................................. 80
4
2.4.3.1 Preparation of 4-Methylumbeliferyl enzyme substrate solutions 80
2.4.3.1.1 TES buffer............................................................................................80
2.4.3.2 Pre-formed enzyme detection assay..................................................... 81
2.4.4 Identification of isolates using comparative 16S rRNA gene sequencing 
 82
2.4.4.1 Preparation of reagents used during comparative 16S rRNA gene 
sequencing......................................................................................................... 82
2.4.4.1.1 TAE buffer............................................................................................82
2.4.4.1.2 Sequence buffer (400 mM TrisHCl, pH 9, containing 10 mMMgCl^) 82
2.4.4.1.3 Sodium acetate.....................................................................................82
2.4.4.2 Polymerase chain reaction (PCR) using universal primers..................82
2.4.4.3 Visualisation of PCR products............................................................... 83
2.4.4.4 PCR product purification...................................................................... 83
2.4.4.5 Sequencing reaction.............................................................................. 83
2.4.4.6 Ethanol precipitation of sequenced product......................................... 84
2.4.4.7 Analysis of sequencing reaction............................................................84
2.4.5 PCR-RFLP of partial sodA gene for the identification of oral 
streptococci........................................................................................................ 86
2.4.5.1 Reagents used for sodA PCR-RFLP......................................................86
2.4.5.1.1 TBE buffer............................................................................................86
2.4.5.2 PCR amplification o f the superoxide dismutase (sodA) internal gene 
fragment using primers D1 and D2 (Poyart et a l, 1998)................................. 86
2.4.5.3 Double restriction digest o f sodA gene using Alul and BgUI...............86
2.4.5.4 RFLPofsodA PCR products.................................................................89
2.5 Molecular detection of bacteraemia......................................................... 89
2.5.1 Lysis buffer (5 M Guanidine HCI -  100 mM Tris [pH 8])....................89
2.5.2. DNA extraction from whole blood containing SPS.............................. 89
2.5.2.1. PureGene® genomic DNA isolation kit............................................. 89
2.5.2.2 Spectrophotometric determination of DNA concentration...................89
2.5.2.3 Amplification of GAPDH to confirm the extraction of DNA................90
2.5.2.4 PCR amplification of 16S rRNA gene from DNA extractedfrom blood 
........................................................................................................................... 90
2.5.2.5 Hemi- nested PCR reaction................................................................... 91
2.5.2.6 Preparation of seeded blood samples for DNA extraction....................91
2.5.2.7 Benzyl alcohol-guanidine hydrochloride organic DNA extraction from 
blood containing SPS.........................................................................................92
2.5.2.8 Spectrophotometric determination of SPS removal..............................92
2.5.2.9 Sau3AI pre-treatment of DNA master mix to prevent amplicon “carry 
over” contamination...........................................................................................92
2.6 MIC determination of bacteraemia isolates............................................. 93
2.6.1 Preparation of antimicrobiotic-containing media................................. 93
2.6.1.1 Isosensitest agar.....................................................................................93
2.6.1.2 Antibiotic agents.....................................................................................93
2.6.2 Inoculation of antibiotic media............................................................... 94
2.7 Cryo storage and retrieval of isolates........................................................95
2.8 Bacterial strains...........................................................................................95
2.9 Statistical analyses of results...................................................................... 96
3.0 Detection and quantification of bacteraemia following multiple dental 
extractions in children......................................................................................99
5
3.1 Introduction................................................................................................. 99
3.2 Materials and methods..............................................................................100
3.2.1 Subjects................................................................................................... 100
3.2.2 Detection of bacteraemia........................................................................100
3.2.3 Statistical analyses of data...........................................  101
3.3 Results.........................................................................................................101
3.3.1 The prevalence of bacteraemia following dental extraction in children 
 101
3.3.2 The intensity of bacteraemia following dental extraction in children 103
3.3.3 Relationship between intensity of post-extraction bacteraemia with age
and dental factors............................................................................................ 106
3.4 Discussion................................................................................................ 106
3.4.1 Prevalence of pre-extraction bacteraemia in children........................ 106
3.4.2 Prevalence of post-extraction bacteraemia in children....................... 107
3.4.3 Intensity of pre-extraction bacteraemia in children........................... 108
3.4.4 Intensity of post-extraction bacteraemia in children following dental 
extraction..........................................................................................................109
3.4.5 Relationship between intensity and dental factors...............................109
3.5 Limitations of the study............................................................................I l l
3.6 Conclusions................................................................................................ 112
4.0 Biochemical characterisation of odontogenic bacteraemia isolates 114
4.1 Introduction............................................................................................... 114
4.2 Materials and methods............................................................................. 115
4.2.1 Standard microbiological tests.............................................................. 115
4.2.2 Use of selective media.............................................................................116
4.2.3 Assigning presumptive identifications..................................................116
4.2.4 Biochemical characterisation of oral streptococci............................... 118
4.3 Results.........................................................................................................119
4.3.1 Gram-stain morphology, catalase and oxidase tests and growth on 
selective media................................................................................................. 119
4.3.2 Characterisation of oral streptococci using carbohydrate fermentation 
and hydrolysis and detection of pre-formed enzyme assays........................ 133
4.4 Discussion.................................................................................................. 141
4.4.1 Cell wall characteristics.........................................................................141
4.4.2 Use of selective media.............................................................................141
4.4.3 Biochemical characterisation of streptococci.......................................142
4.5 Conclusions.......................................................................... 144
5.0 Identification of bacteraemia isolates using comparative gene sequencing
.......................................................................................................................... 146
5.1 Introduction............................................................................................... 146
5.2 Materials and methods..............................................................................146
5.3 Results.........................................................................................................147
5.3.1 Data for the 16S rRNA comparative gene sequencing of bacteraemia 
isolates..............................................................................................................147
5.3.2 Evaluation of web- based sequence match tools...................................156
5.3.2,1. Performance of Ribosomal Database Project II (RDPII)............... 156
5.3.2.2 Performance of BLAST II ....................................................................157
5.3.2.3 RDPII versus BLASTII 157
5.3.2.4 Retrospective comparison of 16S rRNA comparative gene sequencing 
versus phenotypic identification methods........................................................ 158
5.4 Discussion.................................................................................................. 160
5.4.1 Use of 16S rRNA comparative gene sequencing in the identification of 
oral bacteria.................................................................................................... 160
5.4.2 Performance of the Ribosomal Database Project for sequence identity 
  160
5.4.3 Performance of BLAST II for sequence identity................................ 162
5.4.4 Results of comparative 16S rRNA gene sequencing for isolate
identification.................................................................................................... 162
5.5 Conclusions.............................................................................................. 164
6.0 Development of a sodA PCR-RFLP method for the identification of oral 
streptococci..................................................................................................... 166
6.1 Introduction..............................................................................................166
6.2 Materials and methods............................................................................ 167
6.3 Results and Discussion............................................................................ 168
6.3.1 in silico restriction analysis of the sodA gene..................................... 168
6.3.2 Evaluation of a sodA PCR-RFLP method for identification of oral 
streptococci.....................................................................................................168
6.3.3 Anginosus group streptococci..............................................................173
6.3.4 The mitis group streptococci................................................................173
6.3.5 Mutans group streptococci...................................................................174
6.3.6 Salivarius group streptococci...............................................................174
6.3.7 Evaluation of sodA PCR-RFLP method using 16S rRNA comparative 
gene sequence data.........................................................................................174
6.3.8 Retrospective analysis of phenotypic characterisation of oral
streptococci.....................................................................................................177
6.4 Conclusions.............................................................................................181
7.0 The nature of paediatric odontogenic bacteraemia................................183
7.1 Introduction............................................................................................... 183
7.2 Materials and methods.............................................................................183
7.3 Results.........................................................................................................184
7.3.1 The nature of bacteraemia following dental extraction in children.. 184
7.3.2 Nature of pre-extraction bacteraemia.................................................. 185
7.3.3 Nature of post-extraction bacteraemia................................................. 186
7.3.4 Species diversity of post-extraction bacteraemia.................................189
7.4 Discussion...................................................................................................196
7.4.1 The nature of bacteraemia following dental extraction in children .196
7.4.2 Analysis of detected bacteraemia isolates by respiration type 196
7.4.3 Analysis of detected bacteraemia isolates by cell wall type................ 197
7.4.4 Inclusion of isolates in the study........................................................... 198
7.4.5 Pre-extraction bacteraemia....................................................................199
7.4.6 Species diversity of paediatric odontogenic bacteraemia.................... 199
7.4.7 Polymicrobial colonies..........................................................................201
7.5 Conclusions..............................................................................................202
8.0 Culture-independent detection of odontogenic bacteraemia.................204
8.1 Introduction...............................................................................................204
8.2 Materials and methods............................................................................. 204
8.2.1 Pilot study to detect odontogenic bacteraemia from parallel samples 
......................................................................................................................... 204
8.2.2 Amplification of DNA extracted from parallel samples......................205
8.2.3 Preparation of DNA templates seeded with known quantities of 
bacteria............................................................................................................ 205
8.3 Results and Discussion............................................................................. 205
8.3.1 Amplification of DNA extracted from parallel samples......................206
8.3.2 Removal of PCR Inhibitors from whole blood.................................... 208
8.3.3 PCR amplification of Fredricks and Reiman protocol versus 
commercial system extracted DNA...............................................................210
8.3.4 Detection limits of PCR amplification of 16S rRNA gene from spiked 
blood samples..................................................................................................214
8.4 Conclusions................................................................................................217
9.0 Antibiotic susceptibility of bacteraemia isolates.................................... 220
9.1 Introduction...............................................................................................220
9.2 Materials and methods............................................................................. 220
9.3 Results........................................................................................................ 221
9.3.1 Subjects and isolates.............................................................................. 2 2 1
9.3.2 Resistance at breakpoints used.............................................................223
9.3.3 Resistance to ampicillin......................................................................... 227
9.3.4 Resistance to erythromycin................................................................... 227
9.3.5 Resistance to penicillin G ...................................................................... 227
9.3.6 Resistance to tetracycline...................................................................... 228
9.3.7 Resistance to vancomycin...................................................................... 228
9.3.8 Antibiotic-resistance profiles................................................................ 228
9.3.9 MIC50, MIC90 and resistance defined by published breakpoints 232
9.3.9.1 Ampicillin.............................................................................................232
9.3.9.2 Erythromycin........................................................................................232
9.3.9.3 Penicillin G...........................................................................................232
9.3.9.4 Tetracycline..........................................................................................233
9.3.9.5 Vancomycin..........................................................................................233
9.3.10 Comparison between NCCLS and BSAC published breakpoints... 238
9.3.11 Multi-resistant isolates........................................................................ 238
9.4 Discussion................................................................................................241
9.4.1 Methodology and design of study.........................................................241
9.4.2 Subjects and isolates.............................................................................. 241
9.4.3 Resistance at breakpoints used............................................................. 242
9.4.4 Resistance defined by published breakpoints...................................... 242
9.4.5 Carriage of antibiotic-resistant bacteria in study subjects.................242
8
9.4.6 Antibiotic-resistant bacteraemia isolates and infective endocarditis 245
9.5 Conclusions..............................................................................................246
10.0 General discussion................................................................................ 248
References cited...............................................................................................258
Publications arising from this thesis.............................................................. 284
9
Abstract
Transient, asymptomatic bacteraemia can occur following dental extraction. 
Such events may lead to the development of serious systemic disease including 
infective endocarditis and abscesses of the brain and other organs. The aims of 
this PhD were to establish the prevalence, intensity, duration and microbiota 
involved in dental bacteraemia.
Blood was sampled from 500 children before and after extraction; post- 
extraction samples were taken at randomly allocated time intervals ranging from 
10 seconds to 1 hour following treatment. Post-extraction bacteraemia was found 
to be most prevalent at 1 minute post-extraction with 76% of samples being 
culture-positive. Bacteraemia was low grade, with greatest intensity at 1 minute 
post-extraction with a range of 0.17 to 40.83 cfu/mL detected. The majority of 
isolates recovered were typical oral microbiota, most prevalent were streptococci 
and Actinomyces spp. Bacteraemia was judged to be resolved between 7.5 and 
15 minutes post- extraction.
Identification of streptococci, especially those related to the mitis group species 
proved difficult. Streptococci were identified using a polyphasic approach, 
including comparative 16S rRNA gene sequencing, biochemical testing and the 
development of a sodA PCR-RFLP method. The sodA PCR-RFLP method was 
found to identify 71.7% of the isolates to species level compared to only 55.1% 
using 16S sequencing.
Two hundred and twenty eight isolates from 121 subjects were assayed for 
resistance to five antibiotics: ampicillin, erythromycin, penicillin, tetracycline 
and vancomycin. Thirty one percent showed resistance to at least 1 antibiotic at 
the break- point concentrations used, with some isolates displaying resistance to 
4 of the antibiotics tested.
The use of molecular techniques for investigation of bacteraemia was evaluated. 
Detection limits for Gram-positive and Gram-negative isolates and the effect of 
inherent PCR inhibitors were investigated.
10
It is hoped that this work will promote the understanding of bacteraemia 
following dental extraction and provide more information to clinicians assessing 
the risk of focal infection.
11
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1.0 Introduction
1.1 Definitions of bacteraemia
There are three types of bacteraemia: continuous, intermittent and transient (Auckenthaler, 
1984), (Washington and Ilstrup, 1986). Continuous bacteraemia are associated with serious 
conditions such as infective endocarditis (IE) and other endovascular infections (Reimer et 
al, 1997). These conditions are usually fatal unless treated. Intermittent bacteraemia, which 
clear and recur (Reimer et al., 1997), are characterised by chronic localised infection, such 
as undrained abscess, focal infection or during the course of systemic disease.
Many episodes of bacteraemia result in significant morbidity and mortality. These events 
are usually related to the development of sepsis, where infection combined with the 
inflammatory response leads to pathophysiological effects such as hypotension, 
tachycardia, tachypnoea, hypoxia, oliguria, abnormal temperature and altered mental state. 
Septic shock may develop and lead toward multiple organ dysfunction syndrome (MODS) 
and ultimately death (Nystrom, 1998).
Iatrogenic transient bacteraemia, the focus of this thesis, are a common event which may 
occur during manipulation of infected or heavily colonised mucosa such as the tissues of 
the oral cavity (Heimdahl et al., 1990) and gastrointestinal tract or during surgical 
procedures (Heimdahl et al., 1990), (Reimer et al., 1997). Even transient bacteraemia may 
involve morbidity and mortality especially for immunocompromised patients or those with 
acquired or congenital heart abnormalities (Turenne et al., 2000). The degree of morbidity 
and possibility of mortality of such bacteraemic events vary. In the majority of cases 
bacteraemia is asymptomatic, and where symptomatic appearance and severity of 
symptoms depend on the age and immunocompetence of the patient, time course of 
infection, the aetiological agent or agents and their pathogenicity for the host (Frommell 
and Todd, 1984), (Leibovici, 1995).
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1.2 The aetiology of bacteraemia
Paediatric patients are more likely to suffer bacteraemia involving oral and nasopharyngeal 
bacteria such as Streptococcus pneumoniae, Haemophilus influenzae type B and Neisseria 
meningitidis (Frommell and Todd, 1984). Geriatric patients however, tend to be sensitive to 
the gastrointestinal microbiota (Leibovici, 1995). Generally, common aetiological agents of 
bacteraemia fall into nine groups: coagulase-negative staphylococci (CoNS), Escherichia 
coli, Staphylococcus aureus, Pseudomonas auruginosa, Enterococcus spp, Klebsiella spp, 
Enterobacter spp, Proteus spp and Streptococcus pneumoniae (Anthony et al., 2000). 
Many of the common aetiological agents are part of the normal microbiota and are 
opportunistic pathogens. This thesis however, is concerned specifically with bacteraemia 
involving oral bacteria following dental manipulation, especially extraction.
1.3 The intensity of bacteraemia
The intensity of true bacteraemia is widely debated, especially where attempts to correlate 
intensity with prognosis and mortality are made. Generally, bacteraemia, clinically 
significant or otherwise, is low grade in terms of colony forming units per millilitre of 
blood (cfu/mL) (Auckenthaler, 1984), (Beeson et al., 1945). Interestingly, the intensity of 
bacteraemia has been reported to differ with age, as it has been shown that paediatric 
patients tend to have fewer yet more intense bacteraemia than adults but it is unclear why 
(Washington and Ilstrup, 1986), (Coulter etal., 1990), (Roberts etal., 1998). In two similar 
studies using a lysis filtration method of detection, the magnitude of bacteraemia following 
third molar extraction was 0.12 to 9.88 cfu/mL involving adults aged 15 to 75 years 
(Heimdahl et al., 1990) while the extraction of a single tooth in children resulted in a range 
of 1 to 20 cfu/6 mL sample (Lucas et al., 2002a).
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1.4 The duration of bacteraemia
Most everyday episodes of bacteraemia pose little risk to the health of the 
immunocompetent individual. The immune system quickly eradicates invading bacteria 
before colonisation of the tissues can occur, reacting quickly to an influx of bacteria 
(Reimer et al., 1997). Studies which examine the fate of bacteria entering the bloodstream 
have demonstrated that components of the reticuloendothelial system (RES), such as 
polymorphonuclear cells, quickly detect and eliminate bacteria entering the bloodstream. In 
1931, Cannon et al., used animal models to establish that bacteria introduced to the 
bloodstream underwent morphological changes, evidence of their destruction, as quickly as 
two minutes after inoculation. They postulated that the cells of the immune system had 
already “fixed” the bacteria. Once cells are phagocytosed, they are translocated via the 
bloodstream to organs such as the liver, spleen, kidneys and lungs. These tissues are rich in 
macrophage, which destroy the bacteria.
This process was further demonstrated by the work of Beeson et al., 1944 by sampling the 
blood of patients with bacterial endocarditis. Arterial and venous blood was sampled each 
side of the liver then cultured. It was found that recovery of organisms was much lower in 
the hepatic vein, indicating retention and destruction of bacteria in the liver. This process 
was shown to be faster in immunised animals, highlighting the role of antibodies (Beeson et 
al, 1945). Additionally in 1954, research published by Cobe showed that some bacterial 
species including Staphylococcus spp and Streptococcus spp were eliminated faster from 
the bloodstream of vaccinated rabbits than control animals that were not inoculated (Cobe, 
1954).
Host factors such as acquired immunity or diminished immunocompetence therefore 
influence the elimination rate of bacteraemia (Gregory et al., 2002). Different organisms 
persist differently in the bloodstream, and hosts demonstrate varied clearance periods for 
the same organism from their circulation. In 1931, Cannon et a l, demonstrated that 
streptococci inoculated into cats were held in macrophage in the lungs at 30 minutes and 
that the removal rate was dependent on the type, number and pathogenicity of bacteria 
versus the state of the phagocytic cells. Silver et al., inoculated various organisms,
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indigenous and foreign from canine and human oral microbiota, into healthy dogs in order 
to determine the fate of different bacteria. After 20 minutes bacteria were undetectable in 
the bloodstream (Silver et ah, 1975).
Where the host is immunocompromised, they are more susceptible and less able to 
eliminate bacteraemia. This decreased immunity may occur if a person is prescribed 
immunosuppressant drugs (including steroids) or if the person has developed or contracted 
an immunodeficiency disease or syndrome such as HIV/AIDS or leukaemia (Meurman et 
al., 1997). The immune reaction may also be impaired through the use of standard 
anaesthesia, for example several groups have shown that the intralipid base of some 
intravenous anaesthetics and complete parenteral nutrition formulae inhibit RES function. 
These agents include propofol, thiopental, midazolam and ketamine (Krumholz et ah, 
1995). Furthermore, it has been demonstrated that more bacteria are detectable in the 
macrophage of the liver, spleen and kidneys under the influence of these agents, indicating 
reduced phagocytosis within the bloodstream (Katz et ah, 1991), (Kelbel et ah, 1999). This 
effect has implications for not only the seriously ill with blood borne infection, but also the 
immunocompromised about to undergo surgery under general anaesthetic.
Rate of bacterial clearance is not only determined by species or immune status of the host, 
specific characteristics of bacterial groups determine their fate in the bloodstream. Previous 
studies investigating bacteraemia of dental origin in humans have shown fewer detectable 
aerobic bacteria than anaerobic bacteria (Heimdahl et ah, 1990). It is not known whether 
this pattern is due to higher numbers of anaerobic bacteria in the gingival crevice (Coulter 
et ah, 1990) or whether anaerobes can survive for longer than aerobic bacteria in the blood.
The proportions of bacteria reported as detected from bacteraemia also tend to show a 
higher representation of Gram-positive than Gram-negative bacteria. Reported proportions 
detected following dental extractions include 82.5% Gram-positive to 17.5% Gram- 
negative (Roberts et ah, 1998); 85.0% Gram-positive to 15% Gram-negative (Heimdahl et 
ah, 1990) and 64.0% Gram-positive to 36% Gram-negative. Again, no definitive reason for 
why this should be is given. Possible explanations for this may include the different
25
Chapter 1 ~  Introduction
techniques used for detection, the use of additives such as sodium polyanethole sulfonate 
(SPS) found in most commercial culture systems to which Gram-negative bacteria are 
sensitive and the ecological niche (supragingival plaque) from which the blood is 
inoculated (Minkus and Moffet, 1971), (Eng and Ho hen, 1977), (Salako etal., 2004).
1.5 Considerations for the detection of bacteraemia
In a clinical setting, where septicaemia is suspected, it is vital for the outcome of the patient 
that the aetiological agent is quickly isolated and identified. This allows appropriate 
chemotherapy to be administered since treatment with incorrect antibiotics can adversely 
affect the recovery by increasing the time course of infection (O'Sullivan et al., 1996). In 
research laboratories where patient outcome is not paramount, methods are usually tailored 
for maximum bacterial recovery or investigation of specific bacterial species. Various 
detection methods have been described in the literature, but first it is important to discuss 
the problems and considerations associated with blood culture. These issues include anti­
sepsis and avoidance of sample contamination, collection methods, number and volume of 
samples, sample preservation, and time to process the sample.
1.5.1 Aseptic technique
It is routine for clinicians to sterilise any sample site with either alcohol or antimicrobial 
compounds, such as alcohol-iodine solutions (Hockett et a l, 1977) see figure 1.1. These 
procedures attempt to prevent the normal skin-associated microbiota from contaminating 
the blood sample, leading to false-positive results, and precluding appropriate treatment. It 
has been estimated that 2-5% of all blood samples and 25% of positive samples are 
contaminated (Gruneberg et al., 1999). Many organisms traditionally considered as blood 
culture contaminants however, are the aetiological agents of serious systemic diseases, 
including IE (Yagupsky and Nolte, 1990). Coagulase-negative staphylococci (CoNS), 
normally considered skin microbiota, have been recovered from infective heart valves of 
patients (Young, 1987) and are common aetiological agents of IE where the patient has a 
history of intravenous drug usage.
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Recommendations for prevention of blood sample contamination include the use of 
venepuncture rather than indwelling intravascular devices, due to the possible colonisation 
by skin microbiota such as CoNS (Weinstein, 1996). In 1986, Washington & Ilstrup 
suggested that a phlebotomist rather than a clinician, draw blood to eliminate 
contamination; as a person who is trained specifically to obtain samples is likely to do so 
with more attention to detail (Reimer et al., 1997). Some authors however, postulate that 
sample contamination occurs after sampling, regardless of antisepsis and collection 
procedures. In a study by Shahar et al., it was shown that increased antisepsis had no 
significant effect at reducing contamination of blood samples when compared to normal 
antisepsis, but that contamination occurs in the laboratory (Shahar et al., 1990). While 
Heimdahl et al., showed that laboratory observation of culture plates caused contamination, 
plate checks were reduced from daily inspection to once after 10 days of incubation 
resulting in elimination of contamination (Heimdahl et al., 1990). This problem is avoided 
with the closed broth bottle systems, which rely on radiometric, manometric or other 
automated detection of positive cultures without prior aspiration of sample. Generally, the 
majority of paediatric blood cultures (-85%) assayed by automated systems become 
culture-positive within 24 hours if they contain a pathogen; positive cultures that occur 
after 72 hours are much more likely to involve a skin contaminant (McGowan etal., 2000).
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1.5.2 Blood culture
It is argued that “true” bacteraemia, where the aetiological agent is a “traditional” pathogen 
and not a commensal organism, will result in two or more blood cultures positive for the 
same organism (Washington and Ilstrup, 1986). This approach is impractical for single 
bottle culture systems, where obligate aerobes, anaerobes or fastidious organisms are the 
aetiological agent and more importantly, where time is a critical factor to the patient 
outcome. There is debate in the literature as to how long blood cultures should be 
incubated. While some authors argue that incubation of culture should be 7 days (Heimdahl 
et al., 1985), there are many slow-growing and fastidious organisms which require a longer 
period to be detected particularly on primary culture. For example, the aetiological agent of 
Whipple’s disease (Tropheryma whipplei) which primarily affects the bowel but may affect 
any body system, has been shown to have a primary mean detection time of 30 days 
(Fenollar et al., 2003). Where bacteria have slow replication rates, a false negative result 
may be presumed.
1.5.3 Volume and dilution of sample
Sample volume has been shown to influence detection rate (Bender et al., 1961). As 
already discussed, bacteraemia is typically low grade; detection methods must therefore be 
sensitive to detect low numbers of bacteria. Recommendations on sample volume vary in 
the literature from 2 to 30 mL of blood to be obtained from adults (Cobe, 1954), (Bender et 
al., 1961). In children however, the volume of blood taken tends to be smaller, in relation to 
the reduced physical size. Studies have shown that transient bacteraemia can consist of less 
than one colony forming unit per millilitre (cfii/mL), therefore it is advised to take at least 5 
mL for any sample, in order to increase the chances of detecting the circulating bacteria. 
Official guidelines issued by the National Committee for Clinical Laboratory Standards 
(NCCLS), stated that a minimum of 10 mL of blood be cultured for adults, 1-4 mL from 
children and infants under 20 kg in weight and 4-8 mL from children >20 kg in weight 
(NCCLS, 1998).
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1.5.4 Preservation of sample
Detection of low intensities of bacteraemia is further complicated by the antibacterial 
properties of blood, such as complement and phagocytosis (Bender et al., 1961). Dilution 
and inhibition of antibacterial substances in the blood sample are also important 
considerations (Sullivan et al., 1975b), (Washington and Ilstrup, 1986). Generally it is 
suggested that dilutions of 1:15 to 1:20 are used (Sullivan et al., 1975b). Although there are 
studies that claim a dilution factor of 1:50 is necessary unless an additive such as gelatin is 
included (Roome and Tozer, 1968).
1.5.4.1 Blood culture media additives
Generally, blood culture media contain substances such as sodium polyanetholesulphonate 
(SPS) which are added to overcome bactericidal effects of blood. Previously referred to as 
“Liquoid”, SPS inhibits phagocytosis, complement, lysosyme (Garrod, 1966), (Traub and 
Kleber, 1977) and aminoglycoside action (Krogstad et al., 1991). SPS has also been shown 
to aid recovery of oral streptococci, which is advantageous for studies of dental bacteraemia 
which frequently involve these organisms. Working concentrations between 0.025% (Zierdt 
et al., 1977) and 1:10 (Garrod, 1966) have been described in the literature as beneficial for 
this purpose. Commercially available culture systems contain between 0.025% and 0.05% 
(Reimer et al., 1997). SPS inhibits some pathogenic Neisseria spp (Eng and Holten, 1977), 
which are responsible for 3% clinically significant bacteraemia (Morello et al., 1991) and 
some anaerobic streptococci (Roome and Tozer, 1968) [later transferred to the genus 
Peptostreptococcus and Micromonas] (Murdoch, 1998).
Inclusion of SPS in isolation media therefore proves a problem especially where 
meningococcal septicaemia is suspected. The deleterious effects of SPS on bacterial growth 
can be countered in broth culture by the addition of gelatin, which buffers the detrimental 
effects of SPS (Eng and Holten, 1977), (Fredricks and Reiman, 1998). Conventional 
systems also often contain resins or activated charcoal, which absorb and neutralise 
antibiotics (Wallis etal., 1980), (Morello etal., 1991).
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1.6 Detection techniques
1.6.1 Conventional techniques
Conventional techniques are those used on a routine basis to identify the causative agent of 
bacteraemia. Most routine blood culturing occurs in clinical microbiological laboratories, 
therefore the detection method must be rapid, sensitive, involve low labour intensity but 
high sample throughput while being cost effective. Conventional blood culturing usually 
involves a broth bottle technique. These systems can be either single bottle, such as the 
Oxoid Signal system, or dual bottles such as the BACTEC systems (Becton & Dickinson), 
which incorporate both aerobic and anaerobic broth bottles. Advances in technology have 
led to the development of bottles consisting of a layer of solid medium, and a volume of 
broth containing nutrients, preservatives and resins to remove antimicrobial agents 
(Morello etal., 1991).
Several studies have shown that the various BACTEC systems are superior to their 
competitors at speed of detection and recovery of aetiological agents. In the study by Daley 
et a l, where the BACTEC NR660 system was compared with the Oxoid Signal system, the 
BACTEC system detected 61% of bacteraemia versus 49% for the Signal system, which 
had 58.5 % false positive results. The Signal system was also found to be poor at detecting 
non-fermentative gram negative bacilli, Neisseria meningitidis, Nocardia spp and 
Corynebacterium jeikium (Daley e ta l, 1990). Since the introduction of BACTEC systems, 
developments have been made to improve automated detection of bacteraemia. Detection 
has progressed from manometry to radiometry to infrared spectroscopy (Daley et a l, 1990), 
(Kelly et a l, 1990), (Morello e ta l, 1991).
Media formulation has developed to include special paediatric broths which allow 
increased speed of detection, recovery of organisms and reduced sample volume. A 
decreased concentration of SPS has also allowed improved detection of pathogenic 
Neisseria spp, which are important paediatric pathogens in disease such as meningococcal 
meningitis and septicaemia (Daley et a l, 1990). Typical broth culture bottles are shown in 
Figure 1.2.
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Other systems include the Isolator system, which involves 
centrifugation of blood that are subsequently plated onto 
selective media. In a comparative study, the Isolator 
detected 72% of bacteria compared with BACTEC 85%, and 
Isolator was less capable at detecting polymicrobial 
bacteraemia (Isolator 47% versus 71% BACTEC) (Kelly et 
al., 1990).
Fig. 1.2 BACTEC bottles
1.6.2 Experimental techniques
Unlike conventional techniques, experimental detection techniques are less time sensitive, 
and are less concerned with labour intensity and cost. These methods can be employed 
where patient outcome is not a factor, as in the study of transient bacteraemia. Many 
techniques have been developed to isolate and enumerate bacteria. Generally, these 
techniques are similar or have parallels and include plate methods, membrane filtration and 
lysis methods.
1.6.3 Plate-based methods for the isolation and enumeration of bacteria from blood
The use of solid media methods for the detection and cultivation of bacteraemia isolates 
were used mostly in earlier studies. Plating methods can be based either on the pour plate 
technique, which requires blood to be mixed directly with molten agar; or alternatively 
blood samples can be plated neat or in serial dilution onto the solid surface of the media.
Problems associated with plate culture methods, as with all cultivation-based methods 
include the media chosen, as it has to allow both maximum recovery of isolates, with 
minimum inhibition of aetiological bacterial species and maximum inhibition of
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commensal organisms and contaminants. It is impossible to select a growth medium and 
environment in which all bacteria from a specific sample will grow. There is a phenomenon 
known as viable-non-culturable (VNC) state, whereby cells of bacteria exist, in a viable 
state, but fail to grow on solid media in the absence of the correct nutritional requirements 
and/or environment for growth (Bloomfield et al., 1998). For example, a sample of 
Campylobacter jejuni became non-culturable following a period of storage, yet when the 
suspension was fed to mice, the bacteria proliferated (Jones et al., 1991).
Plate methods requiring daily observation are more prone to contamination than automated 
broth culture methods, which allow operator intervention to be minimised. Plating methods 
also allow only a minimal amount of a sample to be analysed, which could lead to false 
negative results in low magnitude bacteraemia or where bacteria are susceptible to the 
antibacterial action of blood or antimicrobials.
The main advantages of plate methods over broth culture methods include the ability to 
determine the level of bacteraemia in terms of colony forming units per mL, and a 
decreased likelihood of overgrowth by a single organism on solid growth media. Detection 
and identification of polymicrobial bacteraemia is also facilitated by plate methods as 
different colony morphologies can easily be observed (Yagupsky and Nolte, 1990). Plate 
methods remain cost effective, and involve low labour intensity, especially since the advent 
of commercially available pre-prepared media.
More advanced plate-based methods have been developed which involve additional steps 
such as lysis and centrifugation of blood samples. The lysis centrifugation technique 
involves the addition of blood to a centrifuge tube containing lytic agents such as SPS and 
saponin. After thorough mixing and centrifugation, the supernatant is plated onto solid 
enrichment and/or selective media. In a study which compared the efficacy of broth-culture, 
pour plate and lysis centrifugation for the detection of Burkholderia pseudomallei, the 
lysis-centrifugation technique allowed the fastest detection of the pathogen (Simpson et al., 
1999). The system was also found to decrease the detection time of clinically significant 
pathogens from children in comparison to a conventional broth culture method (Welch et
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al., 1985). Reported disadvantages of the lysis centrifugation technique however, included 
the additional expense of specialised centrifuge tubes and the incidences of tube breakages 
which resulted in both valuable sample loss and risk of infection to laboratory personnel 
(Gill e ta l,  1984).
1.6.3.1 Lysis filtration technique
The use of lysis of blood samples has also been utilised in the development of lysis 
filtration techniques. As with the lysis centrifugation methods, blood samples are subjected 
to lysis in solutions typically having an alkaline pH, containing detergents and complement 
deactivating agents such as SPS (Sullivan et al., 1975b). After lysis, the samples are 
subjected to filtration under vacuum resulting in the trapping of bacteria onto nitrocellulose 
filters. The filters can then be placed onto solid media and incubated as required depending 
on the target bacterial population.
The advantages of lysis-centrifugation and lysis-filtration methods over conventional broth- 
bottle methods are primarily that bacteraemia can be quantified but also that the bacteria 
can be removed from the deleterious substances contained naturally and present 
chemotherapeutically in patient sera. Such substances include antibodies, complement, 
lysosyme and antibiotic agents (Sullivan et al., 1975b), (Zierdt et al., 1977), (Gill et al., 
1984). The removal of the bacteria from the sample also allows the increased visibility of 
bacterial growth as discrete colonies rather than turbidity of blood-broth mixtures (Farmer 
and Komorowski, 1972). The use of these systems also facilitates the sub-culturing and 
attainment of pure sub-cultures; allowing quicker detection, identification and antimicrobial 
susceptibility testing of isolates than with use of broth-bottle methods (Zierdt et al., 1982), 
(Lucas et al., 2002a).
As with any culture-based detection method however, lysis based systems cannot isolate all 
bacteraemia isolates. For example, the alkalinity required to lyse erythrocytes has been 
shown to reduce the viability of some Gram-negative bacteria by 4 logs in only 10 minutes 
(Farmer and Komorowski, 1972). Conversely, the lysis-filtration system has been found to 
be superior to other culture-based techniques for the detection and isolation of streptococci;
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and to be an effective tool for the detection and isolation of bacteraemia following oral 
surgical and dental procedures (Heimdahl et al., 1990), (Roberts et a l, 2000b), (Lucas et 
al, 2002b), (Lucas et al, 2002a), (Fomer et a l, 2006).
1.7 Molecular methods for detecting bacteraemia
In the majority of cases, bacteraemia is detected by an automated broth culture system, as 
described above. Although blood culture is considered the “gold standard” (Jordan and 
Durso, 2000), time to identification of an aetiological agent can range from 1-8 days; this 
period can include up to 5 days to detect growth (Turenne et a l, 2000), longer for 
fastidious or slow growing organisms such as the mycobacteria, plus an additional period 
for speciation. Where non-cultivable bacteria are involved such as some Coxiella spp, 
identification is not achievable by culture alone.
Identification of the aetiological agent is necessary to allow appropriate antimicrobial 
therapy to begin, and with serious infections, empirical antibiotic therapy is frequently 
started before definitive diagnoses can be made. Incorrect therapy is detrimental in many 
ways; antibiotics in patient sera may kill the pathogen, preventing detection by standard 
culture and increasing the risk of false positive results (Ley et a l, 1998), (Heininger et al., 
1999), (Anthony et a l, 2000), (Turenne et a l, 2000). Incorrect treatment may lengthen 
patient hospitalisation, therefore increasing the cost of patient care and also increases the 
risk of acquired antibiotic resistance in bacteria (Turenne et a l, 2000). Antibiotic resistance 
is especially important in hospital environments where nosocomial infections due to multi- 
resistant organisms are increasing (Moore and Millar, 2000).
Positive samples may appear as false negative results or fail to yield an organism on 
subculture. Cultures may be recorded as negative due to insufficient sample volume, 
infection due to cell-dependent organisms, presence of antibiotic in patient sera or 
bactericidal agents, or through technical errors in the laboratory (Moore and Millar, 2000), 
(Auckenthaler, 1984), (Turenne e ta l,  2000). Studies have shown that 5 to 31% of bacterial 
endocarditis cases are recorded as culture-negative, due to failure of routine diagnostic
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methods to support and isolate the aetiological agent (Washington and Ilstrup, 1986), 
(Moore and Millar, 2000), (Qin and Urdahl, 2001). It is also estimated that 99% of bacteria 
present on earth are not cultivable using standard techniques (Mohlenhoff et al., 2001), 
(Muyzer, 1999). Other bacteria may depend on the complex ecological niche afforded them 
by bacterial biofilms. For whatever reason, therefore some bacteria are not sustainable in a 
normal diagnostic laboratory.
Several molecular approaches have been described in the literature including techniques 
utilising PCR, Denaturing Gradient Gel Electrophoresis (DGGE), Fluorescent In Situ 
Hybridisation (FISH), Single Strand Conformation Polymorphism (SSCP) analysis, and use 
of oligonucleotide arrays.
1.7.1 PCR-based detection assays
Numerous studies utilising PCR to detect bacteraemia have been performed. These methods 
are often designed around broad range universal primers based on the 16S ribosomal RNA 
or 23S rRNA gene (Ley et al., 1998), (Anthony et a l, 2000), (Kattar et al., 2000), (Qin and 
Urdahl, 2001), (Moore and Millar, 2000) and those using species-specific primers (Wilson 
et al., 1990). The 16S rRNA and 23S rRNA genes are invaluable tools for detection as they 
are common to all bacteria, allowing studies of evolution and systematics. The genes 
contain conserved structural regions present within all bacteria as well as variable regions 
that allow species variation (Turenne et a l, 2000), (Moore and Millar, 2000). This is useful 
for the clinical laboratory because it allows detection of pathogens which are difficult or 
slow to culture or even as yet non-cultivable (Wilson et a l, 1990), (Ley et a l, 1998); 
amplification of the 16S rRNA gene also allows detection of non-viable bacteria (Tanner et 
al., 1994).
PCR methods can be refined to allow extreme sensitivity, with some assays showing 
detection limits as low as 0.4 pg of DNA (Wilson et al., 1990), (Johnson, 2000) or 1 to 5 
copies of the target gene which equates to approximately one bacterial cell (Wilbrink et al., 
1998). The disadvantages of 16S rRNA based amplification methods are that they are
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relatively labour intensive; DNA must often be extracted, purified and quantified and PCR 
reagents must be carefully prepared. In addition, where broad range primers are employed, 
mixed bacterial amplicons may be generated necessitating a cloning or separation technique 
to identify co-amplified sequences. Contamination with DNA or amplicon carry over from 
previous amplification reactions may lead to false positive results, especially where nested 
or hemi-nested amplifications are employed (Vaneechoutte and Van Eldere, 1997), 
(Wilbrink et al., 1998), (Johnson, 2000), (Qin and Urdahl, 2001).
Although contamination is a major problem, there are several methods that can be 
employed to help prevent false positive results. Basic principles include the adoption of 
stringent decontamination routines and use of “clean” reagents and disposable media. It is 
also important to implement pre- and post-PCR areas so that reactions are not prepared in 
the presence of environmental DNA or amplicons from previous reactions. Other methods 
can be adopted which effectively destroy any contaminating DNA prior to amplification, 
including: pre-treatment of amplification reactions with restriction endonucleases, DNA 
glycosylases, psoralen compounds and UV exposure or use of DNA polymerases assayed 
to be free of bacterial DNA (Heininger et al., 2003), (De, et al., 1996), (Fahle et al., 1999), 
(Carroll et al., 1999). Although good results have been reported, these methods introduce 
extra time and cost factors into the detection process.
It is important when using molecular methods to establish whether the DNA isolated 
belongs to the aetiological agent or is merely present in the sample. Many body sites 
previously considered sterile actually harbour DNA and other bacterial products (Wilbrink 
e ta l, 1998), (Anthony etal., 2000). For example, DNA has been amplified and sequenced 
from culture media (commercially available broth) and found to belong to species of 
bacteria that may be implicated in human disease, including streptococci and lactobacilli 
spp (Fredricks and Reiman, 1998), (Millar et al., 2000).
1.7.2 Denaturing Gel Gradient Electrophoresis (DGGE)
Another molecular detection tool, is Denaturing Gel Gradient Electrophoresis (DGGE) 
(McBain et al., 2004). DGGE begins with a PCR amplification based on universal primers.
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During subsequent electrophoresis, a urea concentration gradient gel, which behaves as a 
temperature gradient, separates amplicons on the basis of sequence melting temperature 
rather than size. DGGE is widely used to analyse microbial communities and is beneficial 
because mixed samples can be separated and individual species can be isolated whether 
cultivable or not. DGGE does not require specific sequences to be designed to allow 
detection of non-viable, uncultivable species or undiscovered bacteria, it also allows all 
sequences whether present as ten or three thousand copies to be detected (McBain et a l, 
2004). DGGE is however, a time consuming, relatively laborious and extremely sensitive 
technique, (Muyzer, 1999). DGGE is unlikely to replace traditional blood culture, it is 
however an excellent way to study microbial communities and could be used to 
complement traditional methods as it allows polymicrobial samples to be separated and 
sequenced (Wilson et a l, 1990), (Mohlenhoff et a l, 2001).
1.7.3 Single strand conformation polymorphism (SSCP)
A similar method to DGGE, also based on PCR amplification of conserved bacterial 
regions, is PCR single strand conformation polymorphism (PCR-SSCP). As with DGGE, a 
PCR reaction using broad range primers is performed. Usually 16S rRNA primers are 
selected which target conserved regions flanking variable sequences. Subsequent amplicons 
are denatured into single stranded molecules, which adopt sequence specific conformations; 
these are subsequently separated by polyacrylamide electrophoresis. Like DGGE, mobility 
of the molecules is sequence dependent, allowing individual species to form a unique SSCP 
profile (Widjojoatmodjo et a l, 1995), (Turenne et a l, 2000). SSCP is a valuable and 
powerful method because it allows separation of mixed bacterial DNA without the use of 
species specific probes. Individual SSCP profiles can be compared to those of reference 
strains to enable speciation without sequencing. Developments in this technique include the 
performance of the electrophoresis stage on an automated sequencer, in combination with 
fluorescein labelled primers. This allows tight control of the gel temperature, more accurate 
and comparable results and the ability to manage data electronically (Widjojoatmodjo et al., 
1995). Multiplex PCR, can also be utilised. By using a variety of broad range primers, 
better discrimination, especially of closely related species can be achieved through 
amplifying multiple polymorphic sites (Widjojoatmodjo e ta l,  1995).
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1.7.4 Fluorescent in situ hybridisation (FISH)
As knowledge has increased about the aetiology of bloodstream infections, a common 
group of responsible pathogens has emerged. Ninety percent of positive blood cultures have 
been reported to harbour Staphylococci, Streptococci, Enterococci, E. coli, K. pneumoniae 
or P. auruginosa (Kempf et al., 2000), (Jordan and Durso, 2000). This information has 
been used to design fluorescently labelled oligonucleotide probes or peptide nucleic acid 
probes directed against the variable regions of 16S and 23 S rRNA, to detect bacteria 
directly from blood culture (Kempf et al., 2000), (Jansen et al., 2000). Methods based on 
this premise, include fluorescent in situ hybridisation (FISH), a relatively simple and rapid 
way for researchers to visualise the presence of target bacteria (Jansen et al., 2000). These 
methods allow a panel of probes to be designed to detect the commonest aetiological agents 
(Oliveira et al., 2002). The advantages of FISH based methods are that they are cheap, 
rapid, and practical; some assays can report definitive results in under 2.5 hours (Kempf et 
al, 2000), (Oliveira etal., 2002). As new pathogens emerge, new probes can be developed 
and added to the panel. These methods do not require bacterial growth as the abundance of 
rRNA in microbial cells yields up to 10,000 gene copies per cell allowing extreme 
sensitivity (Wilson e ta l,  1990). Disadvantages of FISH based methods include the reliance 
on the aetiological agent being represented on the probe panel. The specificity of the 
probes, may also lead to false negative results or false positives if cross reactivity occurs 
(McBain et a l, 2004).
There are many other molecular methods available which could be applied to detection of 
bacteraemia. Currently, there is no single method that could reliably replace traditional 
culture methods in the routine diagnostic laboratory. Molecular methods do however, have 
a place in the investigation of bacteraemia and blood stream infection, and can be used to 
augment detection and identification of aetiological agents; or to rapidly confirm absence of 
bacterial pathogens (Jordan and Durso, 2000).
Table 1.1 summarises the advantages and disadvantages of culture versus molecular 
detection techniques.
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Table 1.1 Culture versus molecular methods fo r  detection o f bacteraemia
--------------- Cultun
Advantages Disadvantages Advantages
m.et!lods---------------------
Disadvantages
Low labour 
intensity
Viable bacteria 
available for 
susceptibility 
testing
48 hours minimum 
to detection and 
identification
Fastidious, slow 
growing and non 
culturable bacteria 
may lead to false 
negative results.
Rapid,
identification 
available within 
hours
Highly sensitive, 
down to 0.4 pg 
DNA or 10 cfu
Does not require 
viable organisms
Susceptibility testing not possible
High cost of equipment and 
reagents
Balance between specificity and 
sensitivity
1.8 B acteraem ia following dental trea tm en ts
The risk for focal infection such as IE, colonisation of joint replacements or abscess of 
parenchymous organs such as the brain and liver following dental manipulation is well 
documented (Otten et al., 1987), (Li et al., 1999). There is debate regarding which 
procedures elicit bacteraemia and whether dental manipulation is actually responsible for 
the transient bacteraemia which lead to disease such as infective endocarditis. It is 
important for the clinician as well as the ‘risk’ patient to be informed about any procedure 
likely to increase the risk of developing systemic disease. The precise mechanism by which 
bacteria enter the blood stream is however poorly understood. For this reason, studies 
investigating dental bacteraemia are important to acquire information about this 
phenomenon.
1.8.1 Mechanism by which bacteria enter the bloodstream from the tissues of the oral 
cavity
Most authors agree that bacteria from the oral cavity gain access to the bloodstream via the 
gingival sulcus, the space between the gum and the tooth (Burket and Burn, 1937), 
(Lineberger and De Marco, 1973), (Otten et al., 1987), (Bender and Barkan, 1989), 
(Coulter et al., 1990).
Bacteria reflecting the oral microbiota have been recovered from the bloodstream and 
proven to originate from the gingival margins. In 1937, Burkett and Burn proved this by
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painting a solution of Serratia marcescens around teeth before recovering the organism 
from the subjects’ bloodstream in 36 % of cases 10 minutes post extraction.
The actual mechanism of entry has not been elucidated, but there is general agreement in 
principle to the theory of Burket and Bum, 1937. This theory described the process as 
forcing the bacteria into the bloodstream through the piston-like action exerted on the tooth 
during extraction. Burket & Burn’s proposal has been extended upon with the theory that 
positive and negative pressures are created causing the bacteria to be “sucked” into the 
circulation (Bender and Pressman, 1945), (Roberts, 1999). This is supported by the finding 
that the use of local anaesthesia incorporating epinephrine (adrenaline), constricts the blood 
vessels and therefore decreases their permeability, leading to a lower prevalence of 
bacteraemia (Burket and Burn, 1937), (Bender and Pressman, 1945). Other authors believe 
that dental manipulation causes breaks in the epithelium permitting access of bacteria 
(Diener et al., 1964), (Messini et al., 1999).
There is a common belief that gingival bleeding results in a bacteraemia (Chung et al., 
1986), but in many studies patients with positive blood cultures had no discernible bleeding 
(Roberts, 1999) or no relationship was found between bleeding and incidence of 
bacteraemia. For example, a study of the relationship between degrees of gingival disease 
and the development of bacteraemia after flossing was performed; no relationship between 
bleeding and bacteraemia was seen (Carroll and Sebor, 1980).
1.8.2 Dental procedures and their relationship to bacteraemia genesis
The majority of literature on dental bacteraemia and the link with systemic disease focuses 
on dental extraction. Many studies however, dispute whether extractions or indeed any 
professional dental procedures are responsible for initiation of bacterial endocarditis. Table
1.2 shows a list of common dental manipulative procedures and the range of percentage 
positive bacteraemia found described.
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Table 1.2 Reported prevalence o f bacteraemia following den tal manipulations
Procedure Range (%) Reference
Baseline 0-63.6 (Roberts et al., 1997)
(Roberts, 1999)
(Peterson and Peacock, 1976) 
(Bender and Pressman, 1945) 
(Cobe, 1954)
(Robinson etal., 1950)
(Berry, Jr. etal., 1973)
(Romans and App, 1971)
(Otten etal., 1987)
(Chung et al., 1986)
(Lofthus et al., 1991)
(Carroll and Sebor, 1980) 
(Lineberger and De Marco, 1973) 
(Roberts et al., 1998)
(Roberts et al., 1979)
(Diener et al., 1964)
Dental Examination 17-67.6 (Roberts et al., 1997) 
(Roberts, 1999)
Tooth brushing 9-76.3 (Roberts etal., 1997) 
(Roberts, 1999) 
(Cobe, 1954)
(Chung e/ al., 1986)
Chewing 22-55.3 (Roberts, 1999) 
(Diener etal., 1964)
Scaling & Root Planing 20-81.7 (Roberts et al., 1997) 
(Roberts, 1999) 
(Lofthus etal., 1991)
Single Extraction 35.3-56 (Roberts et al., 1997) 
(Roberts, 1999) 
(Cobe, 1954) 
(Roberts etal., 1998) 
(Roberts et al., 1992)
Multiple Extraction 50.9-63 (Roberts etal., 1997) 
(Roberts, 1999)
(Coulter et al., 1990)
(Roberts et al., 1998) 
(Peterson and Peacock, 1976)
Intraligamental 12-96.6 (Berry, Jr. etal., 1973)
Injection (Roberts et al., 1997)
From table 1.2 it is clear that some procedures do lead to a high prevalence of bacteraemia. 
It is also clear that everyday events such as chewing, tooth brushing and flossing can also 
lead to similar or higher prevalence of bacteraemia than procedures such as multiple 
extractions or even those involving surgery.
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No relationship however, has been proved between the degree of trauma and the incidence 
of bacteraemia (Burket and Burn, 1937), (Roberts, 1999). Studies that involve orthodontic 
patients who exhibit good oral hygiene and gingival health and undergo procedures with 
relatively high degrees of trauma yet show low prevalence of bacteraemia; support the 
theory that bacterial load is a crucial factor to the degree of bacteraemia induced (Chung et 
a l, 1986), (Erverdie ta l, 1999).
1.8.3 Oral health as a risk factor for bacteraemia
The relationship between oral health and the prevalence of bacteraemia has been widely 
investigated. Some authors have shown that there is no correlation between poor oral health 
and an increased risk of bacteraemia (Burket and Burn, 1937). This has been demonstrated 
through comparison of extraction of healthy and diseased teeth (Peterson and Peacock, 
1976), in the presence or absence of abscesses (Coulter e ta l, 1990), and in terms of degree 
of gingivitis or hyperplasia (Bender and Pressman, 1945), (Chung et a l, 1986). Whereas 
other studies have found that decreased gingival health results in higher frequency of 
bacteraemia (Roberts et a l, 1998)
There is much evidence that the practice of good oral hygiene can reduce the incidence and 
extent of bacteraemia (Bender and Barkan, 1989), (Scannapieco, 1998). In a study which 
investigated bacteraemia following flossing, it was shown that flossing everyday resulted in 
less bacteraemia than infrequent flossing (Carroll and Sebor, 1980). It is clear that a 
reduction in bacterial load of the gingival sulcus decreases the risk of bacteraemia (Burket 
and Burn, 1937), (Chung et a l, 1986). It would seem sensible to assume that increased 
bacterial load leading to plaque accumulation causes local inflammation and therefore 
increased permeability to microbiota of gingival blood vessels (Asikainen and Alaluusua,
1993).
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1.9 Focal infection theory
The concept of commensal microbiota resident in one area of the body causing disease in 
another part of the body is well established, and can be traced back through time to some of 
the earliest historical medical records (O'Reilly and Claffey, 2000), (Slots, 1998).
Focal infection occurs via the translocation of bacteria or their products from one body site 
to another; where the bacteria or their products may elicit local damage or give rise to a* 
local or systemic inflammatory response (Scannapieco, 1998), (Okuda and Ebihara, 1998), 
(DeBowes, 1998), (Gendron et al., 2000). Examples of focal infection include abscesses of 
the liver and central nervous system, IE and bacterial pneumonia (Mihaila-Amrouche et a l, 
2004). Oral disease is linked to diabetes mellitus, pre-term and low birth weight infants, 
inflammatory disease such as Crohn’s disease, the aetiology of some cancers and in 
atherosclerosis (Ciantar et al., 2005a), (Offenbacher et al., 1996), (Van Dyke et a l, 1986), 
(Mager et a l, 2005), (Haraszthy et al., 2000).
It is important that the recovery of oral commensals from an extra-oral site is not 
automatically labelled as a focal infection but investigated to determine whether systemic 
disease is due to a casual or causal relationship with oral health (Syrjanen, 1990), (Slots, 
1998). For example, there has been speculation that the presence of Helicobacter pylori in 
the oral cavity provides a seeding source for gastric ulcers (Gebara et a l, 2004), (Umeda et 
al., 2003). Yet comparisons of individuals with and without H. pylori infection have 
demonstrated no correlation between the presence of H. pylori in the mouth with presence 
in the stomach (Czesnikiewicz-Guzik et al., 2004). In this case it is more likely that the 
acid-tolerant organisms which are acquired via ingestion, oral and faecal-oral transmission 
(Kignel et a l, 2005) are colonising rather then causing peptic ulcers.
The advent of modem typing methods has given us the ability to prove conclusively that a 
bacterium isolated from an infection is also a commensal of the oral cavity (Debelian et al.,
1994), (Murray and Saunders, 2000). For example, identical isolates of S. sanguinis were 
isolated from patients with infected orthopaedic prostheses and their mouths; strain identity 
was confirmed by cell wall polypeptide analysis (Bartzokas et al., 1994).
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The mouth as a reservoir for bacteria, may contain as many as a thousand billion organisms 
if improperly cleaned (Okuda and Ebihara, 1998), and at least 500 bacterial species have 
been isolated from the human oral cavity, which supports a complex microbial community 
(Debelian et al., 1994), (Tanner et al., 1994). Bacteria and therefore their products are 
concentrated in and around the tissues of the gingival sulcus, with a milligram of dental 
plaque containing as many as 1011 microorganisms (Asikainen and Alaluusua, 1993), 
(Meurman, 1997). The translocation of bacteria or bacterial products from the local blood 
vessels of the gingiva to the distant body site occurs either through the forces exerted 
during chewing, tooth brushing or other dental procedures or as a result of increased 
permeability mediated by bacterial products and the host inflammatory response (Losli and 
Lindsey, 1963), (Gendron et al., 2000). Transient bacteraemia occasionally results in 
bacterial adherence and colonisation of foreign sites causing systemic disease (Meurman et 
al., 1997), (Gendron etal., 2000).
Conditions which weaken the immune system and predispose individuals to focal infection 
include; cardiovascular disease, chronic obstructive respiratory disorders, rheumatic 
disease, diabetes mellitis, psoriasis, severe arthritis, chronic inflammatory bowel disease, 
immunosuppressant medications, cancers, organ transplantation and being elderly 
(Meurman et al., 1997). Examples of reported focal infections where oral microbiota have 
been isolated are shown in fig 1.3.
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Fig. 1.3 Examples o f  focal infection associated with oral microbiota
Cerebral Infarction (Asikainen and Alaluusua, 
1993)
Brain abscesses (Li et al., 1999)
Meningitis (Colville etal., 1993), 
(Chotmongkol et al., 2002), (Pawlak et al., 
1984)
Endophthalmitis (Ishak et al., 1986)
Sinusitis (Paju et al., 2003)
Oral carcinoma (Mager et al., 2005), (Hooper 
etal., 2006)
Mediastinitis (Baqain et al., 2004), (Berlot et 
al., 1997)
Pneumonia (El Solh et al., 2003), (Nijs et al., 
2002)
Lung abscesses (Carrascosa et al., 1994) 
Lemierre’s Syndrome (Tsai etal., 1999)
Diabetes mellitus (Ciantar et al., 2005a)
Premature births and low birth weight babies 
(Offenbacher et al., 1996)
Inflammatory bowel disease (Van Dyke et al., 
1986)
Osteomyelitis (Kalouche etal., 2005) 
Prosthetic joint failure (Bartzokas et al., 1994)
Impetigo (Brook, 1980)
Adapted from www.muslimworld.co.uk
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1.9.1 Infective endocarditis
The most widely investigated type of metastatic infection is infective endocarditis (IE). IE 
can be caused by any organism, bacterial, viral or fungal which can colonise the heart. This 
thesis is concerned only with bacterial agents of endocarditis, although the term IE will be 
used. IE is a rare but potentially fatal disease; it is estimated that there are between 11 and 
50 cases of IE per million population per annum (Pallasch and Slots, 1996), (Young, 1987). 
The mortality rate has been reported at 6-40%, but this rate is decreasing (van der Meer et 
al., 1992a), (Franklin, 1992), (1981). IE is a condition which affects the endothelium, in 
particular the valves of the heart, which become colonised and damaged by bacteria. The 
pathogenesis of the disease is as follows (depicted in figure 1.4): -
1. Abnormal area of valvular surface allows platelet and fibrin deposition.
2. A Non Bacterial Thrombotic Vegetation (NBTV) develops.
3. Bacteria from a local site enter the bloodstream and colonise the NBTV.
4. Further platelet and fibrin deposition occurs, bacteria multiply and the vegetation 
grows.
5. Local and systemic sequelae occur (Freedman, 1987).
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Fig. 1.4 Schematic diagram o f  bacteria entering bloodstream and colonising the heart
Bacteria en:er 
bloodstream
Travel to 
the heart
Colonise
damaged
tissue
Photograph courtesy o f Prof G. Roberts
IE is normally a risk to individuals who have acquired or congenital heart defects such as 
rheumatic heart disease, a ventricular septal defect or a prosthetic valve replacement (Smith 
and Adams, 1993). Congenital risk conditions include; ventricular septal defects, Fallot’s 
tetralogy, patent ductus arteriosus and cyanotic congenital heart disease. Acquired 
abnormalities include regurgitant valves and receipt of a prosthetic valve (Mills, 1987), 
(Mansur et al., 1992), (van der Meer et al., 1992a). These abnormalities provide an 
environment in the heart where pressure and flow are altered, causing additional damage to 
the endocardium providing a nidus for platelet aggregation which organisms colonise 
(Glauser and Francioli, 1987), (Hogg, 1994). This develops into an infected vegetation 
(Fluckiger etal., 1994), (Knox and Hunter, 1991).
Men tend to be at higher risk of contracting IE than women, but sex bias does not occur 
until after the 30th year of age (Netzer et al., 2000), (Franklin, 1992), (van der Meer et al., 
1992a). Patients who have had an episode of IE are also predisposed to further infection, 
especially where the patient has a history of intravenous drug use (van der Meer et al., 
1992a).
Bacteria may infect any area of the endocardium, but generally, the valves are the site of 
colonisation. There are reports in the literature of aortic, mitral and tricuspid valve
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involvement, but the most common site of infection is the aortic valve, alone or in 
conjunction with the mitral (bicuspid) valve (Krcmery etal., 2003), (Netzer etal., 2000). In 
the intravenous drug user (IDU) population the right side of the heart and therefore the 
tricuspid valve is more commonly affected (Moss and Munt, 2003). In demonstration, a 
normal mitral valve (A) is shown alongside a mitral valve with attached vegetation (B) in 
figure 1.5.
Fig. 1.5 Normal mitral valve (a) and mitral valve with vegetation (b) 
(Circled)
Adapted from www.pittsburghheart.com
Endocarditis should be suspected in a patient presenting with any of the following signs 
and symptoms; a predisposing heart condition, fever (above 38°C), chills, general malaise, 
weight loss, new heart sounds or vascular phenomena such as Osier’s nodes or Janeway 
lesions (Mansur etal., 1992), (van der Meer et al., 1992a), (Franklin, 1992). Blood culture 
is the principal method of diagnosis, but echocardiography or histology (during surgery) are 
also demonstrative of infection (Mansur et al., 1992), (van der Meer et al., 1992a). Fig 1.6 
shows an image produced during echocardiography of IE.
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Fig. 1.6 Echocardiogram o f  heart with IE vegetation
Left ventricle
Right ventricle
Mitral valve with vegetation 
indicated
Left atrium
Adapted from www.intermedicina.com 
Patients with native valve endocarditis (NVE) are usually infected with streptococci, 
whereas patients with prosthetic valve endocarditis (PVE) tend to be infected with 
staphylococci (van der Meer et al., 1992a).
Recent studies have shown shifting patterns of aetiology. Traditionally, viridans 
streptococci were responsible for the majority (63%) of cases (Bayliss et al., 1983b), 
aetiology is now shifting with increasing numbers of staphylococci being detected 
(Krcmery et al., 2003), (Wahl and Pallasch, 2005). The changing aetiology is partly due to 
the increase in intra venous drug users, who are most frequently diagnosed with 
staphylococcal IE, and the increase in replacement valve surgery (Franklin, 1992), (Li and 
Somerville, 1998), (Netzer et a l, 2000). Decreases in cases due to oral streptococci is 
believed to be attributable to improving dental health (Hoen et al., 2002). Cases caused by 
staphylococci prove to be fatal more often than those attributed to other organisms, with 
aetiology rather than type of valve involved being more important to patient outcome (van 
der Meer etal., 1992a), (Franklin, 1992).
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Treatment for endocarditis begins with antimicrobial therapy and supportive measures, but 
many patients with endocarditis require surgery including valve replacement (1998), 
(Elliott et a l, 2004), (Gutschik, 1999).
Many cases of endocarditis attributed to dental treatment may be a result of everyday 
bacteraemia. Recent dental treatment has been implicated in as many as 20% of IE where 
the causal organism is a member of the oral microbiota (Wahl, 1994), (Netzer et at., 2000). 
There are reports in the literature where dental treatment in the preceding 3, 6 and even 12 
months are given as the source of bacteraemia responsible for cases of IE. The incubation 
period however, is believed to be nearer to 5 to 10 days, depending on the organism 
involved (Starkebaum et at., 1977). The diagnosis of endocarditis is often delayed due to 
the non-specific symptoms and the use of empirical antibiotic therapy; this can lead to a 
false estimate of the incubation period (van der Meer et at., 1992a), (Franklin, 1992).
Several studies have been conducted which have used animal models to demonstrate the 
oral cavity as the source of infection for IE (Bahn et at., 1978), (Dankert et at., 1995), 
(Rouse et a l, 1997). These models however, are not only restricted to small mammals, but 
use extraordinarily large intensities of bacteria to produce IE in the subject. It has been 
shown in many studies of actual transient bacteraemia, that the intensity of dental induced 
bacteraemia is actually very low, in the order of 1 or 2 cfu/mL (Roberts et at., 2000a). This 
suggests that animal models bear little relevance to the study of dental bacteraemia and that 
the intensity of actual bacteraemic events is much lower than the inoculum needed to 
recreate the disease in in vivo studies.
Bacteraemia following dental manipulation has been shown to be quenched by the 
reticulo-endothelial system within 12 minutes [unpublished data], whereas bacteraemia 
from a chronic infection or site of inflammation would continually re-seed the bloodstream 
(Fine et al, 1998). As the risk of cumulative exposure through everyday events such as 
tooth brushing and chewing are many times more risk associated than dental procedures, 
many of these cases of ‘dental induced’ endocarditis are likely to be wrongly attributed to 
the practitioner (Guntheroth, 1984), (Roberts, 1999).
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Many thousands of dental procedures are carried out each year on patients with cardiac 
abnormalities; yet only between 11 and 16 cases of endocarditis can be expected per 
million people in England and Wales (Young, 1987). It is much more likely then that IE 
caused by recognised oral microbiota are a result of chronic oral infection rather than any 
specific dental treatment.
1.9.2 Antibiotic prophylaxis of Infective Endocarditis and other focal infections 
following dental procedures
The risk of developing IE following dental treatment is low, even amongst those with an 
existing cardiac condition (Roberts, 1999). Despite this, patients considered to be at risk of 
developing IE are often given prophylactic antibiotics prior to dental treatment.
The arguments against the use of routine IE prophylaxis are numerous. Most importantly, is 
the subject of efficacy; do prophylactic regimens prevent IE? There currently exist no 
prospective, controlled studies on the efficacy of IE prophylaxis (Imperiale and Horwitz, 
1990). This has resulted in a lack of evidence to support the current recommendations 
(Seymour, 2004). This situation is unlikely to change due to the ethical problems implicated 
by such a trial. Additionally, because IE is rare, a very large series of patients would be 
necessary to show any association (van der Meer et al., 1992d), (Al Karaawi et al., 2001), 
(Seymour, 2004). Therefore the majority of data in the literature have been obtained from 
retrospective analyses or by the use of experimental models (Pallasch, 1989a). Such studies 
are deemed unreliable, due to the inherent bias of retrospective studies and the artificial 
environment provided by the animal model.
Recent guidelines from the Endocarditis Working Party of the British Society for 
Antimicrobial Chemotherapy (BS AC) acknowledge that without a prospective double-blind 
trial, there is no clear evidence for use of antibiotic prophylaxis prior to dental treatment. In 
respect of this opinion, the recommendations of the working party have changed to apply 
only to patients who have previously suffered IE or who have had valve replacement
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surgery for any invasive dental procedure (Gould et al., 2006). The recommended 
prophylactic regimen are summarised in table 1.3.
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Table 1.3 Recommended prophylaxis for denial treatment under general anaesthesia (Gould etal., 2006)
Population 1U years
-------------- Age------------- ^
> 5 to<10 ears
------------------------------
<5 years
General amoxicillin 3 g amoxicillin 1.5 g amoxicillin 750 mg lh
Penicillin-allergic clindamycin 600 mg clindamycin 300 mg clindamycin 150 mg lh
Penicillin-allergic and unable 
to swallow capsules
azithromycin 500 mg azithromycin 300 mg azithromycin 200 mg lh
Intravenous regimen 
expedient
amoxicillin 1 g amoxicillin 500 mg amoxicillin 250 mg Just prior to procedure or at 
induction of anaesthesia
Intravenous regimen 
expedient and penicillin- 
allergic
clindamycin 300 mg clindamycin 150 mg clindamycin 75 mg Just prior to procedure or at 
induction of anaesthesia, 
over at least 10 min
Where the course of treatment involves several visits, the antibiotic regimen should alternate between amoxicillin and 
clindamycin.
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Due to the nature of this problem however, the use of these studies provide the only data 
with which to decide whether or not to provide chemoprophylaxis to the risk patient 
(Glauser and Francioli, 1987), (Carbon, 1993). As there are arguments to support both the 
argument for and against the use of chemoprophylaxis, practitioner and patient must reach a 
mutual informed decision (Seymour, 2004).
There are many studies which have assessed the impact of prophylaxis on the incidence of 
bacteraemia following dental procedures (De Leo etal., 1974), (Hess e ta l,  1983), (Roberts 
et a l, 1987), (Cannell etal., 1991), (Aitken e ta l,  1995), (Hall etal., 1996), (Wahlmann et 
a l, 1999), (Al Karaawi etal., 2001), (Lockhart et al., 2004). During the evaluation of these 
prophylactic antibiotics, various efficacies at preventing bacteraemia were shown; 
clindamycin: 16-55%, erythromycin: 40%, penicillin: 79%, josamycin: 35% (Hess et a l, 
1983), (Canned etal., 1991), (Aitken et al., 1995), (Had etal., 1996).
In many of the cases where bacteraemia was not prevented, the isolates were found to be 
susceptible to the tested antimicrobial despite the achievement of target serum antibiotic 
concentrations (Hess et al., 1983), (Aitken et a l, 1995), (Had et al., 1996), (Wahlmann et 
al., 1999). It has been concluded by some authors that if prophylaxis does confer a 
protective effect, this must occur during the development of IE rather than at the initial 
phase of bacteraemia (Had et al., 1996). Although these studies can ted us if post­
procedure bacteraemia is effected, they do not often ted us if any of the subjects or matched 
controls (where included) later developed IE.
Other data that is used in the evaluation of chemoprophylactic regimen is the use of 
retrospective analyses of IE patients’ medical history. Case reports of failure of IE 
prophylaxis are common in the literature (O'Sullivan et al., 1996), (Had and Baddour, 
2002), (Huang e ta l,  2002). Such reports, however are often describing single occurrences 
rather than emerging patterns. There are much wider studies in the literature which allow 
some conclusions to be drawn about the use of IE prophylaxis. In 1992, van der Meer et al., 
published a retrospective study of 427 IE patients in the Netherlands. Of the 275 patients 
eligible for prophylaxis, 23.3% had undergone a procedure within 180 days previous to
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their diagnosis, 11.3% within 30 days. The authors concluded that prophylaxis may have 
prevented 17.1% of cases where the incubation period occurred within 180 days of 
treatment and 8.4% where the incubation period was within 30 days. These results 
indicated, that few IE cases were due to dental treatment and that prophylaxis was 
ineffective (van der Meer et a l, 1992b).
Aside from the issue of efficacy, there is also an issue of patient and clinician awareness 
and compliance of the recommended regimen. Analyses of patient compliance conducted 
via questionnaire have demonstrated that there are large numbers of patients with known 
cardiac conditions that do not understand when they should be given IE prophylaxis or the 
importance of maintaining a good standard of oral health (Smith and Adams, 1993), (Hayes 
and Fasules, 2001), (da Silva et al, 2002), (Stucki et a l, 2003). There are also substantial 
data that indicate a large number of clinicians who either do not understand the current 
recommendations or who do not implement them (Nelson and Van Blaricum, 1989), (van 
der Meer et a l, 1992c), (Hayes and Fasules, 2001), (Tomas, I et a l, 2004). The lack of 
clinician compliance is surprising considering the increasingly litigious nature of society. 
Despite a lack of evidence within the literature, several practitioners have been successfully 
sued by patients who developed IE following dental treatment (Pallasch, 1989b), (Martin et 
al, 1997), (Pallasch, 2003).
Irrespective of efficacy or compliance, the future of IE prophylaxis may reside with health 
authority accountants. Investigations of the cost of prophylaxis, of treating a case of IE and 
of treating a patient who suffers an adverse reaction have been undertaken. In the majority 
of studies, it has been concluded that there is a greater risk of death from anaphylactic 
shock following IE prophylaxis than from dentist-induced IE (Pallasch, 1989a). IE 
prophylaxis appears only to be of net benefit when used for the highest risk patients 
undergoing the highest risk procedures (Clemens and Ransohoff, 1984). The use of IE 
prophylaxis for patients who are not indicated as high risk or who are not undergoing a high 
risk procedure has been shown to be of limited clinical value.
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In a climate of increasing resistance to antibiotics among bacteria, the misuse of antibiotics 
is an important issue (Fine et al., 1998). There is a growing theme throughout the literature 
that promotion of good oral health and therefore reduction of the oral bacterial load, 
through regular brushing, flossing, use of antibacterial mouth washes and dental 
examination will be of more value in preventing IE than the current recommended IE 
prophylaxis regimen (Strom et al., 2000). Given the evidence, it would appear that IE 
prophylaxis should be reserved for a minority of high risk patients and that cardiac patients 
should be educated about their condition and the practice of good oral hygiene (1992), 
(Roberts etal., 1997), (Carmona et al., 2002), (Oliver et al., 2004), (Gould et al., 2006).
1.10 The oral microbiota
The bacterial community of the human oral cavity is both complex and diverse. The 
number of cultivated named species ranges from 300 to 500 species, with the total number 
including fastidious and presently non-cultivable bacteria, which may account for up to 
40% of the total oral microbiota (Tanner et al., 1994), (Paster et al., 2001).
Within the oral cavity, there exist many different environments including the tooth surfaces, 
dorsum of the tongue and the gingival sulcus. During disease states, the number of sites 
increases to include, dental tubules, necrotic pulp and periodontal pockets (Socransky and 
Manganiello, 1971). Each of these areas is a specific habitat with different conditions 
including pH, oxygen tension and supply of nutrients such as gingival crevicular fluid 
(GCF). Within each defined area, communities of bacteria develop and interact, providing a 
niche environment in which symbiotic relationships emerge (Schuster, 1999).
Methods to estimate the diversity within the oral cavity have included culture of saliva and 
plaque, using enrichment and selective media to enumerate different species. For example, 
saliva can be diluted and inoculated onto different selective media including mitis salivarius 
agar with the addition of polymixin for the enumeration of oral streptococci (Fitzgerald and 
Adams, 1975). More sophisticated approaches include molecular methods such as cloning 
(Paster et al., 2001), PCR-DGGE (Li et al., 2005), and microarray to screen samples for
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community diversity. The advantage of molecular based methods are that cultivable and 
non-cultivable inhabitants may be detected (Kroes et al., 1999). The disadvantage of such 
molecular methods is that non-cultivable isolates cannot be further characterised, in terms 
of their phenotypic characteristics (Perea, 2004). However, with the recent advances in 
metagenomics this disadvantage may soon be negated, albeit with a large price tag. 
Metagenomic techniques will allow physiological and genetic analyses of non-cultivable 
organisms which will in turn provide knowledge and understanding with which to develop 
culturing strategies for these bacteria (Handelsman, 2004). A list of oral microbiota and 
examples of species from the oral cavity is given in table 1.4.
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Table 1.4 Microbiota o f the oral cavity
—  ,
Genus Examples 0 T  , ■, Specific oral sites Additional references
Abiotrophia A. defectiva
Acinetobacter A. Iwofii
Actinobacillus A. actinomycetemcomitans subgingival plaque
Actinomyces A. naeslundii subgingival plaque
A. georgiae gingival crevice
A. meyeri gingival sulcus
Atopobium A. parvulus
Berg eye I la B. zoohelcum (Kroes et al., 1999)
Bifidobacteri u m B. dentium subgingival plaque, caries
Bordetella B. pertussis (Kroes etal., 1999)
Borrelia B. burgdorferi (Kroes etal., 1999)
Branhamella
Brucella B. abortus (Kroes etal., 1999)
Bulleidea B. moorei (Munson et al., 2004)
Campylobacter C. rectus, C. conciscus periodontal pockets, symptomatic root canals
Capnocytophaga C. ochracea subgingival plaque
Cardiobacterium C. hominis
Centipeda C. periodontii
Corynebacterium C. matruchotii plaque
Cytophaga (Rolph etal., 2001)
Dialister (Paster et al., 2001), (Rolph et 
al., 2001)
Eikenella E. corrodens
Enterococcus E.faecalis (Rolph etal., 2001) (Lana et 
al., 2001)
Eubacterium E. nodatum, E. saburreum plaque, calculus, periodontal pockets
Fusobacterium F. nucleatum
Gemella G. haemolysans, G. morbillorum
Granulicatella G. elegans
Haemophilus H. aphrophilus. H. paraphrophilus
Helicobacter H. pylori
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Genus
1...............  1
Examples Specific oral sites > p- § m
Kingella K. denitrificans, K. orale
Kocuria K. rhizophila (Munson et al., 2004)
Lactobacillus L. oris gingival crevice, periodontal pockets
Lautropia L. mirabilis (Kroes etal., 1999)
Leptotrichia L. buccalis plaque
Leuconostoc (Lana etal., 2001)
Megasphera (Munson et al., 2004)
Micrococcus Micrococcus sp dental plaque
Mitsuokella M. dentalis, M. multiacidus root canals, periodontal pockets
Mogibacterium (Rolph etal., 2001)
Neisseria N.subflava, N. mucosa saliva, plaque
Olsenella O. profit sa, O.uli (Munson et al., 2004)
Pantoea (Rolph etal., 2001)
Parascardovia P. den ticolens (Munson et al., 2004)
Peptostreptococcus P. micros, P. anaerobius subgingival plaque, gingivitis
Porphyromonas P. gingivalis subgingiva, destructive periodontitis
Prevotella P. intermedia, P. melaninogenica gingival sulcus
Propionibacterium P. acnes sub-, supragingival plaque
Pseudoramibacter P. alactolyticus subgingival plaque, gingivitis (Kamma et al., 2000)
Rickettsia R. rickettsii (Kroes etal., 1999)
Rothia R. dentocariosa subgingival plaque, saliva
Scardovia S. inopinata (Munson et al., 2004)
Selenomonas S. sputigena subgingival plaque
Shuttleworthia S. satelles (Munson et al., 2004)
Staphylococcus S.aureus
S. epidermidis, S. haemolyticus saliva, abscesses, endodontic infections
Stomatococcus S. mucilaginosus tongue
Streptococcus S. sanguinis, S. anginosus tooth surface, dental plaque
Tannerella T. forsythensis periodontal pockets, endodontic lesions
Thiobacillus T. cuprinus (Kroes etal., 1999)
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Treponema T. denticola advanced periodontal legions
Veillonella V. dispar, V. parvula, V. atypica sub-, supragingival plaque
Wolinella W. recta
Adapted from Tanner etal., unless specified otherwise (Tanner etal., 1994)
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The oral cavity as a bacterial community develops and diversifies from shortly after 
birth, through the change from primary to adult dentition and as a result of diet, puberty 
(Wojcicki et a l, 1987), oral and systemic health status, bacterial interactions and as a 
result of antimicrobial therapy (Schuster, 1999). Bacteria are acquired vertically, 
generally from the mother (Socransky and Manganiello, 1971). Initially, neonates 
acquire only aerobic species, but as their dentition develops and different environments 
are created, the types of species that can be supported increases (Schuster, 1999). In a 
study of 40 healthy children, by Kamma et a l, it was shown that there were differences 
in the oral microbiota detected from deciduous and permanent dentition. Campylobacter 
concisus, Bacteroides capillosus and Bacteroides egerthii were statistically associated 
with permanent teeth whereas Peptostreptococcus magnus, Actinomyces naeslundii and 
Bifidobacterium adolescens were more frequently detected from deciduous teeth 
(Kamma et a l, 2000). The same authors also found statistical differences in the 
proportions of some bacteria isolated from deciduous and permanent dentition.
The effect of diet can affect the proportions of certain bacterial species within the oral 
cavity. This is particularly evident with cariogenic bacteria such as mutans streptococci, 
which flourish in the presence of high levels of dietary sucrose (Beighton et a l, 2004).
The oral microbiota is also altered by the disease status of the individual. Some 
systemic diseases result in an individual having increased carriage of some bacteria. For 
example, in studies of the metabolic disorder diabetes mellitus, diabetic subjects 
harbour more Capnocytophaga spp than healthy subjects. As Capnocytophaga spp are 
implicated in periodontitis (Ciantar et a l, 2005a), it is postulated that the increase of 
these saccharolytic bacteria is a result of the diabetic exhibiting higher levels of glucose 
in their gingival crevicular fluid (Ciantar et a l, 2002).
Some bacterial species are specifically associated with oral health status. In a study that 
compared the oral microbiota of periodontally healthy and diseased individuals, 
Corynebacterium matruchotii was associated with health, while Streptococcus 
constellatus, Gemella haemolysans and Atopobium spp were most associated with 
disease (Kroes et a l, 1999). It has been shown that individuals with high levels of 
Streptococcus sanguinis carriage have lower levels of mutans streptococci (Schuster,
1999). In a study using species-specific primers in a multiplex PCR protocol, Gafan et
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al., showed that children were 2.3 times more likely to have gingivitis in the absence of 
Tannerella forsythensis from the plaque (Gafan et al., 2004).
Despite the enormous numbers of taxa detectable in the oral cavity, up to 20 species 
account for the majority of the total oral microbiota (Kroes et al., 1999), (Kamma et al.,
2000). It has also been shown from studies of in vitro bacterial biofilms seeded with 
pooled saliva that the majority of the oral microbiota are cultivable (Pratten et al.,
2003).
1.11 Speciation of the oral microbiota
Traditionally, oral bacteria were isolated from samples of plaque and saliva by use of 
non-selective media such as blood agar and selective media such as mitis salivarius agar 
(for the determination of streptococci), Rogosa agar (for the determination of 
lactobacilli) and CFAT agar (for the determination of Actinomyces spp) (Chapman, 
1944), (Rogosa et al., 1951), (Zylber and Jordan, 1982). Use of selective media for the 
isolation and enumeration of oral microbiota has been reported for the investigation of 
effects of fluoridated milk and chlorhexidine on bacterial biofilms (Pratten et al., 2000), 
(Ready et al., 2002) and also to investigate the effect of systemic disease such as 
haemophilia on oral microbiota (Sonbol et al., 2001).
Isolates are usually routinely Gram-stained, assayed for their reactivity in catalase and 
oxidase determination tests and tested for their aerotolerance. Isolates were then 
speciated using biochemical or serological tests, often available as commercial kits 
(French et al., 1989), (Beighton et al., 1991a), (Beighton et al., 1991b), (Inoue et al., 
1998).
Since the advent of molecular technology various methods have been deployed to 
identify bacteria on the basis of stable genotypic tests rather than by use of unreliable 
phenotypic traits (Kawamura et al., 1998). It is the use of comparative 16S rRNA gene 
sequencing however, which has become an invaluable tool in the speciation of oral 
bacteria. As discussed previously in the detection of bacteraemia, the 16S rRNA gene is
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a suitable genetic target, because it is present in all bacteria and contains variable 
sections which allow the identification of isolates to species level (Tanner et al., 1994).
Among the oral microbiota, the oral streptococci have proven to be particularly difficult 
to speciate. This is especially true for the members of the mitis group streptococci. 
Identification to species level of the oral streptococci has historically been a problem for 
many laboratories (Vandamme et al., 1998). Several genotypic methods have also been 
employed to identify the oral streptococci including repetitive extragenic palindromic 
PCR (REP-PCR) (Alam et al., 1999), transfer DNA intergenic spacer polymorphism 
(tDNA-ILP) (De Gheldre et al., 1999) and PCR of the autolysin (lytA) gene and D- 
alanine: D-alanine ligase (ddl) gene (Kawamura et al., 1999). The advent of 16S rRNA 
gene sequencing and homology studies has led to improved identification of the oral 
streptococci. Members of the mitis group of streptococci however, share up to 99% 
homology in this gene (Kawamura et al., 1995b) and therefore comparative sequencing 
of the 16S rRNA gene may not provide discrimination between the closer-related 
species of the group.
In 1998, Poyart et al. described a method using degenerative primers to amplify and 
sequence the gene encoding the manganese-dependent superoxide dismutase of Gram- 
positive bacteria (sodA) to successfully identify streptococci to species level (Poyart et 
al., 1995), (Poyart et al., 1998). Gene sequencing, however, is not available to all 
laboratories, due to the high cost of equipment and reagents and the relative labour 
intensity of the process.
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1.12 Antibiotics and the oral cavity
The antibiotics pertinent to this study were ampicillin, benzylpenicillin, erythromycin, 
tetracycline and vancomycin. Ampicillin, benzylpenicillin and vancomycin were of 
interest due to their use in prophylaxis of IE (see table 1.3), erythromycin due to the 
common prescription for childhood infections and tetracycline because of the 
contraindication for use in children under 12 years. For the reasons outlined above, 
resistance toward these antibiotics among bacteraemia isolates was of interest.
1.12.1 Benzylpenicillin
Benzylpenicillin (penicillin G), was the original penicillin produced by Penicillium 
chrysogeum. A member of the beta-lactam class of antibiotics, penicillins exert a 
bactericidal effect by inhibiting the final stage of peptidoglycan synthesis, inhibiting 
maintenance of the bacterial cell wall (Rolinson, 1998). Benzylpenicillin is indicated in 
the treatment of throat infections, otitis media, endocarditis, meningococcal disease, 
pneumonia, cellulites, anthrax and as a prophylactic drug before some dental and 
surgical procedures (Joint Formulary Committee., 2002). Benzylpenicillin is active 
against staphylococci, streptococci and Neisseria spp.
1.12.2 Ampicillin
Ampicillin is a semi-synthetic derivative of benzylpenicillin (Penicillin G), member of 
the beta-lactam class of antibiotics. The isolation of the nucleus of benzylpenicillin (6- 
aminopenicillanic acid), allowed development of penicillins with a broader spectrum of 
activity, better oral absorption and increased stability against beta-lactamases. 
Ampicillin was the first aminopenicillin of this type to be introduced (Rolinson, 1998) 
and together with amoxicillin, has a broader spectrum of activity against fastidious, 
Gram-negative bacteria including some Enterobacteriaceae (NCCLS, 2000). 
Susceptibility to the penicillins varies depending on the combined effects of 
permeability, penicillin binding proteins and presence of beta-lactamases 
(Georgopapadakou, 1993).
Resistance mechanisms to the penicillins include altered penicillin binding proteins, 
presence of beta-lactamases and outer-membrane permeability (Gram-negative bacteria) 
(Georgopapadakou, 1993).
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1.12.3 Erythromycin
Erythromycin is a member of the macrolide class of antibiotics, produced from a strain 
of Saccoropolyspora erythraea. Launched as Ilosone in 1952, erythromycin has a 
similar spectrum of activity to penicillin and is commonly used to treat respiratory tract 
infections and infections in those with penicillin allergies or where the organism is 
resistant to penicillin (Joint Formulary Committee, 2002). Erythromycin inhibits 
bacterial protein synthesis by interfering with transpeptidation. The main mechanism of 
bacterial resistance to erythromycin is target modification. Bacteria that are resistant to 
erythromycin synthesize a demethylation enzyme, which modifies a ribosome within 
the 23 S rRNA. This demethylation is believed to exert a conformational change which 
prevents binding with the antibiotic. This resistance mechanism confers co-resistance to 
lincosamide and streptogramin antibiotics (Leclercq and Courvalin, 1991). This 
resistance mechanism is conferred by the presence of plasmid encoded erm 
(erythromycin resistance methylase) genes such as ermA and ermC (staphylococci and 
streptococci) (Leclercq and Courvalin, 1991).
1.12.4 Tetracycline
Tetracycline was discovered in 1953. This naturally occurring antibiotic has a broad 
spectrum of activity, and is indicated in the treatment of chlamydial infections, Q-Fever, 
Lyme’s disease and oral infections (British National Formulary, 2002). Tetracycline is 
produced from Streptomyces aureofaciens and exerts an antibacterial effect through 
inhibition of bacterial protein synthesis (Chopra and Roberts, 2001). Due to the risk of 
tooth staining and dental hypoplasia caused by the binding of calcium by tetracycline in 
growing bone, tetracycline administration is contraindicated for children under 12 years 
of age (Joint Formulary Committee., 2005). Tetracycline-stained permanent teeth are 
shown in figure 1. 7.
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Fig. 1.7 Permanent dentition demonstrating tetracycline staining
www. cda-adc. ca/jcda/vol-6 5/issue-2/110/fortin-l .GIF
Antibacterial resistance to tetracycline is achieved by three mechanisms: ribosomal 
protection, presence of efflux proteins and by enzymatic inactivation (Speer et al., 
1992), (Taylor and Chau, 1996). Many tetracycline resistance genes have been 
described in the literature. Resistance determinants are often conferred on mobile 
genetic elements such as transposons; these elements often transfer co-resistance to 
other often non-related antibiotics.
1.12.5 Vancomycin
Vancomycin is a glycopeptide antibiotic, produced by Amycolatopsis orientalis 
(Nagarajan, 1991). Vancomycin is particularly potent against aerobic and anaerobic 
Gram-positive bacterial infections, although due to poor oral absorption, vancomycin is 
usually parenterally administered (Joint Formulary Committee, 2002). Vancomycin 
prevents growth of Gram-positive bacteria through the inhibition of biosynthesis of the 
cell wall (Johnson et al., 1990). Resistance mechanisms to vancomycin are generally 
due to the presence of gene clusters designated van A  or vanB. These gene systems 
confer resistance by the same mechanism of target modification, in which synthesis of a 
peptidoglycan precursor is changed to include a lactate residue precluding binding of 
the drug to its target (Arthur and Quintiliani, Jr., 2001). All Gram-negative bacteria are 
intrinsically resistant to vancomycin (Nagarajan, 1991).
The oral cavity as a diverse ecological system contains many antibiotic resistant bacteria 
and is therefore the perfect environment for the transfer of antibiotic resistance genes
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(Ready et al., 2003). Resistance genes are often transferred between bacterial species on 
mobile genetic elements such as plasmids and conjugative transposons. These genetic 
elements can often transmit resistance to one or more additional antibiotics (Roberts et 
al., 2001), (Lancaster et al., 2003), (Villedieu et al., 2003), (Villedieu etal., 2004).
1.13 Antibiotic sensitivity testing (AST)
It is useful to estimate the susceptibility of microbiota to antimicrobial compounds for 
several reasons. In a clinical setting, it is essential in the appropriate treatment of 
infection, that the correct antibiotic is selected and that the dosage administered to the 
patient can achieve therapeutic levels (BSAC, 1988), (NCCLS, 2000).
It is also necessary to ascertain the levels of antibiotic resistance within bacterial 
communities in order to monitor the growing crisis of antibacterial resistance to 
antibiotics.
There are various methods which have been employed for the determination of 
antibiotic susceptibility in bacteria. These include; agar dilution methods, broth dilution 
methods (NCCLS, 1993) and the application of antibiotic containing media to bacterial 
lawns such as disc diffusion methods (Oxoid Ltd. Basingstoke, UK) and impregnated 
strips e.g., Etest, (http://www.abbiodisk.com/).
Typically, AST is performed by the use of an agar dilution method, where the chosen 
agar medium contains a specified concentration of antibiotic per plate, and a range of 
concentrations are tested (NCCLS, 2000). Using this method the inocula can be 
precisely quantified before application directly to the surface of the prepared media.
Isolate susceptibility is classified in relation to a breakpoint concentration of antibiotic 
e.g., the breakpoint may be 8 mg/L, isolates inhibited by 4 mg/L would be considered 
sensitive, inhibition by concentrations greater than 8 mg/L would be termed resistance 
and inhibition at the breakpoint would be considered intermediate. Breakpoints for 
various antibiotics are formulated for various clinically important bacteria and 
published. There are several different organisations however, that provide information 
on breakpoints and there are some authors who would like to see global consensus
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standards (Baquero, 1990). Typically, breakpoints published by the British Society for 
Antimicrobial Chemotherapy (BSAC) are lower while those released by the American 
National Committee for Clinical Laboratory Standards (NCCLS) are much higher than 
the majority of the European countries. The result of these differing values is the 
discrepancy between surveillance of antibiotic resistance and the inability to compare 
data globally (Baquero, 1990).
The lowest concentration at which an antibiotic inhibits bacterial growth is termed the 
minimum inhibitory concentration (MIC), and it is this value that is often given in 
studies of antimicrobial resistance (NCCLS, 2000). This information can be used to 
select which antibiotic to use and at which concentration (BSAC, 1988).
A limitation of AST is the difference between the in vivo site of infection and the in 
vitro test conditions. AST cannot replicate the host factors that are involved in the 
inflammatory response and organisms undergoing AST are tested in pure culture, 
relieved of bacterial competition and supplied with optimal factors for growth such as 
nutritional and atmospheric requirements (Isenberg, 1988).
Many commercial methods for AST have been developed, although many of these 
methods are expensive and results may differ between laboratories or from those 
obtained using approved reference AST methods (Lovgren et al., 1999). USA and UK 
laboratories can assess their efficacy at AST by participating in assessment schemes 
which supply test organisms with known susceptibilities (Snell et al., 1984), (Jones and 
Edson, 1985).
In order for MIC results to form useful, reproducible data, standards regarding inoculum 
preparation and density, choice of media, preparation and storage of media and 
reagents, inclusion of media and bacterial controls and incubation requirements have 
been published (NCCLS, 1993), (Traub and Leonhard, 1995). These publications are 
intended to standardise AST within each region (Baquero, 1990). Deviation from these 
standards and variations in the use of media and methods of these antibiotic 
susceptibility surveys can result in wide variations of results (Lovgren et al., 1999).
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1.13.1 Genotypic investigation of antibiotic resistance
As well as evaluation of phenotypic levels of antibiotic susceptibility, many protocols 
are emerging in the literature which assay the presence and expression of antibiotic 
resistance genes (Merlino et al., 2002). Surveillance of resistant populations for 
resistance genes provides useful information on the mechanisms of bacterial resistance 
to antibiotic drugs, which will help develop strategies to combat this emerging problem 
(Villedieu et al., 2004), (Ubukata et al., 2004), (Yu et al., 2004). In 2000, Martineau et 
al., assayed a panel of 394 staphylococci for resistance genes for oxacillin, gentamicin 
and erythromycin using a multiplex PCR protocol; strains were also subjected to 
standard AST and the results compared. Correlation between the two methods was 98%, 
100 % and 98.5% for oxacillin, gentamicin and erythromycin respectively. 
Discrepancies occur where resistance genes are found but strains are susceptible and 
where no gene is found but a strain is resistant (Martineau et al., 2000), (Tan, 2002), 
(Villedieu et al., 2003).
Other genotypic studies have highlighted problems in identifying resistant bacteria 
where a strain has intermediate levels of susceptibility or where the recommending body 
has issued high-end breakpoint values (Merlino et al., 2002), (Tan, 2002)
Although these types of study are useful and show major potential for clinical 
microbiology, it should be remembered that presence of antibiotic genes does not 
automatically confer antibiotic resistance. Molecular based protocols are also only as 
valuable as their range of targets, and many more resistance genes are likely to be 
discovered. Bacteria with antibiotic resistance genotypes may still require MIC 
determination in a clinical setting.
It is clear from the enormous range of literature surrounding the topic of dental 
bacteraemia that there is still little understanding of the true mechanisms of production 
of dental bacteraemia and the development of systemic disease. It is important therefore 
in terms of patient care, treatment planning and the cost-effectiveness of focal infection 
prevention that the controversies surrounding IE and dental treatment are dissolved. 
Further understanding of the features of dental bacteraemia needs to be achieved so that 
any potential risk to health can be minimised. More research into the aetiology and 
pathogenesis of focal infections such as IE needs to be commissioned to clarify whether 
dental procedures rather than poor oral hygiene are the true source of infection.
69
Chapter 1 ~  Introduction
1.14 Aims of this thesis
i. To identify the peak incidence of bacteraemia following dental extractions in 
children.
ii. To measure the magnitude of bacteraemia and the persistence of bacteria in the 
blood over time.
iii. To identify the main bacterial species which gain entry to and persist in the 
bloodstream following dental extraction.
iv. To characterise the bacteria isolated from the blood in terms of their phenotypic 
characteristics and susceptibilities to a panel of antibiotics.
v. To develop a strategy for the detection of uncultivated bacteria from the samples 
in order to perform a comparison of detection methods used.
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2.0 Materials and methods
Unless stated otherwise, chemicals and reagents were obtained from Sigma Aldrich Co. 
Ltd. Poole, UK.
2.1 Sample collection
The bacteria for this study were isolated from blood samples taken from healthy 
children and adolescents undergoing dental extractions under general anaesthesia 
(British Heart Foundation Grant: PG/1998042). Exclusion criteria used were:
o Chronic medical disorders
o Predisposing cardiac lesion
o Known or suspected viral carriage
o Haemorrhagic disorders
o ‘Difficult’ veins
o Antibiotic treatment within the preceding month
Subject recruitment, dental treatment and blood sampling were carried out by Professor 
GJ Roberts and Dr VS Lucas.
A cannula was inserted into a vein in the left or right antecubital fossae using aseptic 
technique immediately after induction of anaesthesia. This is demonstrated in figure 2.1.
Fig. 2.1 Cannulation o f vein in the antecubital fossa (superimposed vasculature)
© Emily Evans 2004
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Two 13 mL blood samples were taken from each subject. The first sample was taken 
immediately after anaesthesia (baseline) and the second at a randomly allocated time 
following the maximum dento-gingival manipulation of the last tooth extracted (Table 
2.1). The timing of the post-extraction sample was subjective to the operator’s 
judgement, but was consistently performed by the same operators.
Table 2.1 Post-extraction time groups
Group Time Post-extraction
Number of 
Subjects
1 10 seconds 50
2 30 seconds 50
3 1 minute 50
4 2 minutes 50
5 4 minutes 50
6 7.5 minutes 50
7 15 minutes 50
8 30 minutes 50
9 45 minutes 50
10 60 minutes 50
Each sample was processed as follows:
Two BACTEC “Paed” bottles were each inoculated with 3 mL of blood and incubated 
aerobically and anaerobically respectively. These were processed and identified in the 
Camelia Botnar Laboratory, The Great Ormond Street Hospital for Children. This data 
is discussed in a separate publication (Roberts et al., 2006).
Six mL of each blood sample was aliquoted into a sterile universal container containing 
1.23 mL of a 0.4% sterile sodium polyanethol sulfonate (SPS) solution to prevent 
clotting. This sample was processed using lysis filtration within 2 hours of collection. 
An additional millilitre of blood was frozen at -80 C for future studies.
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2.2 Processing blood samples using lysis filtration
2.2.1 Media for lysis filtration
2.2.1.1 Brain Heart Infusion agar supplemented with 5% v/v sterile defibrinated 
horse blood (BHI blood agar)
Brain Heart Infusion agar (Becton & Dickinson UK Ltd) was prepared following the 
manufacturer’s instructions and autoclaved at 121 °C for 15 minutes. Sterilised agar was 
cooled to 50°C in a water bath (Grant Instruments. Cambridge, UK) before 5% v/v 
sterile defibrinated horse blood (E&O Laboratories Ltd. Bonnybridge, Scotland) was 
added aseptically under laminar flow (Intermed Ltd. Fleet, UK).
Molten agar was poured to a depth of approximately 5 mm into sterile disposable Petri 
dishes (Bibby Sterilin Ltd. Stone, UK) and left to set under laminar flow. Once cooled 
and free of condensation, plates were inverted, packed and stored at 4 °C. Control plates 
were checked before use. Batches of media were made fortnightly and as required.
2.2.1.2 Lysis solution (0.08% NazCOs + 0. 05% Triton X100)
Lysis Filtration solution was prepared weekly. Sodium carbonate (0.76 g) was dissolved 
in 950 mL distilled water. The solution was kept under constant agitation using a 
magnetic stirrer device (Bibby Sterilin Ltd. Stone, UK) and the pH was measured using 
a pH meter (Mettler Toledo. Leicester, UK). Using 10 M HC1, the pH was reduced to 
pH 10 and the total volume adjusted to 1 L. Following acidification, 190 mL of the 
solution was aliquoted into 500 mL bottles. 100 pL of Triton X I00 (BDH Laboratory 
Supplies. Poole, UK) was added to each bottle, which was shaken to aid dispersal. The 
solution was autoclaved at 121°C for 15 minutes. The lysis solution was always pre­
warmed to 37°C prior to use for optimum filtration.
2.2.1.3 Streptokinase-streptodornase solution
Twenty mL of sterile distilled water was added to a vial of freeze-dried streptokinase- 
streptodornase, containing 100,000 units of streptokinase and 25,000 units of 
streptodornase (Varidase. Wyeth Laboratories Ltd. Maidenhead, UK) using a sterile 
syringe and hypodermic needle (Becton 8c Dickinson UK Ltd). The solution was 
agitated to aid dissolution, before the solution was drawn into a sterile syringe. The 
solution was kept refrigerated at 4°C until use. Aliquots of the solution were filtered
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using a 0.2 pM syringe filter (Sartorius Ltd. Epsom, UK). Solutions were used within 
24 hours of preparation, as directed by the manufacturer.
2.2.2 Lysis filtration of blood samples
2.2.2.1 Lysis filtration apparatus
The lysis filtration apparatus (Sartorius Ltd. Epsom, UK) was set up (figure 2.2) before 
sample collection. This was to ensure the shortest time between sample collection and 
processing. The vacuum manifold was set up with silicone rubber stoppers and orange 
filter holders in place to which filter units were attached. Valves beneath each filtration 
position were opened and closed to apply vacuum when required. When not in use the 
valves were set to the horizontal (closed) position.
Fig. 2.2 Assembly o f  lysis filtration equipment
Filter unit 
containing 
sample
Image courtesy o f Dr. Marilou Ciantar
Air vents in the manifold system were plugged with 0.2 pm hydrophobic filters 
(Whatman Inc. New Jersey, USA) to prevent leakage of filtrate and ingress of air.
The manifold was attached to a 5 L capacity water trap using rubber tubing. 
Approximately 500 mL of 1% Virkon disinfectant solution (Antec Int. Ltd. Sudbury, 
UK) was added to the water trap, to provide initial decontamination of the filtrate.
Before sample processing, the silicone stopper of the water trap was checked to assure 
an airtight seal had been formed. Vacuum Silicone gel (Dow Coming GmbH. Germany) 
was used where necessary.
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The water trap was attached to the vacuum pump using rubber tubing, with an in line 
Hepa cap filtration device to minimise local contamination (Whatman Inc. New Jersey, 
USA). The vacuum was tested prior to sample processing using water.
The volume in the water trap was not allowed to reach the level of the waste inlet, to 
prevent material from being sucked into the vacuum pump. A valve was opened after 
filtration to alleviate the pressure build-up in the water trap.
2.2.2.2 Filtration protocol
Following collection of the sample, the blood-SPS solution was taken directly to the 
Paediatric Oral Microbiology Unit, UCL Eastman Dental Institute. Samples were stored 
at 4°C while preparing for filtration. The operator wore a face mask and eye protection 
at all times to prevent contamination with aerosolised microorganisms. Three mL of 
streptokinase-streptodomase solution was filter-sterilised into 190 mL of pre-warmed 
lysis solution, before the 6 mL blood sample was added aseptically. The blood and lysis 
solution was incubated at 37°C for 10 minutes to allow lysis of the white blood cells to 
occur.
After incubation, approximately 100 mL of the lysed blood solution was poured 
aseptically into each of two sterile 45 pm filters attached to ports of the vacuum 
manifold (Figure 2.2).Vacuum was applied (80 mm/hg) to draw the sample solution 
through the filter, until all liquid had dissipated (KNF Neuberger UK Ltd. Witney, UK). 
The paired filters were placed onto labelled BHI blood agar plates using sterile forceps 
flamed in industrial methylated spirits (BDH). One plate was incubated aerobically and 
the other anaerobically for 10 days. Negative media and process controls consisting of 
filtration units containing sterile distilled water were included.
2.3 Enumeration of isolates
The incubated agar plus filter plates were checked daily from the third day of incubation 
using a low power stereomicroscope (Carl Zeiss. Germany) (Figure 2.3).
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Fig. 2.3 Checking filter plates for microbial growth
Image courtesy o f Prof GJ Roberts
Each colony type was described and the number of each was counted and recorded. A 
final count was obtained on the tenth day of incubation and expressed as colony 
forming units per sample (6 mL) (cfu/sample) of blood. Isolates were subcultured onto 
fresh BHI blood agar and incubated appropriately before further characterisation. 
Isolates were chosen for subculture based on the colony morphologies present. For 
example, if  there were only two colonies, but both appeared to be different, both were 
subcultured, whereas if two or more colonies were deemed to be the same, only one 
colony would be sub-cultured.
2.4 Characterisation of isolates
2.4.1 Microbiological methods
2.4.1.1 Gram stain
A flamed nichrome loop (10 pL) (Medical Wire and Equipment Co. Ltd. Corsham, UK) 
was used to pick typical colonies from an overnight culture, which were then suspended 
in approximately 25 pL of sterile distilled water on a clean microscope slide (BDH). 
The film was allowed to air-dry before heat-fixing in a blue flame.
Gram staining was performed (Becton & Dickinson) according to the manufacturer’s 
instructions and observed using oil immersion microscopy (Leitz. Germany).
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2.4.1.2 Cotalose determination
Using a sterile wooden cocktail stick, a typical colony was smeared onto a clean 
microscope slide. A disposable Pasteur pipette (BDH Laboratory Supplies. Poole, UK) 
was used to drop approximately 45 pL of 3% v/v hydrogen peroxide (H2O2) onto the 
colony. The slide was observed for formation of bubbles denoting a positive result. A 
positive control organism Staphylococcus aureus (NCTC 6571) and a negative control 
organism Streptococcus pneumoniae (NCTC 7465) were used weekly to test the 
efficacy of the catalase determination test.
2.4.1.3 Oxidase determination
A 1% (w/v) N,N,NrN' tetramethyl-p-phenylenediamine (BDH) solution was prepared. 
Test colonies were touched with a swab saturated with solution and observed for the 
rapid appearance of a deep purple colouration within 20 seconds denoting a positive 
result. A positive control organism Pseudomonas auruginosa (NCTC 10662) and a 
negative control organism Escherichia coli (NCTC 10418) were used to test the 
efficacy of the oxidase test each time a solution was prepared.
2.4.1.4 Selective media
Selective media including mitis salivarius agar (MS) (Becton & Dickinson), mitis 
salivarius agar plus 15% sucrose and bacitracin 0.2 U/mL (MSB) (Gold et al., 1973), 
mannitol salt agar (MAS) (Oxoid), bile aesculin agar (BAE) (Oxoid), Rogosa agar 
(ROG) (Oxoid), Actinomyces spp agar (CFAT) (Zylber and Jordan, 1982) and 
Veillonella spp agar containing 7.5 pL vancomycin (VEI) (Rogosa et al., 1958) were 
prepared in accordance with manufacturers’ or authors’ instructions. Isolates were 
suspended in 0.5 mL of phosphate buffered saline (PBS) (Oxoid Ltd. Basingstoke, UK) 
and adjusted to a density of 0.5 McFarland Standard. The inocula were added to the pan 
of a 36 well multipoint inoculator (Mast Dianostics Ltd. Bootle, UK) and then 
transferred to the surface of each selective medium plus a BHI blood agar plate (see 
section 2.2.1.1) in duplicate. Staphylococcus aureus NCTC 6571 and Streptococcus 
mutans NCTC 10449 were included in each run as control organisms. During each run, 
one blank space was included and sterile PBS was included to serve as a media control. 
One set of plates was incubated aerobically and one set anaerobically for 48 h, isolates 
were enumerated and the plates re-incubated for a further 72 h to allow lactobacilli
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growth on Rogosa agar. After the incubation period, the presence or absence of growth 
for each isolate was recorded and the results used to obtain a presumptive identification. 
Periodic quality control checks using control organisms were performed (section 2.9).
2.4.2 Biochemical identification of oral streptococci using carbohydrate 
fermentation and hydrolysis assays
2.4,2.1. Preparation of carbohydrate substrates: amygdalin, arbutin, inulin, lactose, 
mannitol, melibiose, N-acetylglucosamine, raffinose and sorbitol substrate solutions
The following were mixed in a 125 mL bottle: 2.4 g Thioglycollate medium (without 
dextrose or indicator) (Becton & Dickinson UK Ltd. Cowley, UK), 1.6 g purple broth 
base (Becton & Dickinson UK Ltd. Cowley, UK) and 1.0 g of carbohydrate were 
dissolved in 100 mL distilled water. The solutions were shaken vigorously before being 
autoclaved at 121°C for 10 minutes.
2.4.2.2 Preparation of aesculin carbohydrate substrate solution
The following were mixed in a 0.5 L bottle: 1.0 g tryptone, 0.5 g yeast extract, 1.0 g 
sodium acetate, 0.05 g ferric ammonium citrate, 0.5 g aesculin, 0.1 ml Tween 80, 0.5 ml 
salt A (0.16 g CaCk, 0.16 g MgS04 and 400 mL distilled water), 0.5 ml salt B (0.8 g 
K2HPO4, 8.0g NaHC03, 1.6 g NaCl, 0.8 g KH2P04 and 100 mL distilled water) and 100 
mL distilled water. The solutions were shaken vigorously before being autoclaved at 
115°C for 10 minutes.
2.4.2.3 Preparation of arginine carbohydrate substrate solution
The following were mixed in a 0.5 L bottle: 0.5 g peptone, 0.3 g yeast extract, 0.3 g 
glucose, 1.0 g sodium acetate, 0.3 g L-arginine, 0.1 mL Tween 80, 0.5 mL salt A, 0.5 
mL salt B and 100 mL distilled water. The solutions were shaken vigorously before 
being autoclaved at 115°C for 10 minutes.
2.4.2.4 Carbohydrate fermentation and hydrolysis assay
The basis of this assay was the detection of decreased pH value due to acid produced by 
fermentation of the carbohydrate substrate; demonstrated by a colour change from 
purple to yellow as pH falls below 5.2. Positive hydrolysis of aesculin was shown by a 
colour change of yellow to black and arginine hydrolysis was recorded as positive when
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the addition of 45 pL of Nessler’s reagent (BDH) which produced a bright orange 
colour, indicating the formation of ammonia or ammonium salts.
Streptococcal test colonies were picked from BHI blood agar plates supplemented with 
5% defibrinated horse blood incubated for 24 hours. 4 mL volumes of sterile Todd 
Hewitt Broth (Oxoid Ltd. Basingstoke, UK) were inoculated and incubated aerobically 
at 37°C for 48 h. Following incubation, the broths were Gram stained to ascertain 
purity. The broths were then used as the inoculum. One hundred and twenty five pL of 
each carbohydrate solution (Appendix 5.8) was aliquoted into wells (in columns) of a 
sterile flat-bottomed microtitre tray as shown in Table 2.2.
Table 2.2 Carbohydrate substrates used in assay
Column number Carboludmle subsume
1 amygdalin
2 arbutin
3 inulin
4 lactose
5 mannitol
6 melibiose
7 N  - acetylglucosamine
8 raffinose
9 sorbitol
10 aesculin
11 arginine
Forty five pL of each culture was aliquoted into each well of a row. During each assay, 
a negative control, containing carbohydrate only was included.
Inoculated trays were incubated anaerobically at 37°C for 24 hours before being 
examined for colour changes.
2.4.3 Biochemical identification of oral streptococci using detection of pre-formed 
enzymes
2.4.3.1 Preparation o f 4-Methylumbeliferyl enzyme substrate solutions
2.4.3.1.1 TES buffer
A 50 mM solution of TES buffer was prepared by dissolving 12.56 g of TES in 1 L of 
distilled water. The pH was adjusted to pH 7.5. The solution was stored at 4°C until use. 
The enzyme assay required a final working enzyme concentration of 100 pg/mL. Each
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substrate was suspended in DMSO before the addition of 50 mM TES buffer to produce 
a concentration of 1 mg/mL. This stock solution was stored at minus 20°C.
2.4.3.2 Pre-formed enzyme detection assay
In this assay, 4-methylumbeliferyl linked glycosidic enzyme substrates were used (table
2.3) to profile streptococci by detecting pre-formed enzymes. Positive utilisation, 
equivalent to the degradation of 20 nM of substrate, and the release of 4- 
methylumbelliferone, was visualised as fluorescence when viewed with a UV 
transilluminator (Alphalmager Inc).
Twenty pL of each enzyme substrate solution was aliquoted into each well of the 
columns of a microtitre tray. Inoculum for the assay was prepared by taking colonies 
from an overnight plate of BHI blood agar and suspending them in 2 mL of 50 mM TES 
buffer. Inocula were adjusted to approximately 0.1 McFarland standard (bioMerieux 
UK Ltd. Basingstoke, UK). Forty five pL of each suspension were added to each well 
of a row in the microtitre plate. Inoculated microtitre plates were covered with 
laboratory film (Parafilm M Pechiney Plastic Packaging, Inc. WI, USA.) to prevent 
evaporation and incubated aerobically at 37°C for 3 hours. Following incubation, 
microtitre trays were observed for fluorescence using a UV transilluminator 
(Alphalmager Inc).
Table 2.3 Enzyme substrates used in assay
Column number Enzyme substrate
1 4 MU p-D-fucoside
2 4 MU N-acetyl-P-D galactosaminide
3 2'4 MU a-D-N-acetylneuraminic acid
4 4 MU a-L-fucoside
5 4 MU N-acetyl-p-D-glucosaminide
6 4 MU a-D-glucoside
7 4 MU p-D-glucoside
8 4 MU a-D-galactoside
9 4 MU oc-L-arabinopyranoside
10 4 MU P-D-galactoside
The methods used were adapted from those described by Whiley & Beighton (1998) 
and Kawamura et al., (1999) and were used in conjunction.
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2.4.4 Identification of isolates using comparative 16S rRNA gene sequencing
2.4.4.1 Preparation of reagents used during comparative 16S rRNA gene sequencing
2.4.4.1.1 TAE buffer
A stock solution of 50X TAE buffer was prepared by addition of 242 g Tris base, 57.1 
mL acetic acid and 100 mL 0.5M ethylenediaminetetraacetic acid (EDTA). The solution 
was made up to 1 L with distilled water and the pH adjusted to pH 8.5 
A working concentration (IX) was prepared by diluting 20 mL of 50X buffer with 980 
mL of distilled water.
2.4.4.1.2 Sequence buffer (400 mM TrisHCl, pH  9, containing 10 mMMgCl2)
0.4844 g of Tris HC1 and 2.033 g of MgCb were added to 7 mL of water. Following 
dissolution, the pH was altered to pH 9 using 1M acetic acid. The solution was made up 
to 10 mL with sterile water and aliquoted into 1 mL quantities before being autoclaved 
at 121°C for 15 minutes.
2.4.4.1.3 Sodium acetate
A 3M solution of sodium acetate was prepared by addition of sodium acetate (2.46 g) 
(BDH) to 10 mL of ultra pure water. The solution was sterile filtered into 1 mL aliquots.
2.4.4.2 Polymerase chain reaction (PCR) using universal primers
The total amplification reaction mixture volume was 100 pL, comprising 50 pL of a 
single bacterial colony suspension and 50 pL of the reaction solution. The total reaction 
volume of 100 pL contained a final concentration of 2 pM each deoxynucleoside 
triphosphate i.e. dATP, dCTP, dGTP & dTTP (Promega Ltd), at pH 8.3, 1 X buffer, 2.5 
mM MgCh (Bioline. London, UK) and 0.3 pM of each primer; 27F (5’- 
AGAGTTTGATCMTGGCTCAG-3 *) and 1492R (5’-TACGGYTACCITGTTACGACTT-3 ’) 
(Genset Corp. CA, USA), and 1 unit of Taq polymerase (Bioline. London, UK).
A colony of Escherichia coli was included as a positive control. A negative control 
comprised the reaction mixture plus sterile distilled water. A thermal cycler (MWG- 
Biotech Ltd. Milton Keynes, UK) was used to carry out the reaction parameters shown 
in table 2.4.
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Table 2.4 Parameters for PCR reaction using universal primers
i®Sil Theimocycling conditions
i Lid Heat 110°C
2 94°C for 5 minutes
3 94°C for 1 minute
4 54°C for 1 minute
5 72°C for 1.5 minutes
6 Loop back to stage 3, 29 times
7 72°C for 5 min
8 Lid Heat off
9 4°C
2.4.4.3 Visualisation of PCR products
A 1% agarose gel (Amresco Inc. Ohio, USA) was prepared with TAE buffer including 1 
pg/mL of ethidium bromide (Promega UK Ltd. Southampton). A 5 pL aliquot of each 
PCR product was mixed with 1 pL loading buffer and subjected to electrophoresis (100 
volts for 30 minutes). A molecular weight marker, PCR DNA marker ranging from 2.0 
kb to 0.5 kb (Amresco Inc. Ohio, USA) was also included to ascertain amplicon size. 
Gels were visualised under UV light (Alphalnnotech Corporation. California, USA) 
photographed and a digital image stored electronically.
2.4.4.4 PCR product purification
PCR products were cleaned using the QIAquick PCR purification kits (Qiagen Ltd. 
Crawley, UK), according to the manufacturer’s instructions. Briefly, DNA was bound to 
a solid matrix, washed and then eluted into a sterile centrifuge tube.
2.4.4.5 Sequencing reaction
The sequencing reaction was prepared as follows. The total reaction volume of 7 pL, 
contained 1 pL of cleaned DNA, 0.7 pM 357F (5’-c tc c ta c g g g a g g c a g c a g -3 5) primer 
and 2 pL Big Dye DNA Sequencing kit (Applied Biosystems Ltd. UK) diluted 1 in 4 
with 5x sequencing buffer A thermal cycler (MWG) was used to carry out the reaction 
parameters shown in table 2.5.
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Table 2.5 Parameters for sequencing reaction
Step Thermocycling conditions
1 Lid Heat 110°C
2 95°C for 10 secs
3 50°C for 5 secs
4 60°C for 4 minutes
5 Loop back to stage 2, 99 times
6 Lid Heat Off
7 4°C
2.4.4.6 Ethanol precipitation of sequenced product
Before analysing, products from the sequencing reaction were cleaned and re­
suspended before being loaded onto the sequencer for analysis. To the 7 pL sequence 
reactions, 15 pL water, 2 pL 3M sodium acetate and 50 pL 95% ethanol (chilled to 
minus 20°C), were added. The solution was incubated on ice for 20 minutes before 
being transferred to a 1.5 mL sterile centrifuge tube and centrifuged at an ref of 20817 x 
g for 25 minutes at 4°C. After centrifugation, the supernatant was carefully removed by 
pipette. Approximately 250 pL of 70% ethanol (chilled to minus 20°C) was added to 
the pelleted DNA.
The DNA plus alcohol were centrifuged at an ref of 20817 x g for 15 minutes at 4°C, 
before the supernatant was carefully removed by pipetting. The pellet was dried briefly 
at 95°C (with the lid open to facilitate evaporation), before being re-suspended in 20 pL 
of Template Suppressor Reaction (TSR) (Applied Biosystems. Cheshire, UK). The 
TSR-DNA solution was vortexed vigorously for 20 seconds, before incubation at 95°C 
for 5 minutes (with the lid closed to prevent evaporation). The suspension was again 
vortexed vigorously for 20 seconds, before being transferred to a septum-lidded 
sequencer tube and stored on ice until ready to be analysed by the sequencing machine 
(ABI310. Applied Biosystems).
2.4.4.7 Analysis of sequencing reaction
Following successful sequencing, data were analysed using the Chromas program 
(version 1.43. Griffith University. Brisbane, Australia). The resulting 
electrophoretogram was checked for peaks, quality and length of sequence (Example 
shown in figure 2.4). Data were then exported as a plain text file before submission to
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online databases, using BLAST version 2.2.9 to submit to the GenBank database (May
2004) (http://www.ncbi.nlm.nih.gov) and the Ribosomal Database project 
(http://rdp.cme.msu.edu) for alignment against held sequences.
Fig. 2.4 Example o f  electrophoretogram resulting from sequence analysis
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In order to obtain a species level identification, submitted sequence data had to have a 
higher than 0.7 match with the catalogued sequence on the RDP database and greater 
than a 95% similarity match using the GenBank database. Identities were assigned to 
isolates on a basis of closest matched similarity.
Only sequence data matched to type strains, complete 16S rDNA or strains that had 
been fully characterised and designated with a collection number were used for 
identification assignments. Sequence data from clones, strains not held in culture 
collections and any sequence shorter than lkb in length was precluded from 
identification comparison.
Where two species were matched to sequence data, both identities were recorded. If 
three or more species were suggested, a genus level identification was assigned. In the 
case of streptococcal isolates showing a high degree of homology but no definitive 
alignment to members of the mitis group streptococci, identity was given as mitis group 
streptococci; similarly with coagulase-negative staphylococci (CoNS), where two or 
more species were returned with equal weighting an identity of epidermidis 
staphylococcus was given.
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2.4.5 PCR-RFLP of partial sodA gene for the identification of oral streptococci
2.4.5.1 Reagents used for sodA PCR-RFLP
2.4.5.1.1 TBE buffer
One hundred and eight grams of Tris base, 55 g boric acid (BDH) were dissolved in 750 
mL of water before adding 40 mL 0.5 M EDTA (pH 8.0). The solution was made up to 
1 L using sterile distilled water. The working solution was prepared by diluting the 
stock buffer 1:10 with distilled water.
2.4.5.2 PCR amplification of the superoxide dismutase (sodA) internal gene fragment 
using primers D1 and D2 (Poyart et a l, 1998)
Single bacterial colonies were suspended in a total reaction volume of 50 pL, containing
1.5 pM of each primer, D1 (5’-CCITAYICITAYGAYGCIYTIGARCC-3’) and D2 (5’- 
ARRTARTAIGCRTGYTCCCAlACRTC-3’) (Sigma Genosys, UK), 0.2 pM each 
deoxynucleoside triphosphate, 1 x reaction buffer, 2.5 mM MgCl2 and 0.75 units of Taq 
polymerase (Bioline).
A thermal cycler (MWG) was used to carry out the reaction parameters shown in table 
2 .6 .
Table 2.6 Parameters o f sodA PCR reaction
Step Thermocycling conditions
l Lid Heat U0°C
2 95°C for 3 minutes
3 95°C for 30 seconds
4 47°C for 90 seconds
5 72°C for 90 seconds
6 Loop back to stage 2, 35 times
7 72°C for 10 minutes
8 Lid Heat off
9 4°C
Products were visualised using gel electrophoresis as described previously (section
2.4.4.3). Amplicons corresponded to bands approximately 0.5 kb in size.
2.4.5.3 Double restriction digest of sodA gene using Alul and Bglll
The restriction endonucleases for this method were selected by aligning the sodA gene 
sequence data for type strain streptococcal species using Clustal W (version 1.81) an 
online alignment program. Aligned sequences were analysed in silico using software
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(NEBcutter v 2.0. http://tcx)ls.neb.cx)m/NEBcutter2/index.php), which “restricted” the DNA 
sequence data. An example is shown in figure 2.5.
Alul and Bglll were the only enzymes which when used in conjunction could be used to 
restrict all the sodA genes from the selected strains and result in differential RFLP 
profiles. Amplicons from the appropriate PCR amplification were subjected to a 
restriction digest. The total reaction volume was 25 pL, containing 10 pL PCR product,
10.5 pL water, 2.5 pL 1 x Buffer, 1 pL Alul and lpL Bglll (New England Biolabs 
(UK) Ltd. Hitchin, UK). The reaction was incubated aerobically for 18 hours at 37°C.
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Fig. 2.5 Example o f an in silico digest of sodA gene sequence data
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2.4.S.4 RFLPofsodA PCR products
Digested products from the above were mixed with 1 pL loading buffer. A 3% SFR 
agarose (NBS Biologicals Ltd. Huntingdon, UK) gel using TBE buffer, containing 1 
pg/mL ethidium bromide solution. The products were subjected to electrophoresis (60 
volts for 2 hours). A molecular weight marker, HyperLadder V with fragments ranging 
from 25 to 500 kb was used (Amresco). The bands were visualised using a UV 
transilluminator. Band patterns were compiled and compared to type strains to build an 
alternative identification system for the oral streptococci.
2.5 Molecular detection of bacteraemia
2.5.1 Lysis buffer (5 M Guanidine HC1 -  100 mM Tris [pH 8])
Solution of 10 M Guanidine HC1 and 200 mM Tris (pH 8) were prepared, a 5 mL 
aliquot of each solution was added to a clean centrifuge tube and mixed before being 
subjected to 0.2 pm filter sterilization.
2.5.2. DNA extraction from whole blood containing SPS 
2.5.2.1. PureGene® genomic DNA isolation kit
DNA was extracted from whole blood containing SPS sample using the PureGene® 
Genomic DNA Isolation Kit (Gentra Systems, Minneapolis, USA). The standard DNA 
isolation from 300 pL whole blood protocol including RNase treatment as specified in 
the manufacturer’s instructions was used. Briefly, cells were lysed and treated with 
RNase solution, before being subjected to protein precipitation, DNA precipitation and 
finally DNA hydration steps.
2.5.2.2 Spectrophotometric determination of DNA concentration
Extracted DNA was assayed for concentration and quality using the automated function 
of the Ultrospec 2000 spectrophotometer (Pharmacia Biotech, Amersham Life Sciences. 
Little Chalfont, UK).
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2.5.2.3 Amplification o f GAPDH to confirm the extraction o f DNA
In order to demonstrate that DNA had indeed been extracted from the four culture- 
negative and four culture-positive samples, a PCR protocol which amplifies GAPDH 
was performed. The protocol was supplied by Dr. S. Lawton (personal communication). 
The total amplification reaction mixture volume was 50 pL, comprising 5 pL of 
extracted DNA and 45 pL of the reaction solution. The total reaction volume of 50 pL 
contained a final concentration of 0.2 mM each deoxynucleoside triphosphate i.e. 
dATP, dCTP, dGTP & dTTP (Promega Ltd), at pH 8.3, 1 X buffer 1.5 mM MgCl2 
(Bioline. London, UK) and 0.5 pM of each primer; GAPDH5’ (5’-TCT AGA CGG CAG 
GTC AGG TCC ACC -3’) and GAPDH3 * (5’- CCA CCA TGG CAA ATT CCA TGG CA -3’) 
(Sigma Genosys), and 1.25 units of Taq polymerase (Bioline. London, UK).
GAPDH template mRNA (courtesy of Dr. S. Lawton) was included as a positive 
amplification control. A negative control comprised the reaction mixture plus sterile 
distilled water. A thermal cycler (MWG-Biotech Ltd. Milton Keynes, UK) was used to 
carry out the reaction parameters shown in table 2.7.
Table 2.7 Parameters for PCR reaction
Step Thermocycling conditions
1 Lid Heat 110°C
2 94°C for 5 mins
3 94°C for 1 mins
4 65°C for 40 s
5 72°C for 1.5 mins
6 Loop back to stage 3, 29 times
7 72°C for 5 min
8 Lid Heat off
9 4°C
2.5.2.4 PCR amplification of 16S rRNA gene from DNA extractedfrom blood
Amplification of the 16S rRNA gene was performed as described in section 2.4.4.2; the 
template however consisted of 10 pL of extracted DNA plus 40 pL of water.
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2.5.2.5 Hemi- nested PCR reaction
A hemi-nested 16S rRNA PCR protocol was performed as per section 2.4.2.2 using the 
primers 27F (as above) and 1392R (5’- ACG GGC GGT GTG TAC A -3’) (Sigma Genosys). 
One pL of amplicons from the 27F and 1492R PCR was used as template.
2.5.2.6 Preparation of seeded blood samples for DNA extraction
S. sanguinis NCTC 7583 was plated out from cryovials onto BHI blood agar and 
incubated overnight under anaerobic conditions. N. mucosa NCTC 10777 was incubated 
overnight under aerobic conditions.
Isolates were assessed using Gram-staining, and catalase and oxidase determination for 
purity. Only Gram-positive cocci present in chains that were catalase- and oxidase- 
negative were used in the Streptococcus experiments. Gram-negative, catalase- and 
oxidase- positive isolates only were used in the Neisseria experiments.
Once purity had been verified a sterile swab was used to “pick” approximately 5 
colonies of each organism, which was then used to inoculate 10 mL of broth; Todd 
Hewitt broth (THB) (Oxoid) was used for streptococcal and Nutrient broth (NB) 
(Oxoid) was used for Neisseriaceae work. The broths were incubated under the 
appropriate conditions with shaking overnight.
Broths were Gram- stained to ensure no contamination had occurred.
The 10 mL broths were subjected to centrifugation at an ref of 1107 x g for 10 mins, 
before careful removal of the supernatant using a pipette. The pelleted cells were gently 
washed with 5 mL of phosphate- buffered saline (PBS) (Oxoid) and centrifuged at an 
ref of 1107 x g for 5 min. The supernatant was removed and the PBS washing step 
repeated.
Broths were serially diluted and cell numbers counted using a haemocytometer 
(Neubauer. Weber Scientific International. Teddington, UK).
For each organism, aliquots of 7 mL sterile defibrinated horse blood were seeded in 
duplicate to give inocula containing 108 cells to 10° cells. The first series were labelled 
A, the second B.
In order to assess the effect of SPS on these organisms, 1.44 mL of a 0.4% solution was 
added to series A. These seeded blood samples were the stock blood samples used for 
the evaluation of DNA extraction methods and PCR detection of bacteraemia.
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2.5.2.7 Benzyl alcohol-guanidine hydrochloride organic DNA extraction from blood 
containing SPS
DNA was also extracted from seeded samples of whole blood containing SPS according 
to a method described by Fredricks & Reiman (Fredricks and Reiman, 1998). Briefly, 
100 pL aliquots were prepared to which 100 pL of lysis buffer was added and vortexed, 
before the addition of 400 pL of water and 800 pL of benzyl alcohol and the solution 
vortexed. This solution was then centrifuged at an ref of 7000 x g for 5 minutes before 
the supernatant was removed to a clean centrifuge tube using a pipette. Forty pL of 3 M 
sodium acetate and 440 pL of isopropanol were added to the supernatant and 
centrifuged at an ref of 20817 x g for 15 minutes at 4°C. After centrifugation the 
supernatant was removed and discarded and the pellet washed using 200 pL 70% 
chilled ethanol; the centrifugation step was repeated. Excess supernatant was again 
removed with a pipette before the pellet was left to air dry. The pellet was then re­
suspended in 100 pL of 10 mM Tris- 0.1 mM EDTA (pH 8.5) solution.
2.5.2.8 Spectrophotometric determination of SPS removal
Sodium polyanetholesulfonate (SPS) was detected in samples by performing a scan of 
the optical density from 200 to 700 nm using a Gilford Response scanning 
spectrophotometer (Gilford Instruments, Ohio, USA). A peak at 284 nm was 
characteristic and indicative of the presence of SPS.
2.5.2.9 Sau3AI pre-treatment o f DNA master mix to prevent amplicon “carry over” 
contamination
Sau3AI pre-treatment of DNA master mix constituents: water, PCR buffer, MgCh and 
Taq DNA polymerase was performed as per the protocol described by Carroll et al 
(Carroll et al., 1999). Briefly, 1 unit of Sau3AI is added per unit of Taq used as well as 
the water, PCR buffer and MgCh in the reaction. This mixture is centrifuged briefly at 
an ref of 7000 x g and then incubated at 37°C for 30 minutes. The restriction enzyme is 
then inactivated by incubation at 95°C for 2 minutes.
The PCR then proceeded as standard.
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2.6 MIC determination of bacteraemia isolates
2.6.1 Preparation of antimicrobiotic-containing media
2.6.1.1 Isosensitest agar
Isosensitest agar (Oxoid Ltd. Basingstoke, UK) containing 5% v/v sterile defibrinated 
horse blood was prepared according to the manufacturer’s instructions. Typically, 380 
mL distilled water, 12 g Isosensitest agar (dehydrated), 20 mL sterile defibrinated horse 
blood were used to make the base agar, to which the antibiotic solution could be added.
2.6.1.2 Antibiotic agents
The antimicrobial agents (Table 2.7) were suspended in the appropriate solvent 
(National Committee for Clinical Laboratory Standards, 2003a) to 10 x breakpoint 
concentration and the stock solution was stored at minus 20°C until required. Stock 
solution of the antibiotic was added to a known quantity of agar to achieve the desired 
final concentration. Concentrations of: 0.125, 0.25, 0.5, 1, 2, 4, 8, 16, 32, 64, 128, 256 
and 512 pg/mL were used.
Table 2.8 Antimicrobial agents and sensitivity testing information
Antimicrobial
Breakpoint
(pg/mL) MIC range tested (pg/mL)
Ampieillin 8 2 -5 1 2 Water
Erythromycin 1 0.25-512 Absolute ethanol
Penicillin G 4 1-512 Water
Tetracycline 8 2-512 50% ethanol
Vancomycin 8 2-512 Water
Table 2.9. Addition o f antimicrobial solutions to agar
Stock solution (mg/mL)
Amount 
Added (pL) Final concentration (pg/mL)
8 100 2
8 200 4
8 400 8
8 800 16
8 1600 32
64 100 64
64 200 128
64 400 256
64 800 512
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The minimum inhibitory concentrations (MIC) of five antimicrobial agents for each of 
the isolates were determined. These agents were ampicillin, erythromycin, penicillin G, 
tetracycline and vancomycin.
2.6.2 Inoculation of antibiotic media
Isolates were cultured overnight on BH3 blood agar. A suspension of approximately 0.5 
McFarland standard of each isolate was prepared in phosphate buffered saline (Oxoid). 
To increase the throughput of isolates, a multipoint inoculator was utilised, up to 34 
isolates per plate to be assayed (Mast Dianostics Ltd). An example of an inoculated agar 
plate is shown in figure 2.6.
Fig. 2.6 An example o f  a chromogenic agar plate inoculated using the multi point 
inoculator
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One hundred microlitres of each bacterial suspension was aliquoted into the wells of a 
PTFE multipoint pan. An automated inoculation head was dipped into the wells, which 
transferred approximately 2 pL of each suspension to the agar plate. Inoculated plates 
were left at room temperature until the inoculum had dried. The plates were then 
inverted and incubated for 18-24 hours at 37°C, before being observed for growth. 
Growth was scored as positive if 5 or more colonies could be counted, these areas of 
growth indicated resistance to the antibiotic. The lowest concentration at which no 
growth was observed was regarded as the minimum inhibitory concentration.
Positive and negative controls were included in the assay, a control organism, S. aureus 
NCTC 6571, sensitive to the antimicrobial agents being tested, and a negative control 
consisting of PBS was also included on each plate.
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Antibiotic free plates were also inoculated to check for bacterial growth under the test 
conditions.
2.7 Cryo storage and retrieval of isolates
Microbank vials containing beads (Prolab Diagnostics Ltd. Wirral, UK) were inoculated 
with pure 18 to 72 hour cultures according to the manufacturer’s instructions and stored 
at -80°C. To grow isolates from cryopreservation, one bead was removed from the vial 
using a sterile pipette tip under aseptic conditions. The bead was rubbed across the 
surface of a BHI blood agar. Plates were incubated anaerobically (unless the isolate was 
an obligate aerobe) at 37°C and checked every 24 hours for a maximum of 5 days.
If isolates failed to grow from cryostorage on two occasions, the isolate was recorded as 
non-recoverable. As a quality control measure, viable isolates were always Gram- 
stained and catalase reaction determined. These results were compared to the expected 
reaction of the isolate and continuation of studies only proceeded if the two concurred.
Subcultures were made twice weekly of “in progress” isolates using BHI blood agar. 
All subcultures were stored at 4°C.
2.8 Bacterial strains
The bacterial strains used in this study were obtained from the National Collection of 
Type Cultures (NCTC), London, UK unless stated otherwise. The bacteria and the 
usage of each strain are listed in table 2.10. All bacteria were maintained on BHI blood 
agar (section 2.2.1.1) and stored long term as described in section 2.8
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Table 2.10 Reference cultures and usage
Organism Designation Purpose
Strep, anginosus NCTC 10713 streptococcal identification
Strep, australis* NCTC 13166 streptococcal identification
Strep, constellatus NCDO 2226 streptococcal identification
Strep, cristatus NCTC 12479 streptococcal identification
Strep, gordonii NCTC 7865 streptococcal identification
Strep, infantis 0 -122** streptococcal identification
Strep, intermedius NCDO 2227 streptococcal identification
Strep, mitis NCTC 12261 streptococcal identification
Strep, mutans NCTC 10449 streptococcal identification
Strep, oralis NCTC 11427 streptococcal identification
Strep, parasanguinis NCTC 55898 streptococcal identification
Strep, peroris 0 -66** streptococcal identification
Strep, pneumoniae NCTC 7465 streptococcal identification, catalase test 
negative control, media validation
Strep, salivarius NCTC 8618 streptococcal identification
Strep, sanguinis NCTC 7863 streptococcal identification
Strep, sobrinus NCTC 12279 streptococcal identification
Strep, vestibularis NCTC 12166 streptococcal identification
Staph, aureus NCTC 6571 catalase test positive control, media 
validation
Staph, epidermidis NCTC 11047 media validation
E. coli NCTC 10418 PCR positive control DNA, oxidase test 
negative control, media validation
Ps. auruginosa NCTC 10662 oxidase test positive control
N. mucosa NCTC 10777 Molecular detection of bacteraemia
NCTC = National Collection of Type Cultures; NCDO = National Collection of Daily Organisms: 
* kindly donated by Dr Willcox; ** kindly donated by Dr. R. Whiley
2.9 Statistical analyses of results
Bacteraemia data was assessed using the statistical software package GraphPad Prism 
version 2.0 (GraphPad Software. CA, USA). Normal data distribution was assessed and 
statistical analyses were chosen. Prevalence of bacteraemia following extraction was 
compared to baseline using the Fisher’s exact test (two-tailed). Intensity of bacteraemia 
was tested for statistical significance using the Wilcoxon’s test (two-tailed) and 
correlation between patient characteristics including age, number of extracted teeth and 
dental status were compared to intensity data using Spearman’s correlation test 
(described in Langley, 1970).
Species diversity was measured using the Shannon-Wiener Index. This index and 
evenness of species distribution were calculated using the Microsoft Excel-based online
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tool: http://wvv\v.\vorldagroforcst.n'.org/sites/rsu/resources/bicxiiversit\/an.alvsist\pes/diversit\:indiccs.asp.
Statistical significance was of species diversity was measured using the unpaired t-test 
within the GraphPad Prism suite.
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3.0 Detection and quantification of bacteraemia following 
multiple dental extractions in children
3.1 Introduction
Patients undergoing dental extraction may experience an asymptomatic, transient 
bacteraemia (Berry, Jr. et al., 1973). During tooth removal, bacteria are forced into the 
bloodstream through the mechanics of the extraction, where they are attacked by the 
reticulo-endothelial system. This was demonstrated in 1937 by Burkett & Bum, who 
painted bacteria around the tooth and tissues prior to extraction before recovering the 
same organism, Serratia marcescens from the patients blood (Burket and Bum, 1937). 
These bacteraemia can instigate serious systemic disease including IE (Bayliss et al., 
1983a), (Beeley, 1969) and abscesses of the brain and other parenchymous organs (Li et 
al., 1999). People who are immunocompromised or who have a history of cardiac 
abnormalities are more predisposed to the sequelae of bacteraemia. In normal, healthy 
individuals however, the chance of a transient bacteraemia resulting in a serious 
systemic infection are low; data suggests that fewer than 20 cases of IE will occur each 
year in the UK (Young, 1987).
There is much data on the prevalence of odontogenic bacteraemia but less information 
is described in the literature regarding the persistence of microbiota in the blood, i.e. the 
duration of bacteraemia (Roberts et al., 1992). The fate of the bacteria in the blood is an 
important issue to investigate in order to understand if the bacteria entering the 
bloodstream during iatrogenic bacteraemia can persist and lead to colonisation of distant 
sites.
The advantages of lysis filtration (LF) over conventional broth based detection methods 
for the detection of odontogenic bacteraemia are well documented. LF has been 
reported as a highly sensitive method for the detection and enumeration of odontogenic 
bacteraemia (Zierdt et al., 1977), (Heimdahl et al., 1985), . LF has been used to 
successfully detect and characterise bacteraemia following oral surgical procedures in 
adults (Heimdahl et al., 1990), and dental extraction in children (Lucas et al., 2002a).
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Advantages include the separation of bacteria from the bactericidal properties of blood 
or antibiotic present in the patient’s sera, the ability to grow bacteria as individual 
colonies in proportion to the original sample without risk of competition and the ability 
to quantitate the intensity of the bacteraemia (Sullivan et al., 1975b), (Hockett et al., 
1977), (Yagupsky and Nolte, 1990).
3.2 Materials and methods
3.2.1 Subjects
Of the 700 patients consulted, 500 consented to recruitment and completed the study. 
The subject group was composed of 277 (55.4%) male subjects aged 1.1 to 18.7 years 
(median 6.2 years); and 223 (44.6%) female subjects aged 2.4 to 15.8 years (median 7.2 
years). The subjects underwent extraction of teeth ranging in number between 1 and 28 
teeth (median 5 teeth from male subjects, 4 teeth from female subjects).
3.2.2 Detection of bacteraemia
Baseline (pre-extraction) and post-extraction samples were collected and subjected, in 
two aliquots, to lysis filtration. Filters applied to BH3 blood agar were incubated for 10 
days and checked for bacterial growth between the third and final day of incubation. 
Figure 3 .1 is an example of a filter colonised by four isolates.
Fig. 3.1 Bacterial colonies grown on LFfilter
Bacterial colonies were enumerated based on colony morphology and basic 
microbiological characteristics such as respiration, Gram-stain, catalase and oxidase 
determination. Isolates were sub-cultured, identified and then stored at -80°C. The
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identification of the isolates recovered from the bacteraemia is discussed later (chapter 
7).
3.2.3 Statistical analyses of data
Data from the 1 minute group subjects including age, number of teeth extracted and 
plaque and gingivitis indices were compared to intensity of bacteraemia to investigate 
correlation using the Spearman correlation (section 2.9).
3.3 Results
3.3.1 The prevalence of bacteraemia following dental extraction in children
The isolated bacteria were compared between the pre-extraction and post-extraction 
sample for each subject. Bacteria were excluded as post-extraction isolates if they 
presented in both the pre- and post-extraction sample; 9 subjects were found to have the 
same organism present both pre- and post-extraction. Isolates were also discounted if 
the same species occurred on a medium or process negative control. Throughout the 
incubation period, it was often found (62 pre-extraction samples, 57 post-extraction 
samples of which 8 subjects had growth on both pre- and post-extraction filters) that 
Micrococcus spp would colonise filters, as suspected contaminants they were 
discounted from this study. The prevalence of bacteraemia found in this study is shown 
in table 3.1.
The prevalence of pre-extraction bacteraemia ranged from 10% in the 30 min group to 
30% in the 15 min group. In total 18.6% of subjects had a detectable bacteraemia prior 
to dental treatment. Following dental treatment, bacteraemia was detected in a total 
46.4% of subjects. Post-extraction bacteraemia was found to be more prevalent among 
the subjects of the 1 min group, with 76% of subjects having a detectable bacteraemia. 
Post-extraction bacteraemia was detected least often in the 45 min group with 22% of 
subjects having culture-positive samples.
To determine the level of bacteraemia induced by dental extraction a comparison was 
made between the prevalence of bacteraemia detected in the pre- and post-extraction 
samples. These data are shown in table 3.1.
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Table 3. L Comparison ofpre- and post-extraction prevalence o f bacteraemia
Time group
Culture- positive samples (n-)
P valuePre-extraction (%) Post-extraction (%)
10 s 10 (20) 31 (62) <0.0001***
30 s 9(18) 34 (68) <0.0001***
1 min 7(14) 38 (76) <0 .0001***
2 min 8(16) 26 (52) 0.0003***
4 min 9(18) 22 (44) 0 .01**
7.5 min 14 (28) 21 (42) 0.21 M
15 min 15 (30) 20 (40) 0.40 m
30 min 5(10) 15 (30) 0 .02*
45 min 6 (12) 11 (22) 029
60 min 10 (20) 14 (28) 0.48115
Statistical significance calculated using Fisher’s exact test
113 = not statistically significant; * = significant; ** = very significant; *** =extremely significant.
The data presented in table 3 .1 shows that the greatest difference between prevalence of 
bacteraemia preceding dental extraction and that of samples taken at different time 
intervals post-extraction occurred in the 1 min group; with a 542% increase in the 
prevalence of bacteraemia. The least difference shown between pre- and post-extraction 
samples occurred in the 60 min group with only a 140% increase. The trend of 
prevalence of bacteraemia decreasing with time elapsed after extraction is also shown in 
table 3.1; following extraction, bacteraemia tends to increase until 1 min and after this 
time begins to gradually decrease in prevalence
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3.3.2 The intensity of bacteraemia following dental extraction in children
The technique of LF is particularly useful for the investigation of bacteraemia because 
unlike other methods such as broth culture it is possible to quantitate the level of 
bacteraemia. The use of filters placed onto agar and incubated also allows the 
quantification of each individual species present in the bacteraemia and prevents 
problems such as competition and overgrowth of dominant species masking the 
diversity of a sample. Figure 3.2 shows the total number of bacteria in colony forming 
units detected for each time group.
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Fig. 3.2 Mean viable bacteria recovered from pre- and post-extraction samples
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Statistical significance calculated using Wilcoxon’s rank test113 = not statistically significant; * = significant; ** = veiy significant; *** = extremely significant
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Figure 3.2 shows that the largest numbers of bacteria were recovered from post­
extraction samples in particular from the 1 min post-extraction group. There was a large 
decrease in number of bacteria recovered from the 30 s group compared to the earlier 10 
s, before a sharp increase in intensity. This pattern differs when compared to the 
prevalence data; the 30 s post-extraction group had the second highest prevalence of 
bacteraemia, compared to the fourth highest level of intensity.
Intensity of bacteraemia was compared for the different time groups to assess if post­
extraction bacteraemia was statistically different if compared to baseline values. Table
3.2 shows the comparative total pre- and post-extraction intensity of bacteraemia.
Figure 3.2 also shows that when compared to pre-extraction values, the intensity of 
bacteraemia was significantly higher from 10 s to 7.5 min following dental extraction in 
the subjects studied. The greatest difference occurred between 30 s and 4 min post­
extraction.
Transient bacteraemia such as those occurring after dental treatment are typically low 
grade in terms of cfu/mL. Table 3.2 presents the range and mean values of intensity of 
bacteraemia recovered for each group. It shows that the intensity of bacteraemia 
detected in the study was very low, ranging from 0 to 53.0 cfu/sample among the pre­
extraction samples and from 0 to 245.0 cfu/sample among the post-extraction samples. 
The sample with the highest detected intensity was a 1 min group subject.
Table 3.2 Pre- and post-extraction range and mean values ± standard deviation o f
intensity
Pre­
extraction (cfii/sample)
Mean flf lllg i! Post­
extraction
Range
(cfu/sample)
Mean £sd
10 s 0 to 21.0 1.42 4.94 10 s 0 to 147.0 8.64 23.58
30 s 0 to 3.0 0.30 0.71 30 s 0 to 17.0 2.48 3.80
1 min 0 to 4.0 0.26 0.75 1 min 0 to 245.0 14.88 39.27
2 min 0 to 8 0.40 1.41 2 min 0 to 162.0 7.82 26.06
4 min 0 to 4.0 0.30 0.79 4 mpi 0 to 14.0 1.68 2.99
7.5 min 0 to 4.0 0.42 0.84 7.5 min 0 to 7.0 1.68 1.39
15 min 0 to 53.0 1.62 7.54 15 min 0 to 20.0 1.18 3.47
30 min 0 to 6.0 0.20 0.88 30 min 0 to 5.0 0.44 0.91
45 min 0 to 2.0 0.20 0.53 45 min 0 to 36.0 2.04 7.46
60 min 0 to 2.0 0.22 0.46 60 min 0 to 34.0 1.20 4.92
sd = standard deviation.
105
Chapter 3 ~ Detection and quantification of bacteraemia following multiple dental extractions in
children
3.3.3 Relationship between intensity of post-extraction bacteraemia with age and 
dental factors
Data from the 1 min subjects was investigated for evidence of relationships between 
intensity, age, number of teeth extracted, plaque and gingival indices. Existence of a 
relationship was assessed using the Spearman correlation test. The relationships tested 
and presence or absence of correlation are summarised in table 3.3.
Table 3.3 Relationship between intensity and dental factors
Parameter versus intensity Range rvalue
Age 3.3 to 13.9 years 0.045 “
No. teeth extracted 2 to 14 teeth 0.24153
Plaque index 0 to 76 0.003 08
Gingival index 0 to 76 0.11 “
Statistical significance calculated with Spearman’s correlation test; m = not statistically significant.
Table 3.3 shows that there was no relationship proven between intensity and the dental 
factors investigated.
3.4 Discussion
3.4.1 Prevalence of pre-extraction bacteraemia in children
During this study, the LF technique was used successfully to investigate the pre- and 
post-extraction blood samples of 500 children undergoing dental extraction. The 
prevalence of pre-extraction bacteraemia was found to occur in 18.8% of the subjects 
overall. Other studies have been undertaken to investigate bacteraemia and oro-dental 
procedures in children, the pre-procedure bacteraemia ranged from 0% to 39% (Bender 
and Pressman, 1945), (Berry, Jr. etal., 1973), (Peterson and Peacock, 1976), (Coulter et 
al., 1990), (Roberts etal., 1992), (Roberts etal., 1997), (Roberts e ta l,  1998), (Lucas et 
al., 2002a). In two studies however, no pre-procedure sample was taken, in one case this 
was for “humanitarian reasons” (De Leo et al., 1974), (Coulter et al., 1990), while the 
other made no reference to pre-extraction samples. Without pre-extraction samples it is 
impossible to gauge the true prevalence and intensity of post-extraction bacteraemia or 
to make valid statistical inferences (Heimdahl et a l, 1990).
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Of the remaining studies, the closest prevalence of pre-extraction but post-intubation 
bacteraemia events is 11.3% (Roberts etal., 1998). The only study however, that is truly 
comparable is that conducted by Lucas et a l, 2002 which used LF as a detection 
method. Lucas et al., detected a pre-extraction prevalence of 31% which is considerably 
higher than the present study. Comparatively the present study differs from the Lucas 
study which included micrococci as legitimate isolates, whereas they were discounted 
from the present study due to concern over contamination (discussed further in chapter 
7).
3.4.2 Prevalence of post-extraction bacteraemia in children
The study showed that post-extraction bacteraemia was most frequently detected in the 
samples taken 1 min after the maximal manipulation of the tissues had occurred. 
Bacteraemia was also frequent at 10 s post-extraction followed by a sudden decrease in 
prevalence of culture-positive samples. From 1 min post-extraction, bacteraemia 
declined steadily. Between 10 s post- to 4 min post-extraction, the differences between 
pre- and post-extraction bacteraemia for each group were found to be significantly 
different. At 30 min post-extraction, another statistically significant increase in 
bacteraemia was detected.
The prevalence data presented in this study showed that the prevalence of bacteraemia 
was greatest at 1 min post extraction, but that the bacteraemia caused by the dental 
manipulation was essentially resolved by the immune system at around 7.5 min post­
extraction, where the statistical difference between pre- and post-extraction could no 
longer be proven. These findings are supported by previous studies. In a study of adults 
undergoing dental extraction, in 1945, Bender et al found that bacteraemia occurring 
immediately after dental extraction occurred in 83.3% of the subjects. This frequency 
was diminished to 33.3% prevalence by 10 min post-extraction; a 50 % reduction 
(Bender et al., 1945). Another study conducted on adults following dental extraction 
found that prevalence of post-extraction bacteraemia diminished from 21.1% at 1 
minute post extraction to 13.1% 5 min post-extraction (Robinson et al., 1950).
The data presented were compared to findings of similar previous studies conducted on 
children. Roberts et al., 1992 sampled blood in odontogenic bacteraemia to determine
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the optimum time and therefore most prevalent period of bacteraemia following 
extraction. The authors found that bacteraemia was most prevalent (56%) at 30 s post­
extraction. The results also showed a gradual decline in prevalence to the lowest value 
(28%) at 10 min post extraction (Roberts etal., 1992).
The results obtained in the present study, showed higher levels of prevalence than the 
study by Roberts et al., this may be due to the different culture and detection methods 
used; Roberts et al., used the automated blood culture system BACTEC, not LF 
(Roberts et al., 1992). The efficacy of LF compared to conventional broth bottle 
systems such as BACTEC has previously been investigated. In 1982, Zierdt et a l, used 
a rabbit model seeded with known concentrations of pathogenic microorganisms. Using 
a 5 mL blood sample, detection of bacteraemia using LF was 81% compared to 56% 
detection using the un-named broth system (Zierdt et al., 1982). In a separate clinical 
study of 43 patients undergoing oral surgery (18 of whom were receiving antibiotic 
prophylaxis). LF detected bacteraemia in 72.1% of patients compared to only 39.5% 
using the BACTEC system. In a further study, LF was significantly better at detecting 
bacteraemia (77.8%) from those patients receiving prophylaxis than BACTEC (27.8%) 
(Heimdahl et al., 1985).
LF is more sensitive for detecting bacteraemia than conventional broth bottle systems 
because the lysing step used releases phagocytosed bacteria for potential detection and 
because the filtration of the sample removes the bacteria from the antibacterial action of 
blood and antimicrobial agents (Sullivan et al., 1975b), (Zierdt et al., 1977), (Heimdahl 
e ta l,  1985).
3.4.3 Intensity of pre-extraction bacteraemia in children
Bacteraemia in children has been described in the literature as being typically low grade 
but of greater magnitude, in terms of colony forming units (cfu/mL), than of that 
described in adults (Washington and Ilstrup, 1986). Due to their smaller physical size, 
smaller volumes of blood are taken from children for culture; theoretically, this 
increases the difficulty of detection of bacteraemia in children and emphasises the 
requirements for a sensitive detection method such as LF.
During this study, 18.8% of the subjects were considered to have experienced pre­
extraction bacteraemia. The intensity of pre-extraction bacteraemia among subjects
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ranged between no bacteria detected to 53.0 cfu/sample; this finding was interesting as 
pre-extraction blood samples were expected to be sterile. Subjects were assigned 
randomly to time groups and were all treated in the same manner at this sample point. 
As LF is a quantitative detection method, the ability to compare intensity of pre-and 
post-extraction bacteraemia allows further understanding of the role of the practitioner 
and the implications for focal infection.
3.4.4 Intensity of post-extraction bacteraemia in children following dental 
extraction
Intensity of post-extraction bacteraemia ranged between no bacteria detected to 245.0 
cfu/sample with the greatest intensity being detected in the 1 min sample group. This 
study found intensity of bacteraemia to be statistically significant when compared to 
pre-extraction intensity from 10 s to 4 min post-extraction, and anomalously at 30 min 
post-extraction. The finding of a statistically significant intensity of bacteraemia at 30 
min post-extraction is an anomaly as the data are somewhat skewed; 3 subjects 
accounted for 89.2% of the colony forming units detected at this time point.
Since very few investigations have been performed which investigate the intensity of 
bacteraemia following dental extraction in children; therefore, comparison of these data 
is difficult. The closest data available, where paediatric odontogenic bacteraemia 
detection was compared for LF and BACTEC, involved blood sampling at 30 s post­
extraction of a single tooth. In the Lucas study, the greatest intensity of bacteraemia 
ranged between 0.17 to 2.83 cfu/mL from the 30 s group subjects, which when 
extrapolated is comparable to the data from this study which isolated 0.17 and 4.7 
cfu/mL at 30 s post-extraction (Lucas et al., 2002a). The intensity data collated from 
these subjects supports the prevalence data in suggesting that post-extraction 
bacteraemia following dental extraction in children reaches a peak at 1 min post­
extraction and that intensity diminishes from this maximal point until 7.5 min post­
extraction. At an undefined point between 4 and 7.5 min post-extraction, the immune 
system appears to clear the invading oral bacteria from the bloodstream. This finding is 
supported by similar quantitative studies which show approximately 90% of 
bacteraemia to have resolved at 10 min post-extraction (Heimdahl et al., 1990).
3.4.5 Relationship between intensity and dental factors
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Data from the 1 min subjects was selected for analysis of correlations between dental 
factors and intensity of bacteraemia because bacteraemia was most prevalent at this time 
point. No relationship was found between subject age, number of teeth extracted and 
dental indices for plaque and gingivitis. Other studies into dental bacteraemia have 
investigated relationships between subject factors and bacteraemia. In a study which 
investigated bacteraemia following dental extractions in children, no relationship was 
found between the incidence of bacteraemia and the number of teeth extracted or 
between the plaque index or the gingival index and the incidence or intensity of 
bacteraemia (Coulter et al., 1990). Different studies however report different trends; in 
another study of bacteraemia following surgical procedures in children, while no 
relationship was found between the number of teeth extracted and bacteraemia 
decreased gingival health was associated with bacteraemia (Roberts et al., 1998). This 
finding was also reported in a study which investigated bacteraemia following 
periodontal probing and scaling (Fomer et al., 2006). The differences in these trends are 
probably due to the wide diversity of design, methods and protocols and choice of 
subjects; therefore, it is difficult to properly evaluate whether such subject factors 
influence bacteraemia or whether the incidence and magnitude o f bacteraemia is 
random.
The low grade nature of post-extraction bacteraemia seen in this study supports 
previously published opinions that contest that dental extraction and other oral surgical 
procedures are responsible for cases of IE. The risk of endocarditis arising from dental 
procedures was estimated by formulation of a cumulative exposure index, in which 
physiological sources of bacteraemia e.g., mastication are compared to a single dental 
extraction (Guntheroth, 1984). These authors postulate that everyday actions such as 
chewing and tooth brushing over one calendar month result in 1000 times greater 
exposure to bacteraemia than a single dental extraction. Therefore IE, even where the 
aetiological agent is considered part of the normal oral microbiota, is more likely to be 
caused by a continual “seeding” of the blood from chronic oral conditions than from 
singular events such as extraction (Guntheroth, 1984). This theory is supported by the 
time elapsed between extraction and onset of symptoms. Although not definitive, the 
incubation period of IE is believed to be up to 14 days, many reports in the literature 
however include dental treatment carried out up to one year before the onset of disease.
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The opinion that dental interventions are not responsible for as many cases of IE has 
been increasingly reported in the literature; many authors now agree that good oral 
hygiene is the best prevention of IE caused by oral microbiota (Cawson, 1981), (Bayliss 
et al., 1983a), (Lockhart, 2000), (Tomas, I etal., 2002), (Wahl and Pallasch, 2005)
A benefit of the LF technique is the ability to isolate and enumerate discreet colonies, 
allowing detection of an organism where only one colony forming unit is produced. 
This sensitivity is precluded from broth culture methods where under-represented 
organisms can easily be hidden from detection due to the antibacterial activity of blood 
or antibiotics and the competition of other organisms (Weinstein, 1996). The design of 
this study allowed the changing nature of post-extraction bacteraemia to be observed.
3.5 Limitations of the study
The largest limitation of this study was the inability to measure bacteraemia over time 
within each patient. This was not possible due to the ethical considerations of sampling 
blood from children over a prolonged period. Had this been possible, for example 
sampling the same patient from 10 s to 30 min, much more detail could have been 
gained about the fate of different bacteria in the bloodstream. Although a good picture 
of bacteraemia has been gained from these data, longitudinal data would have been even 
more insightful as to the persistence of different bacteria in the blood stream.
The act of “splitting” the sample during filtration is another limitation of the LF 
technique. As this data has shown, transient bacteraemia following dental extraction is 
low and only 1 colony forming unit per 6 mL of blood was often detected. For example, 
If only 1 cfu of a strict anaerobe existed in a 6 mL sample and that bacterium was 
aliquoted to the aerobic filter, the sample would have been deemed culture-negative. For 
this reason alone, it would be prudent to investigate the possibility of performing 
anaerobic incubation only.
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3.6 Conclusions
• Post-extraction bacteraemia is prevalent among children and occurs in up to 
76% of those undergoing one or more dental extractions.
• Post-extraction bacteraemia was most prevalent at 1 minute post-maximal 
manipulation.
• The intensity of bacteraemia is significantly greater following dental extraction 
when compared to pre-extraction data from 10 s to 4 min after maximal 
manipulation.
• Bacteraemia is extinguished by the immune system between 4 and 7.5 min after 
a dental extraction.
• Lysis filtration is a useful way to quantitate transient bacteraemia such as those 
following dental extraction.
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4.0 Biochemical characterisation of odontogenic bacteraemia 
isolates
4.1 Introduction
In order to understand the phenomena and implications of iatrogenic dental bacteraemia 
it is important to fully characterise the bacteria involved. The oral cavity is a complex 
habitat involving numerous ecological niches which is believed to encompass at least 
500 species (Tanner et a l, 1994), (Paster et al., 2001). Due to the diversity of the oral 
bacteria and the fastidious nature of many of the isolates of the gingival crevice 
(Socransky and Manganiello, 1971) it was understood from the outset of the study that 
bacterial identification may pose many challenges. The aim of this study was to identify 
bacteria to genus level using standard microbiological tests such as Gram-stain, catalase 
and oxidase tests combined with the results of growth on selective media. Selective 
media have been used to isolate and enumerate oral bacteria from saliva (Kamma et a l, 
2000), (Sonbol et al., 2001), and in biofilms (Pratten et al., 2000), (Pratten et a l,  2003). 
The use of selective media provides a simple, cost-effective means for differentiating 
bacteria.
The identification of streptococci is a major issue in oral microbiology due to the 
various sites colonised in the oral cavity and the frequency of isolation from oral 
sampling sites (Tanner etal., 1994), (Tanner e ta l, 2002). The streptococci are involved 
in early plaque development (Socransky and Manganiello, 1971), associated with 
cariogenesis (Zambon and Kasprzak, 1995) and have been implicated in a number of 
serious systemic infections (White and Niven, 1946), (Brook, 1980), (Pawlak et al., 
1984), (Kalouche et a l,  2005). The fermentation and hydrolysis of carbohydrates and 
the detection of pre-formed enzymes are well established methods which have been 
used to characterise oral streptococci (Beighton et al., 1991b), (Beighton et al., 1991a), 
(Whiley and Beighton, 1998).
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4.2 Materials and methods
4.2.1 Standard microbiological tests
Bacteria were isolated from patients undergoing dental extractions pre- and post­
extraction (Chapter 3). These isolates were routinely subcultured and frozen for later 
use (section 2.7). Gram-staining (2.4.1.1), catalase (2.4.1.2) and oxidase (2.4.1.3) tests 
were performed on all isolates on initial detection; Gram-staining and catalase testing 
was performed on subsequent subcultures to verify purity. The biochemical 
identification process is outlined in figure 4.1.
Fig. 4.1 Flow chart showing biochemical identification process
Subculture
Selective media panel
Pure culture, 
stocks frozen
Presumptive
identification
Gram stain, catalase and 
oxidase determination
Isolates recovered from LF plates
Carbohydrate fermentation 
and hydrolysis +enzyme 
utilisation tests
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4.2.2 Use of selective media
Once purified, isolates were diluted to 0.5 McFarland standard and inoculated into a 
multipoint inoculator; up to 34 isolates could be plated onto each plate of selective 
media. Isolates were then inoculated onto the following selective media mitis salivarius 
agar (MS), MS plus sucrose and bacitracin agar (MSB), mannitol salt agar (MAS), 
Rogosa agar (ROG), cadmium fluoride Acriflavin tellurite (CFAT) (Zylber and Jordan, 
1982), bile aesculin agar (BAE), and Veillonella spp agar (VEI); in addition, isolates 
were inoculated onto a plate of BHI blood agar. Two sets of media were inoculated, one 
set was incubated aerobically and the other set incubated anaerobically (section 2.4.1.4). 
Table 4.1 summarises the selective media and the bacterial growth supported.
Table 4.1 Selective media and cultural response
Selective medium Growth organisms Inhibited organisms Reference
Mitis salivarius agar Streptococci,
Enterococci
Most Gram-negative bacilli and 
gram-positive bacteria except 
streptococci
(Chapman,
1944)
Mitis salivarius + 
sucrose and 
bacitracin
Mutans streptococci Non-mutans streptococci in 
addition to mitis salivarius 
performance
(Gold et al., 
1973)
Mannitol salt agar Staphylococci,
micrococci
Most other bacteria (Chapman,
1945)
Bile aesculin agar Enterococci, bile 
tolerant organisms
Staphylococci (Facklam and 
Moody, 1970)
Rogosa agar Lactobacilli Non lactic acid bacteria including 
streptococci and staphylococci
(Rogosa et ah, 
1951)
CFAT agar Actinomyces spp Gram-negative bacteria and 
streptococci
(Zylber and 
Jordan, 1982)
Veillonella agar Veillonella spp Diphtheroids, streptococci and 
micrococci
(Rogosa et al., 
1958)
4.2.3 Assigning presumptive identifications
Characteristics for each isolate were recorded including results of Gram-stain, catalase 
test, oxidase test, respiration and growth on selective media. These characteristics were 
then reviewed in conjunction to assign a presumptive genus level identification. Figures
4.2, 4.3 and 4.4 summarise the decision processes used for assigning presumptive 
identifications to Gram-positive cocci, Gram-positive rods and Gram-negative cocci 
respectively.
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Fig. 4.2 Gram-positive cocci identification process
peptostreptococci
Oxidase negative
enterococci
Facultative Anaerobe
streptococci
Gemella spp
Growth on mitis 
salivarius agar
Aerobic Growth on 
MS/sucrose/ 
bacitracin agar
Growth on Mannitol 
Salt agar
Gram-positive cocci
staphylococci
Anaerobic
micrococci
Catalase positive
Oxidase positive
Mutans streptococci
Growth on Bile 
aesculin agar
Catalase negative
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Fig. 4.3 Gram-positive rod identification processes
Oxidase positive
Bacillus spp Corynebacterium, 
Rothia & Propionibacterium 
spp
Catalase negative
Actinomyces spp
Catalase positive
Lactobacillus spp
Gram-positive rods
Growth on CFAT agarGrowth on Rogosa 
agar
Oxidase negative
Fig. 4.4 Gram-negative cocci identification processes
_C
Catalase positive
I
Oxidase positive 
■ ------------
Gram negative cocci
X
Aerobic Anaerobic
i
Neisseria spp Acinetobacter spp
Branhamella spp
1
Catalase negative
I
Growth on Veillonella agar
I
Anaerobic
I
Veillonella spp
4.2.4 Biochemical characterisation of oral streptococci
Isolates deemed to be streptococci were Gram-positive, catalase and oxidase negative 
cocci whose growth was supported by MS; these isolates were then further characterised 
using assays for the fermentation and hydrolysis of selected carbohydrate substrates and 
the utilisation of 4-methylumbeliferyl enzyme substrates as described in section 2.4.2. 
Identification data from previously published papers were used to compile identification 
matrices for the present study (Beighton et al., 1991a), (Whiley and Beighton, 1998), 
(Kawamura etal., 1995b).
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4.3 Results
4.3.1 Gram-stain morphology, catalase and oxidase tests and growth on selective 
media
Of the recovered isolates (n = 365), 42.4% were recovered from the aerobically 
incubated filters and 57.6% from the anaerobic filters. Biochemical characterisation was 
used to assign a presumptive identification to each isolate; 209 isolates were subjected 
to characterization on the basis of their biochemical characteristics. The proportions of 
different Gram-stain morphologies are shown in table 4.2.
Table 4.2 Gram-stain morphologies
Gram-stain Morphology n~(%)
Gram-positive cocci 99 (47.4)
Gram-positive rods 97 (46.4)
Gram-negative cocci 6 (2.9)
Gram-negative rods 7 (3.3)
The data in table 4.2 show that the majority of isolates (93.8%) are Gram-positive; 
approximately equally divided between rods and cocci. The results of the biochemical 
characterisation were separated into groups based upon whether an isolate was Gram- 
positive or Gram-negative, rod or cocci. These results are represented along with the 
presumptive identification where possible in tables 4.3 to 4.5.
Using the chart shown in figure 4.2, Gram-positive cocci were assigned presumptive 
identifications where possible. Table 4.3 shows that the majority of the isolates (32.3%) 
that had Gram-positive cocci morphology were characterised as streptococci. Of the 
isolates that were characterised as streptococci, 13 isolates also grew on MSB agar 
indicating that they were mutans streptococci. Isolates characterised as staphylococci 
accounted for 29.3% of the Gram-positive cocci with 7 isolates being characterised as S. 
aureus due to the production of yellow halos around colonies on MAS agar. Twenty 
two isolates were not assigned a presumptive identification where no growth was seen 
on selective media or where conflicting phenotypic results were seen, for example, a 
catalase-positive isolate growing only on MS agar. Of the remaining isolates, 
enterococci and micrococci accounted for 8% and 4% respectively. Unexpectedly, 4%
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of the Gram-positive cocci were assigned as Actinomyces spp. This was due to a 
phenotype of catalase-negative combined with growth only on CFAT agar.
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Table 4.3 Isolated Gram-positive cocci biochemical characteristics and presumptive identification
Gram Cat Ox MS MSB MAS BAE CFAT ROG m i Respiration Presumptive identification
GPC diplococci □ □ □ □ □ □ ■ □ □ 0 2/An02 Actinomyces sp.
GP diplococci □ □ □ □ □ □ ■ □ □ 0  2/An0 2 Actinomyces sp.
GP coryneform □ □ □ □ □ □ ■ □ □ 0 2/An02 Actinomyces sp.
GPC coccobaciliaiy □ □ □ □ □ □ ■ o □ 0 2/An02 Actinomyces sp.
GPC □ □ ■ □ □ ■B □ □ o o 2 Enterococcus sp.
GPC □ □ ■ □ □ ■B □ □ □ 0 2/An02 Enterococcus sp.
GPC coccobaciliary □ □ ■ □ □ ■B ■ □ □ 0 2/An02 Enterococcus sp.
GPC diplococci □ □ ■ ■ □ ■B □ □ □ 0 2/An02 Enterococcus sp.
GPC □ □ ■ □ □ ■B □ □ □ 0 2/An02 Enterococcus sp.
GPC □ □ ■ □ □ ■B □ □ □ 0 2/An02 Enterococcus sp.
GPC coccobaciliary □ □ ■ □ □ ■B □ □ □ 0 2/An02 Enterococcus sp.
GP diplococci □ □ □ □ □ ■B □ □ □ 0 2/An02 Enterococcus sp.
GPC ■ □ ■ □ ■ □ ■ □ □ 0 2/ An02 ?
GPC ■ □ □ □ □ □ □ □ □ 0 2/ An02 ?
GPC ■ □ □ □ □ □ ■ □ □ An02 ?
GPC ■ □ □ ■ □ □ □ □ □ o 2 ?
GPC irregular ■ □ □ □ □ □ □ □ □ o 2 ?
GPC tetrads ■ □ □ □ □ □ □ □ □ o 2 ?
GPC irreg. tetrads ■ □ □ □ □ □ □ □ □ o 2 ?
GPC short chains □ □ □ □ □ □ □ □ □ 0 2/An02 ?
GP = Gram-positive; GPC = Gram-positive cocci; □ = negative; ■ = positive; B = black pigmentation; Y = yellow pigmentation; P = pink pigmentation; O = orange 
pigmentation; 0 2 = aerobic growth; An02 = anaerobic growth;? = no identification inferred
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Cat Ox MS MSB MAS BAE CFAT ROG n n Respiration Presumptive identification
GPC lattice ■ □ □ □ □ p p p p 0 2/An02 ?
GPC ■ □ □ ■ □ p p p □ 0 2/An02 ?
GPC □ □ □ □ □ p p p p An02 ?
GPC □ □ □ □ □ p p p p 0 2/An02 ?
GPC □ □ □ □ □ p p p p 0 2/An0 2 ?
GPC □ □ □ □ □ p p p p 0 2/An02 ?
GPC diplococci ■ □ ■ □ p □ ■ p p 0 2/ An02 ?
GPC short chains □ ■ ■ □ p p ■ p p 0 2/An02 ?
GPC ■ □ □ □ p p p p p 0 2/An02 ?
GPC coccobaciliary? □ □ o □ p □ p p p 0 2/An02 ?
GPC ■ □ □ ■ p p p p p o2 ?
GPC ■ □ □ □ p p p p p An02 ?
GPC □ □ □ □ p ■ p p p 0 2/An02 ?
GPC ■ □ □ □ p p p p p o2 ?
GPC ■ □ ■ □ ■O ■ ■ p p 0 2/An02 Micrococcus sp.
GPC clusters ■ ■ □ □ p p p p □ 0 2/ An02 Micrococcus sp.
GPC tetrads ■ □ □ □ p ■ p p p o2 Micrococcus sp.
GPC lattice ■ □ ■ □ p p p p □ o2 Micrococcus sp.
GPC diplococci □ □ ■ ■ ■ p ■ ■ p An02 mutans streptococcus
GPC diplococci □ □ ■ ■ p □ p p □ 0 2/An02 mutans streptococcus
GP = Gram-positive; GPC = Gram-positive cocci; □ = negative; ■ = positive; B = black pigmentation; Y = yellow pigmentation; P = pink pigmentation; O = orange 
pigmentation; 0 2 = aerobic growth; An02 = anaerobic growth;? = no identification inferred
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§ ® i Ox MS MSB MAS BAE CFAT ROG il!S§ Respiration Presumptive identification
GPC short chains □ □ ■ ■ □ □ □ □ □ 0 2/An02 mutans streptococcus
GPC □ □ ■ ■ □ □ □ □ □ 0 2/An02 mutans streptococcus
GPC □ □ ■ ■ □ □ □ □ □ 0 2/An02 mutans streptococcus
GPC □ 0 ■ ■ □ □ □ □ □ O 2/An0 2 mutans streptococcus
GPC □ □ ■ ■ ■ □ □ □ □ 0 2/An02 mutans streptococcus
GPC □ □ ■ ■ □ □ □ □ □ 0 2/An02 mutans streptococcus
GPC coccobaciliaiy □ □ ■ ■ □ □ □ □ □ 0 2/An02 mutans streptococcus
GPC diplococci □ □ ■ ■ □ □ ■ □ □ 0 2/An02 mutans streptococcus
GPC diplococci □ □ ■ ■ □ □ ■ □ □ An02 mutans streptococcus
GPC short chains □ □ ■ ■ □ 0 □ □ □ 0 2/An02 mutans streptococcus
GPC short chains □ □ ■ ■ □ ■ ■ ■ □ 0  2/ An02 mutans streptococcus
GPC ■ □ ■ □ ■Y □ □ □ □ 0 2/An02 Staph, aureus
GPC lattice ■ □ □ □ ■Y □ □ □ □ 0 2/An02 Staph, aureus
GPC ■ □ □ □ ■Y ■ □ □ □ o2 Staph, aureus
GPC ■ □ □ □ ■Y □ □ □ □ O 2/An0 2 Staph, aureus
GPC large, irreg ■ □ □ □ ■Y □ □ □ □ o2 Staph, aureus
GPC ■ □ ■ ■ ■Y □ ■ □ □ 0 2/An02 Staph, aureus
GPC ■ □ ■ ■ ■Y □ ■ □ □ O2/ An02 Staph, aureus
GPC ■ □ □ □ ■P □ ■ □ □ o2 Staphylococcus sp.
GPC ■ □ □ □ ■P □ □ □ □ o2 Staphylococcus sp.
GP = Gram-positive; GPC = Gram-positive cocci; □ = negative; ■ = positive; B = black pigmentation; Y = yellow pigmentation; P = pink pigmentation; O = orange 
pigmentation; O2= aerobic growth; An02 = anaerobic growth;? = no identification inferred
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f i i i i i f c MS MSB MAS BAE CFAT ROG l i i i l i H i i i i i i ® Presumptive identification
GPC tetrads ■ □ □ □ ■P ■ □ □ □ o 2 Staphylococcus sp.
GPC ■ □ □ □ ■P □ □ □ □ 0 2/An02 Staphylococcus sp.
GPC irregular ■ □ ■ ■ ■P ■ □ □ ■ 0 2/An02 Staphylococcus sp.
GPC clusters ■ □ □ □ ■P □ ■ □ □ 0 2/An0 2 Staphylococcus sp.
GPC clusters ■ □ ■ ■ ■P ■ ■ □ □ 0 2/An0 2 Staphylococcus sp.
GPC clusters ■ □ ■ ■ ■P □ ■ □ □ 0 2/An02 Staphylococcus sp.
GPC ■ □ □ □ ■P □ □ □ □ 0 2/An02 Staphylococcus sp.
GPC clusters ■ □ ■ ■ ■P □ ■ □ □ 0  2/An0 2 Staphylococcus sp.
GPC ■ □ □ □ ■P □ □ □ □ 0 2/An02 Staphylococcus sp.
GPC ■ □ □ □ ■P □ □ □ □ o2 Staphylococcus sp.
GPC tetrads ■ □ □ □ ■P □ ■ □ □ o2 Staphylococcus sp.
GPC clusters ■ □ ■ ■ ■P ■ ■ □ □ 0 2/An02 Staphylococcus sp.
GPC clusters ■ □ ■ ■ ■P □ □ □ □ 0 2/An02 Staphylococcus sp.
GPC ■ □ ■ □ ■P □ □ □ □ 0 2/An02 Staphylococcus sp.
GPC clusters ■ □ ■ ■ ■P □ ■ □ □ An02 Staphylococcus sp.
GPC ■ □ □ □ ■P □ □ □ □ o2 Staphylococcus sp.
GPC ■ □ □ □ ■P □ □ □ □ 0 2/An02 Staphylococcus sp.
GPC ■ □ □ □ ■P □ □ □ □ o2 Staphylococcus sp.
GPC ■ □ □ □ ■P □ □ □ □ o2 Staphylococcus sp.
GPC ■ □ □ □ ■P □ □ □ □ o2 Staphylococcus sp.
GP = Gram-positive; GPC = Gram-positive cocci; □ = negative; ■ = positive; B = black pigmentation; Y = yellow pigmentation; P = pink pigmentation; O = orange 
pigmentation; O2 = aerobic growth; An02 = anaerobic growth;? = no identification inferred
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Gram w m Ox MS MSB MAS BAE CFAT ROG I ® ! Respiration Presumptive identification
GPC ■ □ □ □ ■P □ □ □ □ o 2 Staphylococcus sp.
GPC □ □ ■ □ □ □ □ □ □ 0 2/An02 Streptococcus sp.
GPC □ □ ■ □ □ □ □ □ □ O 2/An0 2 Streptococcus sp.
GPC □ □ ■ □ □ □ □ □ □ An02 Streptococcus sp.
GPC diplococci □ □ ■ □ □ □ □ □ □ 0 2/An02 Streptococcus sp.
GPC short chains □ □ ■ □ □ □ □ □ □ O 2/ An02 Streptococcus sp.
GPC short chains □ □ ■ □ □ □ ■ □ □ 0 2/An02 Streptococcus sp.
GPC short chains □ 0 ■ □ □ ■ ■ ■ ■ 0 2/An02 Streptococcus sp.
GPC diplococci □ □ ■ □ □ □ □ □ □ 0 2/An02 Streptococcus sp.
GPC coccobaciliary □ □ ■ □ □ □ ■ □ □ 0 2/An02 Streptococcus sp.
GPC □ □ ■ □ □ □ □ □ □ 0 2/An02 Streptococcus sp.
GPC □ □ ■ □ □ □ □ □ □ 0 2/ An02 Streptococcus sp.
GPC diplococci □ □ ■ □ □ □ □ □ □ 0 2/An02 Streptococcus sp.
GPC short chains □ □ ■ □ □ □ □ □ □ 0 2/An02 Streptococcus sp.
GPC short chains □ □ ■ □ □ □ □ □ □ 0 2/An02 Streptococcus sp.
GPC ■ □ ■ □ □ □ ■ □ □ 0 2/An02 Streptococcus sp.
GPC □ □ ■ □ □ □ □ □ □ An02 Streptococcus sp.
GPC diplococci □ □ ■ □ □ □ ■ □ □ 0 2/An02 Streptococcus sp.
GPC short chains □ □ ■ □ □ □ □ □ □ 0  2/ An02 Streptococcus sp.
GPC □ □ ■ □ □ □ □ □ □ 0 2/An02 Streptococcus sp.
GP = Gram-positive; GPC = Gram-positive cocci; □ = negative; ■ = positive; B = black pigmentation; Y = yellow pigmentation; P = pink pigmentation; O = orange 
pigmentation; O2 = aerobic growth; An02 = anaerobic growth;? = no identification inferred
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Table 4.4 Isolated Gram-positive rod biochemical characteristics and presumptive identification
i f i i i l l l t t l l Ox MS MSB MAS BAE CFAT ROG I f l l f l l Respiration
Presumptive
identification
GPR short chains - + + . - - - - An02 ?
GPR coryneform - - _ _ - - - - - 0 2/An02 ?
GPR coryneform - + + _ . - - + - 0  2/ An02 ?
GPR - - _ _ _ - - - - 0 2/An02 ?
GPR coryneform - - - . - - - - - 0 2/An02 ?
GPR - - _ _ _ - - - - 0 2/ An02 ?
GPR - . _ _ _ _ - - - 0 2/An02 ?
GPR coryneform - - - . - - - - 0 2/An02 ?
GPR - - - _ _ - - - - 0 2/An02 ?
GPR coryneform - - - - - - - - - An02 ?
GPR - - - _ . - - - - An02 ?
GPR coryneform - - - - - - - - - An02 ?
GPR coryneform - - - - - - - - - 0 2/An02 ?
GPR - - - - - - - - - An02 ?
GPR - - - - - - - - - An02 ?
GPR - - - - - - - - - An02 ?
GPR coryneform - - + - - - + - + An02 ?
GP coryneform? - - - - - - - - - 0 2/An02 ?
GP coccobaciliaiy - - - - - - - - - 0 2/An02 ?
GP coccobaciliary - - + - + - + - - An02 ?
GP = Gram-positive; GPR = Gram-positive rod; GvR = Gram-variable rod; CAT = catalase; OX = oxidase; w = weak reaction; 0 2 -  aerobic growth; An02 = anaerobic 
growth; ? = no identification inferred; CRP = Corynebacterium, Rothia or Propionibacterium.
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Gram Ox MS MSB MAS BAE CFAT ROG VEI Respiration Presumptive identification
GPR coryneform - - - - - - + - - 0 2/An02 Actinomyces sp.
GPR coryneform - - + - - - + - - 0 2/An02 Actinomyces sp.
GPR coryneform - - + - . - + - - 0 2/An02 Actinomyces sp.
GPR - - - - . - + - - 0 2/An02 Actinomyces sp.
GPR chains - - - - - - + - - 0 2/An02 Actinomyces sp.
GPR - - - - - - + - - 0 2/An02 Actinomyces sp.
GPR - - + - . . + - - An02 Actinomyces sp.
GPR - - - - - - + - - 0 2/An02 Actinomyces sp.
GPR coryneform - - - - + - + - - An02 Actinomyces sp.
GPR coryneform - - - - - - - - - An02 Actinomyces sp.
GPR coryneform - - - - - - - - - An02 Actinomyces sp.
GPR coryneform - - - - - - - - - An02 Actinomyces sp.
GPR coryneform - - - - - - - - - 0 2/An02 Actinomyces sp.
GPR coryneform - - - - - - + - - 0 2/An02 Actinomyces sp.
GPR coryneform - - - - - - + - - 0 2/An02 Actinomyces sp.
GPR - - - - - - + - - 0 2/An02 Actinomyces sp.
GPR - - - - - - + - - 0 2/An02 Actinomyces sp.
GPR coryneform - - - - - - + - - 0 2/An02 Actinomyces sp.
GPR coryneform - - - - - - + - - An02 Actinomyces sp.
GPR - - - - - - + - - O 2/ An02 Actinomyces sp.
GP = Gram-positive; GPR = Gram-positive rod; GvR = Gram-variable rod; CAT = catalase; OX = oxidase; w = weak reaction; O2 -  aerobic growth; An02 = anaerobic 
growth; ? = no identification inferred; CRP = Corynebacterium, Rothia or Propionibacterium.
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Gram Cat Ox MS MSB MAS BAE CFAT ROG i f H i Respiration
Presumptive
identification
GvR - - - - - - + - - 0 2/An02 Actinomyces sp.
GPR coryneform w - - - - - + - - 0 2/An02 Actinomyces sp.
GPR coryneform w - - - - - + - - 0 2/An02 Actinomyces sp.
GPR + + - - + +B - - - 0 2/ An02 Bacillus sp.
GPR coryneform + - - - - - + - - 0 2/An02 CRP
GPR coryneform + - - - - - + - - 0 2/An02 CRP
GPR coryneform + - - - - - + - - 0 2/An02 CRP
GPR + - + + + +B + - - 0 2/An02 CRP
GPR + - - - + - - - - 0 2/An02 CRP
GPR coryneform + - - - - - + - - 0 2/An02 CRP
GPR long chains + - - - - - + - - 0 2/An02 CRP
GPR + - - - - - + + - 0 2/An02 CRP
GPR + - - - - - + - - An02 CRP
GPR + - - - - - + - - An02 CRP
GPR coryneform + - + + + + + - - An02 CRP
GPR + - + + + - - - - 0 2/An02 CRP
GPR spores + - - - - - + - - 0 2/An02 CRP
GPR coryneform + - - - - - + - - An02 CRP
GPR + - - - - - + - - An02 CRP
GPR coryneform + - - - - - + - - 0 2/ An02 CRP
GP = Gram-positive; GPR = Gram-positive rod; GvR = Gram-variable rod; CAT = catalase; OX = oxidase; w = weak reaction; 0 2 -  aerobic growth; An02 = anaerobic 
growth; ? = no identification inferred; CRP = Corynebacterium, Rothia or Propionibacterium.
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Gram Cat Ox MS MSB MAS BAE CFAT ROG Respiration Presumptive identification
GPR coryneform + - - - - - + - - An02 CRP
GPR coryneform + - - - - - - - An02 CRP
GPR coryneform + - - - - . + - - 0 2/An02 CRP
GPR coryneform + - + - - - + - - 0 2/An02 CRP
GPR + - + - _ _ . - An02 CRP
GPR + - - - + + + . - 0 2/An02 CRP
GPR coryneform + - - - - - - - An02 CRP
GPR + - + + - + + + + An02 CRP
GPR + - - - - - - - - 0  2/ An02 CRP
GPR + - - - - - - - - 0  2/ An02 CRP
GPR + - - - - - + - - 0 2/ An02 CRP
GPR + - - - - - + - - 0  2/ An02 CRP
GPR + - - - - - - - - 0 2/An02 CRP
GPR + - - - - - - - - o2 CRP
GPR + - - - - - - - - o2 CRP
GPR + - - - - - - - - o2 CRP
GPR + - - - + + + - - 0 2/An02 CRP
GPR + - - - + + + - - 0 2/An02 CRP
GPR coryneform + - - - - - - - - 0 2/An02 CRP
GPR coryneform + - + + + - - - - 0 2/An02 CRP
GP = Gram-positive; GPR = Gram-positive rod; GvR = Gram-variable rod; CAT = catalase; OX = oxidase; w = weak reaction; 0 2 -  aerobic growth; An02 = anaerobic 
growth; ? = no identification inferred; CRP = Corynebacterium, Rothia or Propionibacterium.
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Gram Cat Ox MS MSB MAS BAE I B B t? ROG i l l n Respiration Presumptive identification
GPR coryneform + - - _ + - - - - 0 2/ An02 CRP
GPR lattice - - - . - + - 0 2/An02 L a c to b a c il li sp.
GPR - - - - . - + + - 0 2/An02 Lactobacilli/Actinomyces sp.
GPR - . _ _ _ _ + + - An02 Lactobacilli/Actinomyces sp.
GPR branched - _ _ _ _ _ + + - 0 2/An02 Lactobacilli/Actinomyces sp.
GPR - . _ _ _ _ + + _ 0 2/An02 Lactobacilli/Actinomyces sp.
GPR w - _ _ _ + + _ 0 2/An02 Lactobacilli/Actinomyces sp.
GPR branching w - - - _ _ + + - An02 Lactobacilli/Actinomyces sp.
GPR chains w - - . . . + + - 0 2/An02 Lactobacilli/Actinomyces sp.
GPR chains w - - - _ _ + + _ 0 2/An02 Lactobacilli/Actinomyces sp.
GPR w - - - . _ + + - 0 2/An02 Lactobacilli/Actinomyces sp.
GPR coryneform - - + + - - - - - 0 2/An02 S tre p to c o c c u s  sp.
GPR coryneform - - + - - - - - - 0 2/An02 S tre p to c o c c u s  sp.
GPR - - + - - - - - - 0 2/An02 S tre p to c o c c u s  sp.
GPR - - + - - - - - - 0 2/An02 S tre p to c o c c u s  sp.
GP tiny - - + - - - - - - 0 2/An02 S tre p to c o c c u s  sp.
GP diplococci? - - + + - + - - - 0 2/An02 S tre p to c o c c u s  sp.
GP = Gram-positive; GPR = Gram-positive rod; GvR = Gram-variable rod; CAT = catalase; OX = oxidase; w = weak reaction; 0 2 -  aerobic growth; An02 = anaerobic 
growth; ? = no identification inferred; CRP = Corynebacterium, Rothia or Propionibacterium.
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Table 4.4 demonstrates the phenotypic characteristics of isolates deemed as Gram- 
positive rods. Using the chart shown in figure 4.3, presumptive identifications were 
assigned where possible. The majority of Gram-positive rods (38.1%) were deemed to 
belong to the Corynebacterium, Rothia or Propionibacterium genera as they tested 
catalase-positive; most of these isolates grew on the CFAT medium. Isolates that were 
catalase-negative and grew on CFAT agar were deemed to be Actinomyces spp; these 
isolates accounted for 23.7% of the Gram-positive rods. Twenty isolates (20.1%) were 
not assigned an identification due to missing or conflicting biochemical characteristics, 
for example an isolate that grew on Rogosa agar that had tested positive for oxidase. 
Lactobacillus and Bacillus species accounted for one isolate each. Nine isolates (9.3%), 
could not be separated from Actinomyces spp or Lactobacillus spp due to the fact that 
they tested catalase negative and grew on both Rogosa agar and CFAT medium. 
Surprisingly, 6 isolates were assigned to Streptococcus, due to their phenotype of 
growth on only MS agar; of these 6 isolates, 4 had ambiguous Gram-stain 
morphologies, for example, the rods were short and coccid.
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Table 4.5 Phenotypic characteristics o f isolated Gram-negative bacteria
Gram CAT OX MS MSB MAS BAE CFAT ROG i i i i Respiration Presumptive identification
GNC - - + _ _ _ + - + An02 Veillonella sp.
GNC - - . _ _ _ _ . An02 ?
GNC - - - . _ _ . + An02 Veillonella sp.
GNC - - + . _ + _ . . An02 ?
GNC - + - - - _ + - An02 ?
GNC + + - _ - _ _ _ _ An02 Acinetobacter sp.
GNR w + + _ _ + _ An02 ?
GNR + - - - - +B . . . o 2 ?
GNR filamentous - - - - - - . - + An02 Fusobacterium/Leptotrichia sp.
GNR w - - - - +B . . _ o 2 ?
GNR - - - - - - - - - An02 Fusobacterium/Leptotrichia sp.
GNR + + - - - - - - - 02/An02 ?
GNR + + - + - - - + - 02/An02 ?
GNC -  Gram-negative cocci; GNR = Gram-negative rod; CAT = catalase; OX = oxidase; 0 2 = aerobic growth; An02 = anaerobic growth; ? = no identification 
inferred.
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Of the 209 isolates included in this study, only 13 (6.2%) were Gram-negative bacteria. 
The Gram-negative isolates were assigned presumptive identifications using the chart in 
figure 4.4 for Gram-negative cocci; Gram-negative rods were presumed to be 
Leptotrichia or Fusobacterium spp if they tested catalase- and oxidase-negative and 
were anaerobic. Table 4.5 shows the phenotypic characteristics of the Gram-negative 
bacteria. Of the 6 isolates that were coccid, 2 produced growth on Veillonella agar and 
were identified as Veillonella spp; 1 isolate was identified as Acinetobacter as it tested 
both catalase- and oxidase-positive. Three Gram-negative cocci could not be assigned 
an identity due to lack of phenotypic characteristics. Of the 7 Gram-negative rods, only 
two isolates could tentatively be identified as possible Leptotrichia or Fusobacterium 
spp.
All isolates were subcultured and incubated both aerobically and anaerobically to assess 
the respiration type (these data are shown in tables 4.4, 4.5 and 4.6). The majority of the 
isolates (67.0%) inoculated onto the selective media panel grew both aerobically and 
anaerobically, 12.0% of the isolates grew under aerobic incubation only and 21.0% 
under anaerobic conditions only.
4.3.2 Characterisation of oral streptococci using carbohydrate fermentation and 
hydrolysis and detection of pre-formed enzyme assays
To assess the reliability of the method, type strains of oral streptococci were subjected 
to these identification protocols on two separate occasions using the same reagents but 
with fresh inocula; the results are shown in table 4.6. The results presented in table 4.6 
show that none of the 11 reference strains assayed returned the same profile of 
carbohydrate fermentation and hydrolysis on both occasions. Agreement between the 
two runs varied from 36% agreement for S. vestibularis to 91% agreement for S. 
cristatus. Table 4.6 also shows that only 3 strains (S. cristatus, S. gordonii and S. mitis) 
would have been correctly identified using the protocol on one occasion each using the 
data achieved from this assay.
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Table 4.6 Evaluation o f  carbohydrate fermentation and hydrolysis assay using
type strains
Strain Run
Fermentation Hydrolysis
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5. anginosusNCTC 10713 1 - + - + - 4 4 4 - 4 4
2 + - + + - 4 4 4 - - -
Published data + 4 - + - ~ V - - 4 4
S. cristatus NCTC 12497 1 - - - + - - 4 - - - 4
2 - - - + - - 4 - - 4 4
Published data - 4 - + - - 4 V - - 4
S. gordonii NCTC 7865 1 + + + + 4 4
2 - - + + - - 4 - - 4 4
Published data 4 4 + + - V 4 V - 4 4
S. mitis NCTC 12261 1 - - - + - 4 4 4 - - -
2 + 4 - + - - 4 - - 4 -
Published data - - V 4 - 4 4 4 - - -
S. oralis NCTC 11427 1 - - - + - 4 - - - - -
2 - - 4 + - 4 4 - - - -
Published data V V - + - V 4 V - V -
S. panasanguinis NCTC 55898 1 - 4 - - - 4 4 4 - 4 4
2 - 4 - - - - 4 - - 4 4
Published data V V - 4 - V 4 V v V 4
S. pneumoniae NCTC 7465 1 - - 4 4 - 4 4 4 - - -
2 4 4 - 4 - 4 4 4 - 4 4
Published data - - 4 4 - - V 4 - - V
S. sanguinis NCTC 7863 1 - - + 4 - - 4 - - - -
2 - - - 4 - 4 4 4 - - -
Published data V V V 4 - V 4 V V V 4
S. mutans NCTC 10449 1 - + + 4 4 - 4 4 - - -
2 - - + 4 - 4 4 - - - -
Published data V 4 4 4 4* V 4 V 4 4 -
S. sobrinus NCTC 12279 1 - - - 4 4 4 4 4 - - -
2 - - - 4 - - 4 - - - -
Published data - - 4 4 -L - - - V - -
S. salivarius NCTC 8618 1 4 + - 4 4  • -
2 4 + 4 4 - - 4 - - 4 4
Published data V 4 V 4 - V V V - 4 -
-  = negative; +  = positive; V = variable; AMY= amygdalin; ARB= arbutin; INU = inulin; LAC 
= lactose; MAN = mannitol; MEL = melibiose; NAG = n-acetylglucosamine; RAF = raffinose; 
SOR = sorbitol; AES = aesculin; ARG = arginine.
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Table 4.7 Presumed identities from carbohydrate fermentation and hydrolysis and pre-formed enzyme utilisation assays for 145 streptococci
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- - + + + - + + + + S. mutans + + + - - - + S. oralis/pneumoniae
+ + - + - - + - - + + ansinosus group . - + - + + - - - + CND
+ + + + + + + + + + S. mutans - - - - - + - - - - S. mutans
- - - + - - + + - - - mitis group - - + - + - - - - + S. oralis
+ + + + + + + + + + - S. mutans - - - - - - + - - - S. mutans
+ + + + + + + + + + - S. mutans - - - - - - + - - - S. mutans
+ + + + - - + + - + + S. gordonii non reactive
+ + - + - - + + - + + S. gordonii/intermedius + + + - + + - - - + S. intermedius
- - - + - - - - - - - CND - - - - - + - - - - CND
- - - + - - + - - - - S. oralis - - + - + - - - - + S. oralis
- - + + + - + + + - - S. mutans non reactive
non reactive non reactive
- - - + - - + - - - + mitis group - - + + + - - - - + S. oralis
- - - - - - + - - - + CND - - + - + + - - - - S. oralis/pneumoniae
- + + + + - + + + + - S. mutans - - + - + - - - - + S. mitis/oralis/pneumoniae
- - - + - - + - - - - mitis group - - + - + - - - - + S. oralis
+ + - + - - + - - + + S. gordonii/intermedius + + - - - S. anginosus/mutans
+ + - + - - + - + + + S. sanguinis/parasanguinis + CND
+ + + + + + + + + + - S. mutans - - - - + - + - - - CND
+ + + + - - + - - + + S. gordonii - - - - + - + - - + S. gordonii
+ - - + - + + + - - - S. parasanguinis + S. oralis
+ + + + + + + + + + - S. mutans - - - - - - + - - - S. oralis
- - - + - + + + - - - S. oralis - - + . + - - - - + S. oralis
- - - + - + + + - - - S. oralis - - + _ + _ - - - + S. oralis
- - - + - + + + - - - S. oralis - - + . + - - - - + S. oralis
- - - + - - + + - - - S. oralis - - + _ + - - - - + S. oralis
+ + - + - - + - - + - anginosus group - - _ . + + _ - - + S. anginosus
- - - + - - + + - - S. mitis _ + + _ + + - - - + S. oralis/pneumoniae
- - - + - - + + - - - S. oralis _ _ _ _ - + - - - - CND
- - + + + . _ + + - . S. mutans _ _ _ _ - + - - - - S. mutans
+ + - + - . + _ _ + + anginosus group + _ + + + _ - - + S. intermedius
+ + - + - - + - - + + anginosus group + + + - + + + - - + S. intermedius
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- - - + - + + + - - - S. mitis/oralis _ + + + - - + S. oralis
- + + + - + + + + - - S. mutans melibiose - - - - - - + + - - - S. mutans
- - + + - - + + - - S. mitis non reactive
- - + + - - + - + - + S. mitis + CND
- - - + - - + - - - - S. oralis non reactive
- - - + + CND - - - - - + - - - + CND
+ + - + - - + - - + + anginosus group - - - - - - + - - + S. anginosus
+ + + + - - + + + - anginosus group - - - - - + + - - - S. anginosus
- - + + + - - + + - - S. mutans - - - - - + - - - - S. mutans
- - + + + - + + + + - S. intermedius - - - - - + + - - - CND
- - - + + CND + CND
- - + + - - + - + + + S. sanguinis non reactive
- - + + - - + - + - - S. mitis non reactive
- - - + - + + + - - - S. mitis/oralis - - - - - + - + - + S. mitis
- - - + - + + + - - - S. mitis/oralis - + - + - - - - - + S. mitis/oralis
+ + + + - - + + + + - S. salivarius + + S. salivarius
+ + - + - - + - + + anginosus group - - + - + + - - - + S. intermedius
- - - + - + + + - - - S. mitis/oralis - - + - + + - - - + S. oralis
+ + - + - - + - + + - anginosus group - - + - + + - - - + S. intermedius
+ + + - + - + + + + - S. mutans - - - - - - + - - S. mutans
- - - + - - + + - - - S. oralis - - + - + + - + . + S. mitis/pneumoniae
+ + + + - - + + - + - S. salivarius - - - - - - + - + S. salivarius
+ + - + - - + * - + + anginosus group - - - - - - + - - - S. anginosus
- + + + - - + - + - + CND + CND
- - - + - - + - . - - mitis group - + + - + + _ - + S. oralis
- - + + - - + - - - - CND non reactive
+ + + + - + - + - + S. sanguinis - - _ + + _ + - - + CND
- - - + - + + - - - S. mitis - _ _ _ _ + _ - - CND
- - - + - + + + . + - S. salivarius _ _ _ . + + . - + CND
- - - + + + - + - - S. mutans _ - + + + - - - + S. oralis/pneumoniae
- + + + + + + + + + - S. mutans _ _ _ . _ + + - . - S. mutans
+ + - + - . + _ _ + + S. intermedius _ _ _ _ + . _ - - CND
- - - + - + + + - - - S. mitis/oralis - - + - + + - - - + S. oralis/pneumoniae
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+ + - + - - + - - + + S. intermedius + ~ + - - - - CND
- + + - - - + - - + + S. gordonii . - _ + + - + - - - S. gordonii
- - - •f - - + - - _ _ S.. australis/parasanguinis _ _ _ . - + - - - - CND
- + + + + - + + + + _ S. mutans melibiose - . _ _ . - + - - - - S. mutans mel-
- - - + - - + + - - _ S. oralis CND
+ + + + - - + - - + + S. gordonii . _ . + - + - - + S. gordonii
+ + + + + - + + + + _ S. mutans _ _ _ _ - + + - - - S. mutans
- + + + + + + + + + S. mutans . _ _ _ - + + - - - S. mutans
+ + - + - - + - - + + anginosus group non reactive
- - - + - - + - - - . mitis group _ _ + _ - + - - - + S. oralis
- - + + - - + - + - S. mitis non reactive
- - + + + - + + + - - S. mutans non reactive
- - - + - - + - - - mitis group _ + + _ + + - - - + S. oralis
- + + + + + + + + + - S. mutans _ _ _ . - - + - - - S. mutans
- - - + - + + + - - - S. mitis/oralis _ + - + + - - - + S. oralis
- + - + - - + + + + + CND - - - - - - + - - + CND
- - - + - - + + - - - S. oralis - + - + + - - - + S. oralis
- + - + - - + - - + + CND - - - - - - + - - - S. anginosus
- + + + + + + + + + - S. mutans - - - - - - + - - - S. mutans
+ + + + + + + + + + - S. mutans . non reactive
- - + + - - + + - - - S. oralis - + + - + + - - - + CND
- + + + + - + + + + - S. mutans - - - - - + - - - . S. mutans
- + - + - - + - + + - S. mutans - - - - - - + - - + anginosus group
- + - + - - - + + - S. intermedius - - - - - - + . - + CND
- - - + - . + - - - - mitis group - - + . + _ . . - - S. mitis
- - - + - + + + - - - S. mitis/oralis - - + . + + - . - + mitis/oralis
- + - CND non reactive
- - - + - - + + - - - S. oralis . _ + _ + + _ _ - + mitis/oralis
- - - + + . + - + - . CND _ _ + _ + + + _ - + CND
- - - + + . + - + - - CND _ + - + + + - - + CND
- + + + - . + - + + _ S. sanguinis/mutans _ _ _ _ _ _ + _ - - sanguinis/mutans
- - - + - _ _ . _ _ CND non reactive
- - - + - - - - + + - CND + CND
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+ + - + + - + - + + - CND _ _ + _ + + + - - + S. pneumoniae/intermedius
- - - + + - + - + - - CND _ - + - + - + - - + S. pneumoniae/intermedius
+ + - + - - + - - + . S. intermedius _ _ _ _ ~ - + - - . CND
+ + + + + + + + + + _ S. pamsanguinis/anginosus _ _ _ - + + - - S. anginosus
- - - + - - + - - - . mitis grouo _ _ _ _ + - _ + CND
+ + + + + + + + + + - S. mutans - non reactive
+ + + + - - + - - + + S. gordonii _ _ _ _ + _ + - - S. gordonii
- - - + - + + + - - _ S. oralis _ _ + _ + _ _ - + S. oralis
- - + + + - + + + - - S. mutans + non reactive
+ + - + - - + - - + + anginosus group _ _ + _ + + - - - + S.
+ + - + - - + + - + + S. gordonii/intermedius + + + _ + + - - - + S. intermedius
+ - - + - + + - + - - S. mutans/intermedius - _ + _ + + + - - + S. intermedius
- - - + - + + + - - - S. oralis non reactive
- + + + - - + + + + - S. sanguinis/mutans - - _ - ~ - + - - - CND
- - - + - - + - - - - S. oralis - - + - + - - - - + S. oralis/pneumoniae
- - - + - - + - - - - S. oralis non reactive
+ + - + - - + - - + + S. intermedius/gordonii + + + - + + - - - + S. intermedius
- - - + - - + - - - - S. oralis - - + - + + - - - - S. oralis/pneumortiae/intermedius
- - - + - + + + - - - S. mitis/oralis - - - - - + + - - - S. parasanguinis
- - - + - - + - - - - S. oralis - - - - - + + - - S. parasanguinis
- + + + + - + + + + - S. mutans/sanguinis - - - + + - + - - - S. sanguinis
- - + + - - + - - - - S. mits/pneumoniae CND
- - + + - - + - + - - S. mitis + CND
- + + + - + + + + - - S. mutans melibiose - - - - - - + + - - - S. mutans
- - - - - - + - - - + S. mitis/parasanguinis CND
- - + + - . + - - - + S. mitis CND
- + + + + + + + + + - S. mutans - - . .  ■ - + + - - . S. mutans
+ + - + - - + - - + + anginosus group - - . - - + - - - S. anginosus
+ + - + - . + - - + + anginosus group + + + + + + - + S. intermedius
- - - + - . + + - - - S. mitis + CND
+ + + + _ + . _ _ + S. gordonii _ . _ + + _ + - . + S. gordonii
- - - + ■ - _ + + . _ _ S. oralis _ _ _ _ _ + _ - + S. oralis
- + + + + - + + + + - S. mutans - - - - - + - - - S. mutans
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- - - + - - + - - _ . mitis group - + + + - - - + S. oralis
mitis group S. oralis
- - - + - - - - + _ . S. mitis + + - + + - - - + S. oralis
- - - + - + + + . - S. mitis/oralis _ + - + + - - - + S. oralis
- - - + - - + - - - - mitis group - - - - - - - + - - CND
—  negative; +  — positive; CND = could not determine phenotype
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The characterisation data for 145 strains of streptococci subjected to carbohydrate 
fermentation and hydrolysis and detection of pre-formed enzyme assays are shown in 
table 4.7
By use of the carbohydrate fermentation and hydrolysis assay, 79 isolates (54.5%) were 
assigned a species level identification, a further 24 (16.6%) isolates were identified to 2 
closely related species e.g. S. mitis or S. oralis. A further 26 isolates (17.9%) were 
speciated to the group level e.g. mitis group or anginosus group. Of the remaining 
isolates, 10.3% could not be assigned any identification from their carbohydrate 
phenotype and 0.7% did not display reactions. From the use of the detection of pre­
formed enzyme assay, 71 isolates (49.0%) were assigned a species level identification, 
15 isolates (10.3%) were identified to 2 closely related species and 4 isolates (2.8%) 
were identified to a group. Of the remaining isolates 37 (25.5%) could not be assigned 
any identification from their enzyme phenotype and 18 isolates (12.4%) did not react 
during the assay.
The phenotypes and identifications generated using the carbohydrate fermentation and 
hydrolysis assay were compared to those from the detection of the pre-formed enzyme 
assay. There was very little agreement between the two assays with only 34 
identifications (23.4%) agreed to at a species level, 3 (2.1%) between 2 closely related 
species, and 42 (29.0%) to the same group. A majority of 40.7% isolates could not be 
compared due to one or both assays failing to produce a phenotype or the isolate being 
non-reactive; 7 identifications (4.8%) were in total disagreement i.e. where the species 
level identifications belonged to different groups e.g. S. mutans and S. mitis.
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4.4 Discussion
4.4.1 Cell wall characteristics
Of the 500 samples taken post-extraction it was found that only 4.7% were Gram- 
negative bacteria and that these isolates were detected in only 17 (3.4%) of the post­
extraction samples. This finding was surprising as Gram-negative bacteria have been 
reported as frequent isolates from the subgingiva of children (Kamma et al., 2000). 
Comparison with other post-extraction studies of paediatric odontogenic bacteraemia 
also show low proportions of the Gram- negative phyla with a range of 7.7% to 35.2% 
of the total isolates (Berry, Jr. et al., 1973), (Peterson and Peacock, 1976), (Coulter et 
al., 1990), (Roberts et al., 1992), (Roberts et al., 1998), (Lucas e ta l ,  2002a). Although 
variation between studies is to be expected, the exceptionally low proportion of Gram- 
negative microbiota was not. The loss of some Gram-negative bacteria was probably 
due to the combination of high pH of the lysing solution (Sullivan et al., 1975b) and the 
use of SPS as an anti-coagulant and inhibitor of complement to which some Gram- 
negative species are more sensitive (Eng and Holten, 1977).
4.4.2 Use of selective media
Selective media allow simple means of characterising bacteria by simple means of 
growth requirement determination. By using a range of media, it is possible to gain a 
broad picture of community structure within a sample population. Most selective media 
are designed for use to isolate and enumerate specific species from mixed cultures 
(Chapman, 1944) rather than as an aid to identification. Incorporation of a multipoint 
inoculator allows high throughput; potentially allowing many isolates to be 
characterised simultaneously (Burman and Ostensson, 1978).
Presumptive identifications were made using selective media, Gram-stain, catalase and 
oxidase results for 77.8% of the Gram-positive cocci, 79.4% of the Gram-positive rods 
and 38.5% of the Gram-negative bacteria. On the remaining occasions, either the 
selective media chosen did not support the growth of the isolates or conflicting 
biochemical characteristics existed. Given the large number of species reportedly 
inhabiting the oral cavity (Paster et al., 2001), it would be very difficult to provide 
selective media to support all of the species which may have been isolated from the 
bacteraemia. On several occasions with the Gram-positive bacteria, isolates identified
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by Gram-stain as rods or cocci were later assigned contradictory identifications; for 
example, Gram-positive cocci later being described as Actinomyces spp. It was often 
found that the Gram-stain morphology was ambiguous, with cells appearing 
coccobaciliary and coryneform rather than clearly coccid or rod-shaped. This happened 
most frequently with Actinomyces spp and Streptococcus spp; both genera are catalase- 
and oxidase-negative and grow in air and anaerobically. An advantage of using the 
selective media was that often growth of streptococci and Actinomyces spp were 
inhibited by either CFAT or MS agar allowing isolates to be differentiated even when 
Gram-stain morphology had been difficult to ascertain; similar mistakes have been 
reported in the literature and in one report may have compromised patient care (Petti et 
al., 2005). Difficulties such as this can be minimised by performing Gram-stain films 
from liquid rather than solid media to allow cells to appear in their “true” form. Another 
limitation of the use of multipoint inoculated selective media in assigning identification 
is the absolute necessity to ensure that only appropriate growth is used to decide the 
identity; for example, if a Gram-positive coccus is catalase-negative then growth on 
MAS agar should be ignored.
4.4.3 Biochemical characterisation of streptococci
Initially, the streptococci were to be identified using biochemical assays as previously 
published (Whiley and Beighton, 1998). This method had been used routinely in the 
laboratory but was considered difficult and unreliable, problems which were 
compounded by high numbers of streptococcal isolates recovered from the bacteraemia 
study. The major problem found with the use of these biochemical assays was the lack 
of reproducibility of results day to day; for example an isolate could be assayed using 
the same protocol and reagents on two separate occasions and yield different 
biochemical profiles, a phenomena also reported by others (Clarridge, III, 2004). This 
was demonstrated by performing the biochemical assays on a selection of 12 
streptococcal type strains as shown in table 4.6. The best reproducibility was attained 
for S. cristatus which showed 91% agreement between the repeated assays. This 
discovery was important to the validity of this identification procedure firstly because 
the reliability of the method was questionable but secondly because if well characterised 
reference strains could not be correctly identified then the identification of atypical wild 
type strains was likely to be harder. These issues have also been reported by others in 
the literature who found that strains could display different characteristics on repeated
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testing (Tardif et al., 1989). This lack of reproducibility was also found for the wild 
type strains isolated from the study. Often isolates would display very different profiles 
of biochemical activity when repeated in duplicate or even fail to react to the same 
substrates even when tested in parallel. The continued lack of reactivity made the 
protocol more time consuming through the frequent repetition that was required.
There is much about the speciation of oral streptococci in published literature. The 
streptococci are notoriously difficult to speciate due to their close homology 
(Kawamura et al., 1999). The use of phenotypic methods and the problems associated 
with such approaches are well documented; for the identification of streptococci 
(Coykendall, 1989), (Kawamura et al., 1995a) but also Actinomyces spp (Brander and 
Jousimies-Somer, 1992), coryneform bacteria (Tang et al., 2000), Peptostreptococci, 
Listeria spp and staphylococci (Fontana et al., 2005), Abiotrophia spp, Brevibacterium 
spp and Propionibacterium acnes (Drancourt etal., 2000).
The major limitation found with the carbohydrate fermentation and hydrolysis and 
detection of pre-formed enzyme assays was the lack of reproducibility; it was also 
found that reference strains showed patterns of carbohydrate fermentation or hydrolysis 
not reported in the literature on several occasions, making identification using this 
method much harder and reducing confidence in the value of the results. The lack of 
reproducibility with phenotypic tests is well known (Kawamura et al., 1998) and wild 
strains may produce different results to reference strains of the same species (Gamier et 
al., 1997). Another limitation to using biochemical profiling to identify bacteria is the 
use of published data; it is very difficult to match up phenotypic traits especially where 
there are up to 20 characteristics to compare.
If the aim of a study is to discriminate bacteria to genus level, then biochemical 
characterisation is a very useful, economical tool; if however, more comprehensive 
information is required about a cohort of bacteria, then a stable, reproducible genotypic 
method such as 16S rRNA comparative gene sequencing should be considered.
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4.5 Conclusions
• The majority of bacteria (57.6%) isolated from the odontogenic bacteraemia 
were recovered using anaerobic incubation conditions.
• The bacteria isolated from the bacteraemia were overwhelmingly Gram-positive 
(93.8%) using the methodology described.
• The use of selective media in conjunction with other morphological and 
phenotypic characteristics can be used to form presumptive identifications for 
bacteraemia isolates.
• The use of biochemical assays such as the fermentation and hydrolysis of 
carbohydrates in conjunction with the detection of pre-formed enzymes has 
limited use for the characterisation of streptococcal bacteraemia isolates.
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5.0 Identification of bacteraemia isolates using comparative 
gene sequencing
5.1 Introduction
During the previous study, it became clear that the sole use of phenotypic assays in the 
identification of a varied cohort of clinical isolates from asymptomatic bacteraemia 
would prove difficult and time consuming, not least, because the only information 
available about each isolate was its Gram-film, respiration and growth on selective 
media characteristics (chapter 4). Such limited knowledge of the isolates made choosing 
which tests to subject the strains to difficult and confidence in these methods was low 
due to the lack of reproducibility and strain discrimination aforementioned. In order to 
accelerate the identification process and to raise the confidence in the assigned identities 
it was decided to identify the isolates using comparative gene sequencing of the 16S 
rRNA gene. This approach to identification was already being used successfully in the 
laboratory in order to speciate other oral bacterial populations (Ready et al., 2003), 
(Lancaster et al., 2003), (Villedieu et al., 2003) and is widely accepted as a reliable 
method for bacterial identification (Tanner et al., 1994), (Kiratisin et al., 2003).
5.2 Materials and methods
Isolates from the initial bacteraemia study (chapter 3) were subjected to comparative 
16S rRNA gene sequencing (section 2.4.4). Briefly, single colonies of pure cultures 
were directly subjected to PCR amplification using published primers (27F and 1492R) 
(section 2.4.2.2), amplicons were purified (2.4.2.3) and a sequencing reaction performed 
using primer 357F (2.4.2.4). Sequence data retrieved from the ABI 310 sequencer was 
checked for quality using the Chromas programme (section 2.4.2.6) before being 
submitted to online databases. In order to obtain the closest matched identity for each 
isolate, stringent rules were applied to the sequences retrieved from the publicly 
accessible sequence databases GenBank and RDP II (Altschul et al., 1990) (section 
2.4.2.6).
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5.3 Results
5.3.1 Data for the 16S rRNA comparative gene sequencing of bacteraemia isolates
Isolates were subjected to comparative gene sequencing and the quality of the result 
determined. The comparative results were obtained from both the GenBank (using 
BLAST II) and the RDPII databases for comparison. The data for the 493 isolates were 
divided into Gram-positive and Gram-negative bacteria; the data for the Gram-positive 
bacteria are shown in table 5.1, the Gram-negative bacteria are shown in table 5.2.
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Table 5.1 Comparative sequence identities R D P II versus GenBank for Gram-positive 
bacteria
Isolate RDP II
Similarity
ranking GenBank % similarity
1 Ab. defectiva 0.924 Ab. Defectiva 98
2 Act. bowdenii 0.815 Act. viscosus/naeslundii 96
3 Act. bowdenii 0.783 Act. viscosus 97
4 Act. bowdenii 0.816 Act. naeslundii 97
5 Act. bowdenii 0.854 Act. viscosus/bowdenii 97
6 Act. bowdenii 0.845 Act. bowdenii/sp 98
7 Act. bowdenii 0.872 Act. viscosus 98
8 Act. bowdenii 0.878 Act. viscosus 98
9 Act. bowdenii 0.906 Act. bowdenii 99
10 Act. georgiae 0.777 Act. georgiae 95
11 Act. georgiae 0.83 Act. georgiae 97
12 Act. georgiae 0.891 Act. georgiae 97
13 Act. meyeri 0.759 not acceptable 93
14 Act. meyeri 0.783 Act. meyeri 96
15 Act. meyeri 0.793 Act. odontolyticus 98
16 Act. meyeri 0.913 Act. meyeri 98
17 Act. meyeri 0.824 Act. odontolyticus 99
18 Act. meyeri 0.912 Act. meyeri 99
19 Act. naeslundii 0.742 not acceptable 90
20 Act. naeslundii 0.745 not acceptable 93
21 Act. naeslundii 0.746 not acceptable 94
22 Act. naeslundii 0.75 not acceptable 94
23 Act. naeslundii 0.844 not acceptable 94
24 Act. naeslundii 0.737 Act. naeslundii 95
25 Act. naeslundii 0.802 Act. naeslundii 95
26 Act. naeslundii 0.818 Act. naeslundii 95
27 Act. naeslundii 0.828 Act. naeslundii 95
28 Act. naeslundii 0.861 Act. naeslundii 95
29 Act. naeslundii 0.942 Act. viscosus/naeslundii 95
30 Act. naeslundii 0.756 Actinomyces sp. 96
31 Act. naeslundii 0.806 Act. naeslundii 96
32 Act. naeslundii 0.819 Act. viscosus 96
33 Act. naeslundii 0.84 Actinomyces sp. 96
34 Act. naeslundii 0.876 Act. naeslundii 96
35 Act. naeslundii 0.712 Act. naeslundii 97
36 Act. naeslundii 0.792 Act. naeslundii 97
37 Act. naeslundii 0.806 Act. viscosus 97
38 Act. naeslundii 0.879 Act. naeslundii 97
39 Act. naeslundii 0.883 Act. naeslundii 97
40 Act. naeslundii 0.895 Act. naeslundii 97
41 Act. naeslundii 0.899 Act. viscosus/bowdenii 97
42 Act. naeslundii 0.905 Act. naeslundii 97
43 Act. naeslundii 0.935 Act. naeslundii 97
44 Act. naeslundii 0.798 Act. naeslundii 98
45 Act. naeslundii 0.861 Act. naeslundii 98
46 Act. naeslundii 0.889 Act. naeslundii 98
47 Act. naeslundii 0.89 Act. naeslundii 98
48 Act. naeslundii 0.89 Act. naeslundii 98
49 Act. naeslundii 0.893 Act. naeslundii 98
50 Act. naeslundii 0.895 Act. naeslundii 98
51 Act. naeslundii 0.895 Act. naeslundii 98
52 Act. naeslundii 0.895 Act. naeslundii 98
53 Act. naeslundii 0.898 Act. naeslundii 98
54 Act. naeslundii 0.903 Act. naeslundii 98
55 Act. naeslundii 0.906 Act. naeslundii 98
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Isolate RDP II
Similarity
ranking GenBank % similarity
56 Act. naeslundii 0.908 Act. viscosus 98
57 Act. naeslundii 0.910 Act. naeslundii 98
58 Act. naeslundii 0.911 Act. naeslundii 98
59 Act. naeslundii 0.915 Act. naeslundii 98
60 Act. naeslundii 0.922 Act. naeslundii 98
61 Act. naeslundii 0.923 Act. naeslundii 98
62 Act. naeslundii 0.925 Act. viscosus/naeslundii 98
63 Act. naeslundii 0.927 Act. naeslundii 98
64 Act. naeslundii 0.929 Act. naeslundii 98
65 Act. naeslundii 0.932 Act. naeslundii 98
66 Act. naeslundii 0.932 Act. naeslundii 98
67 Act. naeslundii 0.933 Act. naeslundii 98
68 Act. naeslundii 0.934 Act. naeslundii 98
69 Act. naeslundii 0.942 Act. naeslundii 98
70 Act. naeslundii 0.952 Act. naeslundii 98
71 Act. naeslundii 0.953 Act. naeslundii 98
72 Act. naeslundii 0.822 Act. viscosus 99
73 Act. naeslundii 0.833 Act. viscosus/naeslundii 99
74 Act. naeslundii 0.858 Act. naeslundii 99
75 Act. naeslundii 0.876 Act. naeslundii 99
76 Act. naeslundii 0.899 Act. naeslundii 99
77 Act. naeslundii 0.902 Act. naeslundii 99
78 Act. naeslundii 0.913 Act. viscosus 99
79 Act. naeslundii 0.917 Act. naeslundii 99
80 Act. naeslundii 0.923 Actinomyces sp. 99
81 Act. naeslundii 0.941 Act. naeslundii 99
82 Act. naeslundii 0.948 Act. naeslundii 99
83 Act. naeslundii 0.95 Act. naeslundii 99
84 Act. naeslundii 0.957 Act. naeslundii 99
85 Act. naeslundii 0.957 Act. naeslundii 99
86 Act. naeslundii 0.96 Act. naeslundii 99
87 Act. naeslundii 0.961 Act. naeslundii 99
88 Act. naeslundii 0.963 Act. naeslundii 99
89 Act. naeslundii 0.968 Act. naeslundii 99
90 Act. naeslundii 0.974 Act. naeslundii 99
91 Act. naeslundii/ sp. 0.719 not acceptable 93
92 Act. naeslundii/bowdenii 0.834 Act. naeslundii/viscosus 96
93 Act. naeslundii/bowdenii 0.856 Act. viscosus 96
94 Act. naeslundii/bowdenii 0.876 Act. naeslundii 96
95 Act. naeslundii/slackii 0.737 not acceptable 93
96 Act. naeslundii/viscosus 0.819 Act. viscosus 97
97 Act. odontolyticus 0.938 Actinomyces sp. 99
98 Act. schindleri 0.827 Act. haemolyticus 95
99 Act. urogenitalis 0.725 Act. viscosus/naeslundii 100
100 Act. urogenitalis/naeslundii 0.705 not acceptable 87
101 Act. viscosus 0.73 Act. viscosus 96
102 Act. viscosus 0.823 Act .naeslundii 96
103 Act. viscosus 0.869 Act. viscosus 97
104 Act. viscosus 0.826 Act. viscosus 98
105 Act. viscosus 0.841 Act. viscosus 98
106 Act. viscosus 0.915 Act. viscosus 98
107 Actinomadura viridis 0.717 Roth, dentocariosa 96
108 Actinomyces sp. 0.724 Act. viscosus 95
109 Actinomyces sp. 0.778 Actinomyces sp. 95
110 Bac. jeotgali 0.719 Exiguobacterium sp 99
111 Bac. lichenformis 0.917 Bac. pumilis 99
112 Bac. lichenformis 0.917 Bac. pumilis 99
113 Bac. sonorensis 0.947 Bac. sonorensis 97
114 Bac. Subtilis 0.888 Bac. subtilis 98
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Isolate RDPII
Similarity
ranking GenBank % similarity
115 Bac. subtilis 0.925 Bac. pumilis 100
116 Bac. vallismortis 0.813 Bac. pumilis 98
117 Bac. vallismortis 0.915 Bac. subtilis 98
118 Bac. vallismortis 0.915 Bac. subtilis 98
119 Bac. vallismortis 0.915 Bac. subtilis 98
120 Bacillus sp 0.921 Bac. lichenformis 98
121 Bif. dentium 0.91 Bif. Dentium 97
122 Brev. iodinum 0.906 Brevibacterium sp 98
123 Citrococcus muralis 0.738 not acceptable 94
124 Cor. accolens 0.887 Cor. tuberculostearicum 98
125 Cor. argentoratense 0.916 Cor. argentoratense 98
126 Cor. coyleae 0.869 Cor. coyleae 98
127 Cor. durum 0.869 Cor. durum 97
128 Cor. durum 0.954 Cor. durum 99
129 Cor. mycetoides 0.903 Cor. lipophilum 98
130 Cor. mycetoides 0.778 Cor. appendicis 99
131 Cor. tuberculostearicum 0.923 Cor. Pseudogen/tuberculostear. 98
132 Cor. xerosis 0.939 Cor. xerosis 98
133 Diet, maris 0.991 Diet, maris 100
134 epidermidis gp staph. 0.841 epidermidis gp staph. 96
135 epidermidis gp staph. 0.842 epidermidis gp staph. 96
136 epidermidis gp staph. 0.942 Staph, epidermidis 96
137 epidermidis gp staph. 0.835 epidermidis gp staph. 97
138 epidermidis gp staph. 0.835 epidermidis gp staph. 97
139 epidermidis gp staph. 0.846 Staph, epidermidis/capitis 97
140 epidermidis gp staph. 0.902 Staph, epidermidis/capitis 98
141 epidermidis gp staph. 0.907 Staph, capitas/epidermidis 98
142 epidermidis gp staph. 0.92 Staph, epidermidis/capitis 98
143 epidermidis gp staph. 0.927 Staph, epidermidis 98
144 epidermidis gp staph. 0.951 epidermidis gp staph. 98
145 epidermidis gp staph. 0.954 epidermidis gp staph. 98
146 epidermidis gp staph. 0.956 epidermidis gp staph. 98
147 epidermidis gp staph. 0.965 epidermidis gp staph. 98
148 epidermidis gp staph. 0.942 epidermidis gp staph. 99
149 epidermidis gp staph. 0.955 epidermidis gp staph. 99
150 epidermidis gp staph. 0.965 Staph, epidermidis/capitis 99
151 epidermidis gp staph. 0.971 epidermidis gp staph. 99
152 epidermidis gp staph. 0.973 epidermidis gp staph. 99
153 epidermidis gp staph. 0.98 epidermidis gp staph. 99
154 epidermidis gp staph. 0.98 epidermidis gp staph. 99
155 epidermidis gp staph. 0.991 epidermidis gp staph. 100
156 epidermidis gp staph. 0.841 epidermidis gp staph. 96
157 epidermidis gp staph. 0.7 Staph, epidermidis 97
158 epidermidis gp staph. 0.861 epidermidis gp staph. 97
159 epidermidis gp staph. 0.904 Staph, epidermidis 97
160 epidermidis gp staph. 0.917 epidermidis gp staph. 97
161 epidermidis gp staph. 0.917 Staph, epidermidis/capitis 97
162 epidermidis gp staph. 0.904 epidermidis gp staph. 98
163 epidermidis gp staph. 0.909 epidermidis gp staph. 98
164 epidermidis gp staph. 0.929 epidermidis gp staph. 98
165 epidermidis gp staph. 0.948 Staph, epidermidis/capitis 98
166 epidermidis gp staph. 0.951 epidermidis gp staph. 98
167 epidermidis gp staph. 0.952 epidermidis gp staph. 98
168 epidermidis gp staph. 0.952 Staph, epidermidis 98
169 epidermidis gp staph. 0.95 Staph, epidermidis 99
170 epidermidis gp staph. 0.95 Staph, epidermidids/capitis 99
171 epidermidis gp staph. 0.954 epidermidis gp staph. 99
172 epidermidis gp staph. 0.989 epidermidis gp staph. 99
173 epidermidis gp staph. 0.993 epidermidis gp staph. 99
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Isolate RDPII
Similarity
ranking GenBank % similarity
174 epidermidis gp staph. 0.994 Staph, capitis/epidermidis 99
175 Ex. aurantiacum 0.708 not acceptable 93
176 Ex. aurantiacum 0.747 Exiguobacterium sp 97
177 Gem. morbillorum 0.778 Gem. morbillorum 95
178 Gem. morbillorum 0.771 Gem. morbillorum 97
179 Gem. morbillorum 0.894 Gem. morbillorum 98
180 Gem. morbillorum 0.936 Gem. morbillorum 98
181 Gem. morbillorum 0.936 Gem. morbillorum 98
182 Gem. morbillorum 0.984 Gem. morbillorum 99
183 Koc. rhizophila 0.95 Koc. rhizophila 97
184 Koc. rhizophila 0.807 Koc. camophila 98
185 Lac. casei/zeae 0.833 Lactobacillus sp 96
186 Lac. gasseri 0.959 Lac. gasseri 99
187 Lac. oris 0.822 Lac. oris 97
188 Lac. zeae 0.936 Lac. casei 99
189 Lac. zeae 0.936 Lac. casei 99
190 Lac. casei/paracasei 0.819 not acceptable 91
191 Lactobacillus sp 0.738 Lac. casei 95
192 Lactobacillus sp 0.826 Lactobacillus sp 96
193 Lactobacillus sp 0.835 Lactobacillus sp 98
194 Lactobacillus sp 0.957 Lac. casei/paracasei 99
195 Lactobacillus sp 0.995 Lactobacillus sp 99
196 Leu. mesenteroides 0.869 Leu. pseudomesenteroides 97
197 Micr. antar/luteus 0.855 environmental isolate 95
198 Micr. antarticus 0.904 Micrococcus sp 95
199 Micr. antarticus 0.941 Micr. luteus 97
200 Micr. antarticus/luteus 0.706 not acceptable 92
201 Microbacterium kitamiense 0.836 Microbacterium 96
202 Microbacterium kitamiense 0.87 Microbacterium 98
203 Micr. luteus 0.934 not acceptable 93
204 Micr. luteus 0.94 not acceptable 93
205 Micr. luteus 0.715 Micr. luteus 95
206 Micr. luteus 0.851 Micr. luteus/psychrophilum 98
207 Micr. luteus 0.852 Micrococcus sp 98
208 Micr. luteus 0.855 Micr. luteus 98
209 Micr. luteus 0.889 Micrococcus sp 98
210 Micr. luteus 0.93 Micrococcus sp 98
211 Micr. luteus 0.946 Micr. luteus 98
212 Micr. luteus 0.939 Micr. luteus 99
213 Micr. luteus/antarticus 0.729 not acceptable 92
214 Micr. luteus/antarticus 0.702 not acceptable 94
215 Micrococcus sp 0.906 Micrococcus sp 96
216 Micrococcus sp 0.834 environmental isolate 98
217 mitis group streptococcus 0.796 not acceptable 94
218 mitis group streptococcus 0.846 mitis group streptococcus 97
219 mitis group streptococcus 0.858 mitis group streptococcus 97
220 mitis group streptococcus 0.858 mitis group streptococcus 97
221 mitis group streptococcus 0.874 mitis group streptococcus 97
222 mitis group streptococcus 0.881 mitis group streptococcus 97
223 mitis group streptococcus 0.903 mitis group streptococcus 97
224 mitis group streptococcus 0.856 mitis group streptococcus 98
225 mitis group streptococcus 0.86 mitis group streptococcus 98
226 mitis group streptococcus 0.867 mitis group streptococcus 98
227 mitis group streptococcus 0.892 mitis group streptococcus 98
228 mitis group streptococcus 0.901 Strep, cristatus 98
229 mitis group streptococcus 0.906 mitis group streptococcus 98
230 mitis group streptococcus 0.912 mitis group streptococcus 98
231 mitis group streptococcus 0.92 mitis group streptococcus 98
232 mitis group streptococcus 0.92 mitis group streptococcus 98
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Isolate RJOPH
Similarity
ranking GenBank % similarity
233 mitis group streptococcus 0.944 mitis group streptococcus 98
234 mitis group streptococcus 0.949 mitis group streptococcus 98
235 mitis group streptococcus 0.958 mitis group streptococcus 98
236 mitis group streptococcus 0.925 mitis group streptococcus 99
237 mitis group streptococcus 0.946 mitis group streptococcus 99
238 mitis group streptococcus 0.948 mitis group streptococcus 99
239 mitis group streptococcus 0.951 mitis group streptococcus 99
240 mitis group streptococcus 0.962 mitis group streptococcus 99
241 mitis group streptococcus 0.973 mitis group streptococcus 100
242 Myco. chitae 0.738 Prop, acnes 97
243 Myco. chitae 0.798 Prop, acnes 98
244 Myco. chitae 0.819 Prop, acnes 98
245 Myco. chitae 0.858 Prop, acnes 98
246 Myco. chitae 0.872 Prop, acnes 98
247 Myco. chitae 0.89 Prop, acnes 98
248 Myco. chitae 0.811 Prop, acnes 99
249 Myco. chitae 0.853 Prop, acnes 99
250 Myco. chitae 0.855 Prop, acnes 99
251 Myco. chitae 0.87 Prop, acnes 99
252 Myco. chitae 0.904 Prop, acnes 99
253 not acceptable - Act. naeslundii 95
254 not acceptable - Pepto. micros 97
255 not acceptable - Pepto. micros 97
256 not acceptable - Pepto. micros 98
257 not acceptable - Act. viscosus/naeslundii 99
258 Prop, acnes 0.701 Prop, acnes 98
259 Prop, acnes 0.835 Prop, acnes 98
260 Prop, acnes 0.835 Prop, acnes 98
261 Prop, acnes 0.848 Prop, acnes 98
262 Prop, acnes 0.889 Prop, acnes 98
263 Prop, acnes 0.945 Prop, acnes 98
264 Prop, acnes 0.855 Prop, acnes 99
265 Prop, acnes 0.889 Prop, acnes 99
266 Prop, acnes 0.927 Prop, acnes 99
267 Prop, acnes 0.927 Prop, acnes 99
268 Prop, acnes 0.947 Prop, acnes 99
269 Prop, acnes 0.958 Prop, acnes 99
270 Prop, acnes 0.958 Prop, acnes 99
271 Prop, acnes 0.973 Prop, acnes 99
272 Prop, acnes 0.978 Prop, acnes 99
273 Prop, acnes 0.854 Prop, acnes 100
274 Prop. acnes/Myco. chitae 0.78 Prop, acnes 97
275 Prop. acnes/Myco. chitae 0.821 Prop, acnes 97
276 Prop. acnes/Myco. chitae 0.815 Prop, acnes 98
277 Propionibacterium sp/M. chitae 0.866 Prop, acnes 99
278 Roth, dentocariosa 0.834 Roth, dentocariosa 97
279 Roth. dent/Actinomyces sp. 0.888 Roth. Dent./Actinomyces 98
280 Roth, nasimurium 0.759 Roth, dentocariosa 97
281 Roth, nasimurium 0.74 Roth, dentocariosa 98
282 Roth, nasimurium 0.746 Roth, dentocariosa 99
283 S. mitis/oralis 0.794 mitis group streptococcus 95
284 S. mitis/oralis 0.919 mitis group streptococcus 98
285 S. mitis/oralis 0.925 mitis group streptococcus 98
286 S. mitis/oralis 0.926 mitis group streptococcus 98
287 S. mitis/oralis 0.934 mitis group streptococcus 98
288 S. mitis/oralis 0.931 mitis group streptococcus 99
289 S. mitis/pneumoniae 0.732 mitis group streptococcus 97
290 Staph, aureus 0.981 Staph, aureus 99
291 Staph, capitas 0.917 Staph, epidermidis 98
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Isolate RDPII
Similarity
GenBank % similarity
292 Staph, capitas 0.929 epidermidis group staph 98
293 Staph, capitas subsp. 0.944 epidermidis group staph 98
294 Staph, capitis 0.97 Staph, epidermidis 99
295 Staph, caprae 0.881 epidermidis group staph 96
296 Staph, caprae 0.862 epidermidis group staph 97
297 Staph, caprae 0.862 Staph, epidermidis 97
298 Staph, caprae 0.862 Staph, epidermidis 97
299 Staph, caprae 0.903 Staph, epidermidis/capitas 97
300 Staph, caprae 0.935 Staph, epidermidis 99
301 Staph, caprae 0.956 epidermidis group staph 99
302 Staph, caprae/capitas 0.727 epidermidis group staph 95
303 Staph, caprae/capitis 0.949 epidermidis group staph 97
304 Staph, caprae/capitis 0.888 epidermidis group staph 98
305 Staph, caprae/capitis 0.977 Staph, capitas/epidermidis 99
306 Staph, caprae/epidermidis 0.823 epidermidis group staph 97
307 Staph, caprae/epidermidis 0.889 Staph, epidermidis 98
308 Staph, caprae/epidermidis 0.908 Staph, capitas/epidermidis 98
309 Staph, caprae/epidermidis 0.908 Staph, capitas/epidermidis 98
310 Staph, cohnii 0.888 Staph, cohnii 97
311 Staph, cohnii/saprophyticus 0.807 Staph, cohnii/saprophyticus 95
312 Staph, cohnii/saprophyticus 0.915 epidermidis group staph 96
313 Staph, cohnii/saprophyticus 0.974 Staph, cohnii/saprophyticus 98
314 Staph, cohnii/saprophyticus 0.972 Staph, cohnii 99
315 Staph, delphini/chromogenes 0.957 Staph, delphini/chromogenes 99
316 Staph, epidermidis 0.893 epidermidis group staph 97
317 Staph, epidermidis 0.906 Staph, epidermidis 98
318 Staph, haemolyticus 0.868 epidermidis group staph 97
319 Staph, haemolyticus 0.9 Staph, hominis/haemolyticus 97
320 Staph, haemolyticus 0.9 Staph, hominis/haemolyticus 97
321 Staph, haemolyticus 0.855 Staph, hominis 98
322 Staph, haemolyticus 0.859 Staph, hominis/xylosus 98
323 Staph, haemolyticus 0.902 Staph, hominis/haemolyticus 98
324 Staph, haemolyticus 0.946 Staph, haemolyticus 98
325 Staph, haemolyticus 0.946 Staph, haemolyticus 98
326 Staph, haemolyticus 0.946 Staph, haemolyticus 98
327 Staph, hominis 0.826 not acceptable 92
328 Staph, hominis 0.846 Staph, hominis 96
329 Staph, hominis 0.754 Staph, hominis 98
330 Staph, hominis 0.909 epidermidis group staph 98
331 Staph, hominis 0.916 Staph, hominis 98
332 Staph, hominis 0.943 Staph, hominis 98
333 Staph, hominis 0.961 Staph, hominis 98
334 Staph, hominis 0.949 Staph, hominis 99
335 Staph, hominis 0.959 Staph, hominis 99
336 Staph, hominis 0.966 Staph, hominis 99
337 Staph, hominis 0.962 Staph, hominis 100
338 Staph, pasteuri 0.736 not acceptable 93
339 Staph, pasteuri 0.835 Staph, pasteuri 98
340 Staph, pasteuri 0.857 Staph, pasteuri/warneri 98
341 Staph, pasteuri 0.827 Staphylococcus sp. 99
342 Staph, pasteuri 0.938 Staph, pasteuri/warneri 99
343 Staph, saprophyticus 0.955 Staph, saprophyticus 98
344 Staph, warneri 0.754 Staph, warneri 95
345 Staph, warneri 0.806 Staphylococcus sp. 97
346 Staph, warneri 0.912 Staph, pasteuri/warneri 97
347 Staph, warneri 0.897 Staph, warneri 98
348 Staph, warneri 0.924 Staph, pasteuri/warneri 98
349 Staph, warneri 0.932 Staph, pasteuri/warneri 98
350 Staph, warneri 0.941 Staph, warneri 99
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Isolate RDPII
Similarity
ranking GenBank % similarity
351 Staph, warneri 0.987 Staph, pasteuri/warneri 100
352 Strep, anginosus 0.756 Strep, intermedius 96
353 Strep, anginosus 0.848 Strep, intermedius 96
354 Strep, anginosus 0.785 Strep, intermedius 97
355 Strep, anginosus 0.868 Strep, intermedius 97
356 Strep, anginosus 0.757 Strep, anginosus 98
357 Strep, anginosus 0.864 Strep, intermedius 98
358 Strep, anginosus 0.874 Strep, anginosus 98
359 Strep, anginosus 0.876 Strep, anginosus 98
360 Strep, anginosus 0.939 Strep, intermedius 99
361 Strep, constellatus 0.794 Strep, constellatus 96
362 Strep, downei 0.791 Strep, sobrinus 99
363 Strep, gordonii 0.786 not acceptable 94
364 Strep, gordonii 0.793 mitis group streptococcus 97
365 Strep, gordonii 0.912 Strep, gordonii 98
366 Strep, gordonii 0.946 mitis group streptococcus 99
367 Strep, gordonii/mitis 0.973 Strep, gordonii/mitis 99
368 Strep, gordonii/mitis 0.99 Strep, gordonii/mitis 99
369 Strep, infantis/mitis 0.847 mitis group streptococcus 98
370 Strep, intermedius 0.824 Strep, anginosus 97
371 Strep, intermedius 0.826 intermedius group 97
372 Strep, intermedius 0.855 Strep, anginosus 97
373 Strep, intermedius 0.882 Strep, intermedius 97
374 Strep, intermedius 0.822 Strep, intermedius/constellatus 98
375 Strep, intermedius 0.879 Strep, intermedius 98
376 Strep, intermedius 0.889 Strep, intermedius 98
377 Strep, intermedius 0.892 Strep, intermedius 98
378 Strep, intermedius 0.916 Strep, anginosus 98
379 Strep, intermedius 0.921 Strep, intermedius 98
380 Strep, intermedius 0.946 Strep, intermedius 99
381 Strep, mitis 0.761 mitis group streptococcus 95
382 Strep, mitis 0.767 mitis group streptococcus 96
383 Strep, mitis 0.813 mitis group streptococcus 96
384 Strep, mitis 0.824 mitis group streptococcus 96
385 Strep, mitis 0.813 mitis group streptococcus 97
386 Strep, mitis 0.826 mitis group streptococcus 97
387 Strep, mitis 0.842 mitis group streptococcus 97
388 Strep, mitis 0.855 mitis group streptococcus 98
389 Strep, mitis 0.897 Strep, gordonii/mitis 98
390 Strep, mitis 0.922 mitis group streptococcus 99
391 Strep, mitis/gordonii 0.84 Strep, gordonii 96
392 Strep, mitis/gordonii 0.81 Strep, gordonii/mitis 98
393 Strep, mitis/gordonii 0.843 Strep, gordonii/mitis 98
394 Strep, mitis/gordonii 0.933 Strep, gordonii/mitis 99
395 Strep, mitis/gordonii 0.933 Strep, gordonii/mitis 99
396 Strep, mitis/gordonii 0.955 Strep, gordonii/mitis 99
397 Strep, mitis/gordonii 0.791 Strep, sanguinis 97
398 Strep, mitis/oralis 0.887 mitis group streptococcus 97
399 Strep, mitis/oralis 0.898 mitis group streptococcus 97
400 Strep, mitis/oralis 0.88 Strep, cristatus 98
401 Strep, mitis/oralis 0.949 mitis group streptococcus 98
402 Strep, mitis/oralis 0.921 mitis group streptococcus 99
403 Strep, mitis/oralis 0.971 mitis group streptococcus 99
404 Strep, mutans 0.816 not acceptable 93
405 Strep, mutans 0.706 not acceptable 94
406 Strep, mutans 0.817 Strep, mutans 95
407 Strep, mutans 0.737 Strep, mutans 96
408 Strep, mutans 0.777 Strep, mutans 96
409 Strep, mutans 0.848 Strep, mutans 96
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Isofate RDPII
Similarity
ranking GenBank %  similarity
410 Strep, mutans 0.868 Strep, mutans 96
411 Strep, mutans 0.799 Strep, mutans 97
412 Strep, mutans 0.841 Strep, mutans 97
413 Strep, mutans 0.892 Strep, mutans 97
414 Strep, mutans 0.813 Strep, mutans 98
415 Strep, mutans 0.817 Strep, mutans 98
416 Strep, mutans 0.84 Strep, mutans 98
417 Strep, mutans 0.863 Strep, mutans 98
418 Strep, mutans 0.88 Strep, mutans 98
419 Strep, mutans 0.887 Strep, mutans 98
420 Strep, mutans 0.894 Strep, mutans 98
421 Strep, mutans 0.9 Strep, mutans 98
422 Strep, mutans 0.859 Strep, mutans 99
423 Strep, mutans 0.861 Strep, mutans 99
424 Strep, mutans 0.882 Strep, mutans 99
425 Strep, mutans 0.896 Strep, mutans 99
426 Strep, mutans 0.96 Strep, mutans 99
427 Strep, mutans 0.961 Strep, mutans 99
428 Strep, mutans 0.963 Strep, mutans 99
429 Strep, mutans 0.979 Strep, mutans 99
430 Strep, oralis 0.865 mitis group streptococcus 98
431 Strep, oralis 0.923 mitis group streptococcus 98
432 Strep, oralis 0.937 mitis group streptococcus 99
433 Strep, parasanguinis 0.909 Strep, cristatus 98
434 Strep, parasanguinis 0.947 Strep, australis 99
435 Strep. parasanJoligofermentans 0.914 Strep, parasanguinis 98
436 Strep. parascmJsinensis/oligofer. 0.766 not acceptable 91
437 Strep, peroris 0.798 not acceptable 94
438 Strep, pneumoniae/oralis 0.941 mitis group streptococcus 98
439 Strep, salivarius 0.961 Strep, salivarius 99
440 Strep, sanguinis 0.828 not acceptable 92
441 Strep, sanguinis 0.705 Strep, sanguinis 97
442 Strep, sanguinis 0.844 Strep, sanguinis 97
443 Strep, sanguinis 0.878 Strep, sanguinis 97
444 Strep, sanguinis 0.878 Strep, sanguinis 97
445 Strep, sanguinis 0.878 Strep, sanguinis 97
446 Strep, sanguinis 0.887 Strep, sanguinis 97
447 Strep, sanguinis 0.922 Strep, sanguinis 97
448 Strep, sanguinis 0.964 Strep, sanguinis 97
449 Strep, sanguinis 0.916 Strep, sanguinis 98
450 Strep, sanguinis 0.926 Strep, sanguinis 98
451 Strep, sanguinis 0.929 Strep, sanguinis 98
452 Strep, sanguinis 0.932 Strep, sanguinis 98
453 Strep, sanguinis 0.935 Strep, sanguinis 98
454 Strep, sanguinis 0.935 Strep, sanguinis 98
455 Strep, sanguinis 0.936 Strep, sanguinis 98
456 Strep, sanguinis 0.944 Strep, sanguinis 98
457 Strep, sanguinis 0.885 Strep, sanguinis 99
458 Strep, sanguinis 0.903 Strep, constellatus 99
459 Strep, sanguinis 0.906 Strep, sanguinis 99
460 Strep, sanguinis 0.927 Strep, sanguinis 99
461 Strep, sanguinis 0.949 Strep, sanguinis 99
462 Strep, sanguinis 0.951 Strep, sanguinis 99
463 Strep, sanguinis 0.964 Strep, sanguinis 99
464 Strep, sinensis 0.927 Strep, cristatus 98
465 Strep, thermophillus 0.811 Strep, mutans 98
466 Streptomyces albidoflavus 0.917 Streptomyces sp 97
467 Streptomyces sp 0.712 Roth, dentocariosa 97
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Table 5.2 Comparative sequence identities R D P II versus GenBank fo r  Gram-negative 
bacteria
Isolate RDPfl S ab GenBank %  similarity
1 Aciri. iwoffii 0.804 Acin. Iwoffii 95
2 Acin. Iwoffii 0.856 Acin. Iwoffii 97
3 Acin. Iwoffii 0.815 Acin. Iwoffii 98
4 Acin. Iwoffii 0.815 Acin. Iwoffii 98
5 Acin. Iwoffii 0.956 Acin. Iwoffii 99
6 Acin. Iwoffii 0.956 Acin. Iwoffii 99
7 Acin. Iwoffii 0.976 Acin. Iwoffii 100
8 Enhydrobacter. aerosaccus 0.943 Mor. osloensis 99
9 Fuso. nucleatum subsp 0.817 not acceptable 94
10 Fuso. nucleatum/canifelinum 0.958 Fuso. nucleatum/canifelinum 97
11 Neis. animalis 0.842 Neis. mucosa 99
12 Prev. nigrescens 0.722 not acceptable 94
13 Ps. stutzeri 0.893 Ps. stutzeri 98
14 Ps. stutzeri 0.941 Ps. stutzeri 99
15 Pseudomonas sp 0.738 Ps. oleovorans 96
16 Psychrobacter sp. 0.845 Psychrobacter sp 99
17 Steno. rhizophila 0.786 Pseudoxanthamonas 96
18 Steno. rhizophila 0.786 Pseudoxanthamonas 96
19 Steno. maltophilia 0.855 Steno. maltophilia 97
20 Veil, dispar 0.703 Veil, dispar 95
21 Veil, dispar 0.781 Veil, dispar 96
22 Veil, dispar 0.832 Veil, dispar 97
23 Veil, dispar 0.903 Veil, dispar 98
24 Veil, dispar 0.914 Veil, dispar 98
25 Veil, parvula 0.923 Veil, parvula 98
26 Veil, parvula/dispar 0.833 Veil, dispar 97
Note: Genera names have been abbreviated to facilitate differentiation
5.3.2 Evaluation of web- based sequence match tools
In order to evaluate which database was more efficacious for identity assignment, a total 
of 493 sequences ranging in length from 107 to 506 base pairs were compared. 
Identities were judged to be most successful where a species level identity had been 
assigned, note was made of sequences that resulted in 2 species having equal weight i.e. 
A. viscosus and A. naeslundii 0.966 similarity. Where species could not be assigned due 
to too many species having equal weight or too low a match, genus level identities were 
assigned. In RDP II identification was failed if similarity fell below 0.7 or with BLAST 
II below 95 % (section 2.4.2.6).
5.3.2.1. Performance of Ribosomal Database Project II (RDP II)
Of the 494 sequences analysed using the RDP programme, the majority of isolates were 
identified to species level (71.3%). Often a sequence could not be matched to a single 
isolate and two possible taxa were stated e.g., A. naeslundii and A. viscosus; this
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occurred for 10.3% of the sequences submitted. A further 80 sequences (16.2%) were 
only identified to genus level; 2.2% of the remaining sequences returned non-acceptable 
identities (below 0.7 similarity ranking). The reliability of identities assigned using the 
sequence match tool of RDP II was judged by the similarity ranking assigned to a 
match; this value ranges from 0 to 1.000, with 1.000 being a perfect match. Identities 
above 0.7 were used to assign a presumptive identification for comparison with BLAST 
II assigned identities. Of the 494 sequences submitted to RDP II, 14.8% had a similarity 
ranking of 0.7 to 0.79; 37.9% returned a ranking of 0.8 to 0.89 and 46.2% of 0.9 and 
above. Therefore, the majority of sequences submitted to RDP II (84.1%) returned a 
good similarity ranking of 0.8 to 1.000.
5.3.2.2 Performance of BLAST II
Sequences submitted to RDP II were simultaneously compared to the GenBank 
database using the BLAST II tool. Only sequences over 1 kb in length from type strains 
were included, which often precluded closer matches to clones and other deposited 
sequences. These sequences were universally ignored because the source and 
verification for such deposits is often unknown or poorly described. Despite this 
stringency the majority of sequences (65.0%) were assigned a species level 
identification, 9.72% could not be defined to a single species, and 24.5% were identified 
to genus level only. The quality o f sequence matches using the BLAST II tool were 
judged by the percentage similarity of the submitted sequence to those retrieved from 
the database. Of the 494 sequences submitted, 29 (5.87%) had a percentage similarity 
between 87 and 94.9%, which shows a low level of confidence in the assigned identity 
or indicates a previously non-characterised isolate. A further 31.2% of the sequences 
submitted using BLAST II resulted in a percentage similarity of 95 to 97.9% and the 
remaining 63.0% had a value of 98.0% and above; the higher the percentage scored the 
more reliable the identification.
5.3.2.3 RDPII versus BLASTII
The identities assigned using the two sequence alignment tools were compared. 
Concordance was judged on total species level agreement, partial species level 
agreement (where one tool had not discriminated between two closely related species 
but the other tool had resolved identification fully), genus level agreement and total 
disagreement. In the majority of instances (44.0%), the two methods showed total
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agreement and partial agreement for 21.0% of the sequences i.e. where 2 species 
identities were returned by one database which matched with the identity from the other 
database. For 149 (30.2%) of the submitted sequences, only a genus level agreement 
was reached. There was total discordance between the identities assigned for 26 (5.3%) 
of sequences submitted. Of these discrepancies, 11 (42.3%) occurred where RDP II 
resulted in a closest match to Mycobacterium chitae whereas BLAST II returned 
Propionibacterium acnes. A further 6 discrepancies (23.1%) occurred where RDP II 
failed to match the submitted sequence to Peptostreptococcus micros. The remaining 
disagreement occurred where sequence matches fell below the set targets for similarity 
ranking or percentage similarity.
5.5.2.4 Retrospective comparison o f  16S rRNA comparative gene sequencing versus 
phenotypic identification methods
To assess the value of the use of 16S rRNA comparative gene sequencing for the 
identification of the bacteraemia isolates, the identities achieved using phenotypic 
characterisation and the 16S rRNA comparative gene sequencing were compared for a 
cohort of 209 bacteraemia isolates. These comparisons a shown in Table 5.3.
Table 5.3 Retrospective comparison o f 16S rRNA comparative gene sequencing versus 
phenotypic identifications
Presumed genera - r  m>w Comparative 16S rRNA
Gram-positive cocci 99
Streptococcus spp 19 Streptococcus spp 17
Peptostreptococcus sp 1
Actinomyces sp 1
Staphylococcus spp 29 Staphylococcus spp 19
Micrococcus spp 9
Stenotrophomonas sp 1
mutans streptococci 13 mutans streptococci 2
Streptococcus spp 9
Gemella sp 1
Abiotrophia sp 1
Micrococcus spp 4 Micrococcus spp 3
Staphylococcus sp 1
Enterococcus spp 8 mutans streptococci 5
Streptococcus spp 3
Actinomyces spp 2 Acinetobacter sp 1
Actinomyces spp 1
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Presumed genera («=) Comparitive 16S rRNA in =)
Unknown 22 Corynebacterium spp 2
Gemella sp 1
Micrococcus spp 6
mutans streptococci 1
Pseudomonas sp 1
Rothia sp 1
Staphylococcus spp 4
Streptococcus spp 4
Gram-positive rods 97
Actinomyces spp 23 Actinomyces spp 15
Propionibacterium spp 5
Rothia sp 1
Bifidobacterium sp 1
Streptococcus sp 1
CRP species 34 Actinomyces spp 12
Bacillus spp 7
Brevibacterium sp 1
Corynebacterium spp 4
Lactobacillus spp 2
Propionibacterium spp 7
Rothia sp 1
Lactobacillus spp 1 Lactobacillus sp 1
Lactobacillus spp/
Actinomyces spp 9 Lactobacillus spp 6
Actinomyces spp 2
Bifidobacterium sp 1
Bacillus sp 1 Bacillus sp 1
Streptococcus spp 6 Actinomyces spp 5
Rothia sp 1
Unknown 20 Actinomyces spp 13
Corynebacterium sp 1
Peptostreptococcus spp 5
Propionibacterium sp 1
Gram-negative bacteria 13
Acinetobacter sp 1 Acinetobacter sp 1
Veillonella spp 2 Veillonella spp 2
Fusobacterium spp/
Leptotrichia spp 2 Fusobacterium sp 1
Leptotrichia sp 1
Unknown 8 Acinetobacter sp 1
Bacillus sp 1
Cytophaga spp 2
Peptostreptococcus sp 1
Stenotrophomonas spp 2
Veillonella sp 1
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The data presented in table 5.3 shows that of the Gram-positive cocci isolated to genus 
level using phenotypic characterisation methods (chapter 4), that 50.5% were correctly 
assigned a genus when compared with the identity achieved using 16S rRNA 
comparative gene sequencing. Of the Gram-positive rods, only 29.9% were assigned the 
correct genera using phenotypic characterisation; compared to only 23.1% of the Gram- 
negative bacteria. The phenotypic characterisation was most successful for aiding 
geneus identification of streptococci (89.5%) but was not helpful in assigning any genus 
level identification for 23.9% of the isolates in the cohort.
5.4 Discussion
5.4.1 Use of 16S rRNA comparative gene sequencing in the identification of oral 
bacteria
Sequencing of the 16S rRNA gene has been utilised for the identification of oral 
bacteria for a number of years. The advantages of using the 16S rRNA gene include that 
it is ubiquitous among bacterial species (all life on Earth) allowing amplification of 
DNA across the kingdom, yet contains regions of variability which allow individual 
bacterial species to be identified through gene sequencing (Woese et al., 1985). 
Comparative 16S rRNA gene sequencing has allowed the elucidation of the complex 
community and ecological niches involved in the oral cavity (Tanner et al., 1994). 
Phylogenetic studies of the oral microbiota have included investigation of subgingival 
plaque (Kroes et al., 1999), (Paster et al., 2001), endodontic infections (Rolph et al., 
2001) and in the characterisation of oral bacterial biofilms (Pratten et al., 2003). The 
benefits of using molecular techniques such as 16S rRNA comparative gene sequencing 
are that unlike conventional phenotypic characteristics, genotypes are stable, not 
subjected to bias and unambiguous (Poyart et al., 1995), (Fontana et al., 2005), (Petti et 
al., 2005). The lack of a reliable biochemical method of identification of bacteraemia 
isolates led to the use of comparative gene sequencing of the 16S rRNA gene during 
this project.
5.4.2 Performance of the Ribosomal Database Project for sequence identity
Overall, the RDP II database performed well for the comparative sequencing of the 16S 
rRNA bacteria isolated from the bacteraemia subjects. Of the 493 isolates subjected to
160
Chapter 5  ~  Identification of bacteraemia isolates using comparative gene sequencing
comparative gene sequencing the majority (71%) were assigned a species level identity, 
a further 10.3% were discriminated to between two closely related species and 16.2% to 
genus level; only 2.2% of the isolates were not assigned an acceptable identification 
using the RDP II database. The advantages of using RDP II include the user-friendly 
interface, the ability to select which sequences are included in the alignment including 
factors such as sequence length, inclusion of environmental isolates and comparison to 
or exclusion of type strain sequences. RDP II is updated on a monthly basis using 
sequences obtained from GenBank (BLAST) and the EMBL database (Cole et ol., 
2005). As of May 18, 2006, the database consisted of 226,159 aligned and annotated 
16S rRNA sequences (http://rdp.cme.msu.edu/misc/rel9info.jsp). The authors also claim 
that the sequence match tool of RDP II is superior to BLAST at finding closely related 
sequences (Cole et al., 2005). Problems encountered when using RDP II included the 
occurrence of Propionibacterium acnes isolates being misidentified as Mycobacterium 
chitae (n = 14 isolates). Both P. acnes and M. chitae are Gram-positive rods, but P. 
acnes is an obligate anaerobe whereas M. chitae is described as aerobic; this same 
discrepancy has also been reported in a study which investigated the use of 16S rRNA 
gene sequencing of Gram-positive aerobic rods. The authors’ concluded that sequence 
data from P. acnes strains had been incorrectly named as M. chitae strains (Bosshard et 
al., 2004). In a study which investigated 16S rRNA sequences contained within the 
RDP II database, it was found that 5% of the 1399 sequences screened contained 
“substantial errors” (Ashelford et al., 2005). The problem of unverified sequence data in 
public databases is documented as a major drawback of comparative gene sequencing 
(Harmsen et al., 2002), (Clarridge, III, 2004), (Bosshard et al., 2004). This issue has led 
to the development of a commercially available sequencing system that provides a 
dedicated database (MicroSeq. Applied Biosystems. CA,USA) and the development of 
sequence databases that contain only verified sequence data such as the Ribosomal 
Differentiation of Medical Micro-organisms Database (RIDOM; http://www.ridom.de/). 
The major disadvantage of these databases however is that they contain limited data and 
are therefore not as useful as the large databases in the identification of less common 
isolates (Woo et al., 2003), (Clarridge, III, 2004), (Fontana et al., 2005). It is therefore 
prudent to cross check all sequencing results back to the basic microbiological 
characteristics of each isolate to avoid errors within the public sequence databases 
entering study data.
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5.4.3 Performance of BLAST II for sequence identity
The use of BLAST II to search the GenBank sequence database in the identification of 
bacteria has been reported widely in the literature (Kattar et al., 2000), (Drancourt et al., 
2000), (Ciantar et al., 2005b), (Pratten et a l, 2003). The GenBank database is one of the 
largest sequence databases and is reported to contain at least 90,000 bacterial 16S rRNA 
gene sequences (Clarridge, 2004). During the study, the use of the BLAST tool resulted 
in 65% of the isolates involved being identified to species level, 9.7% were 
discriminated to two related species, 24.5% to genus level and only 5.9% were not 
assigned an acceptable identification. The major limitations of using the BLAST tool 
included the time for sequence matches to be returned. At the time of these analyses, the 
search engine restricted multiple enquiries from a single user by imposing a time delay 
for every subsequent query submitted (http://www.ncbi.nlm.nih.gov/blast/blast_F AQs.shtml#timeout)j this penalty
system increases labour time when large batches of sequence data need to be analysed. 
The tool also lacks user friendliness and often returns numerous pages of data that need 
to be scrolled through. BLAST also includes many sequences that are clones and 
uncharacterised isolates without the option of excluding them from the search; often an 
extremely good match of >99% was returned for a submitted sequence but was rejected 
on the basis that the deposited sequence was from an uncharacterised, unnamed or 
cloned isolate.
5.4.4 Results of comparative 16S rRNA gene sequencing for isolate identification
Isolates were assigned an identity when the resultant sequence match had a percentage 
similarity of >95% (BLAST) or a similarity ranking of > 0.7 (RDP II). These criteria are 
not as stringent as reported by other authors using comparative 16S rRNA gene 
sequencing; percentage similarities of <95% have been described as non-acceptable, 
between 95 and 99% as identified to genus level and >99% as identified to species level 
(Drancourt et al., 2000). The stringencies of percentage similarities used however differ 
markedly in the literature with some authors regarding percentage similarities <97% as 
new taxa and requiring values exceeding >99.5% for a species level identification 
(Janda and Abbott, 2002). In this study, lower stringencies were applied to account for 
the exclusion of sequence data that was derived from clones, uncultured and poorly 
characterised sequences. It is important to remember that when a new genus or species 
is described, it is a requirement that the 16S rRNA gene sequence has been deposited in
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a public database and the accession number included in the description. For this reason, 
sequence data from isolates not formerly described, were not included for comparison.
By submitting sequence data to both the RDP II database and the use of the BLAST tool 
to search the GenBank database, all Gram-negative bacteria (n = 26) and 396 (84.8%) 
of the Gram-positive isolates were identified to species level; all remaining bacteria 
were identified to genus level using either database or by consensus. These data are 
comparable to other studies that have used comparative 16S rRNA gene sequencing to 
identify isolates that could not be reliably identified using conventional phenotypic tests 
and have reported results of 89.8% and 81% identification to species level (Drancourt et 
al., 2000), (Bosshard et al., 2004). In the majority of cases during this study where 
species level identification could not be attained, the isolate involved was a member of 
either the mitis group of streptococci (n = 39) or coagulase-negative staphylococci 
(CoNS) (-n = 43); these isolates accounted for 16.6% of the sequenced isolates.
The high level of sequence homology among the mitis group streptococci has been 
described as >99% (Kawamura et al., 1999), which makes discrimination of these 
closely related species difficult when sequencing small fragments of the 16S rRNA 
gene. It has been reported that the 16S rRNA gene is not useful for discriminating 
between species which share >97% homology (Stackebrandt and Goebel BM, 1994). It 
is suggested therefore that where 2 or more related species are returned during 
comparative gene sequencing, that an alternative gene with higher discrimination be 
sought (Woo et al., 2003). Examples of alternative genetic targets for amplification and 
identification of bacteria include the autolysin gene (lytA) and the D-alanine: D- alanine 
ligase gene (ddt) for discrimination between streptococci (Kawamura et al., 1999), tu f 
genes in the identification of Bifidobacteria spp and lactobacilli (Ventura et al., 2003), 
hsp60 genes in the identification of CoNS and the manganese-dependent superoxide 
dismutase gene (sodA) for the identification of Gram-positive bacteria including 
streptococci, enterococci and CoNS (Poyart et al., 1995), (Poyart et al., 1998), (Poyart 
et al., 2000), (Poyart et al., 2001).
163
Chapter 5  ~  Identification of bacteraemia isolates using comparative gene sequencing
5.5 Conclusions
• The use of comparative 16S rRNA gene sequencing is a powerful tool in the 
identification of bacteraemia isolates. Using RDP II, 71.3% of bacteraemia 
isolates were identified to species level compared with 65.0% using the BLAST 
II tool to search the GenBank database.
• There are several sequence databases available in the public domain and each 
has advantages and disadvantages. There are databases which contain many 
unverified sequences and which lack user-friendliness, there are also databases 
who are limited by their size, cater only for specific bacterial groups or which 
are infrequently updated.
• For closely related bacterial species, such as the mitis group streptococci or the 
coagulase-negative staphylococci, comparative sequencing of the 16S rRNA 
gene may lack discriminatory power; there are alternative genetic targets which 
may enhance resolution of these bacteria to species level.
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6.0 Development of a sodA PCR-RFLP method for the 
identification of oral streptococci
6.1 Introduction
The use of 16S rRNA comparative gene sequencing had greatly simplified and 
improved the identification of the isolates recovered from the culture-positive 
bacteraemia samples. There was still however an issue of identification of oral 
streptococci to species rather than species group level. The failure of the sequencing 
protocol to identify such isolates to species level was important because the majority of 
recovered isolates were such bacteria. Comparative sequencing using the 16S rRNA 
gene is poor at discriminating members of the oral streptococci, specifically the mitis 
group of streptococci, due to the high level of homology between these species within 
this specific gene. This homology has been reported to exceed 99% for several members 
(Kawamura et al., 1999). It was therefore decided to investigate the possibility of 
exploiting an alternative genetic target to 16S rRNA that would possess greater 
variability among these species.
From review of the literature, it was discovered that considerable success had been 
achieved in the differentiation of streptococci through sequencing of an internal 
fragment of the manganese-dependent superoxide dismutase gene (sodA) (Poyart et al., 
1998). Superoxide dismutase is an enzyme carried by almost all aerobes and facultative 
aerobes. The enzyme often acts in conjunction with the catalase and peroxidase 
enzymes to prevent cellular damage caused by superoxide (O2 ) and other toxic forms 
of oxygen. Superoxide dismutase works by combining two molecules of superoxide to 
form one molecule of hydrogen peroxide and one molecule of oxygen; catalase and/or 
peroxidase then act to break hydrogen peroxide into water and oxygen or water and 
NAD+ (Brock and Madigan, 1991). The sodA gene uses manganese as a co-factor and 
has been detected in a wide range of Gram-positive bacteria including enterococci, 
streptococci, lactococci, Listeria spp and Clostridium spp (Poyart et al., 1995). The 
work published by Poyart et al., described much better discrimination between the oral 
streptococci than by use of comparative 16S gene sequencing. Once a potential 
alternative genetic target to the 16S rRNA gene was found, to decrease the use of 
sequencing, it was decided to develop a PCR-RFLP based on the degenerative primers
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described by Poyart et al which would have the discriminative power of a genotypic 
method combined with the cost effectiveness of a phenotypic method.
6.2 Materials and methods
Isolates that had previously been recovered from post-extraction bacteraemia (section 
2.3) had been identified as oral streptococci through use of morphological, biochemical 
(section 2.4.1.) and genotypic characteristics (section 2.4.4). The isolates however, 
proved difficult to identify to species level. Using the sodA sequence data deposited by 
Poyart and other authors in the GenBank database, a virtual restriction digest was 
performed to choose suitable restriction endonucleases for the study. The strain 
designations and sequence accession number and length are shown in table 6.1.
Table 6.1 Accession numbers fo r  sodA sequences held in GenBank database
Strain Designation Accession number Sequence length (bp)
S. anginosus ATCC 33397 Z95895 435
S. constellatus ATCC 27823 Z95897 435
S. intermedius ATCC 27335 Z95908 435
S. gordonii ATCC 10558 Z95905 435
S. mitis NCTC 12261 Z95909 435
S. oralis ATCC 35037 Z95911 435
S. parasanguinis ATCC 15910 Z95913 435
S. pneumoniae ATCC 33400 Z95914 435
S. sanguinis ATCC 10556 Z95918 435
S. salivarius ATCC 19645 Z95916 435
S. vestibularis ATCC 49124 Z95922 435
S. mutans ATCC 35668 Z95910 435
S. sobrinus ATCC 33478 Z95919 435
S. cristatus* NCTC 12497 AB021548 366
S. in f antis* JCM 10157 AB021546 366
S. peroris* JCM 10158 AB021545 366
* shorter sequences deposited by (Kawamura et al., 1998) at a later time
The sequences were subjected to an in silico “virtual” restriction digestion analysis 
using NEBcutter v 2.0 a tool provided by New England BioLabs, which scans their 
range of restriction endonucleases (see section 2.5.4.3). Using this tool allowed the 
determination whether a single restriction endonuclease (or indeed a combination) could 
resolve differences between the strains. Unfortunately, no sequence data were available 
for the sequence of the sodA gene from S. australis. Therefore, the virtual digest
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performed could only assist in selection of which restriction endonucleases to try rather 
than as a representation of the actual RFLP profiles that would emerge. Isolates were 
subjected to direct colony PCR using the published degenerative primers but with 
optimised PCR conditions and thermocycling parameters (section 2.4.5.2) prior to the 
double restriction digest using Alul and Bglll (section 2.4.5.3).
6.3 Results and Discussion
6.3.1 in silico restriction analysis of the sodA gene
From the virtual digest, Alul was identified as the only enzyme with restriction sites in 
each of the streptococci with known partial sequences in the study (i.e. all except S. 
australis). The digestion discriminated and resolved all the strains except for S. mitis 
and S. pneumoniae. Further, in silico analysis revealed that a restriction site for Bglll 
existed in the sequence of S. mitis and not S. pneumoniae and use of this restriction 
endonuclease should resolve the problem. Only S. mitis, S. constellatus, and S. 
salivarius were shown to have sequence with the correct site for restriction by Bglll.
6.3.2 Evaluation of a sodA PCR-RFLP method for identification of oral 
streptococci
The resulting amplicons from the sodA PCR (figure 6.1) were approximately 480 bp in 
size in accordance with the Poyart method (Poyart et al., 1995). The sequence data for 
the genes was only 435 bp in length for the sequences deposited by Poyart and only 366 
bp for the additional sequences deposited by Kawamura (Kawamura et al., 1999). Table
6.1 presents the strains sequenced, and the strain number etc. The restriction 
endonucleases Alul and Bglll were used to digest the 17 reference strains. Figure 6.2 
shows the RFLP patterns generated. It is demonstrated that the RFLP profiles for all 
reference strains are different from each other. The method was then applied to a 
collection of 134 clinical strains isolated from asymptomatic odontogenic bacteraemia 
(as described in section 2.3), 21 isolates were repeated to ascertain reproducibility. 
Examples of RFLP profiles from clinical isolates are shown in Fig. 6.3.
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Fig. 6.1 Amplicons generated by sodA PCR amplification
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MM = Molecular weight marker; lane 1= negative control (water); lanes 2 to 5 = streptococcal DNA.
The sodA PCR-RFLP method was relatively easy to perform and the whole process 
from sodA PCR to RFLP profile could be performed within a single laboratory day if 
necessary. Unlike the use of comparative 16S rRNA sequencing which as well as being 
comparably more expensive than the sodA PCR-RFLP method, took a minimum of 24 
hours, was limited to 48 samples in a 2-day period and yielded less informative data.
It was often found during the RFLP stage of the process that bands exceeding the total 
size of the amplified sodA fragment occurred, either in the form of a single larger band 
or by additional bands present. It was postulated that these occurrences were either due 
to inclusion of non-specific PCR products in the digestion and subsequent RFLP of the 
amplified products, or through incomplete or partial digestion during the incubation 
with the restriction endonucleases.
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A further limitation to this method was the necessity to compare the RFLP profiles 
visually. An improvement to this protocol would be to develop software to reliably 
recognise characteristic profiles which would facilitate and accelerate identification of 
streptococci using this method. Isolates of both & sobrinus and S. salivarius were 
successfully identified using the comparative 16S rRNA gene sequencing and sodA 
PCR-RFLP method; the infrequent isolation of such streptococci in our laboratory 
means further isolates need to be studied to evaluate this method for the identification of 
this group of bacteria.
At the inception of this study, it was not possible to obtain either the type strain or 
genomic DNA of Streptococcus sinensis, and Streptococcus oligofermentans as they 
had yet to be described. Both of these organisms have been shown to be closely related 
to other members of the mitis group by phylogenetic studies of their 16S rRNA, 
therefore it is possible atypical profiles raised by this method belong to either of these 
species (Tong et al., 2003), (Woo et al., 2002).
The majority of clinical isolates were identified to species level using the sodA PCR- 
RFLP method. Some strains showed patterns not identical to a type strain and were 
labelled as ‘variant’ e.g., S. gordonii variant (Fig. 6.3, lane 7). Isolates conforming to 
this pattern were identified as variants of S. gordonii by comparing the identities 
assigned by comparative 16S rRNA gene sequencing and the visual comparison of band 
sizes. Isolates which repeatedly failed to yield RFLP bands, were designated “no 
profile”.
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Fig. 6.2 sodA PCR-RFLP Profiles fo r  Type strains o f  oral streptococci restricted with Alul and Bglll. MM, molecular weight marker (base 
pairs); AN, S. anginosus; CON, S. constellatus; INT, S. intermedius, AU, S. australis, CR, S. cristatus; GO, S. gordonii; INF, S. in f antis; MI, S. 
mitis; OR, S. oralis; PA, S. parasanguinis; PE, S. peroris; PN, S. pneumoniae; SA, S. sanguinis; MU, S. mutans; SO, S. sobrinus; SAL, S. 
salivarius; VE, S. vestibularis
MM AN CON INT AU CR GO INF Ml OR PA PE PN SAN MU SO SAL VE MM
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Fig. 6.3 An example of sodA PCR-RFLP profiles for clinical isolates with inferred identity
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MM, molecular weight marker; 1, S. mitis, 2, S. sanguinis, 3, S. australis; 4, S. gordonii, 5, 51 cristatus, 6, 5. in f antis, 7, Variant 9 (of S. 
gordonii); 8, S. oralis; 9, 5. sanguinis; 10, 5. peroris, 11, 5. anginosus, 12, S. mutans, 13, 5  peroris, 14, 5. mutans.
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6.3.3 Anginosus group streptococci
Of the 20 isolates identified by comparative 16S rRNA gene sequencing to be specific 
members of the anginosus group e.g., S. anginosus, S. constellatus or S. intermedius, the 
sodA PCR-RFLP method identified 14 isolates (70%) in total agreement, 2 isolates 
(10%) as different members of the anginosus group and the remaining 4 isolates (20%) 
as variants of the anginosus group.
6.3.4 The mitis group streptococci
In total 87 isolates identified by comparative 16S rRNA gene sequencing as members of 
the mitis group streptococci. Of these, 54 isolates (63.2%) could not be identified 
beyond the mitis group to individual species. Using the sodA PCR-RFLP method, the 
identity of these isolates was further characterised: 28 isolates (50.9%) matched a type 
strain RFLP profile exactly, allowing a definitive identification to be assigned. A further 
10 (18.2%) isolates resulted in a profile deemed to be a variant of a specific type strain 
RFLP profile allowing a presumptive identification to be assigned. Isolates were 
deemed to be variants of a species by close scrutiny of “unknown” profiles. For 
example, if an expected band sized 200 bp was absent, but 2 “new” bands sized 150 bp 
and 50 bp appeared (evidence of an additional restriction site) results obtained using the 
comparative 16S rRNA gene sequence data were consulted to get some sort of 
identification measure.
A group of 15 isolates (27.3%) generated a variant profile not associated with a 
particular species. Many of these atypical RFLP profiles occurred in isolation i.e. could 
not be compared to other variant or typical patterns; approximately 53.3% (8 isolates) of 
these variants, however, showed a common repeated profile. These isolates had been 
identified to the mitis group of streptococci using comparative 16S rRNA gene 
sequencing. Two isolates (3.6%) identified as mitis group streptococci using 
comparative 16S rRNA sequencing failed to achieve an RFLP profile on repeated 
attempts.
A group comprising 8.3% (n = 7 isolates) of the total mitis group isolates could not be 
distinguished between S. gordonii and S. mitis by comparative 16S rRNA sequencing. 
Using the sodA PCR-RFLP method these isolates were identified as a variant of S. 
gordonii (85%), or matched the S. gordonii type strain RFLP profile exactly (15%).
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The remaining 29.8% of isolates had been identified by comparative 16S rRNA 
sequencing to a single species; in comparison the sodA PCR-RFLP method was in total 
agreement for 92% of these isolates, A further 8% differed by the species identified but 
were still mitis group members.
6.3.5 Mutans group streptococci
Only S. mutans and S. sobrinus were included in this study. Of the 29 mutans 
streptococci analysed, one isolate failed to generate a RFLP profile, despite repeated 
attempts, otherwise profiles matching either S. mutans (n = 27) or S. sobrinus {n = 1) 
were obtained on all occasions and clinical isolates generated the same characteristic 
bands as the type strains used.
6.3.6 Salivarius group streptococci
Of the cohort (n = 2), only one isolate shared an identical profile with the profile 
generated from the type strain of S. salivarius; the other isolate failed to generate a 
RFLP profile, despite repeated attempts. It is possible however, that the failure to yield 
an RFLP phenotype, despite the presence of a PCR amplicon, is representative of 
another profile for S. salivarius. The lack of salivarius group RFLP profiles seen during 
the assay of the bacteraemia isolates was not surprising as very few strains of S. 
salivarius had been isolated previously in our laboratory.
6.3.7 Evaluation of sodA PCR-RFLP method using 16S rRNA comparative gene 
sequence data
The identities assigned to the clinical isolates using the sodA PCR-RFLP method were 
supported by comparative 16S rRNA gene sequence data; identity concordance between 
the two methods to the group level was 100%. The two methods disagreed about the 
specific species within a group for 4 isolates (2.9%) e.g., isolate identified as S. 
anginosus by 16S sequencing but S. intermedius by the sodA PCR-RFLP method. The 
comparative identities achieved using comparative sequencing of the 16S rRNA gene 
and the sodA PCR-RFLP method are shown in table 6.2. Overall, 71.7% of the clinical 
isolates subjected to the sodA PCR-RFLP method were identified to species level 
compared to only 55.1% using comparative 16S rRNA gene sequencing. This was due
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largely to the inability of the comparative 16S rRNA gene sequencing to discriminate 
between the mitis group streptococci using only partial sequencing (up to 400 base pairs 
of sequence compared to sequence held in databases). A limitation of using comparative 
16S rRNA gene sequencing to identify members of species as closely related as some of 
the oral streptococci is that often a definitive identification cannot be achieved. It is 
necessary to limit the outcome to two or three species e.g., S. gordonii or S. mitis or to a 
group of species e.g., mitis group (Kawamura et al., 1995b). It is of note that 22.6% of 
the total mitis group isolates identified by comparative 16S rRNA sequencing as S. 
sanguinis were always identified with both methods in total accordance, supporting 
previous studies which indicate that S. sanguinis is distinct in both 16S rRNA and sodA 
gene sequence from most other mitis group streptococci (Kawamura et al., 1999).
Members of the anginosus group were successfully identified using this method. As 
with the mitis group streptococci, discrimination among the members of this group is 
also difficult by use of comparative 16S rRNA gene sequencing and other genotypic 
methods, with particular difficulty in separation of S. anginosus and S. intermedius 
(Goto et al., 2002), (Whiley et al., 1995).
S. mutans was always identified by comparative 16S rRNA gene sequencing, by the 
sodA PCR-RFLP method on 96.4% of occasions and was easily identified using other 
routinely employed identification schemes such as carbohydrate fermentation analyses 
(see section 2.4.2). S. mutans strains were included in this study as they are frequently 
isolated from the oral cavity and because they are important indicators of a cariogenic 
oral microbiota (Beighton et al., 2004).
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Table 6.2 Comparison o f J6S rRNA gene sequence data and sodA PCR-RFLP
16S rRNA identification (»«> sodA PCR-RFLP identification (»*)
S. anginosus 5 S. anginosus 3
S. intermedius 1
variant 1
S. constellatus 2 S. anginosus 1
variant 1
S. intermedius 13 S. intermedius 11
variant 2
mitis group 55 S. australis 3
S. cristatus variant 2
S. gordonii 3
S. gordonii variant 5
S. infantis 2
S. mitis 6
S. mitis variant 2
S. oralis 6
S. parasanguinis 1
S. peroris 2
S. pneumoniae 5
S. pneumoniae variant 1
other variants 15
no profile 2
S. australis 1 S. australis 1
S. cristatus 3 S. cristatus 2
S. parasanguinis 1
S. gordonii 1 S. gordonii 1
S. mitis/S. gordonii 7 S. gordonii 1
S. gordonii variant 6
S. parasanguinis 1 S. mitis 1
S. sanguinis 19 S. sanguinis 19
S. mutans 28 S. mutans 27
no profile 1
S. sobrinus 1 S. sobrinus 1
S. salivarius 2 S. salivarius 1
no profile 1
138 138
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6.3.8 Retrospective analysis of phenotypic characterisation of oral streptococci
To further assess the usefulness of biochemical tests in the characterisation of oral 
streptococci, the profile of the carbohydrate fermentation and hydrolysis assay and the 
utilisation of enzyme substrates were reviewed blindly in separation and in conjunction 
in order to assign identifications to 100 isolates given a species level identification using 
sodA PCR-RFLP. Strains were assigned a number and were then assayed; the 
biochemical phenotypic identification was then compared to the genotypic identification 
presumed to be correct. A selection of the data are presented in table 6.3.
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Table 6.3 sodA PCR-RFLP versus biochemical identifications
sodA PCR-RFLP Biochemical phenotype sodA PCR-RFLP Biochemical phenotype
S. anginosus S. anginosus/mutans S. intermedius S. intermedius
S. anginosus S. anginosus S. mitis non reactive
S. anginosus anginosus group S. mitis S. anginosus
S. anginosus S. anginosus S. mitis S. oralis
S. australis mitis group S. mitis S. oralis
S. australis S. mitis S. mitis S. oralis
S. australis mitis group S. mitis CND
S. cristatus CND S. mitis CND
S. gordonii S. sanguinis/parasanguinis S. mitis mitis group
S. gordonii CND S. mitis CND
S. gordonii S. gordonii S. mutans CND
S. gordonii S. gordonii S. mutans S. mutans
S. gordonii S. mitis/parasanguinis S. mutans S. mutans
S. infantis S. oralis S. mutans S. mutans
S. infantis S. oralis S. mutans CND
S. intermedius S. intermedius S. mutans S. mutans
S. intermedius S. intermedius S. mutans S. mutans
S. intermedius S. intermedius S. mutans S. anginosus
S. intermedius S. intermedius S. mutans S. mutans
S. intermedius S. intermedius S. mutans S. mutans
S. intermedius S. parasanguinis S. mutans S. anginosus
S. intermedius CND S. mutans S. mutans
S. intermedius S. intermedius S. mutans CND
S. mutans S. mutans S. pneumoniae mitis group
S. mutans S. mutans S. pneumoniae S. oralis
S. mutans S. mutans melibiose negative S. pneumoniae S. oralis
S. mutans S. mutans S. pneumoniae S. mitis
S. mutans S. mutans S. pneumoniae S. oralis
S. mutans S. mutans S. salivarius CND
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sodA PCR-RFLP Biochemical phototype sodA PCR-RFLP Biochemical phenotype
S. mutans S. mutans S. sanguinis S. oralis
S. mutans S. mutans S. sanguinis S. anginosus
S. mutans S. mutans S. sanguinis S. mitis
S. mutans S. mutans S. sanguinis S. salivarius
S. mutans S. mutans S. sanguinis CND
S. mutans S. anginosus S. sanguinis CND
S. mutans S. mutans S. sanguinis S. oralis
S. mutans S. mutans S. sanguinis S. mitis
S. mutans S. sanguinis S. sanguinis CND
S. mutans S. mutans S. sanguinis CND
S. mutans S. mutans S. sanguinis S. sanguinis/mutans
S. mutans S. mutans S. sanguinis CND
S. oralis S. oralis S. sanguinis S. oralis
S. oralis S. oralis S. sanguinis S. mitis/pneumoniae
S. oralis S. oralis S. sanguinis S. mitis/pneumoniae
S. oralis S. oralis S. sanguinis S. mitis
S. parasanguinis S. oralis S. sanguinis S. mitis
S. parasanguinis S. oralis S. sanguinis S. anginosus
S. peroris S. oralis S. sanguinis S. mitis
S. peroris S. oralis S. sobrinus CND
S. peroris S. mitis S. sobrinus CND
CND = could not determine the phenotype from the biochemical data
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By analysing the phenotypic data in this way, it was possible to evaluate the usefulness 
of the biochemical methods for the routine identification of commonly isolated oral 
streptococci. It was found that where carbohydrate fermentation and hydrolysis and 
detection of pre-formed enzymes were used, incorrect identities or low level of 
speciation was assigned. Overall 39% of the isolates (n = 100) were correctly identified 
to species level in agreement with the sodA PCR-RFLP method, 4% could not be 
discriminated between two species (where one of the presumptive species was correct) 
and an additional 3% were speciated to the correct group. In contrast 39% were not 
identified to the correct species and of these 23% (n = 9) were not even identified to the 
correct group of streptococci. The remaining 18% of isolates were not assigned any 
identity due to inconclusive or missing test results.
These findings are supported by other studies conducted, whereby phenotypic and 
genotypic methods have been compared and similarly poor levels of concordance have 
been reported. Kikuchi et al., 1995 compared the results of DNA-DNA hybridisation 
with those attained using a commercially available biochemical assay kit (rapid ID 32 
Strep system, bioMerieux). The authors found that 13% of isolates were incorrectly 
identified or could not be assigned an identity using the biochemical assay . In similar 
studies, authors have found biochemical assays identified between 42 to 73.5% 
compared to comparative 16S rRNA gene sequence analysis (Drancourt et al., 2000), 
(Bosshard et al., 2004), (Song et al., 2005).
As with sequence databases and other methods, biochemical assays are also only as 
effective as the database of individual species characteristics held (Kikuchi et al., 1995), 
(Bosshard et al., 2004). Several species found during the study either had absent or few 
reported phenotypic characteristics including S. australis, S. peroris and S. infantis. As 
new species are described in the literature, it is important for laboratories using 
phenotypic based assays to update their databases. This problem is usually avoided with 
the use of genotypic identification methods such as comparative gene sequencing as 
more and more frequently newly described species have gene sequence deposited in 
public access databases such as GenBank. Where data is sufficiently different to the 
sequences held in the databases a new species may be suggested; such a discovery 
would not be indicated through phenotypic assay (Bosshard et al., 2004).
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Following speciation using the sodA PCR-RFLP method, isolates were grouped via 
species and their phenotypic characteristics compared (Tables 6.3). It was found that 
there was a great deal of intra-species variation in the observed phenotypic profiles 
The use of these data also revealed that a cohort of wild type isolates may not display 
the phenotypic characteristics reported of reference strains.
6.4 Conclusions
•  Identification of the streptococci, especially members of the mitis group, can be 
difficult.
•  The use of biochemical assays is limited to the database of characteristics held 
and the stability of the phenotype expressed.
• Use of the comparative 16S rRNA gene sequencing method is not useful for 
discriminating between very closely related species.
• Genotypic methods based on alternative genetic targets may provide an 
alternative or adjunct method for the speciation of closely related species.
• The use of a sodA PCR-RFLP method supported by the results obtained using 
the comparative 16S rRNA gene sequencing data allowed identification to 
species level for 71.7% of these streptococcal isolates compared to 55% using 
comparative 16S rRNA gene sequencing alone.
• PCR-RFLP protocols provide a cost-effective solution to laboratories that cannot 
afford high throughput gene sequencing to identify closely related bacteria.
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7.0 The nature of paediatric odontogenic bacteraemia
7.1 Introduction
The study of odontogenic bacteraemia is important, because the information collected 
about the organisms involved and their persistence within the blood stream aid 
understanding of the process of bacteraemia genesis i.e. where in the oral cavity the 
bacteria originate and the role of dental bacteraemia in serious systemic disease such as 
BE. When studying the nature of bacteraemia isolates it is important to speciate the 
bacteria to as high a degree possible in order to allow comparison of pre- and post­
extraction samples and to assess the diversity of the microbiota involved. In terms of 
pathogenicity, characterisation to species level is especially important, as certain 
bacteria possess virulence factors which facilitate disease progression; for example 
Streptococcus sanguinis and Staphylococcus aureus have been shown to possess 
fibronectin binding capacity to increase aggregation and therefore pathogenicity during 
BE (Lowrance et al., 1990), (Cheung et al., 1994).
As mentioned in chapter 3, LF is a particularly useful technique not only for the 
quantification of transient bacteraemia but also for the facilitation of speciation of 
bacteraemia isolates. Unlike broth culture where detection of bacteria is hindered by the 
presence of antimicrobial substances and the antibacterial action of blood, LF allows the 
bacteria to be separated from these factors and to grow with minimal competition from 
other bacteria (Sullivan et al., 1975a), (Zierdt etal., 1977), (Heimdahl et al., 1985).
7.2 Materials and methods
Blood was sampled from paediatric subjects following dental extraction at time points 
ranging from 10 s to 60 min post-maximal dental manipulation (section 2.1). These 
blood samples were processed using the lysis filtration (LF) technique (section 2.2). 
Isolates were enumerated, sub-cultured and frozen until identification was assigned 
using a combination of microbiological (section 2.4.1), biochemical (section 2.4.2) and 
genotypic methods (sections 2.4.4 and 2.4.5).Once identified isolates from pre- and 
post-extraction samples were compared, isolates that were present in the blood prior to 
dental manipulation were discounted from the post-extraction bacteraemia.
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Isolates were compared to published results to assess whether or not they could be 
considered as commensal oral microbiota (Tanner et al., 1994), (Kroes et al., 1999), 
(Paster et al., 2001), (Tanner et al., 2002), (Munson et al., 2004).
7.3 Results
7.3.1 The nature of bacteraemia following dental extraction in children.
Each sample was filtered as two aliquots, with one being incubated aerobically and the 
other anaerobically. The proportions of isolates recovered under the different conditions 
of incubation for each time group are shown in table 7 .1.
Table 7.1 Detection o f isolates according to atmosphere o f incubation
Pre-extraction (cfu/time 
group)
Post-extraction (cfu/time 
group)
Time Group o2 An02 o2 An02
10 s 37.0 34.0 180.0 296.0
30 s 6.0 9.0 34.0 96.0
1 min 7.0 6.0 330.0 418.0
2 min 7.0 13.0 189.0 205.0
4 min 2.0 13.0 34.0 50.0
7.5 min 11.0 10.0 23.0 20.0
15 min 13.0 68.0 36.0 57.0
30 min 2.0 8.0 5.0 17.0
45 min 2.0 6.0 59.0 44.0
60 min 4.0 7.0 27.0 52.0
Sub total 91.0 174.0 917.0 1255.0
Total 265.0 2172.0
The data in table 7.1 compares the proportions of bacteria detected under aerobic and 
anaerobic conditions of incubation for both the pre- and post-extraction time groups. In 
both sets of samples, pre- and post-extraction isolates were detected more frequently 
from plates incubated anaerobically. Aerobic isolations accounted for 34.3% of the pre­
extraction and 42.4% of the post-extraction colonies, while anaerobic colonies 
accounted for 65.7% and 57.6% respectively.
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7.3.2 Nature of pre-extraction bacteraemia
The microbiota of the oral cavity is generally fastidious, and this was reflected in the 
loss of isolates on subculture. When isolates were lost, they were referred to as 
unrecovered isolates. For the bacteria that remained viable, the use of comparative 16S 
rRNA gene sequencing (section 2.4.4) and a sodA PCR-RFLP method (section 2.45), 
allowed all of the bacteria in this study to be identified to at least genus level. Figure 7.1 
shows the proportion of genera recovered from the pre-extraction samples.
Fig. 7.1 Genera isolated from pre-extraction blood samples
Corynebacterium sp.
3%
Actinomyces sp. 
5% Kocuria sp. 
4%Unrecovered
20% Lactobacillus sp.
1%
s>\. Pre vote 11a sp.
Propionibacterium sp. 
14%
Streptococcus sp. 
13% Rothia sp.
3%
CoNS
35%
The largest proportion o f isolates recovered from the pre-extraction samples were 
staphylococci (35%). The recovered staphylococcal isolates were all identified as 
coagulase-negative staphylococci (CoNS), in particular, members of the epidermidis 
group of the species. The majority of isolates that were recovered from pre-extraction 
samples were bacteria that are often described as members o f the oral microbiota 
(Tanner et al., 1994). Other genera recovered included Propionibacterium acnes (14%), 
Streptococcus spp (13%), Actinomyces spp (5%) as well as Corynebacterium spp, 
Kocuria spp, Rothia spp, Lactobacilli and Prevotella spp; 20% of isolates were 
unrecovered.
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7.3.3 Nature of post-extraction bacteraemia
The use of time groups allowed investigation into the duration of intensity, and gave an 
indication of persistence of different bacteria within the bloodstream. This data is 
summarised in table 7.2 as the number of taxa in terms of different genera isolated. Of 
the culture-positive post-extraction subjects (n = 232), 80 subjects (34.5%) had culture- 
positive pre- and post-extraction samples, of which, 9 subjects harboured identical 
isolates of the same species in each sample i.e. in both the pre- and post-extraction. The 
isolates involved were R. dentocariosa, P. acnes (3 subjects), mitis group Streptococcus 
and Staphylococcus spp (4 subjects); in these cases, the isolate was not recorded as a 
post-extraction isolate thereby eliminating it as an odontogenic bacteraemia isolate.
Table 7.2 Number o f genera isolatedfrom post-extraction bacteraemia
Time group Genera (n ~)
10 s 11
30 s 10
1 min 10
2 min 8
4 min 7
7.5 min 8
15 min 4
30 min 6
45 min 7
60 min 6
The data shown in table 7.2 shows that the number of different genera isolated during 
bacteraemia ranged from 4 to 11 following dental extraction. The largest number of 
genera (n = 11) was isolated 10 s after dental extraction while the least number were 
isolated 15 min following the procedure.
Isolates from each sample point were grouped together by genus unless where 
unrecovered. Table 7.3 demonstrates the proportions of different bacterial genera 
detected for each of the post-extraction time groups.
There was a trend among the subjects with samples taken up to 30 min post-maximal 
manipulation to have the majority of recovered isolates identified as Streptococcus spp 
and Actinomyces spp, with the exception of the 7.5 min subjects (26.9%). These genera
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account for 67.8% and 68.3% of the total isolates identified at 10 s and 2 min 
respectively to 52.9% of the total identified isolates at 15 min post-extraction. From 30 
min post-extraction there is a gradual decline of these species as CoNS species become 
the most frequently recovered isolates; species that were predominant among the pre­
extraction samples. The other species recovered included bacteria commonly isolated 
from the oral cavity such as Abiotrophia spp, Lactobacillus spp, Veillonella spp, 
Gemella spp and Peptostreptococcus spp. The proportion of isolates that were 
unrecovered either at initial sub-culture or before a final identity could be assigned 
ranged from 7.7% to 35.3% of the isolates detected at each time point.
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Table 7.3 Proportions o f genera isolated at each post-extraction sample point
Species Prevalence of species-positive samples (%)
10 s 30 s 1 min 2 min 4 min 7.5 min 15 min 30 min 45 min 60 min
Abiotrophia spp. 2.3 0 0 0 0 0 0 0 0 0
Acinetobacter spp. 0 0 1.2 0 0 7.7 0 6.3 0 5.3
Actinomyces spp. 24.1 27.6 22.2 28.3 30.6 11.5 29.4 6.3 14.3 5.3
Bifidobacterium sp. 0 0 0 0 0 0 5.9 0 0 0
Corynebacterium spp. 1.1 6.9 0 1.7 2.0 11.5 0 6.3 0 5.3
Cytophaga sp. 0 0 0 0 2.0 0 0 0 0 0
Fusobacterium spp. 1.1 1.7 0 0 0 0 0 0 0 0
Gemella spp. 1.1 0 2.5 0 4.1 0 0 0 0 0
Kocuria sp. 0 1.7 0 0 0 0 0 0 0 0
Lactobacillus spp. 2.3 6.9 2.5 0 0 11.5 0 0 0 0
Leptotrichia spp. 0 0 0 1.7 0 0 0 0 4.8 0
Neisseria sp. 0 0 0 0 0 0 0 0 4.8 0
Peptostreptococcus spp. 1.1 1.7 2.5 1.7 2.0 0 0 0 0 0
Propionibacterium spp. 0 3.4 2.5 5.0 6.1 7.7 0 12.5 9.5 10.5
Rothia spp. 1.1 0 4.9 1.7 0 0 0 0 4.8 0
Staphylococcus spp. 5.7 8.6 7.4 3.3 2.0 23.1 5.9 31.3 23.8 36.8
Streptococcus spp. 43.7 22.4 40.7 40 30.6 15.4 23.5 12.5 19.0 15.8
Veillonella spp. 2.3 5.2 2.5 0 0 3.8 0 0 0 0
Unrecovered isolates 13.8 13.8 11.1 16.7 20.4 7.7 35.3 25.0 19.0 21.1
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7.3.4 Species diversity of post-extraction bacteraemia
The use of molecular identification methods such as 16S rRNA comparative gene 
sequencing and sodA PCR-RFLP allowed increased discrimination between the isolates 
recovered from the LF plates. Where possible isolates were identified to species level and 
where discrimination to individual species could not be attained, isolates were described 
as specific groups of species. For example, an isolate identified using comparative 16S 
rRNA gene sequencing, may have returned identical percent similarity scores with two 
species such as S. pasteuri and S. wameri; on such an occurrence the isolate was 
described as an epidermidis group Staphylococcus (chapter 5).
This detailed speciation data was used to determine which time group involved the 
greatest level of species diversity. The measure of diversity used was the Shannon- 
Weiner diversity index ( / / ’), which is an important measure used for community ecology 
studies. With H  ’, the greater the index value the more diverse the community that has 
been sampled; H ’ equals zero where only one species is present. As the index is affected 
by the equitability and number of species measured, a second measure: evenness, is also 
givea Evenness (E) has a range between 0 and 1.0; if all species have the same number 
of isolates E  equals 1.0. Table 7.4 shows the frequency of species isolation calculated for 
each of the post-extraction time groups as a population with the index for species number, 
diversity and evenness.
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Table 7.4 Post-extraction species isolation frequency and diversity
Species
Number of species-positive samples
Total
t f i f i l l l l l wm 2 min 4 min 7.5
min
l l l l l l ;
min
i t ! !
rain
.§|45;."." ;■ 
min;.
c W m
min
Abiotrophia defectiva 2 0 0 0 0 0 0 0 0 0 2
Acinetobacter Iwoffii 0 0 1 0 0 2 0 1 0 1 5
Actinomyces bowdenii 0 0 0 1 0 0 0 0 0 0 1
Actinomyces denticolens 1 0 0 0 0 0 0 0 0 0 1
Actinomyces georgiae 1 0 1 1 0 0 0 0 0 0 3
Actinomyces meyeri 0 1 0 0 0 0 0 0 0 0 1
Actinomyces naeslundii 10 8 7 9 7 2 3 1 0 0 47
Actinomyces odontolyticus 0 0 0 0 1 0 0 0 0 0 1
Actinomyces viscosus 8 4 6 5 2 0 0 0 1 1 27
Actinomyces spp. 1 3 4 1 5 1 2 0 2 0 19
Bifidobacterium dentium 0 0 0 0 0 0 1 0 0 0 1
Corynebacterium afermentans 0 0 0 0 0 0 0 0 0 1 1
Corynebacterium appendicus 0 1 0 0 0 0 0 0 0 0 1
Corynebacterium coylae 1 0 0 1 1 1 0 0 0 0 4
Corynebacterium durum 0 0 0 0 0 0 0 1 0 0 1
Corynebacterium lipophilum 0 1 0 0 0 0 0 0 0 0 1
Corynebacterium tuberculostearicum 0 0 0 0 0 1 0 0 0 0 1
Corynebacterium spp. 0 2 0 0 0 1 0 0 0 0 3
Cytophaga sp. 0 0 0 0 1 0 0 0 0 0 1
Fusobacterium nucleatum 1 0 0 0 0 0 0 0 0 0 1
Fusobacterium sp. 0 1 0 0 0 0 0 0 0 0 1
Gemella morbillorum 1 0 2 0 2 0 0 0 0 0 5
Kocuria rosea 0 1 0 0 0 0 0 0 0 0 1
Lactobacillus casei 1 1 0 0 0 0 0 0 0 0 2
Lactobacillus gasseri 0 1 0 0 0 0 0 0 0 0 1
Lactobacillus oris 0 0 0 0 0 1 0 0 0 0 1
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Number of soecies-oositive samples
Total
10 s 1 min 2 min 4 min 7.5
mm
15
min
30
mm
45
min
60
min
Lactobacillus spp. 1 2 2 0 0 2 0 0 0 0 7
Leptotrichia buccalis 0 0 0 1 0 0 0 0 0 0 1
Leptotrichia sp. 0 0 0 0 0 0 0 0 1 0 1
Neisseria mucosa 0 0 0 0 0 0 0 0 1 0 1
Peptostreptococcus micros 1 1 2 1 1 0 0 0 0 0 6
Propionibacterium acnes 0 2 2 3 3 2 0 2 2 2 18
Rothia dentocariosa 1 0 4 1 0 0 0 0 1 0 7
Staphylococcus aureus 0 0 0 0 0 0 0 0 1 0 1
Staphylococcus capitas 0 1 0 0 0 0 0 0 0 0 1
Staphylococcus cohnii 2 0 0 0 0 0 0 0 0 0 2
Staphylococcus epidermidis 1 0 1 1 0 0 0 0 0 1 4
Staphylococcus hominis 0 0 2 1 0 1 0 0 0 2 6
Staphylococcus pasteuri 0 0 2 0 0 0 0 0 0 0 2
Staphylococcus saprophyticus 0 0 0 0 0 0 0 0 0 1 1
Staphylococcus wameri 1 0 0 0 0 0 0 0 0 1 2
Staphylococcus spp. 1 4 1 0 1 5 1 5 4 2 24
Streptococcus anginosus 1 0 2 0 1 0 0 0 0 0 4
Streptococcus constellatus 1 0 0 0 0 0 0 0 0 0 1
Streptococcus intermedius 4 3 2 1 0 0 1 1 0 0 12
anginosus group Streptococcus 2 0 2 1 0 0 0 0 0 0 5
Streptococcus australis 0 1 1 1 1 0 0 0 0 0 4
Streptococcus cristatus 0 0 0 1 1 0 0 0 0 0 2
Streptococcus gordonii 1 1 0 1 2 0 0 0 0 0 5
Streptococcus infantis 1 0 0 0 1 0 0 0 0 0 2
Streptococcus mitis 2 0 3 2 1 0 0 0 2 0 10
Streptococcus oralis 1 0 1 1 1 0 0 0 0 0 4
Streptococcus parasanguinis 2 0 0 0 0 0 0 0 0 0 2
Streptococcus peroris 1 0 1 1 0 2 0 0 0 0 5
Streptococcus pneumoniae 2 1 0 1 0 0 0 0 0 0 4
Streptococcus sanguinis 5 3 6 5 2 0 0 0 0 0 21
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Number of species-positive samples
TotalM W i
1 min 2 min 4 min
min
U M m : ■'W &-
min
mitis group Streptococcus 9 2 6 7 2 1 1 1 1 1 31
Streptococcus mutans 6 2 8 2 3 1 1 0 0 1 24
Streptococcus sobrinus 0 0 1 0 0 0 0 0 0 0 1
Streptococcus salivarius 0 0 0 0 0 0 0 0 1 1 2
Streptococcus pyogenes 0 0 0 0 0 0 1 0 0 0 1
Veillonella dispar 2 2 2 0 0 1 0 0 0 0 7
Veillonella parvula 0 1 0 0 0 0 0 0 0 0 1
Unrecovered isolates 12 8 9 10 10 2 6 4 4 4 69
Number of species isolated (S) 75 50 72 50 39 24 11 12 17 15 365
Shannon-Wiener Indices (//) 3.06 2.98 3.05 2.78 2.70 2.63 1.93 1.84 2.32 1 2.43 3.32
Evenness (E) 0.63 0.93 0.75 0.65 0.71 0.87 0.76 0.78 0.85 0.88 0.42
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The data presented in table 7.4 shows the level of diversity of the isolates detected and 
identified from the post-extraction samples. By identifying the isolates to species level 
rather than to genus level, the post-extraction groups with the largest number of species 
isolated were the 10 s, 30 s and 1 min groups, with the 10 s group having a slightly 
larger value for H \  The trend of species diversity versus time following dental 
extraction, showed a larger number of species being isolated in the first minute 
following dental extraction with a gradual decline in species isolation until 15 to 30 
min. After minimal levels o f recovery there was a slight increase in diversity in the 45 
and 60 min groups. To investigate this further, a species diversity calculation was 
performed for each culture-positive sample, the mean and standard deviation was then 
calculated for each post-extraction time group compared to the mean species diversity 
of the total pre-extraction culture-positive sample cohort. These data are shown in figure 
7.2.
Fig. 7.2 Comparison o f species diversity pre- and post-extraction
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The data in figure 7.2 shows that there was far greater biological diversity among the 
post-extraction bacteraemia than the pre-extraction samples (mean FT = 0.12), between 
10 s amd 4 min post-extraction. At an undefined point around 7.5 min post-extraction 
the mean species diversity index of the post-extraction samples is similar to that of the 
pre-extraction cohort until 45 min post-extraction when there is a smaller increase in 
diversity. To test the statistical significance of these observations, the data for each post-
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extraction time group was compared to that of the culture-positive pre-extraction data 
using the unpaired t test. This data is summarised in table 7.5.
Table 7.5 Statistical significance o f post-extraction compared to pre-extraction species 
diversity using the unpaired t-test
Time group n = iS S f tlfc P value Significance
Pre-extraction 93 0.12
10 s 31 0.72 PO.OOOl ***
30 sec 34 0.43 PO.OOOl ***
1 min 38 0.47 PO.OOOl ***
2 min 26 0.56 PO.OOOl ***
4 min 22 0.61 PO.OOOl ***
7.5 min 21 0.19 P=0.3077 ns
15 min 20 0.11 P=0.8656 ns
30 min 15 0.05 P=0.3679 ns
45 min 11 0.4 P=0.0087 **
60 min 14 0.15 P=0.7261 ns
Where: ***  = extremely significant, ** = very significant and ns = not significant.
Overall, the majority of post-extraction isolates speciated (55.3%) belonged to the 
genera Streptococcus and Actinomyces with 32.3% and 23.0% of the total isolates being 
assigned to these groups respectively. It is also of interest that members of these three 
genera were detected from subjects in each post-extraction time group.
Isolates that could not be subcultured either after initial detection or that died before 
identity could be assigned accounted for 15.9% of the cohort. Of the recovered isolates 
(n = 365), 95.1% of the organisms recovered were bacteria that are facultative 
anaerobes or aerotolerant species, only 1.92% of the isolates were obligate aerobes and 
a further 3.0% obligate anaerobes. Of these isolates 42.4% were recovered from the 
aerobically incubated filters and 57.6% from the anaerobic filters respectively.
A rare occurrence of the LF technique noted during the study was the phenomenon of 
polymicrobial colonies, whereby two organisms were isolated from one morphological 
colony. This occurred in 1.2% of the post-extraction samples only and not at all in the 
pre-extraction cohort. The identities of the bacteria involved in these polymicrobial 
colonies are presented in table 7.6.
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Table 7.6 Isolates recovered from polymicrobial colonies
Time group Isolate A AAAmmi Isolate B
10 s 
10 s 
10 s 
10 s 
1 min 
7.5 min 
45 min
A. naeslundii 
L. casei 
S. intermedius 
Sintermedius 
S. mitis 
P. acnes 
N. mucosa
S. mutans 
S. intermedius 
S. constellatus 
S. mitis 
A. naeslundii 
Lactobacillus sp. 
S. salivarius
Table 7.6 shows that a streptococcus was involved in the polymicrobial colony in 85.7% 
of the cases, a lactobacillus or actinomycete 57.1% and P. acnes or N. mucosa 14.3 %.
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7.4 Discussion
7.4.1 The nature of bacteraemia following dental extraction in children
The use of the LF technique allows fastidious bacteria to be recovered from the hostile 
environment of a blood sample by prevention of elimination by the intrinsic 
antibacterial properties of blood (Sullivan et al., 1975b), (Zierdt et al., 1982) and any 
antimicrobial compounds that may have been present in the patient’s sera (Sullivan et 
al., 1975b). LF also reduces the possibility of competition and bacterial overgrowth by 
dominant species that may occur in broth-bottle based culture systems.
By identifying as many of the organisms to species level as possible, the data allowed 
correction of the post-extraction sample data by discounting any isolates that were 
present in the patient’s pre-extraction sample. If the isolates had been identified to genus 
level only or even just described by their Gram-stain and respiration characteristics, 
there would be less power of discrimination between the two samples and a less 
accurate picture of the post-extraction bacteraemia would emerge. In eventuality, only 9 
isolates were deducted from the post-extraction samples using this rationale; these 
bacteria involved Rothia spp, Propionibacterium spp, a streptococcus and 
staphylococci.
7.4.2 Analysis of detected bacteraemia isolates by respiration type
In order to fully investigate the spectrum of bacteria involved in odontogenic 
bacteraemia, filters from each sample were incubated aerobically and anaerobically; the 
distribution of detection is shown in table 7.1. In the pre-extraction samples, 34.3% of 
the colonies enumerated were present on aerobically incubated filters while 65.7% were 
present on the anaerobic filter. Similarly, 42.4% of post-extraction colonies were 
detected on the aerobic while 57.6% were detected on the anaerobic filter. When the 
actual species of the bacteria recovered were examined (Table 3.6) it was found 
however that only 1.9% of the bacteria could be considered obligate aerobes 
(Acinetobacter spp, Kocuria spp and Neisseria spp) while 3.0% were considered strict 
anaerobes (Bifidobacterium sp, Fusobacterium spp, Peptostreptococcus spp and 
Veillonella spp). Even if the isolates which were not recovered were presumed to be 
obligate aerobes or strict anaerobes, the vast majority of isolates (95.1%) were 
considered facultative anaerobes. The lower number of strict anaerobes was expected as
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children harbour fewer anaerobes in their oral cavities than adults due to the absence of 
specific ecological niches such as periodontal pockets etc (Darby and Curtis, 2001).
It is debatable therefore, if the use of aerobic incubation was necessary during this 
study. If very few bacterial cells enter the blood stream, the chances that the cells will 
be sampled in a 6 mL aliquot, remain viable and are equally distributed between the LF 
filters are very slim. Although the LF technique has been proven as a sensitive detection 
technique for transient bacteraemia (Sullivan et al., 1975b), (Zierdt et al., 1977), 
(Heimdahl et al., 1985), (Heimdahl et al., 1990), (Lucas et al., 2002a) the investigation 
of this phenomena may be improved by incubation of a single filter which has had 
contact with the entire sample. Similar conclusions were drawn from a LF study which 
analysed the bacteraemia produced by various oral surgical procedures including single 
dental extraction, third molar surgery, dental scaling, endodontic treatment and bilateral 
tonsillectomy. Of the 20 patients who underwent a single dental extraction, 100% 
proved culture-positive and 70% of those cultures were detected using the anaerobically 
incubated filters. The organisms isolated from the aerobic filters were all Streptococcus 
spp which are facultative anaerobes (Heimdahl et al., 1990)
7.4.3 Analysis of detected bacteraemia isolates by cell wall type
The isolates that were detected and assigned a presumptive identification based on cell 
morphology, respiration and basic phenotypic characteristic were discussed in chapter 4. 
The cohort consisted of 6.2% Gram-negative and 93.8% Gram-positive bacteria. The 
Gram-negative bacteria isolated included Neisseria spp, Veillonella spp, Acinetobacter 
spp, Fusobacterium spp and Leptotrichia spp. Examples of Gram-negative genera that 
have been isolated from similar subjects include Eikenella spp, Actinobacillus spp, 
Prevote Ha spp, Capnocytophaga spp and Bacteroides spp (Kamma et al., 2000), 
(Tanner et al., 2002). The absence (or infrequency) of these species may be explained 
by the proportion of permanent teeth within the mouths of these subjects, who ranged in 
age from 1.1 to 18.7 years (median 6.2 years). The majority of these subjects would not 
have possessed permanent dentition and therefore the ecological niche within the oral 
cavity to support these species. It has been reported that isolation of species such as 
Tcmnerella forsythensis (formerly Bacteroides forsythus) and Porphyromonas gingivalis 
increases as dentition matures (Kamma e ta l, 2000), (Darby and Curtis, 2001). The oral 
microbiota is also influenced by the hormonal changes associated with puberty
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(Wojcicki et al., 1987). The gingival environment is adaptive to puberty; increased 
secretion of sex hormones such as progesterone has been associated with increased 
depth of periodontal pockets (Morishita et al., 1988). Therefore, bacteria such as 
Porphyromonas gingivalis and T. forsythensis are associated with the adult oral 
microbiota and appear to be acquired as hormonal balance changes (Moore et al., 1993). 
On average, puberty begins in children at around 13 years of age for girls and 14 years 
of age for boys (Palmert and Boepple, 2001). It is reasonable then, that bacteria 
associated with puberty or adulthood were not isolated from the subjects involved in 
this study when 90.1% of female subjects and 96.7% of male subjects were below the 
average age for onset of puberty.
The lack of Gram-negative species in this study may also be partly be attributed to the 
alkaline pH of the lysis solution and/or the inclusion of SPS into the collection medium 
as discussed in Chapter 3.
7.4.4 Inclusion of isolates in the study
The present study differed from other studies of odontogenic bacteraemia in that 
organisms that can also be commensals of the skin were included. Many studies have 
discounted Staphylococcus spp, Propionibacterium spp and even a-streptococci as 
contaminants because they are commensals of the human skin surface (Heimdahl et al., 
1985), (Otten et al., 1987), (Minkus and Moffet, 1971). It is inferred in some reports 
that isolates that are known skin commensals are likely to be present in samples as a 
result of contaminated venupuncture (Shahar et al., 1990). Where possible all isolates 
were reported unless they were present in both pre- and post-extraction samples, were 
suspected or could be demonstrated as contaminants of the media, filtration process or 
they were identified as environmental isolates by comparative 16S rRNA gene 
sequencing. The isolates recovered from post-extraction isolates (shown in figure 3.5) 
have all been described as commensals of the human oral cavity (Tanner et al., 1994).
One group that were removed from the data were the micrococci (see section 3.3.1). 
Had micrococci been included in the present study, the prevalence of the baseline value 
would have been increased to 28.4% from 18.6%. Although Micrococcus spp. are 
members of the oral microbiota (Tanner et al., 1994), and have been reported as isolates 
of bacteraemia following dental manipulation (Berry, Jr. et a l, 1973), the frequency
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with which LF plates became contaminated with these organisms during observation, 
led to the removal of these isolates from the data. In two studies involving LF for the 
estimation of odontogenic bacteraemia, Heimdahl et al., found that reduction of plate 
observation from daily checks to one inspection at the end of the incubation period, 
reduced pre-extraction culture-positive plate counts to 0% (Heimdahl et a l, 1985), 
(Heimdahl et al., 1990).
7.4.5 Pre-extraction bacteraemia
The use of pre- and post-extraction samples allowed the comparison not only of 
prevalence and intensity of odontogenic bacteraemia but also the investigation into 
which species of bacteria entered the bloodstream. Figure 7.1 showed that the genera 
recovered from the subjects prior to dental manipulation were all bacteria which are 
commonly isolated from the buccal cavity (Tanner et al., 1994). Following extraction, 
the proportions of these bacteria changed and several genera not detected at baseline 
were isolated. For instance, the proportion of streptococci isolated from baseline was 
13%, while the proportion ranged between 12.5 to 36.9% of the total from 10 seconds to 
45 minutes post-extraction. A similar trend was also observed for the Actinomyces spp 
which increased from a pre-extraction proportion of 5% to a range of 11.5 to 31.8% 
between 10 s and 15 min post-extraction. The trends seen with these two groups of 
bacteria showed a similar pattern to the trends seen with prevalence and intensity of 
bacteraemia over time.
Conversely, the largest proportion of bacteria isolated pre-extraction were coagulase- 
negative staphylococci (CoNS) which accounted for 35%. However, the proportion of 
these species ranged from 2.2 to 16.7% between 10 s and 45 min post-extraction; with 
pre-extraction type levels of isolation being observed from the 60 min samples. This 
may indicate the frequency of asymptomatic bacteraemia events.
7.4.6 Species diversity of paediatric odontogenic bacteraemia
The proportions of genera recovered from the post-extraction samples are shown in 
table 7.3. These data show that between 10 seconds and 7.5 minutes post-extraction 
there were far more genera isolated in comparison to baseline. Bacteria that were 
recovered in post- but not pre-extraction samples included Abiotrophia spp, Veillonella 
spp, Fusobacterium spp, Gemella spp, Peptostreptococcus spp, Acinetobacter spp,
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Bifidobacterium spp, Cytophaga spp, Leptotrichia spp and Neisseria spp. The recovery 
of these organisms however were less an indicator of general odontogenic bacteraemia 
than the streptococci and Actinomyces spp, because although they were not absent from 
the bacteria recovered from the baseline samples they were often found in only one or 
two subjects. An exception to this observation were the peptostreptococci which were 
totally absent from the pre-extraction cohort but which ranged between 1.6 to 12% of 
the post-extraction isolates between 10 seconds and 30 minutes.
The changing proportions of genera were not the only feature of odontogenic 
bacteraemia seen during the study. A benefit of the LF technique is the ability to isolate 
and enumerate discreet colonies, allowing detection of an organism where only one 
colony forming unit is produced. This sensitivity is precluded from broth culture 
methods where under-represented organisms can easily be hidden from detection due to 
the antibacterial activity of blood or antibiotics and the competition of other organisms 
(Weinstein, 1996). The design of this study allowed the changing nature of post­
extraction bacteraemia to be observed and characterised. The changes between time 
groups is easily summarised by comparing the taxa recovered at each time point in 
comparison to the baseline value.
The level of speciation compared altered the perceived variability of the post-extraction 
isolates with those recovered at baseline. If only the number of genera were compared 
as taxa for each time group (tables 7.2 and 7.3) it would appear that there was little 
difference between the samples with 9 taxa being isolated at baseline and a peak of 11 
taxa recovered at 10 seconds post-extraction. The data is more meaningful if individual 
species are considered for comparison and the data analysed using a statistical measure 
of species diversity. The diversity of pre- and post-extraction bacteraemia isolates was 
compared using the Shannon-Wiener diversity index (table 7.4). It was found that there 
was a far greater biological diversity among the post-extraction samples than the pre­
extraction samples from 10 s to 4 min post-extraction. The average species diversity 
among the baseline sample was H ’ = 0.12 whereas the mean post-extraction sample 
ranged in diversity from H* = 0.72 to 0.61 between 10 seconds and 4 minutes post­
extraction. The data for species diversity supported the findings from the data for 
prevalence of bacteraemia by indicating that post-extraction bacteraemia was returned 
to pre-extraction levels at a point between 7.5 to 15 minutes post-extraction.
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It is not possible to compare these results with other studies of post-extraction 
bacteraemia as none has been found in the literature. Comparisons of the bacteria 
isolated from this study have been compared with similar studies of paediatric 
odontogenic bacteraemia and found to be similar (Berry, Jr. et al., 1973), (Peterson and 
Peacock, 1976), (Coulter et al., 1990), (Roberts eta l., 1992). Bacteria isolated from the 
post-extraction bacteraemia that were not isolated from pre-extraction bacteraemia were 
members of the Abiotrophia (2 isolations), Acinetobacter (5), Bifidobacterium (1) 
Cytophaga (1), Fusobacterium (2), Gemella (5), Leptotrichia (2), Neisseria (1) and 
Veillonella (8); the only genus isolated pre- but not post-extraction was Prevotella (1 
isolation). Although the genera exclusive to the post-extraction samples were isolated in 
low frequency (1 to 8 isolations), they contribute to the increased diversity of the post- 
versus pre-extraction community; confirming that dental extraction does induce a 
detectable bacteraemia.
7.4.7 Polymicrobial colonies
It was discovered that 1.2% of the samples processed using LF involved a 
polymicrobial colony and that the organisms involved included a Streptococcus sp in 
85%. Polymicrobial colonies are a phenomenon that has been described in previous 
bacteraemia studies (Heimdahl et al., 1985), (Coulter et al., 1990). This feature of LF 
although rare, makes identification of bacterial isolates more difficult as colonies with 
similar colony morphology cannot be presumed identical. The presence of 
polymicrobial colonies may be explained by the frequent co aggregation which occurs 
between oral bacteria (Kolenbrander et al., 1993). Co-aggregation has been 
demonstrated frequently among early colonisers of dental plaque and frequently involve 
bacteria such as [viridans] streptococci and Actinomyces spp (Kolenbrander et al.,
2002). Co-aggregation is believed to be a function of adherence and gene transfer 
(Palmer, Jr. et al., 2003), and may provide an explanation to the occurrence of 
polymicrobial colonies.
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7.5 Conclusions
• Identification of isolates to species level aids understanding of the odontogenic 
bacteraemia.
• Post-extraction bacteraemia has been shown to involve a greater diversity of 
bacteria than the pre-extraction, spontaneous bacteraemia.
• There are species which predominate during pre-extraction bacteraemia such as 
staphylococci and those which tend to enter the bloodstream as a result of 
gingival disturbance e.g. streptococci and Actinomyces spp.
• The species diversity index indicates that the odontogenic bacteraemia is 
eliminated by the immune system around 7.5 minutes post-maximal 
manipulation
• LF is a useful technique for isolation of bacteria from bacteraemia as it allows 
separation of the organisms from antibacterial factors and helps reduce the effect 
of bacterial competition.
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8.0 Culture-independent detection of odontogenic
bacteraemia
8.1 Introduction
The microbiota of the oral cavity includes many fastidious organisms. As an 
environment the mouth contains many varied ecological niches with differing levels of 
oxygen tension, nutrient supply and symbiosis between the different genera of bacteria 
(Schuster, 1999). Because of the diversity of the oral cavity it is unlikely that one 
method of detection would allow the recovery of all the species of bacteria which 
invade the blood stream following dental extraction (Tanner et al., 1994), (Pratten et al.,
2003). There is also a popular theory that many bacterial species which inhabit the 
mouth have yet to be cultivated or are not cultivable and that at present only molecular 
detection techniques such as those mediated by 16S rRNA PCR and sequencing allow 
the detection of such organisms (Pratten et al., 2003), (Li et al., 2005).
For these reasons, a further aim of this overall piece of work was to use a culture 
independent technique to determine the richness of the microbiota in the blood samples 
obtained for the lysis filtration. A method was consequently developed for the detection 
of bacteria using 16S rRNA gene-based PCR technique.
8.2 Materials and methods
8.2.1 Pilot study to detect odontogenic bacteraemia from parallel samples
During sample collection for the lysis filtration study an additional 1 mL of blood was 
collected and stored in anticipation of a parallel molecular detection study (section 2.1). 
Initially a pilot study involving 8 of these parallel samples (four culture-positive and 
four culture-negative samples) was undertaken. The initial stage of the pilot molecular 
detection study was to amplify the 16S rRNA gene of the 8 samples. The DNA 
extraction method selected was a commercially available kit (PureGene® DNA 
Isolation Kit, Gentra Systems, USA) for the isolation of bacteria from whole blood as 
described in section 2.5.2.1; DNA concentration and quality was determined using a 
spectrophotometer (section 2.5.2.2).
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8.2.2 Amplification of DNA extracted from parallel samples
Amplification of the 16S rRNA gene and the human Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) gene (to confirm the presence of amplifiable DNA) (Jain et 
al., 2006) was performed on the selected samples using PCR and the resultant 
amplicons were resolved using electrophoresis for an expected size of around 1500 bp 
and 600 bp respectively (see sections 2.5.2.3 and 2.4.4.3).
8.2.3 Preparation of DNA templates seeded with known quantities of bacteria
DNA templates of seeded blood samples were prepared using cells from overnight 
cultures of Streptococcus sanguinis and Neisseria mucosa [data not shown] which were 
enumerated using a haemocytometer (section 2.5.2.5). These templates were used in 
place of the parallel blood samples to investigate and optimise the molecular detection 
techniques.
8.3 Results and Discussion
Detection of bacteria from clinical samples poses many problems. Several species of 
bacteria may be present, not all of which are of clinical importance or of interest to the 
study. When using culture-based detection methods, irrelevant or transient bacteria may 
flourish and obscure the true diversity of a sample (Washington and Ilstrup, 1986). 
Culture-based methods are also disadvantageous in the detection of oral bacteria 
because it is not possible to formulate a medium or provide the atmospheric conditions 
that favour the growth of all the organisms of interest (Nadkami et al., 2002). There are 
also bacteria that are difficult or as yet not cultivable using standard culture-based 
detection methods. For these reasons, the use of a molecular detection tool allows the 
microbiologist to detect bacteria present in low numbers or even where the cell is no 
longer viable (Vaneechoutte and Van Eldere, 1997), (Moore and Millar, 2000), (Qin and 
Urdahl, 2001).
Discovery and characterisation of the 16S rRNA gene provided an invaluable resource 
to microbiology, as all known bacterial pathogens belong to the eubacterial kingdom 
(Wilson et al., 1990). The gene is composed of highly conserved regions which are 
present in all bacteria, allowing the amplification of any bacterial species using broad-
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range or “universal” primers. The gene also contains highly variable regions, which 
allow one bacterial species to be differentiated from another (Wilson et al., 1990), (Ley 
et al., 1998). Another advantage of molecular detection methods is their ability to be 
highly sensitive with some broad-range 16S rRNA amplification protocols allowing the 
detection of as few as 48 bacterial cells, equating to less than 238 femtograms of DNA 
(Nadkami et al., 2002).
8.3.1 Amplification of DNA extracted from parallel samples
During the collection of the blood samples for the bacteraemia study, 1 mL samples 
were collected in parallel for future retrospective analysis and comparison to the 
culture-based study. At the inception of the study there was no detailed planning of the 
technique that was to be employed to prepare for or execute a molecular detection 
technique. In the absence of a specific protocol for these additional samples, a scaled 
down sample representing 1/6 of the sample used in the LF study was prepared. The 
PureGene® DNA extraction series was already routinely used for the extraction of 
whole genomic DNA from Gram positive organisms isolated in the microbiology 
department, Eastman Dental Institute. The kit has been shown to successfully recover 
DNA from whole blood clinical samples, is cost-effective and user-friendly (Fahle and 
Fischer, 2000). It was a natural progression therefore, to extend this protocol to include 
the lysis and removal of red blood cells and other components of whole blood as per the 
manufacturer’s instructions.
The analysis of the resultant gels showed amplicons of the correct size for all samples 
with respect to GAPDH (See figure 8.1). The positive amplification of this ubiquitous 
housekeeping gene (Jain et al., 2006) indicated that there was indeed DNA present in all 
8 clinical samples indicating the success of the extraction protocol to isolate DNA from 
each sample.
No 16S rRNA amplicons corresponding to either the culture-positive or the culture- 
negative samples were evident (see figure 8.2). A positive control consisting of E. coli 
mRNA and negative control consisting of sterile water worked as expected with both 
PCR assays. This experiment was repeated a further three times using fresh reagents 
with the same results.
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Fig. 8.1 Gel image of parallel samples GAPDH PCR products
1 2  3 4 5 6 7 8  9 10 11
Lanes: 1 = PCR DNA marker: 2-5 = culture-positive parallel samples; 6-9 = culture-negative parallel 
samples; 10 = GAPDH mRNA positive control; 11 = negative control.
Fig. 8.2 Gel image of parallel samples 16S rRNA PCR products
1 2 3  4 5 6  7 8 9  10 11
Lanes. 1 = PCR DNA marker; 2-5 = culture-positive parallel samples; 6-9 = culture-negative parallel
samples; 10 = negative control; 11 = E. coli spiked positive control.
Following the initial round of 16S rDNA PCR protocol, no bands corresponding to the 
expected size (1.5 kb) were visualised using the gel electrophoresis. This absence of 
amplicons, even from the culture-positive samples may have occurred for any of the 
following reasons:
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1. Absence of bacterial DNA
2. Inhibition of the PCR reaction
3. Low copy number of the target gene
4. Low sensitivity of the PCR protocol
8.3.2 Removal of PCR Inhibitors from whole blood
From the positive amplification of the GAPDH gene, it was known that DNA had been 
successfully isolated from the clinical material. As DNA had been isolated from the 
samples and 50% of the samples were known to contain bacteria from the culture 
studies, the possibility of PCR inhibition was entertained.
PCR is an extremely sensitive method for the amplification of genetic material. The 
success of such methods depends on the correct optimisation of each amplification 
protocol and is therefore liable to fail if any parameters are incorrect. There are a 
number of reasons why a PCR may fail to successfully amplify a target, most 
commonly this is due to the presence of inhibitory substances (Millar et al., 2000). 
Some blood components are widely understood to inhibit PCR, these include 
haemoglobin, lactoferrin (found in leucocytes) (Al Soud and Radstrom, 2001) and 
immunoglobulin G (IgG) (Al Soud et al., 2000). For this reason, a whole blood specific 
DNA extraction protocol was selected which claimed to remove such factors from the 
resultant sample. The components of the parallel samples were human blood and 
sodium polyanethole sulfonate (SPS) an additive used to prevent the antibacterial action 
of blood (Belding and Klebanoff, 1972) which has been shown to help maximise 
recovery of streptococci from blood samples (Garrod, 1966).
Following a search of the literature, it was discovered that SPS co-purifies with DNA 
during DNA extraction and can inhibit PCR at concentrations of 0.0035% (w/v) (Millar 
et al., 2000). Therefore it was decided to compare the DNA extraction protocol for SPS 
removal described in the literature (Fredricks and Reiman, 1998) with the whole blood 
cell protocol initially selected for the protocol.
When it was realised that all parallel samples contained a potential inhibitor: SPS, a 
substance that was likely to impair the detection of bacterial DNA via PCR, a method 
for its successful removal was trialled. Following the difficulties encountered in
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amplification of the 16S rRNA gene, it was discovered that SPS is a potent inhibitor of 
PCR (Fredricks and Reiman, 1998), (Millar et al., 2000) and although essential to the 
recovery of the culturable streptococci, was likely to pose a significant obstacle to the 
detection of non-culturable organisms in the parallel samples.
DNA templates were prepared using horse blood spiked with 10 cells of S. sanguinis 
(+/-0.4% SPS) using either the Fredricks & Reiman DNA extraction protocol (FR) or 
the PureGene® kit. A negative control of sterile horse blood was also included. 
Following extraction, DNA templates were subjected to quantitative spectrophotometry 
and the data are represented in table 8.1. The PureGene® (PG) kit had previously been 
reported as having failed to amplify bacterial DNA from culture media containing SPS 
inoculated with blood (Millar et al., 2000). This method was compared with the 
protocol described by Fredricks & Reiman (FR) for the successful extraction of DNA 
without the co-precipitation of SPS (Fredricks and Reiman, 1998). Sterile horse blood 
was spiked with known numbers of bacteria and SPS added to replicate stored parallel 
samples.
Table 8.1 Quantity o f DNA recovered using two extraction methods
Template
Average DNA yield 
(Mgtob)
Fredricks &  Reiman 
method
SPS- 12.5
SPS + 2.8
Control horse blood 5.4
PureGene® protocol
SPS- 21.0
SPS + 1.0
Control horse blood 9.6
Table 8.1 shows that while the PureGene® method extracted greater quantities of DNA 
from blood not supplemented with SPS, than the FR method, the latter was more 
successful in extracting DNA in the presence of SPS. (21 pg/mL vs. 12.5 pg/mL). The 
FR protocol isolated greater quantities of DNA than the kit when SPS was present as an 
additive (2.8 pg/mL vs 1.0 pg/mL). Low levels of DNA were also recovered from the 
horse blood controls; again, the PureGene® method was found to be more efficient than 
the FR protocol.
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A scanning spectrophotometric assay for the removal of SPS from DNA extractions was 
utilised to detect SPS in the extracted DNA templates (Fredricks and Reiman, 1998). 
The detection limit was determined by using a 10 fold serial dilution of a 0.4% solution 
of SPS assayed for SPS at 284 nm. A representation of these data is shown in figure 
8.3. Prepared DNA templates (from both protocols) were assayed however; the 
concentration of SPS present was below the detection limit of the assay (c. 4 pg/mL).
Fig. 8.3 Scanning spectrophotometric assay for presence of SPS
0.4% SPS
J k
Absorbance
284 nm
8.3.3 PCR amplification of Fredricks and Reiman protocol versus commercial 
system extracted DNA
To further evaluate the efficacy of the two extraction methods, PureGene® and FR, 16S 
rRNA PCR was performed. DNA template prepared from horse blood seeded with cells 
of S. sanguinis with SPS added were subjected to 16S rRNA gene PCR using the 
standard 27f and 1492r primer protocol used throughout this study. Relevant controls 
were included (i) a sample of sterile horse blood plus SPS which had been included in
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the relevant extraction procedure, (ii) an E. coli positive control and (iii) a negative 
control were included.
In order to further evaluate the two extraction methods, the same experiment was 
performed on spiked blood samples without SPS added. The gels depicted in figures 8.5 
and 8.6 demonstrated the same results found with SPS present. These findings were 
important because they revealed that the addition of SPS to the samples made no 
difference to the ability of the original PureGene® extraction method to produce 
amplifiable DNA.
Following PCR, prepared templates were subjected to agarose gel electrophoresis for 
visualisation of the results. All DNA templates extracted using the FR protocols were 
negative for amplicons (data not shown). Amplicons were produced from the DNA 
templates prepared using the PureGene kit, although the bands were extremely faint and 
could only be visualised when the resultant electronic image was manipulated (figure 
8.4).
Fig. 8.4 Results o f 16S rRNA gene amplification of PureGene® extracted DNA template
1 2 3 4 5 6 7 8 9 10 11 12 13
Lanes: 1 = PCR DNA marker; 2 = 108 cells/mL S. sanguinis; 3 = 107 cells/mL; 4 = 106 cells/mL, 5 = 105 
cells/mL ; 6 = 104 cells/mL ; 7 = 103 cells/mL ; 8 = 102 cells/mL ; 9 = 101 cells/mL ; 10 = 10° cells/mL ; 
11 = sterile horse blood ; 12 = E. coli positive control; 13 = sterile water negative control.
The gel image depicted in figure 8.4 shows that DNA was amplified from the templates
8 6containing 10 to 10 cells/mL of S. sanguinis. Figure 8.4 shows the results achieved 
using the PureGene® method, which detected 106 cells of S. sanguinis while the FR 
method failed to amplify bacterial DNA in the presence of SPS. The performance of the 
PureGene® method was better than reported in similar studies where the kit had failed
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to produce amplifiable DNA from blood containing 108 cfii/mL Staphylococcus aureus 
(Millar et al., 2000). The positive and negative controls for the success of the 
amplification were correct; a band corresponding to the expected size for 16S rDNA 
was however detected in the sterile horse blood. Additionally, faint erroneous bands 
occurred in lanes 7, 8 and 10, indicating either contamination of the blood with bacteria 
or bacterial DNA or contamination of the sample during extraction. The detection of 
bacterial DNA from this control template indicated that the blood had become 
contaminated with bacterial DNA. If contamination had occurred during the PCR 
preparation, it is likely that the negative control would have become false positive also. 
The identification of contaminant DNA has been reported in blood culture media 
(Fredricks and Reiman, 1998), (Millar et al., 2000) and the blood of healthy individuals 
(Nikkari et al., 2001). The DNA detected in the negative media control here therefore, 
could also be indicative of inherent DNA in the supplemental blood.
PCR amplification of the spiked DNA templates (from both extraction protocols) that 
had been prepared in the absence of SPS was also performed. The results of this PCR 
reaction are visualised in figures 8.5 and 8.6.
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Fig. 8.5 Results of PCR on Fredricks and Reiman extractions in the absence of SPS
, ;v ’
1 2 3 4 5 6 7 8 9 10 11 12 13
Lanes. 1 = PCR DNA marker; 2 = 108 cells/mL S. sanguinis; 3 = 107 cells/mL; 4 = 106 cells/mL, 5 = 105 
cells/mL ; 6 = 104 cells/mL ; 7 = 103 cells/mL ; 8 = 102 cells/mL ; 9 = 101 cells/mL ; 10 = 10° cells/mL ; 
11 = sterile horse blood ; 12 =E. coli positive control; 13 = sterile water negative control.
Fig. 8.6 Results of PCR of PureGene® extractions in the absence o f SPS
Lanes: 1 = PCR DNA marker; 2 = 108 cells/mL S. sanguinis; 3 = 107 cells/mL; 4 = 106 cells/mL, 5 = 105 
cells/mL ; 6 = 104 cells/mL ; 7 = 103 cells/mL ; 8 = 102 cells/mL ; 9 = 10* cells/mL ; 10 = 10° cells/mL ; 
11 = sterile horse blood ; 12 = E. coli positive control; 13 = sterile water negative control.
The results depicted in figure 8.5 show that the DNA extracted using the FR protocol 
from the spiked blood samples without the addition of SPS yielded no PCR products; 
the positive and negative controls were as expected. Figure 8.6 shows that the DNA 
extracted using the PureGene® protocol from the spiked blood samples without the 
addition of SPS yielded amplicons of the expected size for the samples containing 10 
to 106 cells/mL of S. sanguinis. There was again presence of faint bands in lanes 7, 8 
and 10 and in the negative horse blood control, again indicating the presence of DNA in 
the horse blood or contamination during the extraction or PCR procedures. The failure
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of the FR method and the relative insensitivity of the PureGene® method were 
surprising, as bacterial DNA was present and SPS had been shown to be removed.
8.3.4 Detection limits of PCR amplification of 16S rRNA gene from spiked blood 
samples
Since the presence of SPS had been shown to have no effect on the efficacy of the 
PureGene® method to produce DNA amplifiable by PCR, there was now a need to 
increase the sensitivity of the protocol to detect potentially low numbers of bacteria.
Data from the LF study (chapter 3) had shown that culture-positive patients had 
minimum intensity of 0.16 cfu/mL; therefore, if a colony forming unit was equal to 1 
bacterium, the molecular approach would need to be able to detect the presence of very 
few copies of the 16S rRNA gene. The number of copies of the operon is reported to 
vary between 1 and 15 dependent on the species (Klappenbach et al., 2001). Due to this 
requirement for an extremely sensitive detection protocol, it was decided to investigate 
the efficacy of a nested PCR amplification to increase the sensitivity of the protocol. 
Amplicons from the 27f and 1492r reaction were used as template for a 16S rRNA PCR 
using internal primers 27f and 1392r.
The use of hemi-nested and nested 16S rRNA PCR amplification has been used to 
successfully detect as few as 5 cfu/mL of sample (Rothman et al., 2002). Sensitivity of 
this level was required, if the intensity of the bacteraemia indicated by the culture 
method was the true level of intensity within the sample.
The PCR reactions were performed as described in section 2.5.2.4 using sterile horse 
blood spiked with known numbers of S. sanguinis in the presence and absence of SPS 
and extracted using the PG extraction kit.
First round PCR reactions using primers 27f and 1492r were performed on the samples 
as described in the previous section before being subjected to the hemi-nested PCR 
reaction using internal primers 27f and 1392r. Negative and positive controls were 
included in each round and all samples from the first round including controls were 
nested also. The resultant reactions were then subjected to electrophoresis in order to 
analyse the results (data not shown).
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Although the initial cycle of nested PCR on the spiked samples was successful, only one 
round of nested PCR was successfully performed without the occurrence of a false 
negative result. This experiment indicated that 101 cells/mL of S. sanguinis had been 
detected (data not shown), unfortunately however, this result could never be replicated 
and so is not accepted here as a true indication of the sensitivity of the protocol. In order 
to perform the nested amplification it was decided that attempts would be made to 
counter the false positives that were occurring. It was found on subsequent occasions 
that the negative control from the initial round of PCR was positive in the second, 
nested round of PCR (See figure 8.7).
Fig. 8.7 Gel image showing contamination of negative control
Contaminated
control
1 2 3 4 5 6 7 8 9 10 11 12
Lanes: 1 = PCR DNA marker; 2-9 = hemi-nested sample reactions, 10 = contaminated, hemi-nested first 
round negative control; 11 = hemi-nested first round positive control; 12 = hemi-nested round negative 
control.
A number of procedures were initiated to reduce environmental contamination of 
reagents and amplification mixtures. Where possible separate rooms were used for DNA 
extraction, PCR preparation and gel electrophoresis of PCR amplicons. Separate 
pipettes were employed wherever possible and pre-sterilised filter-plugged pipette tips 
were used. Rooms were also decontaminated using DNAse solutions (Millar et al., 
2002) and autoclaved molecular grade water was used. It was still found however that 
nested PCR reactions were displaying false positives.
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The exquisite sensitivity of broad-range nested PCR protocols is such that a single copy 
of the target sequence may be amplified by 107 to 108 times (Wilson et a l , 1990), 
(Johnson, 2000). This sensitivity is particularly useful because it allows detection of 
very low numbers of bacteraemia, it is however the Achilles’ heel of the technique, 
because just one molecule of contaminating DNA can be amplified as a false positive.
In an attempt to prevent the contamination of reagents and amplification reactions, 
sterile reagents and containment areas were introduced but to no avail. The introduction 
of a reagent decontamination step was introduced whereby the amplification cocktail 
was treated prior to PCR with the restriction endonuclease Sau3AI. To eliminate or 
reduce the presence of contaminating or carry-over DNA during the nested PCR 
reaction, the water, dNTPs, MgCb, PCR buffer, Taq DNA polymerase and the reverse 
primer, 1392r, were all treated prior to the PCR amplification with Sau3AI. The other 
oligonucleotide primers could not be treated using the Sau3AI protocol, due to the 
presence of restriction sites within their sequence. Following a period of incubation, the 
enzyme was heat inactivated before addition of the template. The PCR protocols were 
then performed as described previously with similar results
Disappointingly, this protocol failed to prevent the false positive that recurred in the 
negative control. When compared to the original published work, our protocol differed 
from that reported which had used a very high grade of Taq DNA polymerase, 
AmpliTaq LD (Applied Biosystems, CA. USA). The manufacturers claim this enzyme 
contains very low bacterial DNA contamination (<10 copies of 16S RNA sequences /
2.5 units) and the product is specifically aimed at low copy number PCR applications 
(http//:www.appliedbiosystems.com). The Taq DNA polymerase used in this study was of 
considerably lower grade and is not specially formulated for such applications which 
may account for the inability to achieve success using this protocol. Unfortunately, the 
cost of the high grade Taq at the time prohibited its purchase and inclusion in the 
protocol.
Since this work was performed, the cost of such enzymes has decreased and 
competitors’ products are available; in addition, new approaches have been made to 
avoid contamination of bacterial PCR. Alternative approaches include the use of
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ultrafiltration of the PCR mastermix (Mohammadi et al., 2003) and the use of other 
enzymes such as DNAse I to eradicate bacterial or other contaminating DNA from PCR 
applications (Heininger et al., 2003), (Tondeur et al., 2004). Contamination of low copy 
number PCR protocols remains a problem and constitutes a barrier to the molecular 
detection of bacteria.
8.4 Conclusions
The use of a molecular detection method based on broad-range primers could have 
provided useful information on the levels of species of bacteria involved in odontogenic 
bacteraemia that may not have been detected using the culture-based method. The 
collection of blood samples for bacteriological studies is fraught with problems, the 
most important of which is prevention of bacterial degradation by the antibacterial 
properties of blood (such as complement and phagocytosis). Often within such samples, 
bacteria become internalized by cells of the immune system and are isolated from 
culturable detection methods or destroyed. Unfortunately, the use of additives in blood 
samples may also hinder the use of these samples for less routinely used applications 
such as PCR.
The amplification of DNA from the parallel samples was never achieved due to the 
continual contamination of the PCR reactions by contaminant DNA; the source of this 
contamination was never identified. In spite of this, it is dubious whether any true 
positive results could have been obtained from the samples which may have originally 
contained as few as 0.16 cfu/mL; as only 300 pL was used in the DNA extraction 
protocol.
While the concept of molecular detection of non-culturable and viable non-culturable 
(VNC) bacteria was relatively innovative at the time that these experiments were 
performed (2002), major advances have since occurred. It is now possible to routinely 
amplify low copy number bacterial genes without the contamination issues that are 
described here. The largest improvement being the ready availability and decreased cost 
of specialist exogenous bacterial DNA free Taq polymerase and the widespread use of 
DNA contamination elimination techniques. One such method is the use of a 
combination of 25 pg/mL of 8-methoxypsoralen with 4 min of long wave UV light
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exposure of the PCR reaction mixture. Following such treatment, template DNA is 
added and PCR amplification can proceed (Meier et al., 1993). While this approach was 
not trialled during the data collection phase of the project, it is understood by the author 
that the problems described here are now largely obsolete.
The benefits of molecular-based techniques include the ability to detect non-viable and 
non-culturable bacteria, and the ability to detect all bacteria, as no provision needs to be 
made for respiratory and nutritional requirements. In this instance however, the benefits 
of optimising this protocol for such infinite sensitivity was far outweighed by the cost of 
the extra provisions for sterility and use of ultra pure reagents.
In summary:
• The use of molecular detection methods could provide useful additional data 
about odontogenic bacteraemia that may not be ascertained from the use of 
culture-based detection methods alone
• The PureGene® DNA extraction kit was superior to the Fredricks and Reiman 
method for extracting amplifiable DNA from the seeded samples.
• When planning protocols for the molecular detection of bacterial DNA from 
whole blood, prevention of the degradation of the target DNA and PCR 
inhibition by intrinsic components and additives and the potential contamination 
by environmental DNA must be carefully considered.
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9.0 Antibiotic susceptibility of bacteraemia isolates
9.1 Introduction
Antibiotics are widely used within dentistry, not only to treat oral infections such as 
dental abscesses (Herrera et al., 2000) and periodontitis (Guerrero et a l, 2005) but also 
as prophylactic drugs prior to specific procedures for patients considered at risk of 
developing IE (Roberts et al., 1987). It is useful to monitor antibiotic susceptibility of 
the oral microbiota not only as a means of antibiotic resistance surveillance among the 
population (Karlowsky and Sahm, 2002) but also because the oral cavity as an 
environment is an important reservoir and site for exchange of genetic resistance 
determinants (Bryskier, 2002). Oral bacteria have the opportunity to transfer from 
person to person (via coughing, kissing etc.) and this transfer could further allow the 
spread of a resistant bacterium to a new host and subsequent dissemination of the 
mobile antibiotic resistance genes to susceptible bacteria. As the commensal oral 
microbiota may gain entrance to the bloodstream and elicit systemic effects, it is also 
important to fully characterise antibiotic-resistant bacteria to understand the potential 
implications of dentally induced bacteraemia.
Prophylaxis of IE is a highly controversial issue; IE is estimated to occur in as few as 20 
cases per million per year in England and Wales (Young, 1987) and the link to actual 
dental treatment is not clearly established (Guntheroth, 1984). Recent papers have 
suggested that there is no proven case for the use of antibiotic prophylaxis prior to 
dental treatment and that a prospective double blind study is required to assess the 
risk/benefit of such chemoprophylaxis (Oliver et al., 2004). This recent thinking is 
reflected in the new guidelines issued by the working party of the British Society for 
Antimicrobial Chemotherapy (BSAC) (Gould et al., 2006). Because of the issues 
surrounding the prophylaxis of dental treatment in the cardiac abnormality population, it 
is particularly useful to characterise bacteria isolated from dental bacteraemia.
9.2 Materials and methods
Bacteria, following multiple dental extractions, were isolated from paediatric blood 
samples using a lysis filtration system (section 2.2). As part of the exclusion criteria of
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the original study, none of the children had been prescribed antibiotics in the previous 
month (section 2.1). Bacteria were speciated using a comparative 16S rRNA gene 
sequencing technique (section 2.6). Isolates were analysed for antibiotic sensitivities by 
the use of an agar dilution method described in section 2.6; and multi-point inoculation 
was employed to maximise throughput and minimise media and labour expenditure 
(section 2.6.3). As sensitivity testing methods and published breakpoints are not 
established for many of the isolates in this study, a consensus method was used 
(described in section 2.6) and breakpoints applicable to those organisms described in the 
recommendations published for the staphylococci and streptococci were applied to all 
organisms. Briefly these breakpoints were: ampicillin 8 pg/mL, erythromycin 1 pg/mL, 
penicillin G 4 pg/mL, tetracycline 8 pg/mL and vancomycin 8 pg/mL (Table 2.8). The 
resulting MICs were then analysed in view of the published breakpoints (BSAC and 
NCCLS) to gain a truer picture of the antibiotic-resistant organisms in the cohort.
9.3 Results
9.3.1 Subjects and isolates
Of the 464 bacteria isolated following dental bacteraemia in children, 228 isolates 
recovered from 122 subjects were subjected to antibiotic susceptibility testing (AST). 
The isolates tested represented a range of species commonly detected in the oral 
microbiota, and were representative of the isolates recovered from the post-extraction 
bacteraemia (chapter 7). The number and proportions of each genus are shown in figure 
9.1.
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Fig. 9.I Isolates used for the antibiotic sensitivity testing showing genera as proportions with number of isolations per genus included
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Figure 9.1 demonstrates that the most represented isolates in the MIC study were 
streptococci which accounted for 40.8% of the cohort followed by Actinomyces spp., 
24.6% and staphylococci, 14.9%.
9.3.2 Resistance at breakpoints used
Each MIC agar plate was inoculated with the quality control organism Staphylococcus 
aureus NCTC 6571; no growth of this organism was observed above the published 
target MICs for these antimicrobial agents (Andrews, 2001). Resistant isolates were 
recovered from 60 (49.2%) subjects. The number of resistant bacteria per individual 
ranged from 1 to 4 different isolates with a median value of 1 resistant strain. Of the 228 
isolates assayed for MIC against ampicillin, erythromycin, penicillin G, tetracycline and 
vancomycin a total of 72 isolates (31.6%) displayed resistance to the breakpoints used 
(see table 2.7 section 2.6.1.2). The resistant isolates were composed of a diverse 
community of 12 different genera and 32 different species. Figure 9.2 shows the relative 
proportions of antibiotic-resistant bacteria represented by genus.
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Fig. 9.2 Proportions o f antibiotic-resistant species
%
MAcinetobacter sp. 1.3
■ Actinomyces spp. 8.9
Corynebacterium spp. 2.5
M Fusobacterium sp. 1.3
m Gemella sp. 1.3
□ Lactobacillus spp. 7.5
Propionibacterium spp. 2.5
■ Peptostreptococcus sp. 1.3
m. Rothia sp. 1.3
Streptococcus spp. 40.5
■ Staphylococcus spp. 25.3
■ Veillonella spp. 6.3
224
Chapter 9 ~ Antibiotic susceptibility of bacteraemia isolates
Figure 9.2 clearly demonstrates that the majority of bacterial isolates resistant to the 
antibiotics at the MIC breakpoints used were streptococci, accounting for 40.5% of the 
resistant cohort. The next most significant group of antibiotic-resistant bacteria were the 
staphylococci (CoNS) which accounted for 25.3% of the total antibiotic-resistant 
isolates.
Resistance against each of the five antibiotics for the breakpoints used was observed. 
The antibiotic resistance for each genus and the overall resistance against each antibiotic 
is summarised in table 9.1. Individual MIC values for the resistant bacteria and their 
profile in terms of susceptible, intermediate and resistant are shown in tables 9.2.
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Table 9.1 Isolates resistant to antibiotics tested
Isolate (/!=)
Ampitiltin- 
resistant (%)
Erythromycin-
iite s is fc lS S M
l l i f t i l l l i l l
Peniciliin-
wmmmM
Tetracycline-
resistant
Vancomycin-
resistant
(%)
A. Iwoffti 1 0 0 0 1 (100) 0
Actinomyces spp. 8 0 7 (87.5) 0 1 (12.5) 1 (12.5)
Corynebacterium spp. 2 1 (50.0) 1 (50.0) 1 (50.0) 0 0
F. nucleatum 1 0 1 (100) 0 0 1 (100)
G. morbillorum 1 1 (100) 0 1 (100) 1 (100) 0
Lactobacillus spp. 6 1 (16.7) 0 1 (16.7) 1 (16.7) 6 (100)
P. acnes 2 0 2 (100) 1(50) 0 0
P. micros 1 0 0 1 (100) 0 0
R. dentocariosa 1 0 1 (100) 0 0 0
CoNS 20 7 (35.0) 7 (36.8) 13 (68.4) 12 (63.2) 2 (10.5)
Streptococcus spp. 25 4 (16.0) 15 (60.0) 2 (9.5) 12 (48.0) 2 (8.0)
Veillonella spp. 4 0 4 (100) 1 (25.0) 2 (50.0) 1 (25.0)
Total 72 14 (19.4) 38 (52.8) 21 (29.2) 30 (41.7) 13 (18.1)
CoNS = Coagulase negative staphylococci
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9.3.3 Resistance to ampicillin
Ampicillin resistance (MIC >8 pg/mL) was demonstrated by 19.4% of the total 
antibiotic-resistant isolates, and of these isolates 50% were CoNS. Ampicillin-resistance 
occurred in 35.0% of the CoNS isolates that were additionally resistant to one or more 
of the panel of antibiotics tested (MIC ranges of 8 to >512 pg/mL). Other genera 
showing resistance to ampicillin were the lactobacilli (8 pg/mL), Gemella morbillorum 
(>512 pg/mL), Corynebacterium sp (8 pg/mL) and streptococci with resistant MIC 
ranging from 8 pg/mL to >512 pg/mL.
9.3.4 Resistance to erythromycin
The data presented in tables 9.1 and 9.2 shows that the highest level of resistance was to 
erythromycin with 52.8% of the antibiotic-resistant isolates displaying resistance at the 
breakpoint concentration of 1 pg/mL. The majority of erythromycin-resistant isolates 
were streptococci (39.5%) which accounted for 60% of the streptococcal isolates 
assayed (MIC 1-256 pg/mL). High levels of erythromycin-resistance (87.5%) were also 
observed amongst the antibiotic-resistant Actinomyces spp (MIC <0.5 pg/mL->512 
pg/mL). Other isolates displaying erythromycin-resistance included Fusobacterium sp. 
(2 pg/mL); Veillonella spp. (16 to 32 pg/mL); Rothia sp (256 pg/mL) and 
Propionibacterium spp (16 pg/mL).
9.3.5 Resistance to penicillin G
The majority of the antibiotic-resistant CoNS were resistant to penicillin with 68.4% of 
the isolates showing resistance at the breakpoint concentration of 4 pg/mL. The CoNS 
accounted for 61.9% of the total penicillin-resistant isolates with MICs ranging from 8 
pg/mL to >512 pg/mL. Of the antibiotic-resistant streptococci, 12.0% displayed 
resistance to the penicillin breakpoint used with MIC ranging from 4 pg/mL to >512 
pg/mL. Single penicillin-resistant strains of Corynebacterium sp. (16 pg/mL); Gemella 
sp. (>512 pg/mL); Lactobacillus sp. (8 pg/mL); Propionibacterium sp. (32 pg/mL); 
Veillonella sp. and Peptostreptococcus sp. (16 mg/mL) were also detected.
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9.3.6 Resistance to tetracycline
Resistance to tetracycline was also frequently observed amongst the cohort, with 41.7% 
of the antibiotic-resistant isolates displaying resistance to the breakpoint concentration 
of 8 pg/mL. The majority of these tetracycline-resistant organisms were streptococci, 
with 48.0% of the antibiotic-resistant streptococci isolated, and 63.8% of the antibiotic- 
resistant CoNS were resistant to this antibiotic. These two genera equally comprise 80% 
of the antibiotic-resistant bacteria isolated. The MIC range for both the CoNS and the 
streptococci ranged between 16 and >512 pg/mL.
9.3.7 Resistance to vancomycin
Resistance to vancomycin at a breakpoint of 8 pg/mL was low with of 18.1% of the 
antibiotic-resistant isolates displaying resistance; isolates that are known to be 
intrinsically resistant to vancomycin were included. Of the vancomycin-resistant 
isolates, the majority (46.2%) were Lactobacilli, of which 100% displayed resistance to 
the breakpoint concentration. Other vancomycin-resistant strains included single 
isolates of A. naeslundii (256 pg/mL), S. capitis (4 pg/mL), a CoNS isolate (512 
pg/mL) and S. mutans (>512 pg/mL).
9.3.8 Antibiotic-resistance profiles
In addition to the individual isolate MICs recorded for each antibiotic, a profile of 
susceptible, intermediate or resistant was included in table 9.2. The antibiotic-resistance 
profiles were obtained from the published breakpoints (National Committee for Clinical 
Laboratory Standards, 2003a), (National Committee for Clinical Laboratory Standards, 
2003b), (Andrews, 2005) and aid the user to quickly discern whether an isolate is 
resistant to an antibiotic without the need for supplementary tables. Of the 228 isolates 
assayed, 14 were considered resistant to ampicillin (6.1%), 21 to erythromycin (9.2%), 
23 to penicillin G (10.1%), 26 to tetracycline (11.4%) and 8 to vancomycin (3.5%).
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Table 9.2 Minimum inhibitory concentrations (MIC) for antibiotic-resistant strains
Resistant strain
MICs of antibiotic (pg/mL)
Amp Profile Eiy Profile Pen Profile Tet Profile Van Profile
Acin. Iwoffii <2 ns <0.5 ns <1 ns 32 ns <2 ns
A. naeslundii <2 ns 1 ns <1 S <2 ns <2 S
A. naeslundii <2 ns 32 ns <1 s <2 ns <2 s
A. naeslundii <2 ns <0.5 ns <1 s <2 ns 256 R
A. viscosus <2 ns 256 ns <1 s <2 ns <2 S
A. viscosus <2 ns 256 ns <1 s <2 ns <2 s
A. viscosus <2 ns 128 ns <1 s 32 ns <2 s
Unspeciated Actinomycete <2 ns >512 ns <1 s <2 ns <2 s
Unspeciated Actinomycete <2 ns >512 ns <1 s <2 ns <2 s
Unspeciated Corynebacterium 8 ns 0.25 ns 16 R <2 ns <2 s
Unspeciated Corynebacterium <2 ns 2 ns <1 s <2 ns <2 s
F. nucleatum <2 S 2 ns <1 s <2 S 256 ns
G. morbillorum >512 ns 0.25 ns >512 ns >512 ns <2 ns
L. casei 8 ns 0.5 ns 8 R 8 ns >512 R
L. casei <2 ns <0.5 ns <1 S <2 S >512 R
L. casei <2 ns <0.5 ns <1 s <2 s 512 R
Unspeciated Lactobacilli <2 ns <0.5 ns <1 s <2 s >512 R
Unspeciated Lactobacilli 4 ns <0.5 ns <1 s <2 s 512 R
Unspeciated Lactobacilli <2 ns <0.5 ns <1 s <2 s >512 R
P. acnes <2 ns 16 ns <1 s <2 s <2 S
P. acnes <2 ns 2 ns 32 R <2 s <2 s
P. micros <2 ns <0.5 ns 16 R <2 s <2 s
R. dentocariosa <2 ns 256 ns <1 s <2 s <2 s
S. capitas >512 R <0.5 S >512 R <2 s 4 s
S. cohnii <2 S 128 R <1 S <2 s <2 s
S. cohnii <2 s <0.5 S <1 s 256 R <2 s
S. hominis <2 s <0.5 S 64 R <2 s <2 s
S. pasteuri <2 s <0.5 s <1 S 128 R <2 s
S. pasteuri >512 R <0.5 s >512 R <2 S <2 s
Resistant strain
MICs of antibiotic (pg/mL)
Amp Profile Ery Profile Pen Profile Tet Profile Van Profile
S. warneri >512 R <0.5 S 512 R <2 S <2 S
S. warneri <2 S 8 R 16 R 16 R <2 S
S. epidermidis <2 s 128 R 2 R 32 R <2 s
S. epidermidis 4 R <0.5 S 8 R <2 S <2 s
Unspeciated staphylococci 16 R 256 R 64 R <2 s <2 s
Unspeciated staphylococci 128 R 128 R <1 S 256 R <2 s
Unspeciated staphylococci 512 R <0.5 S >512 R >512 R <2 s
Unspeciated staphylococci 128 R 0.5 S 512 R >512 R <2 s
Unspeciated staphylococci <2 S 8 R <1 S <2 S <2 s
Unspeciated staphylococci 4 R 2 I 16 R >512 R <2 s
Unspeciated staphylococci <2 S 0.5 S 512 R >512 R <2 s
Unspeciated staphylococci <2 S <0.5 S 8 R 256 R <2 s
Unspeciated staphylococci <2 s <0.5 s 16 R 128 R 512 R
Unspeciated staphylococci <2 s <0.5 s <1 S 128 R <2 s
S. anginosus <2 s 8 R <1 S <2 S <2 s
S. australis 128 R <0.5 s 4 R <2 S <2 s
S. gordonii <2 s <0.5 s <1 S 256 R <2 s
S. gordonii <2 s <0.5 s <1 s 16 R <2 s
S. intermedius <2 s <0.5 s <1 s 256 R 8 ns
S. mitis <2 s 1 R <1 s <2 S <2 S
S. mitis <2 s 1 R <1 s <2 s <2 s
S. mitis 8 R <0.5 s 2 R <2 s <2 s
S. mutans >512 R <0.5 s >512 R >512 R <2 s
S. mutans <2 s 128 R <1 s >512 R <2 s
S. mutans <2 s 128 R <1 s 16 R <2 s
S. mutans <2 s 1 R <1 s 256 R <2 s
S. mutans <2 s <0.5 S <1 s <2 S >512 ns
S. oralis <2 s 256 R <1 s <2 s <2 s
S. parasanguinis 4 I <0.5 S <1 s 256 R <2 s
S. salivarius <2 s 256 R <1 s 32 R <2 s
Resistant strain
MICs of antibiotic (gg/mL)
Amp Profile Ery Profile Profile Tet Profile Van Profile
S. sanguinis 8 R <0.5 S 2 R <2 S <2 S
S. sanguinis <2 S 16 R <1 S <2 S <2 s
S. sanguinis <2 s 1 R <1 S <2 s <2 s
Unspeciated streptococci <2 s 16 R <1 s <2 s <2 s
Unspeciated streptococci <2 s 1 R <1 s <2 s <2 s
Unspeciated streptococci <2 s 2 R <1 s <2 s <2 s
Unspeciated streptococci <2 s 8 R <1 s 256 R <2 s
Unspeciated streptococci <2 s 8 R <1 s 32 R <2 s
Unspeciated streptococci <2 s <0.5 S <1 s >512 R <2 s
V dispar <2 s 16 ns <1 s <2 S <2 ns
V dispar 4 R 16 ns 16 R 128 R <2 ns
V. dispar <2 s 32 ns <1 s <2 s 1 >512 ns
V. parvula <2 s 16 ns <1 s 128 R <2 ns
Amp = ampicillin; Ery = erythromycin; Pen = penicillin G; Tet = tetracycline; Van = vancomycin; ns = no published breakpoints available; S= susceptible; I -  
intermediate; R = resistant (National Committee for Clinical Laboratory Standards, 2003a), (National Committee for Clinical Laboratory Standards, 2003b), (Andrews, 
2005).
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9.3.9 MIC509 MIC90 and resistance defined by published breakpoints
To further analyse the levels of antibiotic resistance within the cohort the isolates 
displaying resistance to the breakpoints used were grouped together in species groups. 
For each group, the MIC at which 50% (MIC50) and 90% (MIC90) of isolates were 
inhibited was calculated. The percentage of isolates resistant to each antibiotic 
according to the breakpoints published by the NCCLS are shown (National Committee 
for Clinical Laboratory Standards, 2003a), (National Committee for Clinical Laboratory 
Standards, 2003b). The percentage of resistant isolates calculated using the British 
Society for Antimicrobial Chemotherapy (BSAC) guidelines are included for 
comparison (Andrews, 2005) . These data are presented in table 9.3.
9.3.9.1 Ampicillin
The data in table 9.3 shows that the MIC50 of ampicillin was <2 pg/mL while the MIC90 
was 128 pg/mL for the antibiotic-resistant bacteria. The range of MICs for ampicillin 
were between <2 to > 512 pg/mL. Resistance to ampicillin when evaluated using 
NCCLS breakpoints was low and only observed in 14 (19.4%) of the antibiotic-resistant 
isolates. Ampicillin-resistant isolates were comprised of 9 CoNS isolates, 4 streptococci 
and 1 Veillonella sp. No other species displayed resistance to ampicillin at the published 
breakpoints.
9.3.9.2 Erythromycin
The range of MICs for erythromycin were <0.5 to >512 pg/ml. Among the antibiotic- 
resistant isolates, the MIC50 of erythromycin was 1 pg/mL and the MIC90 was 128 
pg/mL. When the data was compared to NCCLS breakpoints for resistance it was found 
that 6 isolates of CoNS (30%) and 60% of the streptococci (n = 15) were considered 
resistant to erythromycin; a single isolate of Gemella morbillorum was also resistant to 
this antibiotic. Erythromycin resistance was found in 29.2% of the antibiotic-resistant 
cohort when NCCLS guidelines were applied.
9.3.9.3 Penicillin G
For penicillin the range of MICs was <1 to >512 pg/mL with an MIC50 of <1 pg/mL 
and an MIC90 of 512 pg/mL. Resistance to penicillin using the NCCLS breakpoints 
resulted in 31.9% of the isolates (n = 23) being considered resistant. The isolates
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included CoNS (n = 14), streptococci (n = 4) and single isolates of G. morbillorum and 
Veillonella sp.
9.3.9.4 Tetracycline
Susceptibility to tetracycline was shown by a range of MICs from <1 to >512 pg/mL. 
The MIC50 of the resistant isolates was <1 pg/mL while the MIC90 was >512 pg/mL. 
According to the published breakpoints 26 isolates were considered resistant to 
tetracycline, streptococci and CoNS equally formed 80% of these tetracycline-resistant 
isolates. Tetracycline is not prescribed in the UK for the treatment of bacterial infections 
in children under 12 years of age (British National Formulary, 2005); of the 122 
subjects aged 4.0 to 15.7 years who provided isolates for this assay 112 or 91.8% were 
aged 12 years or under. Of the 10 subjects aged over 12 years, 40% harboured a 
tetracycline-resistant isolate this compares to 20.5% of the under 12’s.
9.3.9.5 Vancomycin
There were low levels of resistance to vancomycin (4.2%), with MICs ranging in value 
between <2 to >512 pg/mL. The MIC50 of vancomycin for the resistant isolates was 
<2pg/mL while the MIC90 was 512 pg/mL. Apart from the intrinsically vancomycin- 
resistant lactobacilli, other resistant isolates included single strains of Staphylococcus 
sp., Streptococcus intermedius and Streptococcus mutans.
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9.3 MIC range, MIC50 and MIC90 o f ampicillin-, erythromycin-, penicillin-, tetracycline- and amoxicillin- resistant isolates
Resistant bacteria
Antibiotic MIC (pg/mL) Frequency of resistance (%)
- Range 50% 90% NCCLS BSAC
Ac in. Iwoffii (n = 1) Ampicillin <2 <2 <2 — 0
Erythromycin <0.5 <0.5 <0.5 — —
Penicillin <1 <1 <1 — —
Tetracycline 32 32 32 — —
Vancomycin <2 <2 <2 — —
A. naeslundii (n =3) Ampicillin <2 <2 <2 — —
Erythromycin <0.5 - 32 1 32 — —
Penicillin <1 <1 <1 — —
Tetracycline <2 <2 <2 — —
Vancomycin <2-256 <2 256 — 1 (33)
A. viscosus (n = 3) Ampicillin <2 <2 <2 — —
Erythromycin 128-256 256 256 — —
Penicillin <1 <1 <1 — —
Tetracycline <2-32 <2 32 — —
Vancomycin <2 <2 <2 — —
Unspeciated Actinomyces (n = 2) Ampicillin <2-8 <2 8 — —
Erythromycin >512 >512 >512 — —
Penicillin <1-16 <1 16 — —
Tetracycline <2 <2 <2 — —
Vancomycin <2 <2 <2 — —
Unspeciated Corynebacteria (n = 2) Ampicillin <2-8 <2 8 — —
Erythromycin 0.5-2 2 2 — —
Penicillin <1-16 <1 16 — 1 (50)
Tetracycline <2 <2 <2 — —
Vancomycin <2 <2 <2 — —
F. nucleatum (n=  1) Ampicillin <2 <2 <2 — —
Erythromycin 2 2 2 — —
Penicillin <1 <1 <1 0 —
F. nucleatum (n = 1) Tetracycline <2 <2 <2 — —
Resistant bacteria
Antibiotic MIC (pg/mL) Frequency of resistance (%)
50% 90% NCCLS BSAC
Vancomycin 256 256 256 — —
G. morbillorum (n = 1) Ampicillin >512 >512 >512 — —
Erythromycin 0.25 0.25 0.25 1 (100)
Penicillin >512 >512 >512 1 (100) —
Tetracycline >512 >512 >512 1 (100) —
Vancomycin <2 <2 <2 — —
Lactobacilli spp. (n = 6) Ampicillin <2-8 <2 8 — —
Erythromycin <0.5-0.5 <0.5 0.5 — —
Penicillin <1-8 <1 8 — —
Tetracycline <2-8 <2 8 — —
Vancomycin 512->512 >512 >512 — 6 (100)
P. acnes (n = 2) Ampicillin <2 <2 <2 — —
Erythromycin <0.5-16 2 16 — —
Penicillin <1-32 <1 32 — 1 (50)
Tetracycline <2 <2 <2 — —
Vancomycin <2 <2 <2 — —
Pepto. micros (n = 1) Ampicillin <2 <2 <2 — —
Erythromycin <0.5 <0.5 <0.5 — —
Penicillin 16 16 16 1 (100) —
Tetracycline <2 <2 <2 — —
Vancomycin <2 <2 <2 — —
R. dentocariosa (n = 1) Ampicillin <2 <2 <2 — —
Erythromycin 256 256 256 — —
Penicillin <1 <1 <1 — —
Tetracycline <2 <2 <2 — —
Vancomycin <2 <2 <2 — —
CoNS (n = 20) Ampicillin <2->512 <2 >512 9(45) —
Erythromycin <0.5-256 <0.5 128 6(30) 8 (40)
Penicillin <1->512 16 >512 14 (70) 14 (70)
Tetracycline <2->512 32 >512 12 (60) 12 (60)
CoNS in = 20) Vancomycin <2-512 <2 <2 1(5) 1(5)
Resistant bacteria
Antibiotic MIC (pg/mL) Frequency of resistance (%)
50% 90% NCCLS BSAC
S. anginosus (n = 1) Ampicillin <2 <2 <2 0 —
Erythromycin 8 8 8 1 (100) 1 (100)
Penicillin <1 <1 <1 1 (100) 1 (100)
Tetracycline <2 <2 <2 0 0
Vancomycin <2 <2 <2 — 0
S. australis (n = 1) Ampicillin 128 128 128 1 (100) —
Erythromycin <0.5 <0.5 <0.5 0 0
Penicillin 4 4 4 1 (100) 1 (100)
Tetracycline <2 <2 <2 0 0
Vancomycin <2 <2 <2 — 0
S. gordonii (n = 2) Ampicillin <2 <2 <2 0 —
Erythromycin <0.5 <0.5 <0.5 0 0
Penicillin <1 <1 <1 0 0
Tetracycline 16-256 16 256 2 (100) 2 (100)
Vancomycin <2 <2 <2 — 0
S. intermedins (n = 1) Ampicillin <2 <2 <2 0 —
Erythromycin 1 1 1 0 0
Penicillin <1 <1 <1 0 0
Tetracycline <2 <2 <2 1 (100) 1 (100)
Vancomycin <2 <2 <2 — 1 (100)
S. mitis (n = 3) Ampicillin <2-8 <2 8 1 (33.3) —
Erythromycin <0.5-1 1 1 2 (66.6) 2 (66.6)
Penicillin <1-2 <1 2 0 1 (33.3)
Tetracycline <2 <2 <2 0 0
Vancomycin <2 <2 <2 — 0
S. mutans (n = 5) Ampicillin <2->512 <2 <512 1 (20.0) —
Erythromycin <0.5-128 1 128 3 (60.0) 3 (60.0)
Penicillin <1->512 <1 >512 1 (20.0) 1 (20.0)
Tetracycline <2->512 256 >512 4 (80.0) 4 (80.0)
Vancomycin <2->512 <2 >512 — 1 (20.0)
S. oralis (n = 1) Ampicillin <2 <2 <2 0 —
Resistant bacteria
Antibiotic MIC (pg/mL) Frequency of resistance (%)
50% 90% NCCLS BSAC
Erythromycin 256 256 256 1 (100) 1 (100)
Penicillin <1 <1 <1 0 0
Tetracycline <2 <2 <2 0 0
Vancomycin <2 <2 <2 — 0
S. parasanguinis (n = 1) Ampicillin 4 4 4 0 —
Erythromycin <0.5 <0.5 <0.5 0 0
Penicillin <1 <1 <1 0 0
Tetracycline 256 256 256 1 (100) 1 (100)
Vancomycin <2 <2 <2 — 0
S. sanguinis (n = 3) Ampicillin <2-8 <2 8 1 (33.3) —
Erythromycin <0.5-16 1 16 2 (66.6) 2 (66.6)
Penicillin <1-2 <1 2 0 1 (33.3)
Tetracycline <2 <2 <2 0 0
Vancomycin <2 <2 <2 — 0
Unspeciated streptococci (n = 6) Ampicillin <2 <2 <2 0 —
Erythromycin <0.5-16 2 16 5 (83.3) 5 (83.3)
Penicillin <1 <1 <1 0 0
Tetracycline <2->512 <2 >512 3 (50.0) 3 (50.0)
Vancomycin <2 <2 <2 — 0
S. salivarius (n = 1) Ampicillin <2 <2 <2 0 —
Erythromycin 256 256 256 1 (100) 1 (100)
Penicillin <1 <1 <1 0 0
Tetracycline 32 32 32 1 (100) 1 (100)
Vancomycin <2 <2 <2 — 0
Veillonella spp. (n =4) Ampicillin <2-4 <2 4 1 (25.0) —
Erythromycin 16-32 16 32 — —
Penicillin <1-16 <1 16 1 (25.0) —
Tetracycline <2-128 <2 128 2 (50.0) —
Vancomycin <2->512 <2 >512 — —
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9.3.10 Comparison between NCCLS and BSAC published breakpoints
The differences between the guidelines published by the NCCLS and by BSAC 
included the organisms which have breakpoints and the value of the breakpoints. 
NCCLS differed from BSAC in that no guidelines were provided for Acinetobacter spp 
and the coryneform bacteria; whereas NCCLS published guidelines for Fusobacterium 
spp, Gemella spp, and peptostreptococci where BSAC did not. For the streptococci 
NCCLS published guidelines for ampicillin, erythromycin, penicillin G and tetracycline 
but not vancomycin; BSAC includes guidelines for erythromycin, penicillin G, 
tetracycline, vancomycin but not ampicillin. Resistance using the NCCLS guidelines 
resulted in 84 incidences (each isolate resistant to each individual antibiotic) of 
antibiotic resistance among the cohort while use of the BSAC guidelines amounted to 
78 incidences.
9.3.11 Multi-resistant isolates
From 228 isolates, 31.6% displayed resistance to one or more antibiotics at the 
breakpoints used. Multi-resistance to two or more antibiotics occurred in 43.1% of these 
bacteria. Figure 9.3 illustrates the numbers of resistant bacteria that displayed multi­
resistance to one or more antibiotics.
Fig. 9.3 Percentage o f multi-resistance among antibiotic-resistant bacteria
1 2  3 4
Number of antibiotics to which resistance shown
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Figure 9.3 shows that multi-resistance to one or more antibiotics was common with 
26.4% of isolates being resistant to 2 antibiotics, 15.3% resistant to 3 antibiotics and 
1.4% resistant to 4 antibiotics. None of the isolates tested were resistant to all five 
antibiotics. Table 9.4 shows the multi-resistance patterns observed in the resistant 
isolates.
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Table 9.4 Multi-resistance among antibiotic-resistant bacteria
Antibiotics Iff fill© Multi-resistant organism
Ampicillin + Penicillin 4 Corynebacterium spp., Staph, warneri, Staph, pasteuri, Strep, australis.
Erythromycin + Penicillin 1 P. acnes.
Erythromycin + Tetracycline 9 A. viscosus, Staph, epidermidis, Strep, mutans (3), 
Strep, salivarius, Strep, mitis, V. parvula.
Erythromycin + Vancomycin 2 F. nucleatum, V. dispar.
Penicillin + Tetracycline 2 epidermidis group staphylococcus.
Tetracycline + Vancomycin 1 Strep, intermedius.
Ampicillin + Erythromycin + Penicillin 1 epidermidis group staphylococcus.
Ampicillin + Erythromycin + Tetracycline 1 epidermidis group staphylococcus.
Ampicillin + Penicillin + Tetracycline 4 epidermidis group staphylococcus (2), G. morbillorum, Strep, mutans.
Ampicillin + Penicillin + Vancomycin 1 epidermidis group staphylococcus.
Erythromycin + Penicillin + Tetracycline 3 epidermidis group staphylococcus, Staph, warneri, V. parvula.
Penicillin + Tetracycline + Vancomycin 1 epidermidis group staphylococcus.
Ampicillin + Penicillin + Tetracycline + Vancomycin 1 L. casei.
31
240
Chapter 9 ~ Antibiotic susceptibility of bacteraemia isolates
9.4 Discussion
9.4.1 Methodology and design of study
As part of the characterisation of the bacteria isolated from the post-extraction 
bacteraemia, determination of antibiotic susceptibility to a panel of commonly used 
(ampicillin, penicillin, erythromycin), infrequently used (vancomycin) and 
contraindicated (tetracycline) antibiotics was performed. The antibiotics selected for 
antibiotic susceptibility testing (AST) were ampicillin, erythromycin, penicillin, 
tetracycline and vancomycin. Ampicillin/amoxicillin, erythromycin and penicillin are 
frequently prescribed for childhood infections (Millar et al., 2001), (Joint Formulary 
Committee., 2005) and therefore the surveillance of carriage of isolates resistant to these 
drugs among children is valuable. Additionally amoxicillin and vancomycin are 
recommended for the chemoprophylaxis of patients at risk of IE and it is therefore of 
interest to screen potential aetiological agents of IE for resistance to ampicillin and 
vancomycin to evaluate the risk of bacteria that are resistant to these chemoprophylatic 
antibiotics entering the bloodstream. Tetracycline was incorporated into the AST panel 
as administration is contraindicated in children under 12; therefore, any resistance 
among bacteria found in young children should not have been acquired through direct 
exposure to antibiotic therapy, but through close contact with family members, pets and 
food consumption (Kononen et al., 1994), (Millar et al., 2001).
An agar dilution method was selected for the determination of susceptibility to the 
antibiotics as it allows accurate MIC determination through careful control of medium 
and inoculum (White et al., 2001). The use of a multipoint inoculator also allowed high 
throughput of isolates, minimising the labour intensity and cost of the agar dilution by 
decreasing the time and amount of media required further maximising the benefits of 
the agar dilution technique (Burman and Ostensson, 1978).
9.4.2 Subjects and isolates
The AST was performed on 228 isolates recovered from asymptomatic bacteraemia 
following dental extractions. The proportions of bacteria assayed are shown in figure 
9.1, and these isolates form a representative cohort of the isolates as discussed in 
chapter 7. A limitation of this study was that not all the isolates recovered from the 
bacteraemia were successfully assayed for susceptibility to the panel of antibiotics. This
241
Chapter 9  ~  Antibiotic susceptibility of bacteraemia isoiates
failure was due to the loss of isolates on thawing of frozen stock cultures, where a 
colony failed to subculture from initial isolation (15.9% of total enumerated bacteria); 
or where the isolate would not grow on the AST media or under the conditions used (30 
isolates).
9.4.3 Resistance at breakpoints used
The majority of the bacteria tested were susceptible to ampicillin, erythromycin, 
penicillin, tetracycline and vancomycin at the breakpoints used with 68.4% from 62 
(50.8%) individuals not carrying antibiotic-resistant bacteria. A large proportion of the 
isolates were however resistant to these antibiotics. The majority of these isolates were 
streptococci (40.5%) or staphylococci (25.3%), interestingly the two most common 
aetiological agents of IE; these organisms accounted for 19.7% of the cohort tested, and 
were isolated from 19% and 20% of the subjects respectively.
9.4.4 Resistance defined by published breakpoints
Of the resistant isolates found, only the CoNS, streptococci, Fusobacterium spp, 
Gemella spp, Acinetobacter spp and Veillonella spp had relevant published MIC 
breakpoints with which to assess the “official” resistance among the cohort. Using the 
guidelines published by BSAC (Andrews, 2005) and the NCCLS (National Committee 
for Clinical Laboratory Standards, 2004), it was found that a maximum of 64 or 28.1% 
of the cohort were resistant to one or more of the antibiotics tested. This lack of 
guidance for determining antibiotic resistance in important agents of IE is disappointing 
and reflects the bias in the guideline towards medically important bacteria, rather than 
dental-related pathogens. There are several different organisations that provide 
information on breakpoints. Typically, breakpoints published by the British Society for 
Antimicrobial Chemotherapy (BSAC) are lower while those released by the American 
National Committee for Clinical Laboratory Standards (NCCLS) are much higher than 
the majority of the European countries. Without agreement between these guidelines it 
is difficult to monitor global trends of antibiotic-resistance (Baquero, 1990).
9.4.5 Carriage of antibiotic-resistant bacteria in study subjects
The high levels of resistance discovered were surprising as the participants of the 
original study were included only where no antimicrobial therapy in the month prior to 
the study was declared by the consenters. The data presented here is also of interest
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because of the levels o f tetracycline resistance shown by the bacteria assayed; 20% of 
isolates from children aged less than 12 years of age were considered resistant to the 
antibiotic using published breakpoints.
It is also important to note that some of the isolates displaying resistance are known to 
be intrinsically resistant to certain antibiotics. For instance, the lactobacilli are known to 
be intrinsically resistant to vancomycin (Facklam, 1989). Other examples of oral 
bacteria that are intrinsically resistant to the antibiotics used include the widespread 
resistance of Gram negative bacteria to glycopeptides (Russell & Chopra, 1990)
The acquisition and persistence of antibiotic resistance determinants in the oral cavity of 
children has been widely studied. It has been shown that children can acquire resistant 
bacteria possessing resistance determinants including tet(M) and tet{W) in the absence 
of selective pressure such as receiving the antibiotic (Millar et al., 2001), (Lancaster et 
ah, 2003). The transfer of genetic elements between members of the oral microbiota, 
such as the oral streptococci is also well documented (LeBlanc et al., 1978), (Roberts et 
a l, 2001) and (Villedieu et al., 2003).
It is important to evaluate these data in the context of similar studies. There are however 
few comparable studies with which to perform this evaluation. Similar work included a 
study performed to evaluate the need for antibiotic prophylaxis prior to routine dental 
extractions for children with cardiac abnormality. Streptococcal isolates were identified 
from whole blood samples from 15 children and subjected to AST with penicillin, 
amoxicillin and erythromycin. The MIC range for penicillin was from 0.01 to 2.0 mg/L 
and between 0.01 to 4.0 mg/L for erythromycin (Coulter et al., 1990). In comparison, 
the streptococci isolated during this study had MIC ranges of <1 to >512 pg/mL for 
penicillin and <0.5 to 256 pg/mL for erythromycin indicating much higher levels of 
antibiotic resistance among these isolates compared to the results of the previous study.
In a later study investigating dental bacteraemia in children, 20% of oral streptococci 
were described as resistant to erythromycin (0.5 mg/L), 26% to penicillin G (0.1 mg/L) 
and 3% to vancomycin (4.0 mg/L). Of the staphylococci, 28% were resistant to 
erythromycin and penicillin G; exact MICs were not given (Roberts et al., 1998). If 
evaluated using the breakpoints in the comparable publication, 15 (16.7%) of assayed
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streptococci would be resistant to erythromycin, 2 (2.2%) to penicillin G and 
vancomycin. Of the staphylococci 7 (20.6%) would be resistant to erythromycin, 12 
(35.3%) to penicillin G and 2 (5.9%) to vancomycin. Comparison of the data presented 
in this section with this published data indicates that resistance among the streptococci 
was similar but that resistance of the staphylococci to penicillin G and vancomycin was 
much higher among our cohort. Unfortunately, the differences between the present and 
previous study methodologies are too large to draw any firm conclusions from 
comparison of the data.
Other studies have been performed using similar AST methodology on paediatric 
isolates of the oral microbiota (Ready et al., 2003), (Lancaster et al., 2003), (Pike et al., 
2002). A study was performed which isolated antibiotic-resistant bacteria from the 
plaque of healthy children who had not received antibiotics in the preceding 3 months 
(Ready et al., 2003). It was found that all 35 children sampled harboured bacteria 
resistant to ampicillin or erythromycin, and 97% of the children carried penicillin- or 
tetracycline-resistant bacteria, but none of the Gram-positive bacteria isolated were 
resistant to vancomycin. The study also showed high levels of multi-resistance 
displayed by the isolated bacteria; for example of the 14 ampicillin-resistant bacteria, 
16.2% were additionally resistant to erythromycin, 60.4% to penicillin and 11.7% to 
tetracycline. The isolation method of this study was very different to the present study 
and the subjects from whom the plaque was sampled were healthy children whereas the 
present study involved the sampling of blood from children undergoing between one 
and twenty extractions of carious teeth. Comparison between the two studies is however 
important as it illustrates that high levels of antibiotic-resistant bacteria can be readily 
isolated from various groups of children; those considered healthy and those attending 
for dental treatment.
The children included in the current study from whom these bacteria were isolated, were 
attending the hospital for extractions of 1 to 20 teeth due to carious lesions. The bacteria 
commonly associated with caries formation and development (Marchant et al., 2001) 
are also frequently described as possessing and transferring antibiotic resistance 
determinants; it is possible therefore that these children would harbour more antibiotic- 
resistant bacteria than would similar children without carious lesions.
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The data presented here and the studies detailed show that antibiotic resistance is 
common place among the oral microbiota of children (Millar et al., 2001), (Lancaster et 
al., 2003). As this thesis is primarily concerned with the characterisation of paediatric 
odontogenic, bacteraemia it is also important to discuss antibiotic resistance detected 
among these isolates in terms of the prophylaxis and treatment of endocarditis.
9.4.6 Antibiotic-resistant bacteraemia isolates and infective endocarditis
Although considered by many authors to be blood culture contaminants (Washington 
and Ilstrup, 1986), many of the antibiotic-resistant oral microbiota described in this 
section have been isolated as the aetiological agents of IE from children and adolescents 
(Vanagt et al., 2004), (Malik, 1995), (Stuart and Wren, 1992), (Reacher et al., 2000). As 
there is a risk that such isolates cause IE, it is important to know if such bacteria are 
susceptible to antibiotic prophylaxis. The most widely recommended prophylactic drug 
for dental procedures is amoxicillin which has the same mode of action and spectrum of 
activity as ampicillin (Joint Formulary Committee., 2005). Of the 228 isolates assayed, 
6.1% were resistant to 8 pg/mL of ampicillin which would indicate therefore that at 
least 6.1% of the bacteraemia events in this study would not have been covered by the 
recommended prophylaxis for IE. Indeed there have been many recorded instances of 
failed antibiotic prophylaxis or IE with resistant strains of bacteria (O'Sullivan et al., 
1996), (Hall and Baddour, 2002), (Huang et al., 2002). It is however important that 
these events are placed into proper perspective.
It has been discussed in the literature that iatrogenic dental bacteraemia as individual 
events are unlikely to precipitate IE. Where IE is caused by a bacterium which is an 
indigenous oral microorganism, the source is most likely to be a chronic seeding of the 
blood due to poor oral hygiene and decreased oral health (Guntheroth, 1984), (Roberts, 
1999).
In conclusion, although awareness of the resistance among these bacteria is important 
for the study and surveillance of antibiotic resistance amongst the population, it has 
little bearing on the clinical management of patients with or without predisposition to IE 
as the best course of defence is scrupulous attention to oral health.
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9.5 Conclusions
•  The use of multipoint inoculation technology facilitates and increases the 
efficiency and throughput of bulk antibiotic sensitivity testing.
• Selection of an antibiotic sensitivity testing medium which supports a diverse 
cohort of fastidious organisms is difficult.
• Children that have not recently received antibiotic treatment still harbour 
antibiotic resistant bacteria.
• Tetracycline resistant bacteria can be isolated from children for whom 
tetracycline use is contraindicated; highlighting that antibiotic resistant 
determinants can be acquired from the environment.
• Levels of antibiotic resistance among the cohort were low, however 6.1% of 
these subjects experienced odontogenic bacteraemia which would not have been 
covered by current prophylactic regimen.
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The Lysis Filtration technique (LF) was used to investigate the pre- and post-extraction 
blood samples of 500 children undergoing dental extraction. The subjects included in 
the study were found to have statistically significant bacteraemia from around 10 s to 4 
min post-extraction; the highest prevalence of bacteraemia occurred at 1 min post 
maximal dental manipulation. Prevalence amongst baseline, pre-extraction samples was 
much higher than anticipated at 18.8%. The culture-positive samples may have been the 
result of either idiopathic transient bacteraemia, iatrogenic bacteraemia caused during 
patient intubation or as a result of sample contamination at some point between 
venupuncture and the end of the sample incubation period.
The intensity of odontogenic bacteraemia ranging from 0 to 245 cfii/mL, was also 
statistically significant between 10 s and 4 min post maximal dental manipulation; 
supporting the prevalence data.
Data from the 1 minute subjects was selected for analysis of correlations between dental 
factors and intensity of bacteraemia because bacteraemia was most prevalent at this time 
point. No relationship was found between subject ages, number of teeth extracted and 
dental indices for plaque and gingivitis. The lack of correlation between patient factors 
and the intensity of bacteraemia would suggest that the incidence and intensity of 
odontogenic bacteraemia are determined by some other factor.
The low magnitudes of bacteraemia indicate that LF is a sensitive technique which is 
valuable for quantitative studies of bacteraemia. LF also allows the growth and 
enumeration of several organisms from one sample, and removes bacteria from 
antibacterial properties of blood and media. Conventional broth bottle systems which 
are indicated as positive, need sub-culturing, do not allow the quantification of 
individual species, and indeed are prone to allow the competition of bacteria and 
antibacterial action within the sample thus obscuring the detection and identification of 
bacteraemia. It must be remembered however, that while LF is an effective method for 
the detection and enumeration of transient bacteraemia among study subjects, it is not 
suitable for the routine analysis of blood cultures. Clinical microbiology laboratories
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require an automated, low-labour detection system; needs which could not be met by 
LF.
Identification of the bacteria recovered from the post-extraction bacteraemia revealed 
that all identified bacteria were species commonly isolated from the oral cavity. The 
majority of the species involved were streptococci and Actinomyces spp.; which 
accounted for between 50 and 67.8% of all identified bacteraemia isolates recovered 
between 10 s and 4 min post maximal dental manipulation.
The species diversity of the post-extraction bacteraemia showed a similar trend of 
involving more species between 10 s and 4 min post-extraction than during pre­
extraction bacteraemia and after 7.5 min post-extraction. The species richness data, 
combined with the statistically significant prevalence and intensity of bacteraemia show 
that at an undefined point around 7.5 min post-extraction, the immune system appears to 
clear the invading oral bacteria from the bloodstream.
The identification of odontogenic bacteraemia isolates was expected to pose many 
problems due to the number of fastidious bacteria that are known to exist among the 
oral microbiota. Originally, bacteria were to be speciated by means of Gram-stain, 
respiration, possession of catalase and oxidase and by use of a range of biochemical 
assays. It quickly became clear that a simplistic approach would prove both inaccurate 
(for speciation purposes) and provide too little information about the bacteria involved 
in the post-extraction bacteraemia.
A major draw-back of using phenotypic identification methods was the inability to 
select the correct tests to differentiate the bacteria. For example all Gram-positive, 
catalase negative cocci were originally classified as streptococci, but it later emerged 
that among these isolates were Gemella spp and Abiotrophia spp which could not be 
easily differentiated from the streptococci and any enterococci or Granulicatella spp 
that may be isolated. Additionally, it was found that the profiles generated using the 
carbohydrate fermentation and hydrolysis and the detection of pre-formed enzyme 
assays were often not reproducible or did not conform to those of published data. This 
was true of both reference and wild-type strains. As the desire was to characterise the 
bacteraemia isolates as fully as possible in order to gain as much information as
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possible about paediatric odontogenic bacteraemia, it was decided to approach 
identification by use of a genotypic method.
The use of comparative 16S rRNA gene sequencing during this study revolutionised the 
identification of the bacteraemia isolates and quickly showed that speciation using the 
method would lend greater power to the results. By identifying as many bacteria as 
possible to species level, close comparison of the pre-extraction and post-extraction 
bacteraemia was allowed. For example, if a catalase-negative, Gram-positive coccus 
was isolated from both pre- and post-extraction samples and was not fully speciated, the 
post-extraction sample could be assumed to be identical to the pre-extraction sample, 
whereas full speciation might reveal involvement of two different species. Full 
speciation of the isolates allowed trends in persistence over time to be identified; for 
example between 10 s and 4 min post-extraction, the predominant species isolated were 
identified to be Actinomyces spp and streptococci, after this point the oral microbiota 
recovered resemble the composition of the baseline pre-extraction isolates including 
coagulase-negative staphylococci (CoNS).
Comparative 16S rRNA gene sequencing enabled the majority of isolates to be 
identified to species level. There remained however, problems in the differentiation of 
some of the closely related species of the genera Staphylococcus and Streptococcus. It 
was of particular interest to fully speciate the streptococci, because they are classic 
members of the oral microbiota and they are frequently implicated as the aetiological 
agents of IE. Full characterisation of these isolates is also important because different 
species of streptococci are traditionally considered more pathogenic than others; for 
example, S. mutans and S. sanguinis have been shown to possess virulence factors 
which increase their pathogenicity for the host (Douglas, 1994), (Banks et al., 2002).
Although comparative 16S rRNA gene sequencing had been invaluable to the 
identification of the isolates, it lacked discriminatory power for the streptococci, 
specifically the mitis group streptococci which can share up to 99% homology 
(Kawamura et al., 1995). The sodA gene had been identified as an alternative genetic 
target with which to identify the streptococci and other Gram-positive bacteria such as 
the staphylococci, enterococci and Mycobacterium spp.
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Laboratory constraints including funding and competition for equipment encouraged the 
search for an alternative characterisation method to gene sequencing; therefore, 
development of a PCR-RFLP method based on the previously published successful 
comparative sodA gene sequencing method of identification was pursued (Poyart et al., 
1995; Poyart et al., 1998). Initially, the published amplification protocol failed to result 
in amplicons, which led to a need to optimise the protocol for the needs of the study. 
Finally, the thermocycling parameters and proportions of the reagents in the PCR 
master mix were optimised to generate sufficient product for the protocol.
A limitation of the sodA PCR-RFLP method was selecting and sourcing the strains to 
include in the study. It was decided to include all isolates which had been successfully 
identified using comparative 16S rRNA gene sequencing and recently described species 
such as & peroris, S. infantis, S. australis, and S. sinensis. Unfortunately, it was not 
possible to obtain a sample o f S. sinensis as it was not available from the National 
Collection of Type Cultures (NCTC) at the time and which could not be obtained from 
the author who had initially described it. S. thermophilus and several mutans 
streptococci were not included in the study as these strains were either rarely isolated in 
the department or because no speciation problems existed.
On commencement of the RFLP stage of the study, it was necessary to optimise the 
concentration and grade of agarose as some band sizes were found to be smaller than 50 
bp in size; much smaller than the resolution capabilities of standard agarose. TBE was 
used instead of the laboratory standard TAE as an electrophoresis buffer due to its 
reported efficacy for resolution of small fragments (Miura et al., 1999). A special DNA 
marker (HyperLadder V) was selected which ranged from 25 bp to 500 bp.
Overall, 71.7% of the clinical isolates subjected to the sodA PCR-RFLP method were 
identified to species level compared to only 55.1% using 16S sequencing. The 
remaining isolates that did not match a type strain profile were often deemed to be 
variants of existing profiles (probably the result of sequence mutation, deletion or 
improper digestion); such conclusions were made by comparison of band sizes and 
existing comparative 16S rRNA gene sequencing data.
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The data arising from the biochemical characterisation, comparative 16S rRNA gene 
sequencing and the sodA PCR-RFLP technique were collated and identities assigned to 
the bacteraemia isolates. All of the bacteria that were identified had previously been 
described as members of the oral microbiota, unfortunately the composition of the 
isolated cohort revealed that the detection method used had an inherent bias toward 
Gram-positive, facultative anaerobic bacteria. The cohort consisted of 93.8% Gram- 
positive bacteria and 6.2% Gram-negative bacteria; a trend toward Gram-positive 
bacteria was anticipated as the oral microbiota of children tends to contain many such 
species, and as the subjects were having teeth removed due to rampant caries a 
predominance of streptococci, Actinomyces spp and lactobacilli was expected. The tiny 
minority of Gram-negative species was of concern. Gram-negative species that were 
expected but not isolated included Actinobacillus actinomycetemcomitans, Haemophilus 
aphrophilus, Eikenella corrodens, Campylobacter spp, Capnocytophaga ochracea, 
Porphyromonas gingivalis and Tannerella forsythensis. The absence of these species 
was partially attributed to the alkaline pH of the lysis solution and/or the inclusion of 
SPS into the collection medium and it was hypothesised that the predominance of the 
Gram-positive species related to the colonisation of the gingival margin of the extracted 
teeth with predominantly cariogenic species.
It was also found that only 1.9% of the bacteria could be considered obligate aerobes 
(Acinetobacter spp, Kocuria spp and Neisseria spp) while 3.0% were considered strict 
anaerobes (Bifidobacterium sp, Fusobacterium spp, Peptostreptococcus spp and 
Veillonella spp). Which meant that over 87.2% of isolates were facultative anaerobes 
(not including isolates which were unrecovered). Although the majority of bacteria were 
expected to be facultative anaerobes as the majority were likely to be streptococci and 
Actinomyces spp, the lack of obligate aerobes and strict anaerobes was surprising. 
Again, this was partly explained by the age of the subjects but may also be due to the 
detection system used. In previous studies which have used LF, filtration has been 
performed in an anaerobic chamber under a continuous flow of sterile nitrogen; this part 
of the technique were not possible due to lack of space in the anaerobic chamber, but 
may well have increased the detection of strict anaerobes and decreased the loss of 
isolates on initial sub-culture.
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The infrequent isolation of strict anaerobes, the levels of filter contamination and low 
magnitude of the odontogenic bacteraemia would support consideration of a change in 
methodology. A single 6 mL sample was added to lysing solution and distributed 
approximately between two filters; one incubated aerobically the other anaerobically. 
The low incidence of aerobic isolates using this method would suggest that by not 
splitting the sample and incubating a single filter anaerobically, more isolates and less 
contamination would be supported.
It was also postulated that the choice of media to which the filters were applied 
influenced the microbiota detected. Brain heart infusion agar supplemented with blood 
is well known to support the growth of fastidious organisms such as those of the oral 
microbiota, it is unknown however if this medium was sufficiently reduced to support 
the growth of strict anaerobes. Given the large number of species reportedly inhabiting 
the oral cavity however, it would be very difficult to provide selective media to support 
all of the species which may have been isolated from the bacteraemia. A possible 
development of the protocol could be the use of an anaerobe agar, such as 
Bioconnection’s fastidious anaerobe agar (http://www.bioconnections.co.uk/) which has 
been specifically formulated for the primary isolation of fastidious strict anaerobes and 
which contains additional reducing agents, menadione and bio-available haemin.
Another methodological consideration was the checking of filter plates. This was 
performed daily from the third to the tenth day of incubation where possible; the 
contamination of filter plates was believed to stem from this protocol and may well 
have contributed to loss of isolates on initial subculture. An improvement on the 
protocol would have been to avoid examination of the plates until 7 to 10 days of 
incubation.
Therefore the use of culture-based methods in the detection of oral bacteria are 
disadvantaged because it is not possible to formulate a medium or provide the 
atmospheric conditions that favour the growth of all the organisms of interest; there are 
also bacteria that are difficult or as yet not cultivable using standard culture-based 
detection methods. For these reasons, it was desirable to analyse parallel blood samples 
with a molecular technique in order to gain more information about the bacteria 
involved in paediatric odontogenic bacteraemia.
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In the absence of a specific protocol, a scaled down sample representing 1/6 of the 
sample used in the LF study was prepared at the same time as the LF study samples. 
The original intentions were to perform denaturing gradient gel electrophoresis 
(DGGE), using amplicons from the amplification of the 16S rRNA gene from DNA 
extracted from the parallel samples. Unfortunately, the use of the parallel samples in a 
molecular detection protocol was fraught with difficulty.
Initially, DNA was extracted from the parallel samples using a commercially available 
extraction kit; following the initial round of 16S rRNA PCR protocol however, no 
bands corresponding to the expected size (1.5 kb) were visualised using the gel 
electrophoresis ethidium bromide technique. This absence of amplicons, even from the 
culture-positive samples may have occurred because of an absence of DNA template, 
low sensitivity of the PCR protocol or inhibition of the PCR reaction.
The possible reasons for the failure of the PCR were approached systematically; 
spectrophotometry and amplification of the GAPDH gene proved that there was 
abundant DNA extracted but did not provide information about the presence of bacterial 
DNA. As DNA had been isolated from the samples and 50% of the samples were 
known to contain bacteria from the culture studies, the possibility of PCR inhibition was 
considered.
The components of the parallel samples were human blood and sodium polyanethole 
sulfonate (SPS) an additive used to prevent the antibacterial action of blood. It was 
subsequently discovered that SPS was a potent inhibitor of PCR and that it co-purified 
with DNA during extraction (Fredricks and Reiman, 1998). Attempts were then made to 
extract and purify bacterial DNA from whole blood with SPS added, seeded with Gram- 
positive and Gram-negative bacteria. The commercial kit was compared with a 
published method which described the successful extraction and assay for removal of 
SPS from whole blood samples. Although the commercial method extracted greater 
quantities of DNA from blood not supplemented with SPS, than the published method, 
the latter was more successful in extracting DNA in the presence of SPS.
It was found that SPS was being removed sufficiently by both the commercial and the 
published method but that the published method resulted in a loss of PCR sensitivity
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that was crucial to the detection of low intensity and culture-negative bacteraemia. The 
problem therefore remained the sensitivity of the PCR protocol rather than the efficacy 
of the extraction method.
Culture-positive patients had a minimum detectable intensity of 0.16 cfu/mL; therefore, 
if a cfu was equal to 1 bacterium, the molecular approach would need to be able to 
detect the presence of very few copies of the 16S rRNA gene. To this end, the use of 
nested PCR was trialled. An inherent problem of the use of the 16S rRNA gene 
amplification of bacteria however is linked to the ubiquity of the gene among all 
bacteria. Protocols based on the amplification of this gene therefore, are prone to 
contamination from environmental and amplicon “carry-over” contamination.
It became impossible to perform nested PCR using 16S rRNA primers without 
encountering DNA contamination o f the negative control, despite the introduction of a 
Sau3AI decontamination procedure, the use of separate pipettes fitted with expensive 
sterile, filter pipette tips and the use of separate rooms for the preparation of DNA, 
preparation of PCR samples, template amplification and electrophoresis of amplicons. 
Only one round of nested PCR was successfully performed without the occurrence of a 
false negative result. The continual failure of this protocol was attributed to a number of 
factors. These included the likelihood that the local environment was contaminated with 
amplicon carry-over (comparative 16S rRNA gene sequencing was used extensively 
within the department at the time), the contamination of Taq polymerase with bacterial 
DNA and the inherent over-sensitivity of the PCR protocol that was necessary to detect 
low copy numbers of the target gene. It was decided therefore, that the molecular 
detection of the odontogenic bacteraemia should be abandoned in the absence of a 
reliable protocol.
As part of the characterisation of the bacteria isolated, determination of antibiotic 
susceptibility to a panel of commonly used (ampicillin, penicillin, erythromycin), 
infrequently used (vancomycin) and contraindicated (tetracycline) antibiotics was 
performed on 228 isolates recovered from asymptomatic bacteraemia following dental 
extractions.
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The bacteria assayed formed a representative cohort of the isolates but did not include 
all the isolates initially recovered from the bacteraemia. The reasons for this included 
the gradual loss of some isolates during thawing or sub-culture and the failure of a 
further group of isolates to grow on the AST medium. The study was further limited by 
a lack of guidelines for break-points for some of the isolates tested. Primarily the desire 
was to assay levels of antibiotic resistance among the streptococci and CoNS isolates, as 
it is these species that are most frequently associated in the aetiology of IE. It was also 
important however, to assess the levels of antibiotic resistance among all bacteraemia 
isolates, because once entry to the bloodstream has been achieved, any bacterium has 
the potential to generate a serious systemic infection.
According to the breakpoints published by the NCCLS, it was found that a maximum of 
64 or 28.1% of the cohort were resistant to one or more of the antibiotics tested. 
Bacteria that are intrinsically resistant to an antibiotic were also included in these data 
because such organisms can complicate the prophylaxis and treatment of infection. The 
high levels of resistance discovered were surprising as the participants of the original 
study were included only where no antimicrobial therapy in the month prior to the study 
was declared by the consenters. Of considerable interest were the levels of tetracycline 
resistance shown by the bacteria assayed as 20% of the isolates were from subjects aged 
less than 12 years of age amongst whom tetracycline prescription is contraindicated. 
Such resistance indicates that these subjects, must have acquired antibiotic-resistant 
bacteria from their environment either by vertical transfer from their parents or by 
consumption of food or contact with other children harbouring the bacteria.
It was also of interest that of the 228 isolates assayed 6.1% were resistant to 8 pg/mL of 
ampicillin. The beta-lactam antibiotics are widely prescribed for childhood infections 
and the acquisition of antibiotic-resistance determinants is common place among oral 
bacteria such as the streptococci, therefore these levels of resistance were not surprising. 
Ampicillin-resistance is important in the spectrum of odontogenic bacteraemia since 
this antibiotic has the same mode of action and spectrum of activity as amoxicillin, the 
most widely recommended prophylactic drug for dental procedures. The level of 
ampicillin-resistant bacteria detected here would indicate therefore that at least 6.1% of 
the bacteraemia events in this study would not have been covered by the recommended 
prophylaxis for IE.
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The low grade nature of post-extraction bacteraemia and the rate at which the post­
extraction bacteraemia was eliminated in this study supports previously published 
opinions which contest that dental extraction and other oral surgical procedures are 
responsible for cases of IE. IE, even where the aetiological agent is considered part of 
the normal oral microbiota, is more likely to be caused by a continual “seeding” of the 
blood from chronic oral conditions than from singular events such as dental extraction. 
This is supported by the pre-extraction bacteraemia shown in this study of 18.6%; 
which equates to almost 1 in 5 subjects with a detectable asymptomatic bacteraemia. 
These theories are also supported by the time elapsed between extraction and onset of 
symptoms. Although not definitive, the incubation period of IE is believed to be up to 
14 days. Many reports in the literature however include dental treatment carried out up 
to one year before the onset of disease.
In summation, the data presented and discussed in this thesis aid understanding of the 
bacteraemia that can be elicited during dental procedures such as multiple extraction. 
The prevalence of pre-extraction bacteraemia combined with the low level intensity of 
post-extraction bacteraemia and the rapid elimination of the bacteria from the 
bloodstream, support the growing trend in the literature that the incidence of IE 
following dental procedures is both overestimated and poorly understood. It is hoped 
that the work generated during this thesis will help provoke further debate and research 
into odontogenic bacteraemia and the promotion of better dental health, not just for 
children with congenital or acquired cardiac disorders, but also for the general populace.
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